data_6qam_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6qam _Structure_validation_residue.Date_analyzed 2020-01-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.757 0.313 . . . . 73.32 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.964 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.02 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.889 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 74.43 111.127 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.3 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 71.05 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.21 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 60.04 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 64.11 110.898 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.24 111.147 179.874 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.863 0.363 . . . . 73.53 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.43 111.161 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 61.14 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.05 111.132 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 75.44 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.24 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 75.34 111.141 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 52.3 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.13 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.35 111.143 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.51 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 74.11 110.865 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.04 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.34 111.091 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.4 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.15 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.877 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.771 0.319 . . . . 61.11 111.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.125 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.904 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.973 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.938 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.699 0.761 . . . . 74.4 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 73.13 112.335 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.44 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 72.1 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.05 111.113 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.31 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 73.41 111.161 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.53 112.462 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 75.14 110.857 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.676 . . . . 74.04 111.148 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 74.22 112.315 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.4 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.94 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.53 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 54.55 112.479 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 74.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.932 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.338 . . . . 74.54 110.915 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 63.3 110.847 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.5 110.891 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.88 0.371 . . . . 75.41 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.139 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.958 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.22 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.42 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 74.14 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 53.22 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.21 111.109 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.44 110.889 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.77 0.319 . . . . 75.24 110.933 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 72.05 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.54 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.084 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.095 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.11 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.11 110.877 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.32 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 70.23 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.133 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.369 . . . . 75.13 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 64.32 110.921 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.11 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.43 110.893 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 61.15 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 73.34 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.14 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.42 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.32 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 74.14 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 74.22 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.54 110.897 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.1 111.198 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 75.32 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.13 110.925 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 72.42 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.21 112.448 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.752 0.311 . . . . 64.4 111.139 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.119 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.42 110.904 -179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.656 0.741 . . . . 64.4 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.01 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.15 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.01 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.54 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 75.22 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.43 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.44 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.44 112.451 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.638 0.732 . . . . 71.32 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 72.13 112.356 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.42 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 65.41 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.12 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.31 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.903 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.744 0.306 . . . . 74.44 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.41 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 64.42 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.111 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.907 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.776 0.322 . . . . 73.03 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.942 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.771 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.55 110.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.54 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.12 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 62.13 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.42 110.91 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.77 0.319 . . . . 71.51 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.04 112.504 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.45 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.875 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.105 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 64.12 111.13 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.42 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.13 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 71.45 111.173 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 71.02 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 74.12 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 75.33 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.13 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 72.3 111.116 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 74.25 111.105 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.03 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 75.53 110.884 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.105 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.119 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.42 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.887 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.42 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 65.43 112.509 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.793 0.33 . . . . 73.23 111.076 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 73.25 110.941 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.886 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.935 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.676 0.75 . . . . 73.41 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 61.31 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.967 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.52 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 74.12 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 63.01 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.13 111.163 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.01 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.43 110.879 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 75.34 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.33 112.343 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 73.05 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.24 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 62.24 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 71.33 112.471 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 74.34 110.865 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 70.53 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.14 110.947 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 73.24 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.52 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 74.23 110.866 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.23 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 64.41 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 74.12 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.3 111.147 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.45 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 64.41 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.929 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 62.14 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.34 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.31 110.955 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 75.44 111.084 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.54 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.94 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.751 0.31 . . . . 72.44 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.21 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.11 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.24 110.892 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 71.51 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 75.4 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.33 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.35 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.01 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.123 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.903 0.383 . . . . 74.04 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.15 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.55 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 73.21 111.142 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.32 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.935 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.1 111.154 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 62.35 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.04 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 72.22 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 70.1 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 74.02 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.05 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 73.53 111.174 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 61.42 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.11 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 71.4 110.878 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.875 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.34 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.35 112.559 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.668 0.271 . . . . 73.34 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.21 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 72.11 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.52 110.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.43 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.914 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.585 0.707 . . . . 72.34 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.12 112.372 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.45 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 70.41 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 72.22 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.44 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 74.53 111.138 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 74.5 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 74.21 110.864 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.55 0.691 . . . . 73.3 111.146 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 74.33 112.378 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.31 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.33 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.51 111.07 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.23 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.13 110.946 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.99 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.791 0.329 . . . . 74.33 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.24 110.901 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.91 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.32 111.177 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.87 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 70.01 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 64.32 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 74.11 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.44 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 54.5 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.03 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.3 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.3 110.927 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.779 0.323 . . . . 71.23 110.918 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.936 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.32 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 70.44 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 60.43 111.114 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.849 0.357 . . . . 71.11 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 75.45 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.14 111.103 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 75.42 111.113 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 72.43 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.52 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.22 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.42 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 73.25 110.831 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.43 112.459 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.767 0.318 . . . . 71.32 111.09 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.102 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 75.22 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.961 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 64.11 110.929 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.671 0.748 . . . . 73.32 110.866 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 71.5 111.111 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.3 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 64.41 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 65.1 112.522 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.41 110.941 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.579 0.705 . . . . 72.45 111.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.2 112.369 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.54 111.118 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 75.12 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.896 -179.872 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.725 0.298 . . . . 74.24 110.975 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.35 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.43 111.071 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.876 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.736 0.303 . . . . 73.25 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.1 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 65.42 110.948 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.53 110.861 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 71.24 110.941 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.23 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 71.03 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.961 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 62.41 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 75.41 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.878 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.78 0.324 . . . . 73.13 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 42.33 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.41 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 75.31 111.157 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 63.2 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 62.14 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 75.24 111.102 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.857 0.361 . . . . 75.45 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.22 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 64.42 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.05 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 74.12 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 75.03 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.45 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.23 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 71.12 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.03 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 75.43 111.094 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 74.2 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 72.14 110.876 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.1 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 71.13 112.409 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 74.52 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.4 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.42 110.966 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 74.51 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 74.41 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.15 110.932 -179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.676 0.75 . . . . 75.34 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.34 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 74.34 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 74.32 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.4 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.24 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.34 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 74.2 110.861 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.56 0.695 . . . . 72.22 111.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 70.22 112.351 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.11 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.21 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 71.03 111.082 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.24 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 62.42 110.861 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.2 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.12 110.924 -179.875 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.715 0.293 . . . . 74.22 110.958 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.915 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.893 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.855 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 71.34 111.177 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.863 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.779 0.323 . . . . 75.31 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.33 111.157 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.88 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.22 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.14 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 64.13 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.13 110.917 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.42 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.897 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.746 0.308 . . . . 71.02 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.903 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.11 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 75.05 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.33 111.153 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.42 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.43 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 72.34 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 73.21 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.31 111.105 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.931 0.396 . . . . 74.24 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 73.12 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.24 110.915 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.54 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.141 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.12 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.887 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.155 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 65.4 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.24 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.163 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.11 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 111.095 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.818 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.04 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.53 112.499 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.757 0.313 . . . . 73.52 111.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.41 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.908 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.948 -179.859 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.671 0.748 . . . . 75.42 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 75.12 112.337 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 75.13 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.18 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.2 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.44 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.11 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.33 111.068 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 63.2 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.34 110.819 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.564 0.697 . . . . 73.35 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.32 112.276 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 73.35 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 72.41 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 70.41 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 75.32 110.914 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.932 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.725 0.298 . . . . 74.12 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.21 110.914 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.44 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.846 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 73.13 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 70.02 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 73.44 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.14 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 63.45 111.097 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 75.35 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.54 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.3 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.11 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 72.4 111.096 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.119 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.22 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.21 110.874 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.44 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.107 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.852 0.358 . . . . 72.02 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.54 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.916 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 63.12 110.87 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.092 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 73.14 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 72.23 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.01 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 65.03 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.12 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.33 111.149 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 73.55 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 74.44 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.53 112.52 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.749 0.309 . . . . 73.24 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.45 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 70.15 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.34 110.894 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.876 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.704 0.764 . . . . 74.43 110.954 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.51 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.52 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.21 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.52 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 54.33 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 71.52 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.13 111.171 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 72.23 110.923 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 121.573 0.702 . . . . 73.54 111.094 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.54 112.314 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.45 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.201 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 44.54 112.451 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.32 110.894 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.947 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.82 0.343 . . . . 75.24 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.02 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 72.11 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 72.45 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.136 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.896 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 74.15 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 74.43 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.957 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.15 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 71.12 112.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 74.05 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.841 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.34 111.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.761 0.315 . . . . 73.1 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.32 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.5 111.168 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.14 111.147 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.861 0.363 . . . . 74.55 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.41 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.11 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.1 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.12 111.083 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.42 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.35 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.111 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 64.04 111.151 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.12 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.34 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.52 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.34 112.523 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.756 0.313 . . . . 63.02 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 75.35 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.41 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.13 110.886 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.32 110.883 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.989 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.655 0.741 . . . . 73.11 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.11 112.378 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 72.21 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.42 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.34 111.106 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.43 112.5 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.34 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.15 110.885 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 121.622 0.725 . . . . 73.34 111.158 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 71.1 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.904 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.04 111.166 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 72.31 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.14 110.857 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.53 110.93 -179.857 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.859 0.361 . . . . 74.35 110.854 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 73.12 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.43 110.915 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.13 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.3 111.133 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.868 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 75.12 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.32 111.156 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 74.34 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.53 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 74.4 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.31 111.08 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.53 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.752 0.311 . . . . 61.13 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.15 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 60.12 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 75.53 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.33 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 71.4 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 71.12 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 72.21 111.128 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.84 0.352 . . . . 71.14 111.117 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.31 111.219 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.43 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.137 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.075 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.887 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 71.2 110.862 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.51 111.147 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.33 111.082 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.137 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.857 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.858 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 63.41 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.13 112.528 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.809 0.338 . . . . 62.22 111.12 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.15 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.96 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.894 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.665 0.745 . . . . 74.52 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.44 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.24 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.52 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.1 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 70.54 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.01 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 62.32 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.52 110.893 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.573 0.702 . . . . 71.53 111.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 74.53 112.324 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.33 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.2 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.01 111.146 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.2 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.53 110.877 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.873 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.959 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 74.23 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 73.33 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.54 110.87 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.05 110.909 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.21 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.33 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.126 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.924 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.906 0.384 . . . . 71.43 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.42 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 71.22 110.885 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.13 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 70.43 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 71.44 111.135 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.21 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.43 110.946 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.809 0.338 . . . . 64.51 110.828 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.88 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.24 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.34 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.23 111.113 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.45 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.54 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.836 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.801 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 75.41 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 74.43 111.087 179.882 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.858 0.361 . . . . 65.15 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.34 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 75.22 110.892 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 73.41 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 65.02 111.163 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 65.11 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.42 110.866 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.13 111.078 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.14 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.093 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.123 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.932 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.5 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 73.2 112.448 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 72.24 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.13 111.177 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 71.12 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 110.911 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 75.54 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.933 -179.843 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.717 0.77 . . . . 73.41 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.35 112.327 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.217 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.12 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.51 111.177 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.34 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.476 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.24 110.859 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.628 0.727 . . . . 72.42 111.107 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 73.31 112.291 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.15 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.893 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.154 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 72.54 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.33 110.89 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 71.43 110.936 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.727 0.298 . . . . 75.52 110.957 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.4 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.4 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.22 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.23 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.082 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.904 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 75.21 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 72.51 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.1 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.975 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.42 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.22 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.15 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.925 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 74.25 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.24 110.944 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.763 0.316 . . . . 71.45 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.31 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.3 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.934 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.078 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 54.31 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.21 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 62.01 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 75.21 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.33 111.093 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.858 0.361 . . . . 74.24 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.13 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.893 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.22 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 73.34 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 75.14 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.094 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.1 111.154 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 54.34 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.2 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.204 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.066 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.33 110.875 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.35 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.21 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 34.12 112.464 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 64.55 111.074 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.152 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.52 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.907 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 60.41 110.902 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.24 110.924 -179.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.727 0.775 . . . . 75.45 110.845 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 74.34 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 73.21 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 73.33 111.087 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.15 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 65.33 111.104 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 73.22 112.44 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 75.33 110.873 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.639 0.733 . . . . 61.33 111.099 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.881 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 75.53 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.509 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.11 110.84 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.949 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 74.15 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.44 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.861 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.811 0.338 . . . . 72.41 110.882 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 74.44 111.082 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.929 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.41 110.823 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.42 110.958 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 65.32 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.55 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.51 111.191 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.13 110.943 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.757 0.313 . . . . 73.25 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.947 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.42 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.02 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.144 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.35 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.14 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 75.51 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.31 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.14 111.091 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.93 0.395 . . . . 74.31 111.16 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.14 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 64.22 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.13 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.33 111.165 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.129 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 64.54 110.806 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.43 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.35 110.866 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.33 111.138 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.083 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.89 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 64.21 112.527 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 74.43 111.05 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.03 110.909 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.887 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.892 -179.837 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 121.702 0.763 . . . . 73.31 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.35 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.044 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.32 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.53 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.13 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 75.42 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.33 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.3 110.866 -179.801 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.596 0.712 . . . . 74.15 111.071 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.22 112.388 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 74.11 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 64.42 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.55 111.186 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.51 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 74.24 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.3 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.94 -179.833 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.787 0.327 . . . . 73.04 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.849 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 72.1 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.24 111.079 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 75.04 110.911 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.875 0.369 . . . . 71.11 110.881 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 72.03 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.42 110.95 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.53 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.14 110.937 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.42 112.51 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.23 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.1 111.138 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 62.05 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.905 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.795 0.331 . . . . 70.14 110.885 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.13 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.3 111.152 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 54.03 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 75.51 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 74.21 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.79 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.2 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 74.34 111.096 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 70.01 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 71.44 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 75.4 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 74.24 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 74.52 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.145 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 74.24 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.04 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.3 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 74.55 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.848 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.896 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 63.45 112.418 -179.957 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.763 0.316 . . . . 63.44 111.087 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.33 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.878 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.808 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 73.54 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 72.22 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.932 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.624 0.726 . . . . 75.2 110.925 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 75.42 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 74.24 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 74.51 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.15 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 64.14 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 74.24 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 74.34 110.872 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.621 0.724 . . . . 75.3 111.072 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 73.34 112.277 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.24 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.35 112.533 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.92 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.755 0.312 . . . . 73.14 110.93 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.02 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 75.54 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.14 111.156 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.831 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 74.01 110.868 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.42 111.112 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.44 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 72.44 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 71.11 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 43.41 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.22 110.888 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 74.41 111.138 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.35 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.91 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.761 0.315 . . . . 72.01 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 75.13 112.541 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.05 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 74.04 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 74.42 111.154 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.32 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.53 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 73.3 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.2 111.161 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 74.52 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 64.25 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.887 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 73.21 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.44 111.106 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.32 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.101 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.1 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 75.13 110.839 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.127 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.114 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.41 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.893 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 73.23 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.515 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.796 0.331 . . . . 74.54 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.53 111.148 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.94 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.5 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.916 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.712 0.768 . . . . 73.11 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.31 112.35 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 73.51 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.21 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.13 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 72.44 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.41 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.02 111.096 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.05 112.519 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 75.13 110.861 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.601 0.715 . . . . 74.22 111.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 74.33 112.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.45 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.127 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.4 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 72.23 110.913 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 17.9 p90 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.945 -179.832 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.781 0.324 . . . . 73.33 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.45 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.886 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.42 110.863 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.42 110.912 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.23 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.43 111.151 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.921 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.2 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.795 0.331 . . . . 74.15 110.874 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.32 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.909 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 61.31 110.875 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.1 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.02 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.52 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 72.11 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.41 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.196 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.854 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.765 0.317 . . . . 74.23 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.11 112.485 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.41 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.943 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.19 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.103 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 75.11 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.882 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.213 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 74.34 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.31 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.34 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.2 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.164 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.134 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 64.5 111.066 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.04 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.1 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.1 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 74.41 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.11 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.876 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.31 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 74.32 111.067 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.54 112.501 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 65.53 111.076 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.174 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.857 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.99 -179.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.665 0.745 . . . . 72.43 110.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.42 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 73.53 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.22 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 64.54 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.52 111.143 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.461 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.24 110.921 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.602 0.715 . . . . 62.54 111.164 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.41 112.361 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.33 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.45 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.102 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.03 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 63.13 110.843 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.875 -179.837 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 75.24 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 52.41 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.55 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.137 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 73.24 110.895 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.312 . . . . 73.44 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.55 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.54 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.931 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 74.03 111.149 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.876 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 74.53 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.1 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 65.12 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.23 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.21 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.24 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.45 111.111 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.13 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.863 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.3 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 70.01 111.108 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 75.35 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.04 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 74.03 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.136 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 75.42 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.893 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 74.14 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.52 111.155 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.45 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.53 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 74.14 111.143 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.071 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.24 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.54 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 72.3 110.84 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 64.13 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.25 112.517 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.842 0.353 . . . . 74.32 111.008 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.51 111.108 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.43 110.999 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.4 110.911 -179.867 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.617 0.722 . . . . 74.2 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.13 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.53 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.11 111.1 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.43 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.35 111.146 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 72.1 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 75.21 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.02 110.886 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.602 0.715 . . . . 65.11 111.144 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.34 112.329 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.41 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 75.1 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.122 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.03 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 73.21 110.927 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.883 -179.812 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.73 0.3 . . . . 74.23 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 73.31 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.14 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.43 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 72.3 111.108 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.862 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 72.2 110.84 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.35 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.43 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 62.53 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.44 110.964 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.21 111.111 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.855 0.359 . . . . 73.11 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.12 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.127 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.42 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.1 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.909 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.44 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.55 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.146 179.854 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 74.53 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 73.12 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.896 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 72.51 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.21 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 74.3 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 73.22 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.03 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 64.34 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.904 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.13 111.12 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 73.22 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.33 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.873 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 72.13 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 63.43 112.517 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.67 0.271 . . . . 64.02 111.11 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.11 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.34 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.43 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.915 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.42 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.896 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.753 0.787 . . . . 74.32 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 74.33 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.32 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.45 111.088 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.35 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 73.33 111.083 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.45 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.34 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 71.11 112.469 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.34 110.869 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.33 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 60.33 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.11 111.13 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.42 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 71.44 110.97 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.52 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.14 110.978 -179.928 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.338 . . . . 75.12 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 73.4 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.42 110.922 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.23 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.23 111.087 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.41 110.922 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 75.31 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.923 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 74.33 110.894 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 70.4 112.446 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 75.42 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.44 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.4 111.116 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.51 110.936 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 72.32 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 61.03 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.11 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.35 110.887 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.171 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 61.52 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 75.04 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.44 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 60.22 111.062 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.919 0.39 . . . . 65.41 111.145 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 73.44 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.24 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 74.44 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 71.02 111.124 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.23 111.12 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 75.44 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 65.31 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.22 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.058 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 74.41 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.89 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.41 112.476 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.753 0.311 . . . . 73.3 111.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.136 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.945 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.922 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.901 -179.803 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.672 0.748 . . . . 74.32 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.53 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.55 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.44 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.14 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 74.11 111.122 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.41 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.42 110.899 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.51 112.35 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.109 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.1 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.163 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.34 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.14 110.879 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.944 -179.899 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.742 0.306 . . . . 74.21 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.3 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.101 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.836 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 74.23 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 75.13 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.913 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.891 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.947 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.44 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.12 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.53 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.02 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.05 111.126 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.44 110.899 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.814 0.34 . . . . 75.2 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 72.25 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.22 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.15 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.893 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.178 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.22 111.136 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.855 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.818 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 62.32 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 74.4 111.173 179.83 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.856 0.36 . . . . 73.32 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 75.4 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.13 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.24 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.157 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.11 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.14 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.24 111.192 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.35 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 74.12 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.869 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.54 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.2 112.459 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.782 0.325 . . . . 71.54 111.044 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 72.34 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.93 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.12 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.21 110.946 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.888 -179.854 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 121.72 0.771 . . . . 75.15 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 74.04 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.04 111.158 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 75.23 111.088 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.33 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.22 111.129 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 75.24 110.852 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.639 0.733 . . . . 74.14 111.077 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.1 112.312 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.2 111.162 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.484 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 74.12 110.931 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.53 110.904 -179.816 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.69 0.281 . . . . 73.34 110.866 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.3 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.1 110.888 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 61.44 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.922 -179.944 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.839 0.352 . . . . 74.45 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.45 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.94 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 64.45 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 71.21 111.128 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 71.42 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.12 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.41 110.88 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.84 0.352 . . . . 74.2 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.42 157.59 45.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.826 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.12 144.15 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -102.8 162.02 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 72.11 110.926 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -152.38 73.43 7.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.689 0.757 . . . . 74.24 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.11 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 73.24 112.345 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.14 165.29 24.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 70.01 111.081 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -130.96 -173.71 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.88 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -53.11 103.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.882 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.61 -172.52 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.088 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.68 -157.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 74.33 112.459 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -175.92 140.48 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 72.32 110.888 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.41 -170.09 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 73.32 110.866 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.964 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.02 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.889 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 74.43 111.127 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 63.3 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 71.05 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.21 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 60.04 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 64.11 110.898 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.9 p -88.98 123.42 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.24 111.147 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.06 104.47 14.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.61 144.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 74.04 111.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.36 90.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 71.01 112.461 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -84.83 -40.84 16.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 65.34 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -52.1 -37.93 55.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 73.21 110.937 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -58.82 -44.23 90.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 75.42 110.919 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.98 3.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 63.44 112.497 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -143.49 105.75 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 70.24 110.897 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp 56.52 43.2 26.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 74.53 110.923 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -141.46 140.1 33.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.911 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.35 131.96 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 75.31 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.63 152.81 6.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 72.14 112.503 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.15 52.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 71.4 112.493 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.47 128.21 3.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 53.41 112.508 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.46 57.14 3.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 71.2 111.157 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -99.1 158.87 31.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 74.13 110.901 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 118.65 5.81 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 74.23 112.37 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -174.38 150.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 72.35 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 51.99 43.17 30.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.072 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.83 141.63 48.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 70.1 110.854 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.76 143.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.43 111.077 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -76.62 132.47 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.02 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 tp -54.84 137.94 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 70.14 111.159 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.15 -160.97 32.14 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.719 -0.753 . . . . 73.12 112.456 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -129.75 135.56 48.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 75.31 110.851 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -119.4 30.52 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 74.43 110.879 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -75.14 119.64 19.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.102 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.43 111.161 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 61.14 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 73.05 111.132 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 75.44 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.24 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 75.34 111.141 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 52.3 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.13 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.35 111.143 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.51 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 74.11 110.865 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.04 111.109 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.34 111.091 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.4 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 74.15 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.877 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.25 171.59 36.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.65 155.52 14.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.732 . . . . 71.31 111.125 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 172.7 12.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 62.52 112.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.57 158.0 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.34 111.15 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -54.95 120.52 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 75.13 110.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -173.25 174.17 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 71.11 111.14 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.93 171.77 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.885 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -119.91 -67.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.05 110.908 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.53 -36.26 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 70.23 110.885 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 62.08 5.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 75.2 112.482 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -174.84 145.39 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 71.15 110.874 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -63.83 122.68 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 75.2 110.9 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 t -64.89 124.28 21.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 73.4 110.87 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.91 -37.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 73.45 111.088 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 m -151.32 111.85 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 64.34 110.856 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 t -173.02 167.74 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 75.05 110.822 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.7 tp -170.57 126.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 73.04 110.929 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.83 -143.68 10.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.741 -0.742 . . . . 71.24 112.492 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -128.68 -41.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 73.34 110.843 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.7 t 53.17 78.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 73.12 111.073 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -86.27 167.22 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 75.33 110.844 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -114.42 71.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 64.31 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.6 m -114.76 40.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 74.42 111.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.43 135.83 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.856 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -100.52 -42.31 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.945 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.87 75.82 0.42 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.451 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.82 10.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.264 . . . . 74.21 112.374 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.93 130.54 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 61.11 111.113 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 74.42 111.125 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.904 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.973 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -132.6 133.2 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.938 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -131.07 163.45 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 73.41 110.874 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.5 37.23 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.919 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.25 -39.87 6.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.33 110.863 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.7 m 53.02 36.78 23.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 54.03 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -177.4 178.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 74.54 110.898 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.16 97.9 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 71.11 110.869 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 -161.89 174.31 13.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.0 94.58 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.05 153.4 78.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.699 0.761 . . . . 74.4 110.916 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 73.13 112.335 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.44 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 72.1 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.05 111.113 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.31 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 73.41 111.161 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.53 112.462 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.28 -176.98 6.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 75.14 110.857 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.79 152.55 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 72.02 111.141 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.93 129.86 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.949 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 53.33 43.9 30.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 61.54 110.937 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.51 -36.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 73.53 110.832 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -62.12 127.8 33.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 65.4 110.881 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -92.29 178.65 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 t -113.1 73.27 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 64.43 111.106 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -154.51 147.64 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 64.42 110.854 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.8 80.61 1.78 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.35 112.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.15 -64.98 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 74.43 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mt -137.4 110.46 7.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.907 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 t -76.66 160.71 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 74.21 110.834 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t 57.53 48.43 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 72.1 110.877 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -124.46 43.53 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 74.21 110.905 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -142.33 144.05 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 70.11 110.887 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.71 150.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 72.53 111.129 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -51.95 -64.33 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.904 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -152.35 122.67 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -126.33 98.65 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.91 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -124.32 147.66 48.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.878 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.08 159.93 59.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.521 0.676 . . . . 74.04 111.148 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 74.22 112.315 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.4 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.94 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.53 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 54.55 112.479 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 74.0 110.912 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -136.02 148.0 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.11 110.932 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.42 110.15 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 73.05 110.882 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.44 -40.13 12.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -133.5 -139.17 4.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 73.44 112.477 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -111.28 -56.5 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 74.43 110.848 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.3 p -74.31 -62.96 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.53 110.908 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -92.13 148.14 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.54 110.915 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 63.3 110.847 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 75.11 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -143.98 130.31 19.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.5 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -77.16 139.71 40.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 75.21 110.925 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 48.6 mm -120.95 133.1 24.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.626 0.726 . . . . 75.41 111.111 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 150.08 67.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 71.04 112.355 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -114.97 118.62 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.33 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -64.5 151.88 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.31 110.89 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.4 m -61.63 109.16 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 74.24 111.129 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -171.02 150.94 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.53 110.859 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.1 p -107.35 139.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.21 111.168 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.5 p -132.6 107.09 8.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.169 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.67 -162.73 10.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 72.12 112.483 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 9.2 m -133.66 153.85 51.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 72.11 111.136 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -54.59 162.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.02 110.871 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.49 71.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 70.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.89 55.31 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 74.12 112.279 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.4 156.19 70.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.671 0.748 . . . . 74.2 111.139 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -38.08 8.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.638 2.225 . . . . 74.54 112.373 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -70.05 174.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 75.51 111.148 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 36.9 m -129.28 151.35 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.31 110.843 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p -133.27 151.38 51.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 74.43 111.139 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -70.6 152.56 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.922 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.1 89.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 72.13 111.118 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -121.95 90.46 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.891 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.68 -70.42 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.42 111.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.88 71.12 1.29 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.642 0.734 . . . . 73.41 110.856 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.29 69.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.243 . . . . 75.11 112.35 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -161.38 174.76 13.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.41 110.865 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.139 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 72.13 110.958 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.22 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.42 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 74.14 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 53.22 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.925 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.21 111.109 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 74.3 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -121.33 100.34 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.44 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 71.42 110.898 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 58.81 48.71 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 73.13 111.095 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.28 109.12 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.072 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.21 149.61 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 61.0 111.12 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.95 118.6 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.865 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.763 0.316 . . . . 74.2 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.89 131.63 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -146.51 127.99 15.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -119.17 151.79 37.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 62.2 110.908 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -72.78 160.46 82.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.727 0.775 . . . . 74.43 110.899 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 98.18 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.628 2.219 . . . . 75.11 112.431 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 141.8 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 62.0 111.012 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -117.34 37.32 3.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 73.14 110.945 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -91.25 119.49 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 74.41 110.892 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.64 162.35 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 111.145 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.92 -155.1 6.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 74.02 112.498 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -163.91 133.51 4.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 72.55 110.921 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -158.45 158.43 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 75.24 110.933 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 72.05 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.54 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.084 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.095 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.11 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.11 110.877 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 72.3 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 73.41 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.32 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 70.23 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.18 113.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 74.23 111.133 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -103.76 110.64 22.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.1 110.929 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.82 149.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 74.3 111.099 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.95 70.14 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 71.41 112.448 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -87.64 -46.41 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 72.12 110.877 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.02 37.67 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 71.13 110.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.15 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 73.51 110.933 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.65 -126.59 7.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.783 -0.723 . . . . 61.14 112.522 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.31 129.34 16.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 64.31 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.16 -50.2 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.903 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -52.56 156.71 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.962 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 p -87.94 146.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.45 111.109 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.17 -122.23 0.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.803 -0.713 . . . . 73.54 112.501 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.76 -99.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 64.42 112.53 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.08 -155.03 3.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 61.15 112.522 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.89 -58.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.8 0.333 . . . . 75.33 111.059 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -110.31 91.1 11.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.666 0.746 . . . . 75.23 110.922 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.609 2.206 . . . . 73.33 112.372 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -119.43 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 73.11 110.913 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.25 136.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.35 111.069 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -119.09 -43.23 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.1 m -142.56 145.55 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.53 111.127 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.9 t -108.36 126.37 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.1 110.849 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 pp -51.96 145.67 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 75.34 111.12 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.15 4.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 75.25 112.455 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.8 146.63 35.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 71.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -123.4 -36.9 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -57.15 121.27 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 75.13 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 74.14 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 64.32 110.921 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.11 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 72.43 110.893 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 61.15 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 73.34 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.14 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.42 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.32 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 74.14 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 74.22 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.54 110.897 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.1 111.198 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 75.32 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 72.44 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.13 110.925 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 72.42 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.46 -167.81 21.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.21 112.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.34 156.23 72.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 71.53 111.125 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 175.3 8.3 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.622 2.215 . . . . 74.31 112.313 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.24 168.86 9.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.11 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -59.68 105.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 75.42 110.897 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.55 178.16 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.165 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -143.42 121.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.24 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -126.79 167.59 15.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 73.33 110.881 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -154.3 -178.66 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 75.15 110.859 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.46 106.13 1.51 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 54.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.38 154.82 50.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.44 110.894 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 40.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.907 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -66.62 -175.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 75.11 110.882 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -95.07 -57.08 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.164 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 p -73.62 95.2 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.31 110.854 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.4 p -63.21 145.55 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 73.15 110.914 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.66 45.47 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.876 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.28 130.94 29.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.716 -0.754 . . . . 51.22 112.477 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 -30.14 24.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 74.15 110.849 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.74 102.43 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.154 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -170.28 119.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 71.43 110.814 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.64 -65.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 72.41 110.841 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 t -85.9 117.24 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.24 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -137.21 170.91 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 73.02 110.897 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -89.85 150.48 22.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 75.24 110.897 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.28 -170.21 26.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.771 -0.728 . . . . 75.13 112.517 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.72 135.87 31.66 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 74.23 112.366 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.92 131.43 21.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 64.4 111.139 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 73.22 111.119 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.4 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -128.59 137.46 51.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.42 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -130.92 145.35 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 74.21 110.852 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.45 -35.75 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 65.25 110.851 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.7 -36.34 9.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 75.5 110.891 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.0 m 63.28 62.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 74.45 110.93 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -167.4 143.27 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.843 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -54.07 102.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 74.13 110.933 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -176.04 158.79 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 73.42 110.867 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.59 98.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 73.5 110.871 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.26 160.53 26.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.656 0.741 . . . . 64.4 110.935 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.01 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.15 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.01 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.54 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 75.22 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.43 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.44 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.44 112.451 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -141.42 134.65 29.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.0 141.54 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 73.4 111.081 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.41 115.5 30.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 75.43 110.902 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -54.8 135.86 47.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.13 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -98.18 168.27 10.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.52 110.902 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 56.35 53.55 8.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.889 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -71.66 142.01 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 74.13 110.955 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.9 t -85.3 168.14 14.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 75.22 111.189 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -85.26 -52.92 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 75.31 110.932 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.2 78.33 1.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.784 . . . . 72.34 112.513 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.48 -38.88 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 74.23 111.079 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.7 mt -86.2 -69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 73.2 110.906 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 p -113.07 171.77 7.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 75.41 110.855 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 m -112.48 135.84 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 75.03 110.845 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.854 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -118.77 157.01 28.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.894 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tp -82.26 135.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 74.25 111.096 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -96.02 150.38 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 75.02 110.907 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -61.92 177.1 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 64.35 110.882 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -123.02 -62.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.928 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.3 m95 52.03 56.05 8.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 75.31 110.885 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.42 160.47 56.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.638 0.732 . . . . 71.32 111.069 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 72.13 112.356 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.42 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 75.14 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 65.41 111.177 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.12 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.31 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 72.34 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -131.12 105.35 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.903 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.52 99.98 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 75.4 110.869 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.5 -62.07 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.959 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -57.04 147.54 34.08 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 73.45 112.477 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -57.76 -36.43 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 74.13 110.875 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -110.5 -67.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 75.5 110.841 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -72.45 146.9 46.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 74.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 74.22 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.41 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 64.42 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.23 111.111 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -149.58 147.62 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.907 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -114.55 127.55 55.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 72.14 110.913 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -108.74 132.1 21.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.604 0.716 . . . . 74.55 111.174 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 55.43 112.366 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -130.3 145.12 51.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.897 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -93.56 123.5 36.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 75.42 110.923 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 t -143.2 158.38 43.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.31 111.108 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.47 156.05 17.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.44 110.877 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.3 m -66.45 177.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.204 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.8 t -164.29 152.62 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.23 111.168 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -109.77 173.3 16.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.677 -0.773 . . . . 72.41 112.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.2 t -132.58 137.27 47.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 64.31 111.106 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -147.03 145.2 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 72.33 110.946 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.91 177.74 20.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 71.22 112.476 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 81.73 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 75.13 112.389 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.8 t 63.22 73.8 0.48 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.598 0.713 . . . . 73.32 111.151 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 92.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.709 2.273 . . . . 71.21 112.375 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 25.5 m -113.95 152.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 75.3 111.097 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 83.4 p -145.51 172.48 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.892 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 -42.15 4.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 73.51 111.177 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -99.39 139.14 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.936 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.4 mt -123.72 110.48 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 72.23 111.113 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.14 112.96 3.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.882 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.05 -70.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 73.03 111.114 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.65 160.62 61.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 73.1 110.876 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.79 48.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.718 2.279 . . . . 72.5 112.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.09 136.56 33.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 73.03 110.908 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 73.51 110.942 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.771 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 73.55 110.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.54 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.12 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 62.13 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -126.45 89.39 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.42 110.91 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.65 -44.09 14.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 74.2 110.903 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.66 91.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.125 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.64 178.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 75.21 111.128 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.29 -54.8 5.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 73.21 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.6 tp -74.4 -62.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 74.04 110.922 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.882 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.728 0.299 . . . . 71.42 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.56 136.98 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 72.53 110.911 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.01 178.16 4.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.905 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.74 171.74 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.843 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -126.87 69.18 72.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.706 0.765 . . . . 74.43 110.929 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -41.79 3.98 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 64.22 112.348 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.12 -177.93 3.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.106 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.08 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 75.53 110.923 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t 62.45 40.0 11.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 63.44 110.834 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.66 118.58 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.1 111.024 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.32 -161.54 18.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.77 . . . . 74.33 112.451 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -140.12 116.65 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 74.12 110.901 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.19 131.87 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 71.51 110.89 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.04 112.504 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.45 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.875 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.105 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 64.12 111.13 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.42 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.45 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.5 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.13 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.67 125.62 40.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 71.45 111.173 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -114.1 108.08 16.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 72.54 110.935 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.54 151.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.24 111.134 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.22 48.19 0.46 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.753 . . . . 65.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.32 -43.82 93.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 72.44 110.876 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 57.41 52.13 9.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.14 110.945 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -131.82 -55.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 75.14 110.936 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.94 -143.5 17.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 55.23 112.479 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -122.21 165.04 16.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 72.53 110.829 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.84 75.9 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 71.21 110.913 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.72 140.22 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.24 110.913 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -173.61 135.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 75.1 111.123 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.89 -43.38 8.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 71.25 112.449 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.83 47.61 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 71.22 112.454 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.83 53.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 61.04 112.495 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.31 165.86 10.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 74.35 111.046 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -104.81 159.21 30.08 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.589 0.709 . . . . 75.33 110.889 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 174.51 9.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.622 2.215 . . . . 72.34 112.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -94.99 124.29 38.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.956 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.84 -52.32 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 74.22 111.142 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.37 152.27 34.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.8 t -130.04 129.84 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.3 111.169 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.4 p -77.73 99.12 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.53 110.841 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -124.4 124.61 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.25 111.068 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.31 -72.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.781 -0.723 . . . . 61.32 112.508 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.26 121.72 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 65.23 110.911 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -118.41 -36.98 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 74.2 110.831 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -54.93 132.66 47.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 71.02 111.116 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 74.21 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 74.12 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 75.33 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 73.14 111.13 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 72.3 111.116 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 74.25 111.105 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.03 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 75.53 110.884 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 74.21 111.105 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 74.34 111.119 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.42 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.887 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.42 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.53 -157.37 17.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 65.43 112.509 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.67 156.18 45.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.628 0.728 . . . . 75.35 111.196 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 138.26 37.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.628 2.218 . . . . 64.4 112.363 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.48 -176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 73.45 111.095 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -81.68 128.62 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.34 110.894 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.64 132.74 48.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.145 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -105.31 170.0 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 73.13 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.4 179.56 3.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.849 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -83.07 115.79 22.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -97.88 -166.25 31.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 74.54 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.42 -57.89 2.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.398 . . . . 72.22 110.897 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -103.04 39.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.51 110.929 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.3 m -125.5 176.36 6.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 71.21 110.811 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.8 pt -55.61 165.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 72.1 111.195 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 m -160.22 148.66 16.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 63.52 110.894 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -122.19 115.36 22.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.41 110.858 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 98.57 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 75.45 110.874 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.2 99.59 2.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 75.42 112.507 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 169.21 18.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 74.15 110.818 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.68 -35.59 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.141 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 57.44 50.13 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 63.34 110.893 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' VAL . 98.0 mt-10 -141.91 -178.08 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.885 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 95' ' ' GLU . 27.1 m 36.88 44.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 75.24 111.166 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -113.97 172.59 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 63.52 110.907 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -69.59 138.69 53.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.941 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.66 -69.93 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 63.42 112.497 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -174.43 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 62.15 112.303 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.32 173.01 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 73.23 111.076 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.23 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 73.25 110.941 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.14 110.886 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -153.23 152.36 31.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.935 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -131.01 144.7 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 73.45 110.832 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -52.33 -39.84 61.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.892 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -91.76 -37.25 13.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.826 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.1 t 61.41 52.83 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.868 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.42 179.28 4.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.863 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.09 73.09 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.923 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -170.03 -175.85 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 75.23 110.836 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 100.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 73.41 110.946 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.28 160.46 26.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.676 0.75 . . . . 73.41 110.988 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 61.31 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.967 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 73.33 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.52 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 74.12 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 63.01 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.13 111.163 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.01 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.24 172.1 3.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.43 110.879 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.82 149.98 5.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.15 111.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.76 114.01 27.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.936 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -62.57 132.76 53.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.848 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -122.4 156.18 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 73.2 110.838 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -112.69 65.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.833 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.37 37.5 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 75.51 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 t -131.11 164.1 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 72.24 111.11 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -113.61 96.51 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 74.32 110.895 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.56 21.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 75.24 112.537 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.78 -42.01 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 71.13 111.141 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 mt 57.8 43.25 22.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.5 110.965 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m 52.36 37.58 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 63.2 110.875 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -61.2 143.59 55.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 75.23 110.855 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -137.99 141.14 40.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.53 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -118.3 143.86 46.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.829 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 38.5 mm -82.68 142.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 72.33 111.11 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -70.71 -38.11 73.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.865 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.62 -69.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 63.21 110.853 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm 53.56 42.42 31.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.924 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -151.91 107.26 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.6 95.24 15.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 75.34 111.026 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.33 112.343 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 73.05 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.24 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 62.24 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 71.33 112.471 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 74.34 110.865 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 70.53 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -136.04 111.66 9.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.14 110.947 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.08 120.04 39.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 74.01 110.863 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.23 -47.03 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 75.11 110.899 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 151.66 41.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 62.01 112.479 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -168.2 -176.74 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 65.53 110.93 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.0 m -55.59 -46.79 77.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -78.42 135.27 37.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.94 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.52 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 74.23 110.866 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.23 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 64.41 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 74.12 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 73.3 111.147 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.54 144.83 23.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 71.45 110.878 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -124.3 144.03 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 72.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -112.48 132.06 22.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.607 0.717 . . . . 73.33 111.174 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.12 1.78 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 74.43 112.392 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -131.54 -68.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.916 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -164.16 144.52 8.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.84 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 m -147.04 151.26 36.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 73.0 111.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.99 152.87 41.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 70.23 110.912 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.37 67.62 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 72.33 111.189 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.83 162.2 34.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 70.23 111.194 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.21 171.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 75.41 112.457 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -115.49 -41.78 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.05 111.173 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.68 119.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 73.52 110.922 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.29 174.47 27.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.529 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.22 17.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.664 2.243 . . . . 73.24 112.315 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t 63.72 73.93 0.46 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.62 0.724 . . . . 74.3 111.021 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -33.1 17.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.679 2.252 . . . . 63.05 112.346 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.19 -174.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 73.34 111.104 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 p -52.07 168.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 54.15 110.868 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -51.79 156.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 63.2 111.122 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -53.5 141.08 26.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.33 -35.62 63.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.21 111.155 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 63.07 52.89 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 75.12 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.8 m -61.64 171.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.44 111.171 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.24 160.05 1.8 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.576 0.703 . . . . 71.34 110.93 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.01 3.56 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.735 2.29 . . . . 71.31 112.305 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -143.8 145.63 32.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.41 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.33 110.929 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 62.14 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.34 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.31 110.955 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 75.44 111.084 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.54 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -110.59 95.82 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.94 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -33.84 38.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 61.12 110.895 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -115.46 121.44 42.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.42 110.997 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.69 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 75.53 111.136 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.31 178.15 10.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 63.23 111.089 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.94 84.32 5.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 75.24 110.853 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 75.3 110.92 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.848 0.356 . . . . 72.21 110.916 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.46 174.97 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 75.52 110.94 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.83 148.33 49.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.22 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -107.82 159.1 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 72.22 110.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -82.37 160.58 61.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.625 0.726 . . . . 53.22 110.961 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 153.17 68.73 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.631 2.221 . . . . 75.33 112.318 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.33 160.33 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.117 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -89.98 154.4 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.921 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -91.61 172.2 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.43 110.858 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.55 139.16 56.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.082 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.51 -169.54 35.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.666 -0.778 . . . . 55.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -161.38 125.11 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 75.12 110.927 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -140.23 155.13 47.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.21 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.11 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.24 110.892 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 71.51 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 75.4 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.33 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.35 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 75.2 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.01 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.66 123.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.123 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -112.63 126.68 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.04 110.883 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.29 142.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 64.11 111.185 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.35 132.19 46.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 64.01 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -67.17 -37.34 83.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 75.33 110.878 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -53.96 -42.22 68.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.929 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 mt 55.49 39.03 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 72.2 110.888 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.85 -178.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 53.13 112.499 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.09 73.25 1.44 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.86 0.362 . . . . 73.23 110.883 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -145.66 77.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 64.43 110.913 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -137.67 159.3 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.855 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.78 -70.45 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.095 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.9 -179.56 44.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 64.31 112.495 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.86 -172.31 45.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 71.4 112.49 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.7 -133.94 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 52.24 112.474 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.59 64.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 74.53 111.064 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.1 tp -109.84 90.98 9.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.561 0.696 . . . . 74.33 110.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 144.91 55.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.645 2.23 . . . . 74.33 112.332 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -172.1 130.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 74.22 110.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 141.71 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.11 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.87 176.6 7.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.25 127.41 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 73.31 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 t -115.1 118.88 34.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.8 tt -139.5 143.0 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 73.5 111.049 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.51 -117.91 0.59 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 75.2 112.526 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -106.78 115.22 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 75.21 110.932 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -111.23 30.55 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.864 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -109.8 129.59 55.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.04 111.141 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.15 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.55 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 73.21 111.142 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 65.32 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 74.42 110.935 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.1 111.154 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 62.35 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.04 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.42 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 72.22 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 70.1 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 74.02 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 73.05 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 73.53 111.174 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 61.42 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.11 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 71.4 110.878 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.875 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.34 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 147.76 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.35 112.559 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.61 155.61 13.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 73.34 111.102 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 117.27 4.99 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 62.23 112.324 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.47 55.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 75.13 111.095 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -131.82 120.59 22.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.4 110.91 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.24 88.05 2.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 75.55 111.139 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -117.89 170.81 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.938 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -169.84 132.95 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.834 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -59.72 126.82 29.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.939 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.58 -156.96 45.5 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 53.35 112.546 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -156.41 154.59 30.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 74.42 110.87 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -131.74 162.67 29.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.911 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -58.81 -37.74 77.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 63.14 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.7 tt -66.37 141.87 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.43 111.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -99.9 176.42 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 71.12 110.87 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.79 43.12 9.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.854 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 mt -85.42 119.23 25.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.84 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.54 -176.92 36.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 64.33 112.492 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -110.49 170.88 7.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 74.44 110.846 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.6 m -73.03 178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 73.23 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -84.7 121.15 27.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.14 110.938 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -95.37 128.02 41.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 74.2 110.881 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -100.95 44.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.151 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.36 -179.55 3.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.1 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -107.33 -177.0 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 73.34 110.87 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.31 -71.21 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 75.22 112.567 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 145.77 58.66 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.736 2.29 . . . . 72.34 112.379 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -152.47 135.74 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 73.34 111.113 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.21 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 72.11 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.52 110.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.43 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -147.24 140.82 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -131.01 134.55 46.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 71.13 110.895 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -60.26 -36.09 76.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.909 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.94 -40.82 38.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.6 t 61.42 42.95 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.847 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -150.92 130.84 13.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 74.53 110.899 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.08 112.36 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.885 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -177.64 159.85 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 74.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 94.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.93 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.17 160.52 26.58 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 72.34 110.963 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.12 112.372 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.45 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 70.41 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 72.22 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.44 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 74.53 111.138 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 74.5 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.5 125.62 34.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 74.21 110.864 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.08 138.25 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 72.35 111.144 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.9 119.71 39.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.865 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -86.46 128.24 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 72.25 110.884 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -95.55 151.65 19.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -110.05 148.75 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.15 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -129.3 115.85 18.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.861 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -129.86 -44.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 74.02 111.171 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 51.59 55.35 9.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.33 110.893 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.69 -31.26 8.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 74.2 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.88 171.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.326 . . . . 74.24 111.092 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.89 104.71 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.919 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 t -143.4 151.75 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.855 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -140.15 117.9 11.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.818 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -149.66 146.26 27.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 73.01 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.43 136.55 54.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.823 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.82 132.37 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 71.31 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -100.19 161.48 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.31 96.6 8.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 71.13 110.959 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.922 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -88.62 157.88 18.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 74.12 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.16 160.36 50.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.55 0.691 . . . . 73.3 111.146 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 74.33 112.378 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.31 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.33 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.51 111.07 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.23 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.13 110.946 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -137.41 135.23 36.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.99 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.42 105.31 17.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.944 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt -121.74 -58.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 73.12 110.953 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.52 -179.22 30.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 70.43 112.464 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -102.22 -38.1 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.5 110.936 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.1 m -92.26 -50.49 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 74.02 110.809 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -106.76 162.8 13.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 74.05 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.24 110.901 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.91 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.32 111.177 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -134.04 122.07 22.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.87 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -139.73 153.01 47.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 75.31 110.938 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -141.89 132.16 12.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 63.21 111.107 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 161.21 46.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 63.4 112.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -60.98 176.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.2 110.887 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -150.88 121.95 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 73.22 110.883 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.1 p 49.94 40.58 21.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 75.34 111.059 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.76 149.74 30.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 70.13 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.26 137.94 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.66 115.21 8.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.35 111.145 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.05 -142.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 72.02 112.464 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.8 m -64.63 158.26 24.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.33 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.47 136.62 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 74.0 110.94 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.53 71.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.686 -0.769 . . . . 72.43 112.514 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -179.65 3.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.647 2.231 . . . . 70.12 112.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.4 t 55.9 71.69 1.17 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 73.51 111.079 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.83 179.38 3.78 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 63.44 112.322 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.71 172.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 74.34 111.065 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 p -59.54 173.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 74.42 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.2 p -52.59 145.28 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 73.24 111.163 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -174.21 141.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.898 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.3 pt -57.95 169.08 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.31 111.081 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -159.34 160.46 35.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 74.44 110.932 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -58.36 129.21 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 63.02 111.102 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -176.16 71.75 0.26 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.638 0.733 . . . . 71.42 110.874 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 145.0 55.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 73.43 112.285 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.24 171.41 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 70.01 110.887 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 64.32 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 74.11 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.44 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 54.5 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.03 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.3 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 97.1 4.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.3 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.85 -33.87 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 73.14 110.899 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.98 63.58 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 73.1 111.097 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.58 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 75.23 111.087 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.29 49.25 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 73.21 111.109 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 78.4 mt -125.84 -51.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 71.0 110.963 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 63.34 110.868 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.791 0.329 . . . . 74.33 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -165.12 171.33 13.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 64.44 110.942 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.03 175.65 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.846 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 178.51 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 72.5 110.898 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.67 160.56 34.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.678 0.752 . . . . 72.3 110.96 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 156.78 62.43 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.65 2.233 . . . . 75.42 112.336 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.39 111.23 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 72.15 111.085 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -64.86 -178.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 73.51 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.8 m -103.59 -178.74 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 70.34 110.834 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.8 159.54 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 73.34 111.09 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.34 -175.65 24.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 70.12 112.467 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -157.38 117.72 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 74.55 110.875 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -136.08 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 71.23 110.918 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.936 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.32 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.45 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 70.44 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 73.54 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.52 137.33 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 60.43 111.114 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -118.76 111.66 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 74.32 110.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 141.91 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.04 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.49 149.7 19.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 62.25 112.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -59.99 -41.99 93.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 71.23 110.899 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 63.17 53.48 2.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 52.55 110.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.03 -35.61 69.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 74.45 110.944 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.34 -151.87 8.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 64.34 112.482 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.38 52.73 5.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.902 0.382 . . . . 75.11 110.894 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.47 60.07 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 75.13 110.911 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.67 152.15 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 75.32 110.931 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.06 -35.81 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.105 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.54 -119.26 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 74.55 112.521 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.41 -175.94 20.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 61.12 112.54 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.78 -37.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.762 . . . . 60.04 112.453 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.29 158.21 44.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.836 0.35 . . . . 73.45 111.122 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.38 91.04 11.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.572 0.701 . . . . 72.33 110.847 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.31 47.3 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.71 2.274 . . . . 73.43 112.338 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.4 173.33 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 64.4 110.896 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.9 -178.85 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.34 111.158 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -117.72 -74.27 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 75.12 110.836 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.23 136.7 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.104 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.6 t -149.18 132.86 16.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.889 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.15 139.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 74.13 111.13 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.5 -123.95 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 74.14 112.464 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -123.42 46.78 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 70.55 110.923 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -95.26 -38.44 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.904 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p -51.85 121.44 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 71.11 111.181 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 75.45 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 71.32 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.14 111.103 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 75.42 111.113 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 72.43 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.52 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 74.22 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.42 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 73.25 110.831 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 74.5 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.28 133.57 11.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.43 112.459 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.59 133.22 33.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 73.22 111.13 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 170.62 16.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 74.34 112.313 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -164.19 125.86 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 74.03 111.074 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.87 146.59 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.826 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.47 128.97 4.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 71.25 111.089 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -81.69 151.16 27.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 71.51 110.827 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -110.18 159.31 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.941 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.27 137.04 9.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.876 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.32 142.4 11.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 73.22 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.48 128.11 28.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 64.13 110.965 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 55.29 40.8 31.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 74.14 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.0 m -118.5 38.34 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 74.52 110.808 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mp 54.23 79.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 74.35 111.136 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -160.64 -62.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 75.23 110.84 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.9 t -137.04 103.48 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 74.25 110.917 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -87.04 76.36 9.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 71.3 110.882 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.18 -166.12 29.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 55.54 112.499 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -130.53 58.09 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 75.13 110.89 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.46 175.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 73.04 111.193 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t 55.9 44.51 25.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 61.44 110.836 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -122.85 36.94 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.883 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.17 -176.43 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.3 111.061 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.44 159.92 19.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 61.22 110.846 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.88 163.41 32.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.4 110.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.03 75.74 0.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 45.55 112.421 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.66 20.9 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 75.12 112.399 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.23 119.28 8.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 71.32 111.09 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.102 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 75.22 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.44 110.961 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.99 135.06 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 64.11 110.929 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -131.0 166.84 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 63.43 110.838 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -131.24 36.3 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.891 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.04 -37.67 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 71.3 110.843 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t 63.17 39.0 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 74.2 110.85 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -149.45 -178.99 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 74.2 110.891 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.45 50.44 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 72.3 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -131.54 -174.06 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.34 110.834 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 115.58 4.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 73.43 110.931 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.3 160.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.671 0.748 . . . . 73.32 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 71.5 111.111 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.3 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 64.41 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 65.1 112.522 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -144.7 161.89 38.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.41 110.941 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.05 142.28 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 72.02 111.137 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.2 134.37 49.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 72.11 110.983 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -102.98 125.38 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.844 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -122.16 94.31 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.17 142.91 51.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.34 110.898 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -111.15 77.95 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 71.33 110.886 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.73 150.34 47.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.126 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.06 129.24 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 71.42 110.821 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.32 119.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 73.51 112.415 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.82 -30.24 71.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 70.13 111.143 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.08 33.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 65.45 110.914 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -120.18 49.19 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 72.44 110.863 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t -64.24 -69.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.756 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 55.45 40.17 31.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.862 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.06 41.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 72.1 110.908 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -121.5 82.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.54 111.158 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -155.92 162.78 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.965 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -103.3 137.57 41.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 75.25 110.86 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -35.98 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 74.32 110.971 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -54.88 115.87 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 74.22 110.966 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -124.25 160.39 52.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.579 0.705 . . . . 72.45 111.134 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.2 112.369 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 74.12 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 73.54 111.118 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 75.12 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 72.23 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -114.78 114.01 25.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.896 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.72 155.28 40.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 73.32 110.84 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 23.6 tp -162.14 116.28 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 75.33 110.896 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -84.29 69.94 3.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.14 112.526 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -141.09 -58.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 74.33 110.918 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -142.42 -74.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -123.31 178.63 5.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 74.24 110.975 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 74.55 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.35 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.43 111.071 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -143.44 109.54 5.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -95.56 127.66 41.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.927 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 45.5 mm -82.38 133.12 50.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 72.21 111.104 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 169.63 18.51 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 75.45 112.32 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -66.12 129.13 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 75.34 110.843 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -174.3 104.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 74.45 110.911 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p -140.53 135.93 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 73.22 111.143 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.75 144.88 31.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.02 110.819 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.22 150.83 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 72.41 111.139 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.58 108.88 9.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.128 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 99.5 1.94 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 44.22 112.499 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 m -137.74 136.68 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 72.54 111.131 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.33 166.73 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 61.12 110.92 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.21 176.79 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.787 -0.72 . . . . 74.34 112.47 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 128.07 15.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.212 . . . . 73.21 112.372 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.7 t -131.94 71.17 80.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.596 0.712 . . . . 74.43 111.141 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -45.78 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 75.54 112.337 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.36 143.38 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.15 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 70.7 m -80.29 131.68 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 72.03 110.852 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 t -134.06 123.21 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.14 111.125 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -173.56 124.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 74.43 110.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.38 -35.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 63.13 111.155 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -98.91 65.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 73.3 110.866 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.81 -64.58 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.133 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -174.53 72.25 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.525 0.678 . . . . 75.54 110.895 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 144.6 54.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.741 2.294 . . . . 73.21 112.347 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.53 171.04 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.92 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.1 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 65.42 110.948 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.53 110.861 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 71.24 110.941 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.23 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 71.03 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.961 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 62.41 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 75.41 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.65 85.96 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.878 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.19 -33.8 42.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 74.45 110.933 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.77 59.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 71.41 111.123 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -173.31 111.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.057 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.75 144.35 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 73.45 111.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 101.31 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 74.52 110.949 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.925 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.814 0.34 . . . . 75.22 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -143.86 -176.92 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 70.25 110.863 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.32 161.66 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.18 -179.14 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 75.05 110.859 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -115.61 157.63 43.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.67 0.748 . . . . 74.52 110.936 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -178.15 2.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 74.33 112.354 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -176.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 65.05 111.094 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -123.03 -40.99 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.11 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -73.89 134.86 43.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.95 -178.99 7.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.98 -175.01 39.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.504 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -163.34 120.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.882 0.372 . . . . 64.33 110.944 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.17 160.31 42.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.927 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 42.33 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.41 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 75.31 111.157 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 63.2 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 62.14 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 73.23 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 m -81.29 133.04 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 75.24 111.102 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.31 104.51 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 75.05 110.919 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.53 151.69 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 75.3 111.1 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.89 5.68 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 61.51 112.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -92.21 8.31 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 73.24 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -55.51 -41.02 72.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.2 110.913 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.07 40.57 30.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.878 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.09 149.0 35.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 53.34 112.527 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -53.61 156.15 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 73.34 110.84 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -107.38 62.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 73.34 110.867 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -82.12 62.85 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.45 110.905 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.26 162.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 64.34 111.134 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.03 87.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.68 -0.771 . . . . 62.42 112.509 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.9 157.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.728 -0.749 . . . . 75.15 112.483 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.73 161.61 37.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 63.11 112.435 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.84 54.95 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 61.01 111.108 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.7 159.22 30.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 74.42 110.875 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 173.47 10.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.67 2.246 . . . . 74.12 112.35 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.5 174.99 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 64.31 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.62 160.45 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 170.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 73.43 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.62 177.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 73.43 111.042 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 p -71.71 125.83 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 72.32 110.885 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 tt -85.82 142.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 72.23 111.148 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.35 -101.42 0.15 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.765 -0.731 . . . . 75.4 112.496 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -96.95 62.49 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 72.25 110.862 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -107.33 -37.06 6.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.902 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -70.55 143.57 51.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 75.45 111.156 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.22 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 64.42 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.05 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 73.14 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 74.12 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 74.21 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 75.03 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 72.45 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.23 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 71.12 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.03 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 75.43 111.094 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 63.43 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 74.2 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 72.14 110.876 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.1 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.64 138.45 6.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 71.13 112.409 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.02 85.6 10.25 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.626 0.727 . . . . 75.13 111.089 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.16 57.87 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.731 2.287 . . . . 71.54 112.327 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 36.73 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 75.33 111.071 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 168.81 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 73.21 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.64 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 72.24 111.058 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.01 170.74 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -79.01 161.67 26.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 74.35 110.955 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.56 175.55 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.915 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.75 -59.06 0.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 73.31 112.54 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -92.81 125.92 37.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 72.13 110.928 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -64.88 94.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.91 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.0 m -159.81 116.24 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 72.12 110.86 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -61.74 -50.46 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 65.41 111.076 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t 62.77 37.82 12.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.839 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 t 53.61 53.69 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 71.05 110.84 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.8 tt -75.9 131.33 39.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 75.14 110.958 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -87.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 73.21 112.477 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -88.08 -73.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 73.41 110.964 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.3 t 58.05 73.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -100.72 138.73 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 72.54 110.841 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.83 127.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.897 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -53.08 138.63 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 73.53 111.15 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -149.3 156.04 41.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 75.24 110.826 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.6 114.86 18.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.72 165.87 52.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 52.33 112.504 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 178.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.682 2.255 . . . . 74.4 112.4 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -158.42 122.48 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.121 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.4 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.42 110.966 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 64.41 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 74.51 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 74.41 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.92 114.01 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.15 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -132.32 87.89 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 74.44 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -114.67 29.42 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 73.51 110.92 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.07 18.36 22.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 75.13 110.858 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 m -77.54 55.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 74.51 110.812 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -119.9 84.69 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 73.55 110.914 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.95 39.32 30.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 73.23 110.915 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.1 -173.42 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 74.54 110.894 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.86 166.64 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 72.04 110.871 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -114.08 70.85 1.97 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.75 . . . . 75.34 110.95 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.34 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 74.34 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 74.32 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.4 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.24 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.34 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 74.2 110.861 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.3 144.47 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 45.55 111.174 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.43 119.72 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 73.54 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.92 151.01 20.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.1 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.83 -176.54 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.887 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.99 144.04 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.83 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.52 -37.06 4.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.22 110.921 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 m 56.42 44.1 24.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.33 111.122 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -69.82 143.35 52.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 72.24 110.847 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.93 -95.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 63.24 112.532 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.58 43.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 74.51 111.105 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.48 176.97 6.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 74.54 110.934 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -104.07 144.28 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.878 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -150.92 170.15 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 64.52 110.853 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -118.65 -61.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.892 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -128.23 -62.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 72.54 110.87 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.5 tt -172.2 145.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.45 111.141 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -64.34 162.6 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.914 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -110.9 167.09 10.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 74.23 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -115.42 -55.25 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.883 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -63.4 122.03 15.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.1 110.975 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -125.74 160.44 56.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 72.22 111.155 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 70.22 112.351 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.11 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.21 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 71.03 111.082 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.24 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 62.42 110.861 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 71.2 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -133.68 144.7 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.12 110.924 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -104.91 104.23 13.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.55 110.935 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mp -74.46 -55.72 5.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.42 110.922 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.34 43.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 72.21 112.416 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -150.23 179.39 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 65.23 110.908 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 p -52.08 -38.64 57.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.828 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -104.04 153.08 21.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.22 110.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 74.45 110.915 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.893 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.855 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 71.34 111.177 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 158.47 42.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.863 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -128.45 149.15 50.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 73.13 110.924 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -111.75 132.12 22.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 74.24 111.118 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 81.22 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.66 2.24 . . . . 73.4 112.355 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -88.09 -72.44 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -72.61 134.7 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.872 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.2 m -120.9 154.37 35.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.124 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -78.89 88.73 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 71.34 110.881 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.12 147.63 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 73.13 111.134 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -103.22 -55.64 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 73.0 111.19 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.38 52.05 7.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 60.12 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.18 169.95 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 63.54 111.076 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.12 83.5 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.04 110.958 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 174.76 174.48 41.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.7 -0.762 . . . . 63.43 112.495 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -174.99 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.746 2.298 . . . . 74.24 112.352 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.74 69.39 44.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.688 0.756 . . . . 73.51 111.149 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -40.92 4.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.65 2.233 . . . . 71.41 112.309 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.02 136.23 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 74.25 111.063 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 m -141.54 -176.84 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 63.14 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 p 49.84 38.6 16.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 73.34 111.114 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -126.35 55.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 72.14 110.916 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.34 114.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 75.35 111.087 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -70.55 160.63 32.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.935 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 m -75.35 146.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.119 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 156.53 36.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 73.32 110.918 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 148.77 65.72 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.716 2.278 . . . . 75.25 112.318 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.18 150.02 52.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 75.31 110.888 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.33 111.157 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 72.11 110.88 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.44 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.22 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.14 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 64.13 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.13 110.917 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.42 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.11 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm -117.62 69.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 74.32 110.897 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.7 tt -65.42 -36.82 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.908 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -82.73 83.83 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 62.12 111.134 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.09 103.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 74.25 111.11 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.01 77.84 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 75.11 111.098 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 19.6 tp -137.31 126.45 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 75.13 110.882 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.892 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.828 0.347 . . . . 73.42 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -54.79 136.52 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.43 -60.11 2.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 72.53 110.891 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -150.68 147.76 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 64.05 110.903 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -51.72 156.91 2.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 75.12 111.003 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 140.28 42.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.734 2.289 . . . . 73.4 112.335 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.26 171.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 74.44 111.092 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -75.83 -175.97 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.33 110.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -69.33 133.45 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 62.52 110.865 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.55 118.02 8.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 71.51 111.095 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.71 -150.71 8.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 63.1 112.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -129.73 115.15 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 73.3 110.973 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -118.92 168.44 10.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 71.02 110.927 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 74.41 110.903 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.11 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 75.05 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.33 111.153 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.42 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 62.34 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.43 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 72.34 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 73.21 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.9 129.77 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.31 111.105 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -137.45 143.56 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.859 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.4 137.91 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 71.21 111.13 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.806 -0.712 . . . . 72.22 112.552 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -83.47 -47.33 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 72.32 110.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -126.1 -54.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mt 60.56 39.23 18.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 72.03 110.876 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.09 51.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 73.41 112.485 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -127.47 139.48 52.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 74.13 110.855 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.97 35.84 25.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 74.41 110.9 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.34 69.81 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 72.21 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.57 -35.49 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 72.33 111.138 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.93 141.64 3.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 74.12 112.538 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.9 106.58 0.37 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.674 -0.774 . . . . 75.41 112.476 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.34 132.98 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 63.4 112.452 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.21 -62.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.325 . . . . 75.53 111.087 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.11 91.03 10.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.612 0.72 . . . . 74.15 110.888 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 129.32 17.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.644 2.229 . . . . 75.33 112.345 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -138.55 121.03 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 75.41 110.897 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.02 115.09 29.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 54.1 111.085 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -132.84 167.56 19.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.878 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.26 171.12 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.079 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.4 p -158.41 123.93 4.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 71.24 110.841 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.44 111.174 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.96 95.35 2.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 50.0 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.3 m120 58.9 45.83 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 74.23 110.88 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.54 -37.54 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.853 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -102.9 138.95 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.24 111.092 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 73.12 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.24 110.915 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.54 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.141 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.12 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.887 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.155 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 65.4 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.24 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 75.34 111.163 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.11 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 74.12 111.095 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 74.31 110.818 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.04 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.31 158.98 27.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.53 112.499 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -116.36 85.62 16.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.32 111.164 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.9 64.68 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 70.21 112.336 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.36 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.061 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm-85 -66.31 143.46 57.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 75.31 110.827 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.54 168.55 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 73.35 111.068 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -119.2 46.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 73.21 110.894 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 61.17 53.28 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.861 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.65 148.04 32.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 72.42 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.67 -145.47 18.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 42.41 112.487 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -157.92 150.74 22.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 73.44 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 164.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 t -168.77 155.9 7.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 72.21 110.836 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 pt -67.29 159.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.176 -0.465 . . . . 71.44 111.203 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 p -109.15 178.43 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 71.03 110.909 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 p -103.63 176.67 5.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 71.2 110.843 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -53.09 145.5 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 73.33 110.985 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.05 -164.92 48.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 74.22 112.477 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -75.6 -175.16 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 73.43 110.881 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 t -136.48 130.74 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 64.22 111.192 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -70.73 117.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.846 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.33 -61.09 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 70.21 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.55 139.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 72.44 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.26 112.66 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.926 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.0 -51.7 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.964 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.53 73.91 0.45 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 63.32 112.454 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -179.55 3.01 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.696 2.264 . . . . 74.15 112.294 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.6 120.56 3.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 73.52 111.115 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 74.25 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.41 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.908 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -153.26 150.55 29.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.948 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -131.03 96.3 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 75.22 110.837 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -111.75 32.78 5.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.926 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -93.97 -36.76 12.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 74.4 110.945 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.9 t -143.47 -74.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 73.11 110.834 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.36 -169.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 75.24 110.838 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -74.99 72.17 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 63.14 110.871 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -153.51 -175.91 5.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.897 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.54 95.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 74.54 110.854 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.77 160.91 22.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 75.42 110.897 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 75.12 112.337 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 75.13 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.18 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.2 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.44 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.11 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.33 111.068 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 63.2 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.96 177.02 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.34 110.819 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.9 p -129.35 137.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 74.33 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 119.74 25.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -81.73 93.16 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 71.34 110.894 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -86.77 131.84 34.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 65.04 110.828 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.55 160.39 23.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 75.24 110.798 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -121.27 -51.39 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 74.52 110.905 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.3 m -119.31 142.9 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 74.14 111.184 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -66.93 171.28 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.923 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.59 -119.21 5.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 64.45 112.432 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.05 44.62 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 64.41 111.082 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.9 -38.54 73.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 62.41 110.958 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -118.29 69.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 53.32 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 t -138.37 -178.67 5.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.84 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.13 169.4 9.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 74.02 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.8 131.0 40.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.949 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.99 108.95 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 73.45 111.131 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.38 42.81 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.34 110.896 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -130.38 65.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.827 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -115.63 36.48 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.849 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -62.43 135.84 57.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.451 . . . . 75.45 110.955 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -132.14 95.14 22.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.564 0.697 . . . . 73.35 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.32 112.276 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 75.43 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 73.35 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 72.41 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 70.41 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 75.32 110.914 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -140.18 116.29 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.932 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -106.52 94.84 5.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 71.11 110.875 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.51 -71.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 74.2 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -65.48 -168.89 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 72.34 112.497 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -115.82 -36.16 4.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 52.54 110.842 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 t -56.54 -60.56 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 70.42 110.859 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -134.43 170.63 15.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.954 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.941 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 73.21 110.914 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.44 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -148.29 153.54 38.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.99 135.58 53.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.22 110.874 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 tp -109.66 131.54 21.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 73.15 111.125 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -45.09 1.69 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.245 . . . . 73.04 112.4 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -161.18 147.79 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 74.52 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -117.61 129.12 55.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 75.42 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.4 m -76.94 81.33 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 71.01 111.085 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -93.04 179.21 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.873 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.61 145.27 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 73.02 111.153 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 18.4 p -69.72 158.53 35.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 73.34 111.208 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.91 155.12 11.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 73.11 112.514 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 73.1 p -66.11 -174.92 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 65.04 111.163 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -131.07 -176.39 3.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.942 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.28 -177.35 40.37 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 41.43 112.457 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 162.44 42.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 75.41 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 33.7 t 51.72 68.25 3.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.614 0.721 . . . . 75.53 111.134 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 98.72 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 75.13 112.353 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.64 67.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 75.13 111.095 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 161.78 31.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 64.35 110.869 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.1 p -129.96 -62.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 73.11 111.112 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -128.15 70.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.54 110.874 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.09 -34.48 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 73.24 111.095 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -141.17 134.92 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.21 110.861 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.79 -58.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.101 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -126.65 69.92 71.35 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.607 0.718 . . . . 72.11 110.894 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 142.94 48.77 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 75.11 112.333 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.65 153.81 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 73.13 110.906 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 74.32 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 70.02 110.888 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 73.44 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 74.41 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.14 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 63.45 111.097 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 63.04 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.911 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -52.41 28.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.25 110.889 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.67 111.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 74.23 111.125 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -110.47 92.68 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 65.13 111.072 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.43 92.42 4.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 73.03 111.124 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.44 85.56 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 65.25 110.88 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 74.2 110.843 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.841 0.353 . . . . 71.33 110.871 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -143.95 147.08 33.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.888 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -127.9 141.26 51.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.875 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -132.48 137.21 47.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 73.1 110.962 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -168.41 68.24 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.728 . . . . 74.21 110.902 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.72 113.53 3.4 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 74.43 112.328 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.33 109.1 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 65.51 111.07 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -64.79 163.64 13.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 75.35 110.894 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -129.68 156.48 44.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 70.42 110.906 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.63 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 62.44 111.143 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.92 -170.54 32.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 74.04 112.462 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -172.08 129.42 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 74.52 110.943 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -134.96 166.51 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.54 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.3 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.11 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 72.4 111.096 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 53.13 111.119 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.22 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.21 110.874 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.44 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 74.13 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -81.39 114.91 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.107 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -114.06 144.46 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 74.13 110.948 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.14 148.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.31 160.64 44.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.829 -0.701 . . . . 75.21 112.495 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -79.62 -48.55 13.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 74.41 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.55 50.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.903 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 mt 53.82 43.09 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 73.23 110.9 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.88 -123.54 4.89 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 52.3 112.509 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -71.29 178.44 3.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.36 . . . . 74.32 110.829 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.11 66.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 75.24 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -105.67 105.8 16.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 65.23 110.915 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.56 128.96 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.05 111.152 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.52 68.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 65.12 112.534 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.5 71.41 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 72.13 112.499 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.39 -141.21 9.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 64.45 112.494 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 143.71 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 63.03 111.083 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.35 160.68 70.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 72.42 110.875 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 129.42 17.6 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.695 2.264 . . . . 64.34 112.375 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -134.89 170.68 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.45 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.46 117.04 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 71.4 111.052 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 47' ' ' VAL . 81.4 m-20 -102.96 -45.18 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 64.31 110.844 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ASP . 27.0 m 37.05 44.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 72.2 111.082 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 p -117.56 75.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 75.34 110.858 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.24 107.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 71.32 111.148 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.65 -143.66 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.516 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -75.65 75.65 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 74.11 110.858 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -92.51 -36.38 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 65.3 110.847 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m -60.17 102.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 72.02 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.54 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 75.24 110.916 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.147 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 63.12 110.87 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.092 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 73.14 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 72.23 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.01 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 65.03 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.12 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.863 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 71.33 111.149 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 73.55 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 74.44 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.72 177.75 36.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.53 112.52 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.46 155.54 13.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 70.34 111.173 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 139.17 39.4 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 74.34 112.374 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.83 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 70.44 111.079 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -171.78 112.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 70.44 110.822 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.65 169.76 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 72.35 111.071 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -118.23 169.87 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.917 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -149.3 164.75 33.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.905 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.35 172.03 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.926 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.05 166.39 3.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.75 . . . . 60.25 112.47 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -117.23 161.44 19.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 73.21 110.852 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -61.23 -71.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.934 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -174.8 122.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 70.42 110.82 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.2 mt -89.24 -53.56 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 71.13 111.135 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 t 61.5 38.88 15.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 72.25 110.908 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 t 52.53 50.21 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.513 . . . . 74.32 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.1 tt -109.79 109.07 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.998 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.66 146.43 0.51 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 45.45 112.512 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -99.32 -61.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 74.52 110.883 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 m -148.94 142.1 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 p -104.77 -72.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 70.22 110.853 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -151.06 159.75 44.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.24 110.877 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.4 133.81 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -148.86 110.29 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.854 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -103.71 85.87 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.23 68.74 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.719 . . . . 72.04 112.522 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 178.37 4.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 61.32 112.377 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -171.88 148.82 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 73.24 111.155 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.45 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 70.15 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.34 110.894 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -148.65 129.77 14.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -131.49 167.09 19.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 74.34 110.892 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -82.25 89.45 6.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.938 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.92 17.48 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.911 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.7 m -53.71 -36.33 62.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 65.14 110.921 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -136.14 -173.91 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 72.22 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.44 90.62 3.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 63.11 110.919 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -173.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.87 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.7 139.18 58.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 64.31 110.943 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -157.13 158.78 31.25 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.704 0.764 . . . . 74.43 110.954 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.51 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.52 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.21 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.52 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 54.33 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 71.52 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.13 111.171 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -125.73 127.6 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 72.23 110.923 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.0 p -121.73 139.61 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 74.15 111.144 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 119.35 21.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 70.13 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -109.84 164.96 12.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -67.46 104.73 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.882 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.59 109.24 19.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 75.51 110.825 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -106.96 91.56 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.928 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -164.19 136.35 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 61.2 111.163 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.59 -71.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.192 -0.458 . . . . 60.22 110.91 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.97 148.19 4.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.757 -0.735 . . . . 73.12 112.462 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.64 171.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.339 . . . . 75.23 111.097 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.95 75.13 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.939 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -148.96 179.42 7.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 71.22 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -68.34 152.59 45.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.44 110.876 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.65 151.58 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 70.14 110.929 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.63 147.65 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 63.55 110.783 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.2 mt -63.22 134.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 75.1 111.09 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -103.63 144.51 31.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.877 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -165.13 -176.49 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.859 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -140.19 122.73 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 73.15 110.865 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 25.3 p-90 -118.72 131.07 56.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.983 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -127.8 159.96 63.58 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.573 0.702 . . . . 73.54 111.094 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.54 112.314 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.45 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.201 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 44.54 112.451 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.32 110.894 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -152.35 153.08 32.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.947 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.36 144.44 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 72.52 110.855 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.1 93.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 72.54 110.878 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.71 -159.61 22.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 75.51 112.446 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.95 125.91 50.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 62.34 110.871 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.5 m 51.74 35.23 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 64.15 110.838 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -159.97 142.56 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 75.24 110.88 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.918 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.02 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 72.11 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 72.45 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.136 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -146.05 146.2 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -112.07 131.98 55.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.969 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 67.5 mt -68.35 133.12 91.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.753 . . . . 74.54 111.082 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -44.9 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.669 2.246 . . . . 71.35 112.31 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.09 123.99 31.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 71.52 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -173.08 104.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 72.5 110.922 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.8 t -141.15 150.12 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 64.53 111.14 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -169.03 117.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 75.23 110.847 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.97 134.15 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 75.31 111.131 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -172.04 129.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 70.52 111.23 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.04 52.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.692 -0.766 . . . . 70.34 112.414 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.7 p -85.49 60.21 6.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 71.34 111.153 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.3 tt -175.19 146.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 72.34 110.865 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 171.74 174.87 39.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.793 -0.718 . . . . 62.33 112.535 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -45.88 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 75.21 112.333 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.95 156.24 74.29 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.643 0.735 . . . . 75.11 111.14 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 110.99 2.72 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.633 2.222 . . . . 73.41 112.335 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.25 176.72 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 75.31 111.128 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 t -52.38 118.6 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 62.53 110.842 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -116.45 -38.78 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 63.51 111.198 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 136.43 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.15 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -118.39 -35.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 72.32 111.147 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.13 131.01 53.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 64.23 110.838 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.74 -36.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 72.44 111.129 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.65 73.33 0.95 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.698 0.761 . . . . 71.2 110.879 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.22 59.33 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.619 2.213 . . . . 75.42 112.355 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -116.8 146.42 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 74.15 110.894 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 74.43 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.957 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 71.15 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.93 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 71.12 112.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 74.05 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.23 110.841 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.34 111.115 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 67.28 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.876 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.09 -58.72 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.989 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -112.74 134.85 54.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 73.11 111.149 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.63 161.87 36.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 72.44 111.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.31 84.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.126 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 pp -165.28 175.23 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.972 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 61.34 110.849 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.748 0.308 . . . . 74.11 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -131.23 86.12 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -113.34 133.33 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 74.53 110.835 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.88 154.13 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 72.52 110.861 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.09 160.51 56.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.724 0.773 . . . . 72.22 110.884 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 132.57 23.7 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 74.41 112.346 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.45 176.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 71.04 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 161.28 28.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 73.43 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -160.15 160.93 33.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 71.42 110.862 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.82 114.11 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 64.14 111.084 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.94 47.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 60.15 112.449 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -117.58 103.83 10.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 74.51 110.92 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -103.99 164.27 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 73.1 110.882 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.32 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.5 111.168 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 74.22 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -85.96 135.77 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.14 111.147 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -132.26 141.04 48.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -122.26 139.19 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.148 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -129.68 0.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 75.21 112.527 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.44 -40.34 78.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.336 . . . . 70.01 110.904 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 62.48 38.18 12.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.907 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.35 -61.32 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 73.24 110.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.49 -103.94 1.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 63.23 112.526 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -127.11 166.15 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 72.34 110.88 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -121.07 74.24 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 75.43 110.952 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.13 170.15 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 73.24 110.916 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.72 160.43 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.187 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.61 -99.3 0.38 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.757 -0.735 . . . . 72.24 112.462 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.41 91.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 65.21 112.505 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.4 129.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.662 -0.78 . . . . 74.22 112.477 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.98 -71.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 72.14 111.05 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.15 160.68 29.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 75.51 110.902 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 104.49 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.709 2.273 . . . . 73.03 112.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -169.62 125.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.853 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.49 113.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 75.5 111.106 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.5 115.45 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.17 138.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.43 111.132 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -172.84 115.34 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.881 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 tp -169.04 135.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 75.0 111.11 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.27 175.38 14.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 73.11 112.497 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.35 87.06 2.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 71.42 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.24 30.58 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -104.19 134.25 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 74.55 111.141 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.41 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 75.11 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 73.1 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.12 111.083 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.42 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.35 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 75.21 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 75.44 111.111 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 64.04 111.151 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.12 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.34 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.52 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.8 176.25 39.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.34 112.523 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.09 85.36 15.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 74.3 111.09 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 173.64 10.7 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 74.41 112.403 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -37.51 85.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.22 111.107 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -84.33 77.71 9.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 74.05 110.852 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.1 -37.59 5.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 74.44 111.088 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -126.25 58.75 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 72.33 110.929 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -126.16 71.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.27 -64.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.72 128.49 42.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 75.33 112.444 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -127.6 -40.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 72.44 110.934 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -105.56 -74.42 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.881 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -164.08 160.4 21.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.86 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.07 68.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.45 111.14 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 t -125.3 44.12 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 62.14 110.823 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 t -118.29 -179.81 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.922 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.1 mt -124.78 65.24 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.888 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.92 -108.24 0.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 70.43 112.456 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.47 93.42 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 72.41 110.919 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.54 167.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 73.33 111.105 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -73.21 -176.73 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.874 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.3 167.61 29.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 71.44 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.84 -35.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 72.4 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -52.06 157.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.4 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -149.02 168.21 23.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 75.03 110.891 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.16 72.29 1.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 71.1 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.87 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.656 2.238 . . . . 53.42 112.37 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -163.93 140.95 6.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 63.02 111.094 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 75.35 111.152 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.41 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.13 110.886 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.32 110.883 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 72.13 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -153.26 137.29 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.989 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -130.92 88.01 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 71.12 110.845 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -106.66 37.42 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.931 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.18 -40.16 15.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 70.44 110.835 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -142.47 -74.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.873 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -174.61 -176.65 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 74.24 110.931 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.52 95.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 75.1 110.817 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.51 -173.72 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.925 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 98.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 74.13 110.919 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -161.17 161.0 24.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.655 0.741 . . . . 73.11 110.945 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.11 112.378 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 72.21 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.42 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.34 111.106 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.43 112.5 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.34 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -145.1 164.39 31.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.15 110.885 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.48 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 75.35 111.072 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 15.9 tp -86.39 146.53 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 62.41 110.915 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -123.52 -36.31 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.893 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.08 86.22 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.898 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -115.33 -61.82 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 75.33 110.812 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -151.47 146.25 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 74.21 110.844 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.6 p -105.89 85.22 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.157 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.94 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 72.04 110.856 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.43 -62.67 1.26 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.501 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.46 43.55 19.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 64.02 111.147 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 tt -72.54 91.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.888 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.7 m 53.84 40.62 31.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.25 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -122.84 71.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.88 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -113.16 42.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 74.14 110.844 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -172.24 109.78 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.903 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.6 mm -121.6 124.97 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.117 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -90.61 154.34 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 74.45 110.919 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -88.63 133.65 34.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.435 . . . . 60.13 110.855 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -118.08 72.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 74.41 110.949 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -53.68 139.32 32.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 75.42 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -137.03 95.04 12.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 73.34 111.158 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 71.1 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.904 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 73.04 111.166 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 72.31 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.14 110.857 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -152.65 141.31 20.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.53 110.93 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.98 155.38 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.83 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -125.45 37.59 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 75.53 110.951 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.65 82.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 61.23 112.453 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -175.81 169.72 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 74.42 110.997 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.6 m -56.05 -36.31 67.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 70.42 110.783 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -108.65 164.47 12.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.854 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 73.12 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.43 110.915 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.13 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.3 111.133 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.55 165.63 34.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.868 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -142.08 152.34 43.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 73.54 110.913 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 55.3 mt -120.5 130.0 25.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.743 . . . . 73.53 111.073 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 -36.83 10.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 73.22 112.392 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.68 179.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.874 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.11 91.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.909 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -172.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 71.35 111.133 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -101.79 102.86 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.04 110.876 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.7 p -89.45 133.25 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 72.42 111.121 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 72.4 p -91.8 146.91 23.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.149 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.31 83.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.659 -0.782 . . . . 74.21 112.459 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.6 m -156.59 122.5 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 71.45 111.172 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 mt -69.67 -57.48 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.32 110.973 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 133.55 -74.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 74.33 112.524 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 149.31 66.4 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.714 2.276 . . . . 74.11 112.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 38.2 t 61.39 69.89 0.97 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.665 0.745 . . . . 71.11 111.148 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 88.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 72.14 112.361 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 41.0 t -102.35 -70.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 64.04 111.054 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.9 t -139.16 151.69 46.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 73.41 110.8 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.4 t -171.94 142.57 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 73.23 111.186 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -133.79 147.35 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.901 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.14 132.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.1 111.062 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -100.14 113.73 26.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 53.42 110.918 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.18 88.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.3 111.136 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.2 t0 52.88 74.59 0.75 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 63.42 110.816 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 148.7 65.61 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 72.51 112.325 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.53 144.27 48.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 75.12 110.861 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 75.32 111.156 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 74.34 110.951 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.53 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 74.4 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.31 111.08 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.53 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.05 68.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.31 110.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.49 -37.37 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.945 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 57.23 46.59 18.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 74.1 111.12 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -101.32 83.36 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 64.14 111.081 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.66 168.98 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 62.33 111.092 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.4 109.97 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.903 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.897 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.803 0.335 . . . . 73.24 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -161.93 159.49 26.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 60.02 110.858 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -129.12 125.1 36.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 71.31 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -121.24 143.23 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 74.31 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -143.93 157.56 57.51 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.627 0.727 . . . . 74.34 110.957 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.16 34.7 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.701 2.267 . . . . 74.52 112.347 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.5 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 71.1 111.094 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -119.39 -38.69 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.908 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -138.54 138.66 38.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 74.3 110.823 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.8 140.67 32.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 63.01 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.93 -152.28 9.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.723 . . . . 60.42 112.529 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -145.5 119.15 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 74.13 110.947 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -149.96 149.77 30.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 61.13 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.15 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 60.12 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 75.53 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.33 111.128 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 71.35 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 71.4 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 64.13 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 71.12 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.83 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 72.21 111.128 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -123.92 148.93 46.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.931 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.01 -179.52 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 75.02 111.114 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.78 -162.22 18.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 75.53 112.44 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -52.27 -40.9 62.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.778 0.323 . . . . 74.13 110.875 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 64.38 57.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.2 110.864 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.83 34.49 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.87 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.59 119.69 19.69 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 74.52 112.468 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.41 169.19 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 73.24 110.831 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 tp 60.11 36.71 21.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.907 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.52 -38.03 11.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.948 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.97 132.98 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.25 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -86.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.768 -0.729 . . . . 61.21 112.418 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 160.46 40.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.761 . . . . 63.02 112.526 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.52 82.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 44.42 112.457 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.5 70.76 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 63.35 111.074 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.2 159.19 32.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.554 0.692 . . . . 74.35 110.946 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 169.86 17.88 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 75.22 112.358 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -156.08 120.08 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 72.32 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.65 47.86 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 64.25 111.04 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.67 150.48 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 71.03 110.82 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.94 147.13 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 74.23 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -169.06 132.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.88 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 tp -119.97 134.7 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.093 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.75 142.3 13.78 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 75.42 112.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -81.11 100.9 9.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 71.23 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.4 30.56 7.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 70.33 110.872 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -67.42 126.02 27.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.117 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.31 111.219 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.43 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.33 111.137 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 75.53 111.075 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.887 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 71.2 110.862 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.51 111.147 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 72.32 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 64.12 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 74.33 111.082 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.137 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.857 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.858 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 63.41 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.97 -154.64 7.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.13 112.528 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.06 155.88 42.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.622 0.725 . . . . 75.13 111.125 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 174.5 9.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.679 2.253 . . . . 73.35 112.334 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.21 77.67 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 71.13 111.095 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -52.59 -37.37 57.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.918 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.71 -55.52 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.22 111.146 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -76.91 133.36 39.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 71.45 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.82 160.88 39.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 73.45 110.889 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -172.7 150.88 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.986 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.45 153.28 5.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 53.31 112.506 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.3 -37.63 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 74.32 110.838 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.65 149.0 19.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.93 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 p -162.05 108.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 72.45 110.897 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.73 94.78 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.32 111.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 p -159.35 179.63 8.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.914 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -164.75 139.7 5.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.913 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -146.53 163.91 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.957 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.31 77.51 0.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 71.32 112.512 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.39 41.59 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 73.44 110.843 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 p -144.52 139.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.02 111.131 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -132.16 -61.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 72.51 110.86 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.61 -69.23 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.5 140.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 72.34 111.17 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -117.06 137.31 52.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 70.42 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -74.1 -67.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.958 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.73 -167.96 28.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.33 112.446 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 141.48 45.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.658 2.238 . . . . 63.13 112.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.82 137.68 35.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.12 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 73.15 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 72.12 110.96 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -153.49 157.42 39.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.894 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -121.98 143.28 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.803 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -49.37 -46.82 47.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.923 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.4 -41.9 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.21 110.898 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 t 50.43 64.42 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.34 23.26 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.9 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 48.54 85.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 65.14 110.91 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -173.44 173.31 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 70.42 110.874 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.34 96.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.51 110.862 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -162.87 161.07 19.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.665 0.745 . . . . 74.52 110.952 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.44 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 75.24 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.52 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.1 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 70.54 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.01 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 62.32 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -171.52 156.72 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.52 110.893 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.25 136.92 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.43 111.132 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.98 111.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.898 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -52.68 145.04 12.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 71.42 110.916 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -100.0 97.72 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 74.51 110.909 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -59.74 168.89 1.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 63.25 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -74.33 -175.26 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 73.53 110.846 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.45 163.77 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.14 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.03 38.95 13.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.913 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.95 -174.64 6.59 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.518 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.19 36.33 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 74.04 111.106 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 tp 59.43 37.72 23.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.99 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 t -96.52 164.42 12.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 73.41 110.821 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 p -141.34 174.59 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -168.96 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 74.03 110.853 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.73 145.9 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 54.41 110.933 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.2 mt -116.26 132.08 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 74.04 111.135 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -123.01 60.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.892 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.58 -176.98 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.05 110.882 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -140.27 170.31 16.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 75.11 110.826 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -65.87 152.22 44.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 65.22 110.907 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -110.31 160.4 28.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 71.53 111.086 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 74.53 112.324 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.33 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.2 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 73.01 111.146 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.2 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.53 110.877 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.873 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -118.73 115.17 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.959 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.3 96.09 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.841 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 4.6 tp -60.27 -36.04 76.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 63.01 110.926 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 139.45 -47.68 0.89 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 73.13 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.23 174.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 74.51 110.937 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.0 p -52.35 -36.81 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 71.43 110.931 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -87.61 150.2 23.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.09 -0.505 . . . . 74.23 110.975 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 73.33 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.54 110.87 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 72.05 110.909 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.21 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.33 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.43 111.126 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -149.44 135.41 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -141.71 139.96 33.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.941 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.6 153.11 81.01 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.64 0.733 . . . . 71.51 111.123 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 132.91 24.2 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.683 2.255 . . . . 65.1 112.355 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -143.88 131.34 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.924 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -139.46 140.35 37.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 71.24 110.903 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.2 m -148.2 144.53 27.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 72.31 111.159 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.37 98.36 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.13 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.73 109.98 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 65.35 111.099 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.3 t -56.47 -35.31 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 71.31 111.105 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.51 172.79 38.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 65.2 112.493 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.7 t -98.73 145.26 27.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 72.31 111.169 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.7 tt -112.35 93.36 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.91 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.43 175.14 20.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 61.34 112.453 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 126.01 12.83 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.729 2.286 . . . . 74.44 112.326 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.3 t -134.11 133.22 21.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 72.24 111.127 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.66 -48.35 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.673 2.249 . . . . 71.23 112.381 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.6 t -148.09 139.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 75.42 111.19 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -172.39 113.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.943 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 68.6 p -118.85 107.67 13.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 74.01 111.144 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -89.64 -64.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 74.3 110.841 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.2 tt -167.32 137.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.14 111.117 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -52.74 163.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.921 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.19 -55.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 73.34 111.091 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -153.55 71.54 6.75 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.64 0.733 . . . . 73.24 110.867 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 134.13 27.27 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.666 2.244 . . . . 64.13 112.367 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -98.53 141.91 30.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 71.43 110.812 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 75.42 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 71.22 110.885 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.13 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 70.43 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 71.44 111.135 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.21 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -115.04 84.13 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.43 110.946 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.83 -62.04 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.975 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.09 16.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.32 111.105 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -169.11 165.55 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.047 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.62 96.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 73.54 111.165 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.27 65.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.928 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 60.15 110.893 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.754 0.312 . . . . 74.05 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -140.43 151.4 44.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.929 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -119.07 179.8 4.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 74.41 110.89 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -141.7 165.71 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 61.42 110.917 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -150.39 72.2 9.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.74 0.781 . . . . 74.11 110.929 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 149.41 67.24 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.632 2.222 . . . . 72.01 112.378 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.44 160.45 31.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.079 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.42 58.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.34 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -81.88 157.87 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 74.43 110.867 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 171.31 11.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 64.11 111.095 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.45 163.78 27.8 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.75 . . . . 70.32 112.441 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -140.65 117.55 11.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.392 . . . . 72.14 110.98 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -152.79 173.41 15.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 64.51 110.828 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.88 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.24 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.34 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 75.21 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.23 111.113 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 72.45 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 72.41 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.54 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.836 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.801 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 75.41 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -84.87 132.61 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 74.43 111.087 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -129.08 154.21 46.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 74.24 110.919 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -138.51 142.85 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 73.14 111.14 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.98 133.19 11.2 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 65.41 112.486 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.57 -42.67 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 74.05 110.883 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 63.2 45.97 4.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 75.32 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 tp -99.94 36.29 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.71 135.04 13.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 73.45 112.484 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -163.76 166.33 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.333 . . . . 74.33 110.881 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.27 -47.06 83.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.929 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -151.94 122.58 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.22 110.897 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.07 -36.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 75.11 111.114 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.88 -176.61 42.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.791 -0.719 . . . . 70.33 112.506 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.06 -133.24 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 71.14 112.533 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.33 -158.75 26.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 73.21 112.405 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.72 -68.56 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 74.14 111.124 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.64 160.68 58.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.647 0.737 . . . . 75.33 110.874 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 113.68 3.45 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 73.41 112.336 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -108.84 105.65 15.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.886 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.17 110.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.044 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.51 149.86 28.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 64.12 110.863 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.4 p -139.5 137.14 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.3 111.18 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.7 m -125.63 39.72 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 74.02 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 pt -142.56 -178.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 65.34 111.068 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.39 -137.2 4.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 72.11 112.502 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 53.62 45.83 27.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 63.5 110.883 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.05 -37.32 5.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.83 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t -57.76 138.27 55.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 65.15 111.14 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.34 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 75.22 110.892 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 73.41 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 65.02 111.163 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 65.11 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.42 110.866 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 74.13 111.078 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.14 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 72.15 111.093 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.123 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.932 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 75.11 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 74.5 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.76 -157.04 27.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 73.2 112.448 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -89.27 133.3 35.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 75.11 111.187 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 166.72 26.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 75.12 112.308 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.56 -59.82 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 62.51 111.18 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 -178.84 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.21 148.71 41.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.02 111.1 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -159.55 137.64 10.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.43 110.931 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.33 -39.66 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 73.3 110.905 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -114.15 -68.21 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.882 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.05 -79.16 0.25 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 72.52 112.478 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -94.07 66.5 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 72.04 110.906 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -162.44 135.42 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 73.41 110.901 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -52.67 160.87 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.819 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 pt -54.94 173.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 72.5 111.134 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -131.8 -60.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 64.01 110.87 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 p -170.47 172.29 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 61.31 110.909 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.82 146.43 54.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.916 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.04 140.08 3.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.752 . . . . 74.22 112.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -172.45 127.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.377 . . . . 75.24 110.894 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.23 176.28 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 73.41 111.125 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 p -131.49 -175.44 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 74.42 110.844 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -161.5 121.56 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 70.43 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.89 43.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 73.12 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 150.58 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 65.01 110.87 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -54.56 145.21 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 73.45 110.909 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.4 -71.87 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.664 -0.779 . . . . 74.22 112.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 154.75 67.1 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.702 2.268 . . . . 74.34 112.332 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -171.51 166.86 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 72.24 111.117 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 73.13 111.177 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 71.12 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 73.23 110.911 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 75.54 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -132.3 144.32 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.933 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -112.6 150.83 30.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.32 110.913 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -47.58 64.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 75.43 110.889 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.13 -41.76 5.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 73.42 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 35.78 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.811 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.31 33.18 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.86 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 51.55 59.03 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 75.24 110.935 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.8 mtp85 -137.65 165.92 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 73.51 110.876 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.0 mp -68.75 98.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.91 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -160.33 160.6 26.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.717 0.77 . . . . 73.41 110.894 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.35 112.327 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.217 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.12 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.51 111.177 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 52.42 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.34 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.476 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.16 110.38 14.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.24 110.859 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 t -140.39 134.46 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.102 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.445 ' CD1' ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.68 157.18 45.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.864 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.78 55.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 75.41 110.817 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -52.18 140.94 19.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 65.03 110.839 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -160.68 130.84 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 64.32 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -151.98 133.77 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.88 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 p -84.11 69.72 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 74.24 111.106 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -158.54 151.3 22.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.33 110.89 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.03 56.24 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 62.13 112.535 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.07 53.36 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.32 111.115 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tp 52.54 37.0 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 65.02 110.933 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 p 51.88 37.66 21.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 62.12 110.87 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.6 p -84.59 -179.19 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 72.03 110.891 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 56.91 50.27 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.88 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.4 61.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.825 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.4 pt -95.96 45.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 73.11 111.106 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.22 132.61 43.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.877 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.83 164.4 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -160.45 152.94 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 75.03 110.862 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -152.96 160.66 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 74.23 110.989 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -161.65 160.44 22.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 72.42 111.107 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 73.31 112.291 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.15 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.893 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 64.21 111.154 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 72.54 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.33 110.89 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 74.31 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.31 131.59 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 71.43 110.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.26 127.13 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 72.31 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.8 tt -170.16 119.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.915 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 147.26 -120.03 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 44.44 112.484 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -114.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 72.24 110.925 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.6 p -120.62 -48.86 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.45 110.898 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -72.33 172.26 10.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 75.52 110.957 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.4 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.4 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.22 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.23 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.082 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -149.27 129.25 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 75.43 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.29 127.45 35.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.903 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 3.3 tp -143.83 96.55 5.54 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.65 0.738 . . . . 64.13 111.158 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 91.44 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 70.21 112.308 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -81.89 100.9 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 74.2 110.871 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -70.65 158.34 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 75.41 110.945 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p -111.51 164.65 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 62.4 111.155 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -125.59 101.37 6.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 64.42 110.88 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.41 136.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 73.34 111.122 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.2 m -56.61 145.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 73.35 111.173 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.61 94.4 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 72.24 112.467 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 63.1 p -128.95 126.95 40.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 63.33 111.169 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -123.66 90.01 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 73.14 110.916 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 177.93 -74.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.709 . . . . 55.22 112.493 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -173.66 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.247 . . . . 72.35 112.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.68 70.19 11.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.568 0.699 . . . . 71.32 111.121 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -179.77 3.11 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.754 2.303 . . . . 64.23 112.396 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.17 102.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 72.2 111.151 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 187' ' ' THR . 3.1 p -83.07 -60.51 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.833 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 186' ' ' SER . 10.1 t 37.39 43.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.54 111.188 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -128.67 72.82 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.882 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.74 -63.27 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 75.31 111.087 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -67.74 96.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 74.32 110.888 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.35 108.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 111.133 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -164.69 73.18 1.55 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.609 0.718 . . . . 73.31 110.869 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 146.78 60.97 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.651 2.234 . . . . 70.02 112.325 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -133.05 156.2 47.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 75.21 110.845 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 75.01 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 72.51 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.1 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 74.2 110.975 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.42 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.22 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.15 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.925 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 74.25 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.25 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 61.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.24 110.944 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.1 pp -52.14 -36.19 50.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.35 110.866 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -80.17 127.61 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 64.13 111.045 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -108.87 -51.49 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 111.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.43 128.71 48.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.42 111.171 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.0 pp -129.15 -176.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 72.41 110.907 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.32 110.89 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.726 0.298 . . . . 75.35 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -136.73 -179.77 5.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 71.15 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.82 176.01 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.49 111.01 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.27 159.43 29.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.69 0.757 . . . . 74.11 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.84 107.76 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.683 2.255 . . . . 73.33 112.343 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.48 155.99 38.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.038 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 159.61 33.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 73.01 110.909 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -143.37 169.68 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 54.23 110.811 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.42 179.33 4.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 62.44 111.079 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.65 -174.0 27.8 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 61.15 112.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -150.1 124.08 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 72.21 110.904 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -153.98 -176.26 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.45 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.31 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.3 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.934 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.33 111.078 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 54.31 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 74.31 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.21 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 62.01 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 75.21 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.03 135.48 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.33 111.093 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -122.74 115.49 22.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 75.41 111.001 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.54 152.68 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 72.14 111.192 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.77 -39.45 5.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 74.34 112.491 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -34.7 41.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 73.41 110.831 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.19 -44.72 75.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.902 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.38 -36.12 68.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.53 110.889 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 168.45 36.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 64.33 112.475 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -83.32 89.71 7.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 73.52 110.91 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.64 -51.11 71.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 64.23 110.873 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -142.58 174.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 75.52 110.939 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.62 -36.53 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.4 111.115 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -149.72 37.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 61.24 112.484 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.92 166.78 17.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.748 . . . . 70.32 112.556 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.02 174.59 31.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 63.41 112.431 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.18 68.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 61.03 111.153 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.71 159.25 72.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 169.97 17.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 64.33 112.363 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -78.94 88.63 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 70.13 110.935 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.8 143.27 43.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 74.11 111.072 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 41.82 39.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.885 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.01 -35.79 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.13 111.067 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -52.08 -61.51 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 64.15 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.9 mm -91.28 102.78 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 73.31 111.185 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.36 136.57 30.24 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.735 -0.745 . . . . 72.53 112.493 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -88.7 74.14 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 74.12 110.907 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -98.69 30.56 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 64.42 110.932 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -60.61 128.0 34.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 74.24 111.183 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.13 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.893 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.22 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 73.34 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 75.14 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.094 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 75.1 111.154 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 54.34 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.2 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 75.12 111.204 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.099 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.066 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 73.42 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.33 110.875 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.35 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.21 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.67 -178.01 32.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 34.12 112.464 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -113.8 85.28 9.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.651 0.739 . . . . 74.24 111.138 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 132.17 22.78 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.274 . . . . 73.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.86 86.63 6.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 72.32 111.115 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -107.53 149.6 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.889 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.1 101.19 5.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.032 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -171.0 156.93 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 74.25 110.898 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -112.39 178.63 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.24 110.91 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -88.79 175.67 7.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 73.2 110.953 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.9 76.2 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.504 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.51 84.48 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 73.52 110.895 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -100.07 142.89 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 72.11 110.884 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.0 m -94.7 -42.36 8.8 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 54.34 110.838 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -51.78 -35.55 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 74.52 111.135 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.3 m -120.88 85.45 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.873 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 t -149.72 145.02 26.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.959 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 -40.4 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.67 -119.57 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.764 . . . . 70.54 112.492 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -111.16 96.16 5.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 74.14 110.896 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.81 91.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.087 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -99.49 53.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.804 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.35 104.96 13.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.832 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.17 136.55 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 63.31 111.121 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.35 165.75 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 75.54 110.856 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.26 -36.82 20.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.909 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.25 -167.78 22.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 65.1 112.481 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 138.73 38.48 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.733 2.289 . . . . 74.44 112.35 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -176.33 164.7 2.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 64.55 111.074 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.152 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.52 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.907 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 60.41 110.902 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -143.36 140.7 30.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.24 110.924 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.02 166.83 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.04 110.819 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -132.33 36.03 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.935 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.11 -41.57 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 74.05 110.854 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.62 55.49 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 74.41 110.881 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.37 174.0 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 74.53 110.867 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.06 94.78 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 72.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -174.58 -173.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 74.33 110.942 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -81.0 134.01 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 75.14 110.877 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -173.05 157.02 3.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.727 0.775 . . . . 75.45 110.845 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 74.34 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 73.21 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 73.33 111.087 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.15 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 65.33 111.104 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 73.22 112.44 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -139.08 123.93 18.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 75.33 110.873 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.92 133.95 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 71.24 111.119 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.9 tp -130.91 139.49 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.12 110.936 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.08 127.69 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.879 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -102.48 90.64 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.846 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.37 124.66 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 72.04 110.856 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -136.73 150.02 48.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 75.33 110.925 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 t -163.81 135.57 4.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 75.53 111.117 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.45 121.63 29.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 63.01 110.902 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -175.37 -119.38 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 71.23 112.482 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 73.42 111.077 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 128.0 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.2 110.937 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 p -89.78 -44.39 10.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 74.02 110.886 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 m -120.93 108.24 13.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 73.34 110.875 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -118.38 37.39 4.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 70.42 110.842 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.29 68.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 73.22 110.913 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -159.98 144.57 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.081 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.69 165.47 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 64.31 110.915 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.42 116.15 31.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 74.32 110.848 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -100.6 -43.94 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 75.11 110.873 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -106.47 81.23 1.57 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 64.25 110.894 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -106.33 95.67 12.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 61.33 111.099 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.881 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 75.53 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.509 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 73.11 110.84 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -130.49 129.07 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.949 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -103.53 122.53 45.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 74.05 110.853 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.5 mt -140.99 -179.89 6.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.34 110.89 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.31 -125.99 29.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 64.3 112.497 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -127.73 -52.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 73.4 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 m -114.95 -44.52 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 73.01 110.827 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -71.23 124.14 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.934 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 71.42 110.879 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.44 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -130.98 123.99 30.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.861 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -140.6 126.86 19.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 75.5 110.915 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 5.2 mp -85.14 133.11 43.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 73.11 111.141 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 140.0 41.5 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.718 2.279 . . . . 71.53 112.389 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -114.18 149.21 36.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 75.13 110.915 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 135.58 38.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 72.22 110.921 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 77.9 p -70.26 168.19 16.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.32 111.167 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.98 143.1 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 73.23 110.867 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.54 141.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.03 111.128 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.5 p -121.18 155.26 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 73.24 111.218 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.43 158.69 19.34 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 63.25 112.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -118.2 74.59 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 73.02 111.123 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.3 137.24 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.986 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.35 -174.61 55.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 71.52 112.511 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -33.93 15.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 71.41 112.347 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.2 156.12 72.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 64.51 111.164 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 114.93 3.86 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.71 2.273 . . . . 74.14 112.318 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.15 105.14 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 72.3 111.127 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.1 t -164.33 149.23 10.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 72.41 110.812 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.46 75.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 74.54 111.154 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -103.16 86.27 2.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.856 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.1 mt -107.03 106.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 73.43 111.107 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.06 105.67 8.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 64.14 110.951 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.31 -38.18 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.32 111.181 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.14 160.54 0.12 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 74.42 110.916 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 148.78 66.38 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.716 2.278 . . . . 75.11 112.349 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.47 177.47 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 72.41 110.882 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 74.44 111.082 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 73.22 110.929 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.41 110.823 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.42 110.958 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 65.32 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.55 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.51 111.191 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -116.91 70.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 74.13 110.943 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.8 -60.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.43 110.903 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.46 93.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.14 111.107 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -123.26 177.63 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 75.4 111.052 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.06 98.88 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.151 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 tp -83.77 138.35 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 74.31 110.908 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.927 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.82 0.343 . . . . 72.33 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -144.5 106.2 4.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 65.2 110.867 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.68 123.0 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 53.44 110.819 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -147.19 128.69 15.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.902 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -115.87 160.63 34.4 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.712 0.768 . . . . 74.14 110.87 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 145.37 57.36 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.708 2.272 . . . . 74.31 112.354 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.2 121.61 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 73.11 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -93.05 106.17 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 72.13 110.908 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.4 t -171.08 131.14 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 75.41 110.844 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 97.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 64.24 111.109 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.5 -172.11 38.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.772 . . . . 50.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -129.17 102.13 6.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.389 . . . . 75.24 110.935 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.3 175.07 6.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.947 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.42 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.02 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 72.12 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.144 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.35 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 62.14 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 75.51 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 71.15 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.31 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.07 134.18 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 65.14 111.091 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -132.39 108.19 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 75.43 110.978 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.44 -179.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 64.54 111.099 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.95 -165.56 25.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 51.12 112.454 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -93.4 8.5 40.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 73.53 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -63.65 -37.75 88.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.891 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.8 61.91 0.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.953 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.3 -155.88 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 74.42 112.473 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -122.36 116.0 23.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 72.0 110.858 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.76 53.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.3 110.901 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -52.74 123.09 10.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 64.12 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.14 -36.29 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 74.22 111.146 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.47 155.98 5.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.81 -0.71 . . . . 61.32 112.437 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.5 142.15 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 73.14 112.53 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.3 34.19 5.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.32 112.537 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 52.33 36.75 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 71.22 111.147 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.41 159.64 33.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.699 0.762 . . . . 73.51 110.866 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 130.33 19.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.693 2.262 . . . . 70.22 112.394 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -141.21 118.83 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.905 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.69 168.5 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.131 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -77.19 135.79 38.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.417 . . . . 75.43 110.872 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -106.52 116.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 74.23 111.151 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.5 t -108.65 113.93 27.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 72.43 110.883 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 pt -67.52 169.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 71.11 111.109 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.35 -57.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 64.32 112.527 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -58.71 117.89 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.801 0.334 . . . . 74.33 110.857 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -119.36 30.64 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.839 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p -144.42 117.84 9.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 74.31 111.16 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 72.14 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 74.41 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 64.22 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 75.13 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.33 111.165 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 63.12 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.129 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 64.54 110.806 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.43 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.35 110.866 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.33 111.138 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.083 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.89 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.62 -174.86 16.22 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 64.21 112.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.52 155.55 13.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.594 0.712 . . . . 74.12 111.133 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.64 3.45 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.239 . . . . 74.23 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.31 165.46 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.1 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.08 133.97 45.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.848 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -133.84 179.27 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 71.41 111.068 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -89.49 156.32 18.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.936 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -97.29 45.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 73.52 110.913 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -112.64 137.52 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 75.14 110.866 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.08 -152.54 12.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 75.42 112.506 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -121.63 120.45 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 61.34 110.883 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.67 151.82 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 63.21 110.855 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.8 t -142.36 134.16 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 72.31 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -91.67 -70.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 74.5 111.102 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -63.82 147.98 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.913 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 p -172.42 161.8 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 74.45 110.871 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.95 133.32 53.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.959 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.04 131.4 3.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.753 . . . . 64.44 112.493 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -117.5 -44.43 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 75.41 110.914 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.49 130.44 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 72.54 111.141 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.4 p -104.8 116.28 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 73.44 110.889 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.03 155.96 49.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.888 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.9 41.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 74.3 111.126 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.63 67.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.874 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -149.17 137.91 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.14 110.901 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 -167.6 11.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.794 -0.717 . . . . 73.05 112.514 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 166.35 27.92 Favored 'Trans proline' 0 N--CA 1.466 -0.137 0 C-N-CA 122.706 2.27 . . . . 72.2 112.324 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -159.27 140.71 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 74.43 111.05 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.44 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.03 110.909 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.887 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -138.4 108.77 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.24 110.892 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -130.86 166.81 20.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -113.09 87.1 2.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.96 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -51.93 -41.74 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 63.21 110.874 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.8 t 51.5 36.03 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.873 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 t80 62.92 63.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.15 110.885 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 63.27 95.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.3 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.0 ttt85 -179.17 137.47 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 74.43 110.869 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.22 131.86 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 71.25 110.966 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.57 160.43 23.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.702 0.763 . . . . 73.31 110.848 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.35 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.044 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.32 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.53 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.13 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 75.42 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.33 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -152.83 165.06 36.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.3 110.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.6 m -130.14 138.47 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 73.11 111.149 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.6 tp -108.27 136.22 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.892 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -168.23 130.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.828 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -79.18 172.28 14.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 73.34 110.786 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.97 162.03 33.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.858 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -96.07 52.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 72.4 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -96.3 143.82 27.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.4 111.124 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.03 157.72 15.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 71.12 110.866 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.69 80.08 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.804 -0.712 . . . . 64.24 112.546 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.89 109.68 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 74.13 111.101 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 52.69 36.04 19.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 73.11 110.949 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.7 m -152.48 159.38 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 73.43 110.809 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.8 t -131.66 -47.22 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 74.41 110.789 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.72 155.28 25.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 74.15 110.926 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -88.42 -73.27 0.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.849 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.0 pt -148.96 140.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 71.34 111.148 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -123.87 -40.35 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 72.42 110.911 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -80.03 108.32 13.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 73.34 110.905 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -171.68 123.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 72.42 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -179.03 153.72 0.64 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 74.11 110.923 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -140.84 160.34 58.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 74.15 111.071 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.22 112.388 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 74.11 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 64.42 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.55 111.186 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.51 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 74.24 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.3 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.76 105.35 10.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 75.31 110.94 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -79.76 96.93 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 75.22 110.884 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 tt -179.4 122.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.945 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.28 176.01 30.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 74.4 112.467 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -74.57 84.98 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 65.44 110.934 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.1 t 65.84 29.83 10.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.01 110.927 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -162.79 164.66 26.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 73.04 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.849 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 72.1 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.24 111.079 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -151.95 144.42 24.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 75.04 110.911 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -141.88 153.28 44.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 73.24 110.936 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.8 tt -67.65 132.04 92.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.575 0.703 . . . . 64.41 111.127 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 82.1 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 74.13 112.302 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.65 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.808 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 153.19 27.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.954 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.8 m -142.94 148.34 36.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 75.41 111.159 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -128.35 149.77 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 61.13 110.913 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.01 127.87 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.113 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -56.59 166.79 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 75.34 111.187 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.01 89.66 0.88 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.704 -0.76 . . . . 65.02 112.522 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 180' ' ' LEU . 60.8 m -71.99 -36.0 69.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 73.34 111.095 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.458 ' C ' ' O ' ' A' ' 179' ' ' THR . 1.5 pp 33.58 47.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 74.44 110.891 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.27 -169.98 14.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 73.43 112.53 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 112.95 3.23 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.668 2.245 . . . . 75.22 112.292 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.0 p -160.32 77.96 2.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 52.31 111.135 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -45.17 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 73.23 112.3 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.5 p -99.66 141.88 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.1 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 66.5 m -127.43 57.01 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.806 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.2 p -115.84 38.13 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.51 111.177 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -127.61 77.66 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.13 110.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 -66.91 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 63.12 111.12 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 54.42 51.54 13.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 74.33 110.804 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.1 -70.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.14 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.05 160.59 57.42 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 73.01 110.88 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 126.83 13.78 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.701 2.267 . . . . 64.33 112.351 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -140.0 122.61 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 71.11 110.881 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 72.03 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.42 110.95 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.53 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 73.14 110.937 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.42 112.51 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.23 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.1 111.138 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 62.05 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -94.86 74.72 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.0 tp -52.06 -44.01 64.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 75.24 110.953 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.85 108.4 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 75.21 111.119 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -100.58 50.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.25 111.083 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -148.94 150.33 32.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 73.44 111.124 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -120.25 173.25 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.892 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 72.52 110.933 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.785 0.326 . . . . 74.32 110.835 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.51 155.17 31.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 72.31 110.925 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -57.96 167.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.932 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -141.29 173.84 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 62.15 110.906 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -117.17 157.63 46.41 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.755 0.788 . . . . 75.51 110.903 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.99 69.59 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.716 2.278 . . . . 72.51 112.323 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -178.95 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.32 111.106 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -96.34 141.24 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 71.23 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -74.96 159.08 32.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 74.0 110.844 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -157.12 145.89 19.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.43 111.05 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -150.08 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 54.12 112.498 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -166.87 135.62 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.371 . . . . 64.51 110.931 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -115.65 175.33 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.14 110.885 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 75.13 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.13 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.31 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.3 111.152 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 54.03 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 75.51 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 74.21 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.79 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.2 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 75.43 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m -89.37 139.33 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 74.34 111.096 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.18 131.61 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 75.23 111.026 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.88 141.69 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 64.2 111.112 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.92 -33.51 36.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 72.5 112.463 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -51.98 -45.69 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 72.12 110.911 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 58.78 52.72 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.0 tp -65.31 -37.53 87.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.917 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.67 -123.83 8.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 75.32 112.509 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -168.97 162.17 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 73.44 110.864 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.54 89.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.919 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.5 167.75 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.902 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.92 144.46 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.174 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.22 167.56 28.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 65.33 112.449 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.11 -146.44 17.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.522 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.53 81.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.687 -0.768 . . . . 62.41 112.528 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.67 -176.6 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 64.14 111.089 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.61 159.28 1.75 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 74.25 110.897 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 125.7 12.4 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 73.31 112.316 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -144.26 168.23 20.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.897 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.82 143.31 37.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -136.57 159.19 42.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.855 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.47 141.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.32 111.144 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -104.67 145.59 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 63.43 110.841 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.7 mt -90.38 121.24 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 74.31 111.097 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.18 -33.45 2.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 73.34 112.427 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.02 77.48 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 73.15 110.897 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -97.76 30.54 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 71.14 110.883 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -128.62 153.25 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 70.01 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 75.24 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 71.44 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 75.4 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 74.24 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 74.52 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.145 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 74.24 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.04 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.3 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 74.55 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.848 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.896 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.79 -179.33 16.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 63.45 112.418 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.7 133.27 20.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 63.12 111.078 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 150.73 68.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.686 2.258 . . . . 74.31 112.331 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.16 86.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 65.31 111.087 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -66.92 126.55 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 63.21 110.904 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.12 91.36 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 74.42 111.083 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -100.36 117.67 35.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 71.11 110.853 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -128.2 154.51 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 75.24 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -55.51 122.11 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 75.24 110.823 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.71 92.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.24 142.63 51.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.913 0.387 . . . . 72.5 110.928 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -85.58 -45.73 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.927 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.7 p -53.09 121.27 7.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.879 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.04 -35.8 74.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.122 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 t -77.59 139.78 39.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -93.38 108.66 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 74.33 110.888 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.83 178.03 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 73.41 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.89 150.05 22.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 52.51 112.475 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.7 174.05 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 72.52 110.861 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.44 139.08 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 64.31 111.121 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 p -77.01 134.34 38.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 70.31 110.82 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -154.0 171.51 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 70.33 110.861 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.61 133.37 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.33 111.182 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -109.46 127.26 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.888 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -105.88 151.59 24.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 72.55 110.91 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.27 -74.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 70.44 112.456 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 147.56 63.31 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.242 . . . . 73.33 112.376 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -175.42 161.0 2.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.087 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.33 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.878 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.808 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 73.54 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 72.22 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -129.65 133.81 47.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 75.11 110.932 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -129.15 136.63 50.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 65.34 110.811 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -66.32 -33.32 75.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.965 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.51 -35.64 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.806 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 t 63.36 56.81 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.874 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -155.97 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 73.43 110.918 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.45 101.83 14.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 71.53 110.877 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.59 169.73 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.859 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.2 mp -86.43 103.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 75.14 110.982 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -166.34 163.07 11.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 75.2 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 75.42 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 74.24 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 74.51 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.15 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 64.14 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 74.24 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 72.2 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -141.22 117.09 10.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 74.34 110.872 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.75 151.32 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 71.41 111.156 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 91.74 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 70.51 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -76.56 -43.3 39.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 55.55 110.846 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.47 77.32 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.889 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -91.35 -53.91 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 74.12 110.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 58.77 43.29 18.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 75.13 110.849 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.1 m -52.68 -40.7 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 73.22 111.178 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -69.21 170.79 9.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.25 110.829 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.92 -179.7 19.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.451 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.58 -53.6 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.41 111.1 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.93 115.32 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 71.14 110.882 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 t -157.67 140.7 15.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.865 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 t -168.79 115.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.54 110.892 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.14 165.45 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.843 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -102.64 167.03 10.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 62.41 110.831 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.68 120.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 71.24 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -100.14 53.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.894 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.77 53.93 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.864 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -90.3 96.81 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -169.9 165.42 9.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 71.34 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -158.07 160.4 29.83 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.621 0.724 . . . . 75.3 111.072 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 73.34 112.277 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.24 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.35 112.533 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -120.85 178.59 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.92 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -106.8 135.75 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 72.24 110.816 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.91 -68.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 63.43 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -136.27 -85.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 75.14 112.498 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.51 -40.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 74.42 110.888 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.29 -53.72 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 72.24 110.948 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 151.22 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 73.02 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 75.54 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.14 111.156 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -137.86 141.42 40.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -130.99 118.01 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.944 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 tp -75.04 131.57 78.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.727 . . . . 73.23 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.5 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.72 2.28 . . . . 61.22 112.342 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.73 56.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.24 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -169.45 147.81 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 75.14 110.913 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.1 p -91.86 89.41 7.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 74.45 111.111 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.56 170.74 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 65.13 110.889 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 169.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 74.24 111.136 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -115.34 153.2 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 74.13 111.102 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.01 -99.8 2.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.693 -0.765 . . . . 62.35 112.541 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.5 p -128.27 99.38 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 72.53 111.174 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.63 159.16 11.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.909 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 139.33 179.09 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.496 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -173.14 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.678 2.252 . . . . 71.41 112.334 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.4 t 61.12 68.74 1.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 70.41 111.148 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 149.11 66.53 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.638 2.225 . . . . 62.12 112.343 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -125.74 135.25 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 74.3 111.12 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -82.7 107.63 15.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.857 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.1 t -104.22 159.68 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.51 111.161 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.06 154.11 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.859 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.2 tt -125.99 142.32 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 70.34 111.084 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.15 143.82 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.9 t 56.51 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 72.53 111.127 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.46 73.5 9.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 75.44 110.812 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 130.15 18.97 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.732 2.288 . . . . 73.22 112.421 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.07 178.19 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 74.01 110.868 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.42 111.112 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.44 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 74.22 110.918 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 72.44 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 71.11 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 43.41 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.22 110.888 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 74.41 111.138 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.35 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -118.14 101.94 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.72 -45.7 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 71.25 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.56 40.36 8.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.088 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -122.33 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 71.31 111.15 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.47 121.39 11.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.32 111.048 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.44 43.36 2.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.891 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.891 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.758 0.313 . . . . 75.43 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -58.44 155.91 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 65.41 110.838 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -108.82 178.6 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.856 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -130.39 32.68 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 75.13 110.875 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 145.04 47.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.676 0.75 . . . . 72.34 110.908 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.81 52.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.653 2.235 . . . . 74.04 112.323 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.19 151.77 20.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.44 111.02 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -88.45 176.57 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 74.15 110.924 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 t -130.45 145.74 51.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 60.54 110.88 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.1 -53.46 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.091 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.64 -153.21 27.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 75.45 112.49 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -136.69 116.94 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 73.15 110.91 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.49 -170.59 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 72.01 110.882 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 75.13 112.541 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.05 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 74.04 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 74.42 111.154 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 74.1 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.32 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 73.22 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 74.24 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.53 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 73.3 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -87.7 138.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -131.55 137.06 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.945 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.7 t -120.44 132.25 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 72.43 111.129 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.44 -33.61 40.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 74.1 112.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.22 -46.89 65.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 71.25 110.91 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 60.72 47.67 7.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.53 110.883 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.5 mt -103.58 -42.86 5.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.941 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.79 75.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 74.43 112.441 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.7 106.87 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 71.03 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.97 48.72 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 75.31 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -165.35 161.51 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.922 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.45 111.134 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.34 178.36 44.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 75.21 112.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.92 -135.85 7.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.768 -0.73 . . . . 73.43 112.574 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.39 -141.56 9.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 65.21 112.514 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.39 -45.77 4.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 62.23 111.12 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.01 159.21 73.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.667 0.746 . . . . 74.4 110.911 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.07 2.46 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 75.31 112.379 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -164.49 151.18 11.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.46 112.78 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.25 111.116 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -94.39 102.12 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 63.44 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 t -85.89 86.97 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 74.33 111.095 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -136.22 116.37 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 72.34 110.836 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -147.2 131.63 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 73.1 111.154 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.59 -175.91 14.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 65.31 112.523 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -60.82 156.16 17.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 74.14 110.871 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -123.62 30.6 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 62.11 110.814 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t -106.75 163.19 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 74.52 111.177 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 64.25 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.887 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.25 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 73.21 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.44 111.106 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.32 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.101 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.1 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 75.13 110.839 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.127 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.114 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.41 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.893 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 73.23 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.22 -159.94 35.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 73.25 112.515 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.55 133.29 70.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.736 . . . . 61.12 111.12 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 155.71 65.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 71.24 112.371 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.7 70.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.02 111.074 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -137.06 141.7 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 74.44 110.836 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.55 156.37 47.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 72.04 111.104 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.66 38.46 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.34 110.894 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -98.96 104.59 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 72.52 110.92 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -109.0 155.85 20.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 65.15 110.895 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.89 147.87 16.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 71.45 112.487 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.44 120.99 29.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.924 0.393 . . . . 70.03 110.92 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -109.37 135.28 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 71.43 110.985 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 p -79.37 164.85 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 72.23 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.99 -35.82 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 64.25 111.154 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 m -80.68 160.29 25.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 75.02 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.5 t -156.9 115.71 3.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.71 -54.19 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 73.24 110.869 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.5 40.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 60.01 112.512 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -157.22 133.9 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.2 110.911 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.34 169.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.7 p -156.72 123.55 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 62.41 110.885 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.4 171.45 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 74.51 110.912 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.03 129.29 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.145 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.06 136.89 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 71.31 110.827 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -129.48 99.38 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.935 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.57 -165.86 39.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.424 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.68 45.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 72.03 112.403 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -178.0 -177.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.54 111.046 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.53 111.148 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.94 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.5 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 74.24 110.916 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -153.32 156.24 38.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -131.57 163.84 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 60.12 110.854 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.47 -41.76 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.97 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -104.81 -41.82 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.842 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.89 75.05 0.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.842 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.97 144.2 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.45 110.931 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.05 107.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.894 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.71 -172.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 75.13 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.46 98.41 9.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.927 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -160.55 162.18 23.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.712 0.768 . . . . 73.11 110.909 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.31 112.35 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 73.51 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.21 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.13 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 72.44 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.41 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.02 111.096 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 54.05 112.519 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -141.23 112.54 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 75.13 110.861 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 m -122.23 149.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 74.43 111.183 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.51 146.86 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 74.41 110.877 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 54.61 36.13 25.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.872 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -51.92 -37.4 52.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 64.01 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -150.53 169.35 21.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 74.23 110.865 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -113.94 150.9 33.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 74.12 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.3 m -114.05 -67.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 73.02 111.157 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -170.71 164.73 8.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.885 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.56 44.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.23 112.527 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.84 -175.68 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 73.41 111.036 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.76 41.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 71.42 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.65 162.55 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.889 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 p -124.61 141.34 52.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 72.22 110.883 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.97 -176.93 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.4 110.901 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 141' ' ' ILE . 6.3 m-20 -81.25 -74.36 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 73.53 110.882 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.414 ' C ' ' O ' ' A' ' 140' ' ' ASP . 41.3 pt 36.74 44.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 71.32 111.097 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -58.83 -74.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.831 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.08 43.27 30.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 70.21 110.887 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -67.86 -49.94 59.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 75.4 110.957 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -139.26 125.27 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 74.14 110.949 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -113.94 160.28 32.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.601 0.715 . . . . 74.22 111.113 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 74.33 112.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.45 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.127 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.4 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 72.23 110.913 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 73.44 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -152.41 132.54 13.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 72.13 110.945 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.52 154.19 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 63.54 110.862 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.6 tp -150.54 -74.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 73.5 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.59 175.84 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 72.22 112.497 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -79.21 135.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 63.11 110.886 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.4 m 51.32 34.41 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.05 110.885 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -162.22 131.84 4.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 73.33 110.906 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 74.45 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 74.31 110.886 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.42 110.863 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 74.42 110.912 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.23 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 73.43 111.151 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -132.89 116.43 16.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -103.86 153.32 20.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 46.9 mt -106.43 96.55 14.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.655 0.74 . . . . 74.14 111.092 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.64 -172.2 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 72.54 112.398 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -169.02 162.87 11.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 75.51 110.888 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.81 120.55 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 75.51 110.909 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.7 m -113.85 135.97 53.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 73.21 111.206 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.68 174.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 71.12 110.816 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.6 p -80.25 142.17 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.31 111.135 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.3 t -71.12 148.73 47.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 65.21 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.16 140.28 17.52 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 65.4 112.439 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.7 -48.66 80.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 61.31 111.168 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 tt -139.99 154.6 47.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.948 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 168.41 -171.61 42.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 73.53 112.471 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -38.77 7.16 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.671 2.247 . . . . 74.33 112.296 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.9 p -155.24 77.96 4.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.622 0.725 . . . . 74.4 111.109 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -47.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 72.33 112.343 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.01 131.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 72.15 111.137 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.6 t -125.65 174.49 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 63.33 110.853 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -98.66 -39.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 72.15 111.22 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -148.4 120.57 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 72.54 110.91 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.82 63.12 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.22 111.142 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -176.15 148.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.83 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.96 88.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 62.11 111.106 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -150.57 160.51 32.58 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.683 . . . . 74.05 110.893 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 169.01 19.84 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.752 2.302 . . . . 74.13 112.371 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -157.18 168.51 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 74.15 110.874 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 74.32 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.909 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 61.31 110.875 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.1 110.907 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.02 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.52 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 72.11 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 72.41 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 73.04 111.196 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -112.85 97.78 6.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.854 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.89 -36.24 11.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 75.31 110.941 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.36 120.78 6.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 75.55 111.1 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 149.21 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.15 111.099 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.15 169.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 64.4 111.049 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.61 166.43 18.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 73.32 110.954 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.955 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.786 0.327 . . . . 73.43 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -99.45 170.96 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 63.23 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.13 159.18 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 61.14 110.884 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.97 173.3 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.918 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -126.65 160.5 58.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.637 0.732 . . . . 74.43 110.972 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 162.02 43.68 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.674 2.249 . . . . 74.51 112.32 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.27 168.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 55.41 111.118 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -117.55 153.75 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 m -68.77 -177.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.7 153.85 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.176 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.5 -150.81 5.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 42.41 112.424 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.9 118.82 8.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 75.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -116.82 171.27 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.943 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.918 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.11 112.485 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.41 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.943 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.41 111.19 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.103 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 75.11 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 73.11 110.882 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.53 134.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.213 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -128.68 116.17 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 74.51 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.0 t -140.08 144.23 28.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 72.32 111.152 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.1 -172.75 0.48 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 72.24 112.456 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -90.44 -36.16 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 74.12 110.883 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -52.18 -36.17 51.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 71.24 110.867 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.8 tp -91.92 46.92 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.32 110.888 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.49 33.53 2.27 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.682 -0.77 . . . . 74.21 112.447 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 71.04 110.892 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tp -99.7 49.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 75.31 110.911 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.75 54.71 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 60.23 110.89 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.72 142.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.139 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.53 -87.47 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 74.35 112.478 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.84 175.16 30.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.76 . . . . 74.12 112.437 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.53 57.12 2.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 73.31 112.485 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.63 146.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 73.23 111.127 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 163.1 20.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.564 0.697 . . . . 75.01 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 119.82 6.71 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.705 2.27 . . . . 75.11 112.31 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -170.18 130.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 72.34 110.913 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -177.44 137.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.121 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -144.8 171.99 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 72.15 110.875 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 t -111.97 68.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.145 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.3 p -115.47 36.35 3.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.498 . . . . 64.22 110.886 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.23 142.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.064 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.06 155.85 13.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 74.14 112.447 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 62.21 38.71 13.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 74.34 110.895 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -114.49 30.5 7.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.869 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -69.98 136.71 50.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.34 111.156 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.31 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 74.34 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.2 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 75.32 111.164 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 71.1 111.134 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 64.5 111.066 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.04 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.1 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 73.1 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 74.41 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.11 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 73.01 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 75.11 110.876 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.31 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 74.32 111.067 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.6 -166.85 35.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.54 112.501 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.66 133.2 95.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.596 0.712 . . . . 74.4 111.168 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 141.1 44.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.763 2.309 . . . . 71.22 112.338 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.52 -74.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.081 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 140.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 74.1 110.802 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.41 156.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 75.21 111.101 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.59 134.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 73.54 110.897 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.46 165.29 26.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 75.45 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -69.34 147.14 51.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.921 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.08 -157.77 13.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.789 -0.719 . . . . 74.35 112.477 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.67 -36.73 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 74.33 110.847 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -62.3 -176.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.875 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 p -52.47 134.35 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 52.23 110.854 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.02 -177.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 75.13 111.185 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 p 51.91 37.54 21.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.847 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t -114.31 64.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 71.13 110.797 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 tp -169.72 131.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.924 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.05 123.09 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 73.21 112.474 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 164.26 38.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 64.51 110.848 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.99 -36.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.3 111.149 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -159.17 124.97 4.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.11 110.881 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -169.93 175.95 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 73.45 110.919 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.65 150.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.17 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.46 173.48 11.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.01 110.871 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -119.33 -67.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.968 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.09 75.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.787 -0.721 . . . . 64.34 112.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 162.2 43.03 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.663 2.242 . . . . 75.44 112.337 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -164.71 151.39 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 65.53 111.076 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.174 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 71.51 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 74.32 110.857 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -153.13 148.49 27.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.99 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -130.98 166.88 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 74.13 110.892 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -130.29 35.32 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 74.34 110.888 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.15 -41.61 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 64.21 110.877 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t 54.77 65.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 75.05 110.872 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -152.36 -177.52 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 64.04 110.855 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.29 36.12 4.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 55.03 110.79 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.31 -179.32 5.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 75.52 110.922 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.02 131.44 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 74.5 110.969 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -161.51 160.45 23.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.665 0.745 . . . . 72.43 110.884 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.42 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 73.53 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.22 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 64.54 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.52 111.143 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.461 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -154.0 151.92 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 74.24 110.921 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.23 134.99 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 73.42 111.128 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 tp -92.28 136.91 32.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 73.41 110.895 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -106.59 162.39 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.924 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -135.57 105.87 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.95 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.4 150.45 31.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 73.35 110.914 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -133.45 145.2 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 m -56.02 133.52 51.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 71.33 111.173 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.52 173.91 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 61.21 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.74 -64.95 3.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 70.35 112.495 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.78 122.33 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 72.21 111.164 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.66 121.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 73.04 110.919 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.3 t -149.29 113.39 5.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.457 . . . . 51.14 110.851 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -173.65 147.47 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 65.05 110.91 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -81.51 153.35 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.893 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -118.67 170.85 8.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 75.44 110.869 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.7 pt -150.52 150.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 65.41 111.145 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -116.51 -179.18 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.869 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 52.33 44.81 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 63.41 110.875 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.56 104.07 13.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 74.41 110.908 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 64.1 p-90 -124.96 151.78 45.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.913 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -135.6 160.39 67.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 62.54 111.164 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.41 112.361 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.33 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 74.24 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 74.45 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 74.42 111.102 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.03 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 63.13 110.843 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -140.14 110.31 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.875 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -106.5 155.04 20.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 73.14 110.854 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.91 -63.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.26 -126.48 0.91 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.768 -0.73 . . . . 74.5 112.465 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -81.93 57.0 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 73.53 110.858 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.4 m -160.96 -172.85 3.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.24 110.852 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -70.81 135.92 48.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 75.24 110.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 73.12 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 52.41 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.55 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.137 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.7 135.68 26.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 73.24 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -94.6 140.62 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 65.31 110.912 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 67.5 mt -129.64 133.12 24.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.669 0.747 . . . . 72.54 111.128 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 173.75 10.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.717 2.278 . . . . 74.12 112.365 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -153.71 143.14 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 73.35 110.861 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -127.9 89.41 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 75.31 110.842 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 p -84.19 -179.54 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 71.24 111.107 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -112.51 130.37 56.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 61.42 110.845 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.1 t -80.32 135.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 73.13 111.128 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m 54.55 43.63 29.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 71.43 111.142 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.8 -95.43 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 64.23 112.517 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 72.31 111.124 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.0 mt -130.18 -49.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.943 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.57 176.97 3.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 70.0 112.476 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 135.11 29.54 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 71.44 112.328 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 156.15 49.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 70.52 111.142 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.16 64.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 72.35 112.337 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 13.0 p 39.68 38.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 61.12 111.152 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.7 t -167.58 148.35 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.838 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.1 m 65.17 48.72 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 73.2 111.161 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -110.73 35.19 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.955 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 25.7 mm -133.48 66.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 74.3 111.159 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -154.05 118.62 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.39 -70.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 73.45 111.087 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.2 144.87 0.5 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.65 0.738 . . . . 62.42 110.852 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 64.4 112.299 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -153.55 175.1 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.23 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.55 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.54 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.931 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 74.03 111.149 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -91.65 83.83 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.876 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -34.83 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 74.01 110.869 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 64.13 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 61.24 111.117 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -51.78 164.16 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.53 111.069 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.35 -176.42 5.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.115 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.0 tt -51.85 -37.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.32 110.89 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.868 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.733 0.302 . . . . 70.55 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -173.48 128.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 72.32 110.915 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -125.36 -178.09 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.824 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -130.01 177.6 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.86 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -145.28 157.59 52.8 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 74.41 110.981 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 154.39 67.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.261 . . . . 73.04 112.417 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.3 140.55 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 63.23 111.119 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -85.55 172.02 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.917 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 p -84.51 170.62 13.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.943 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.81 144.72 37.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 74.03 111.055 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.78 -177.09 15.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 73.55 112.499 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -47.43 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 74.43 110.928 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -114.86 -175.81 2.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 74.53 110.937 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.1 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 65.12 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.23 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.21 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 75.24 111.106 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.45 111.111 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.13 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.863 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 75.3 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.73 131.81 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 70.01 111.108 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.15 140.9 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 74.12 110.913 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.22 123.28 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 74.01 111.175 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.51 51.52 0.41 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.733 . . . . 71.44 112.506 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.57 -38.86 65.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.752 0.31 . . . . 74.21 110.803 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.07 -36.3 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.894 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.43 -58.95 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 62.54 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.08 -106.2 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.5 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -150.31 141.74 23.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.89 0.376 . . . . 71.15 110.858 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -126.77 74.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.4 110.91 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -124.79 -44.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 74.4 110.878 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -118.25 36.82 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.181 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.41 -130.09 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 62.14 112.539 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.04 175.03 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.419 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.11 -179.45 16.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 62.51 112.497 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.3 105.06 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 73.13 111.132 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.85 160.68 26.46 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.566 0.698 . . . . 73.42 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 131.64 21.59 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.64 2.226 . . . . 75.44 112.364 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -98.14 167.96 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 64.34 110.922 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.11 118.9 10.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 75.12 111.053 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -56.48 167.39 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.867 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.8 p -157.44 143.85 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 75.21 111.164 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -99.47 55.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.866 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -53.42 146.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 74.01 111.183 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.35 -90.82 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 64.24 112.436 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -163.0 115.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.85 0.357 . . . . 73.35 110.896 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.68 30.5 7.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.842 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -60.32 128.39 36.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 75.35 111.169 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.04 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 74.03 110.886 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.136 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 75.42 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.893 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 74.14 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.52 111.155 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.45 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.53 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 74.14 111.143 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 75.02 111.071 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.24 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.54 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 72.3 110.84 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 64.13 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.0 -173.32 19.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 65.25 112.517 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.87 133.24 39.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 71.2 111.136 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 128.41 15.96 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 74.22 112.336 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.66 37.56 4.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 73.11 111.133 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 55.41 51.32 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 74.02 110.896 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.17 142.64 20.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.05 111.035 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.85 164.87 21.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.893 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -108.12 -175.18 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.892 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -124.27 162.99 22.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 75.11 110.935 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.18 -123.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 74.13 112.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -160.66 139.06 10.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 75.2 110.85 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -144.3 138.83 28.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 73.44 110.888 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -70.38 97.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 74.23 110.764 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -145.25 137.91 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.44 111.088 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.2 m -57.85 173.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.907 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.8 m -81.42 64.18 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 62.21 110.891 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.32 125.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 74.42 110.919 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.36 174.8 37.97 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 51.14 112.512 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.52 91.29 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 73.52 110.914 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 p -175.83 137.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 75.01 111.17 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 p -105.08 142.56 34.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 73.21 110.913 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -82.35 177.34 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 74.14 110.844 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.11 57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.108 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.7 173.63 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 73.42 110.866 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -95.26 -63.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.882 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.67 68.61 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 73.4 112.475 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -170.96 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 75.12 112.268 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -132.6 125.85 31.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.008 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.51 111.108 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 75.43 110.999 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -120.26 114.34 21.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.4 110.911 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.16 166.87 20.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 74.33 110.838 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -124.09 80.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.896 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.29 17.69 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 65.32 110.84 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -95.15 36.39 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 63.21 110.803 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -161.95 151.83 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.894 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 87.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.899 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -179.83 -173.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 74.31 110.826 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.43 165.54 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 73.45 110.892 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.29 70.46 2.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 74.2 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.13 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.53 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.11 111.1 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.43 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.35 111.146 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 72.1 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 75.21 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -143.89 165.9 26.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.02 110.886 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.34 156.52 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 75.14 111.112 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -133.49 143.72 48.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.91 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -152.75 175.49 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 70.35 110.866 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -139.56 133.48 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 70.22 110.977 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.92 102.98 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 63.22 110.808 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -77.65 171.41 14.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 64.13 110.896 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 69.67 3.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 63.42 111.143 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.53 80.61 8.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.846 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.59 -109.73 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.753 . . . . 64.52 112.542 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -129.25 41.49 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 71.03 111.055 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.95 120.0 37.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.892 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -157.8 122.3 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.53 110.877 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 t -173.64 164.18 4.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.42 110.909 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -98.27 147.2 24.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 62.31 110.897 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -127.51 126.88 43.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 70.14 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.7 tt -118.96 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.41 111.089 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -151.76 178.96 8.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 72.42 110.819 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -80.89 64.18 5.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.15 110.863 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -76.05 -38.35 57.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.912 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -55.14 119.89 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 75.24 110.904 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -131.73 160.41 67.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 65.11 111.144 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.34 112.329 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.41 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 75.1 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 73.31 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.122 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.03 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 73.21 110.927 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.2 132.91 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.883 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -58.47 111.6 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 72.3 110.93 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 tt -151.51 104.35 3.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 74.5 110.916 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 130.68 -139.43 10.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.689 -0.767 . . . . 74.05 112.501 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -112.13 -65.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 72.54 110.85 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.2 m -108.0 -46.79 3.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 72.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -80.76 141.56 34.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 74.23 110.911 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 73.31 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.14 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.43 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 72.3 111.108 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -146.26 145.05 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.862 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.75 112.59 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.32 110.916 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 50.2 mm -130.49 133.07 24.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.699 . . . . 74.25 111.129 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 132.59 23.72 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.713 2.275 . . . . 74.34 112.342 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -83.98 154.07 23.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 72.43 110.865 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -87.19 -42.02 13.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.909 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 t -170.72 161.82 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 75.02 111.176 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.41 173.11 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.842 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.1 142.81 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 75.32 111.143 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.0 m -79.83 142.19 35.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.172 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.38 -134.41 4.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 62.03 112.473 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.0 t -138.96 149.2 44.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 73.23 111.128 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -133.17 163.85 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.94 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.63 -73.64 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 43.34 112.483 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.24 14.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 72.13 112.41 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 58.1 t -121.65 133.33 24.22 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.642 0.734 . . . . 75.01 111.088 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 135.26 29.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 73.44 112.328 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.09 121.87 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 74.13 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.9 t -76.43 -176.93 3.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.12 110.832 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -53.3 120.3 5.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 63.11 111.104 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -82.4 93.17 7.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.908 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.58 145.14 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 65.35 111.14 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -52.04 139.75 22.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.878 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.87 139.88 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 72.43 111.083 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.12 73.51 2.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 75.12 110.864 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 140.31 42.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.77 2.313 . . . . 73.21 112.33 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -104.59 162.88 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 72.2 110.84 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.35 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 75.22 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.43 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 62.53 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 74.21 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.44 110.964 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 74.21 111.111 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -106.43 76.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.13 -50.17 56.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.939 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 53.44 53.44 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 60.3 111.077 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -82.85 161.99 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.2 111.09 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.43 129.03 34.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.24 111.061 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mt -123.28 138.21 54.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 74.2 110.929 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.51 110.881 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.847 0.356 . . . . 75.15 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -154.72 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.41 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.25 174.35 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 72.31 110.872 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -114.89 141.31 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -87.21 161.01 47.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 74.13 110.92 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 157.34 60.83 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.655 2.237 . . . . 71.41 112.334 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.76 -177.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 72.22 111.098 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -118.77 160.64 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 74.35 110.906 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -103.93 158.61 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.02 110.836 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.47 -175.54 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 74.2 111.039 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.4 -175.81 49.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 73.4 112.495 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -173.28 129.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 71.24 110.925 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -133.18 163.48 29.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.837 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 71.43 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.12 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.127 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.42 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.1 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.909 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 72.44 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.43 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.55 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.31 129.54 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -119.82 107.05 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 71.43 110.916 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -134.61 145.35 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 75.13 111.145 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.44 138.48 10.23 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.699 -0.763 . . . . 73.23 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.88 -44.0 17.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 72.32 110.851 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 53.54 48.12 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.926 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.5 36.29 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 71.05 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.67 -124.49 29.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -129.83 177.19 7.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.362 . . . . 73.11 110.842 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mt -107.56 61.07 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 74.32 110.922 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.74 119.9 10.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 62.32 110.971 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -169.08 148.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 64.43 111.098 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.18 106.15 2.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 33.43 112.485 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.13 -110.66 3.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.33 112.481 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.89 -133.59 7.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 71.34 112.483 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.59 -50.8 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 71.33 111.111 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.67 90.93 7.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 75.54 110.952 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.64 135.53 30.96 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.721 2.281 . . . . 74.51 112.381 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -148.15 113.94 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.1 110.916 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.4 134.82 20.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 53.34 111.088 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -160.53 106.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 70.43 110.929 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -174.44 138.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 73.12 111.086 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -162.74 136.15 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 72.24 110.822 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -136.56 124.68 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 73.12 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.36 70.68 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.738 . . . . 61.33 112.487 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -120.86 79.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 74.11 110.89 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.67 30.54 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 74.15 110.807 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p -65.32 96.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.102 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 73.12 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.896 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 72.51 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 75.13 110.902 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.21 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 74.3 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 73.22 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.03 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 64.34 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.904 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 74.13 111.12 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 73.22 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 72.33 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.873 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 75.51 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 72.13 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.03 170.09 24.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 63.43 112.517 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -57.34 133.26 81.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 61.22 111.172 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -177.37 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.675 2.25 . . . . 65.51 112.374 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.77 45.17 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 72.22 111.093 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -62.34 116.05 4.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.874 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.32 95.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 65.13 111.132 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -128.91 166.96 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -69.59 173.11 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.861 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -75.41 -71.27 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 72.13 110.885 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.45 -45.38 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 73.53 112.468 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 53.24 44.82 29.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 73.04 110.894 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -116.27 133.85 55.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t 58.02 50.81 9.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 63.11 110.836 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.41 142.38 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 72.11 111.153 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -151.57 148.15 27.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.21 110.884 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -99.82 148.85 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 45.14 110.869 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.86 38.29 24.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.985 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.76 53.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 74.53 112.529 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -117.98 61.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 73.2 110.885 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.4 t -93.82 96.8 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.129 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 p -119.22 42.55 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.801 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -55.98 -37.41 69.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 74.33 110.852 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.76 179.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 74.24 111.153 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -136.3 179.29 6.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.53 110.814 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.26 149.74 44.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 71.45 110.969 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.23 76.03 0.3 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 73.34 112.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.605 2.203 . . . . 61.3 112.4 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -136.67 135.87 38.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 64.02 111.11 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.11 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.34 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.43 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.915 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.42 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -141.22 143.01 33.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -130.97 103.8 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 75.55 110.869 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -51.66 -35.13 41.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.922 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.83 -41.54 18.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 72.35 110.891 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t 52.41 39.39 27.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 70.43 110.946 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -102.34 176.11 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 70.43 110.916 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -105.1 39.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 73.31 110.886 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -144.39 -175.87 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.2 110.86 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.5 pp -60.09 116.48 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.866 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.29 160.53 26.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.753 0.787 . . . . 74.32 110.866 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 74.33 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.32 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.45 111.088 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.35 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 73.33 111.083 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.45 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.34 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 71.11 112.469 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -160.83 -175.18 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.34 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.55 101.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.01 111.231 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.6 tt -89.14 155.08 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.976 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -116.05 138.4 51.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.842 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.17 169.76 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 75.24 110.91 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -136.7 154.66 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 74.12 110.855 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.03 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.852 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -71.73 91.03 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 75.23 111.176 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -157.05 151.35 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.814 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.41 135.91 29.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.767 -0.73 . . . . 74.13 112.42 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -124.98 -45.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 71.24 111.145 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 41.44 37.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.951 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 p -117.31 143.19 46.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.85 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 t -145.85 172.1 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.54 110.859 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 54.97 48.62 19.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.25 153.03 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.7 mm -82.8 145.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 74.01 111.128 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.22 174.84 6.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.864 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.99 171.25 8.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 73.4 110.839 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -112.45 178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.835 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -97.05 149.78 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.935 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -125.83 95.15 40.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.33 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 60.33 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.879 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.11 111.13 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.42 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 71.44 110.97 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.52 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.79 150.71 49.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.14 110.978 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -104.46 95.12 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.877 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.36 -74.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 72.4 110.942 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.34 -160.41 12.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 52.41 112.512 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -110.81 -36.4 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 60.33 110.898 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.1 m -60.43 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 54.15 110.873 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -128.95 171.87 11.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 75.12 110.954 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 73.4 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.42 110.922 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.23 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.23 111.087 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.57 160.79 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 72.41 110.922 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -124.41 98.28 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 72.44 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 64.3 mt -70.9 133.07 86.36 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.635 0.731 . . . . 74.32 111.148 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 95.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.615 2.21 . . . . 74.5 112.344 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -62.49 171.17 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -153.14 113.46 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 p -152.1 170.63 19.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.22 111.109 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -80.33 -179.87 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.53 110.86 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -58.27 160.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 54.45 111.183 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.0 p -117.72 -55.06 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 74.45 111.126 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.26 -168.14 28.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 74.53 112.509 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 8.9 t -119.66 165.46 14.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 74.33 111.093 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.4 mp -149.19 138.95 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 65.23 110.869 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.92 166.06 24.14 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.759 -0.734 . . . . 72.45 112.512 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -47.64 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.695 2.263 . . . . 73.14 112.354 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.6 73.42 12.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 75.12 111.1 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 130.46 19.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.658 2.239 . . . . 63.11 112.408 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.85 -36.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 75.4 111.1 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.5 p -132.35 48.89 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 72.14 110.813 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.7 p -127.41 83.06 2.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.25 111.133 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 151.34 36.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 74.32 110.931 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -33.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.53 111.145 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -53.17 156.23 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 75.24 110.863 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.05 102.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 71.22 111.152 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.85 73.51 2.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.551 0.691 . . . . 74.32 110.815 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 142.28 47.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.687 2.258 . . . . 73.44 112.334 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.3 152.75 34.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 75.31 110.862 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.923 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 71.03 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 74.33 110.894 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 70.4 112.446 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 75.42 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.44 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.4 111.116 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.03 77.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.51 110.936 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.28 -36.72 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 75.21 110.921 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.35 107.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.11 111.035 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -119.84 177.32 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 70.41 111.091 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.93 157.4 20.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.113 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -62.49 135.46 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.41 110.882 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.862 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.78 0.324 . . . . 73.13 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.09 89.22 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.34 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -114.25 178.06 4.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 72.12 110.915 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.08 78.28 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 73.02 110.841 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.65 160.48 68.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 71.14 110.966 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 97.45 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 71.35 112.314 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 133.59 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.11 111.111 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -143.85 136.25 26.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 75.12 110.9 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 t -119.17 142.27 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 60.44 110.935 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.92 -56.85 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 74.11 111.029 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.44 -154.36 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 60.54 112.495 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -119.99 102.89 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.345 . . . . 72.42 110.898 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.07 155.96 17.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.32 110.911 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 61.03 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.11 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.35 110.887 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.171 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 74.12 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 61.52 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 75.04 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.44 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.13 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.29 132.89 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 60.22 111.062 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -125.02 105.87 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.4 110.918 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -133.44 -179.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.173 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.67 34.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 64.3 112.499 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.89 -40.35 96.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.14 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 63.29 47.97 3.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.31 110.889 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -43.69 22.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 70.44 110.907 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.05 -169.52 34.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 74.53 112.452 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.33 90.29 4.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 74.12 110.91 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -48.32 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.873 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -86.28 146.06 26.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.945 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.23 147.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 72.13 111.153 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.05 116.75 7.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 71.34 112.541 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 108.2 0.86 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.744 -0.741 . . . . 55.13 112.541 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.72 172.54 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.705 -0.76 . . . . 64.5 112.503 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.76 -67.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 63.31 111.085 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.6 mt -111.49 91.05 13.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.632 0.73 . . . . 70.1 110.864 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 102.6 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.678 2.252 . . . . 73.1 112.357 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -171.33 140.29 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.17 169.07 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 75.41 111.102 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.71 -48.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.878 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.99 127.72 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.02 111.131 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -151.01 104.4 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 75.33 110.875 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.97 122.46 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.101 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.38 -159.61 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.718 . . . . 42.52 112.544 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -129.39 56.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 75.35 110.834 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.96 30.58 7.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 73.32 110.915 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -86.19 131.44 34.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 65.41 111.145 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 73.44 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.24 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 74.44 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.45 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 71.02 111.124 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.23 111.12 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 75.44 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 65.31 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.22 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.058 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 70.12 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 74.41 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.32 110.89 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 75.42 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.79 -157.25 7.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.41 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.06 133.27 23.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 75.41 111.091 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 138.64 38.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.731 2.288 . . . . 73.0 112.294 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.81 -175.77 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 72.01 111.113 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -67.9 139.77 56.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 65.32 110.879 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.82 106.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 65.03 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.39 120.46 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.892 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -129.64 -42.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.21 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -111.71 142.15 44.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 64.5 110.917 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.72 109.07 2.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -95.83 128.54 42.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 61.12 110.935 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -115.2 73.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 73.35 110.903 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.5 t -80.44 174.07 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.897 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.49 -36.91 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.32 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 p -152.0 126.15 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 65.14 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 p -168.62 107.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 72.13 110.853 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.18 -65.54 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.921 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.2 137.87 1.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.21 112.478 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -122.54 75.93 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 73.42 110.867 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.96 124.94 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.151 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 t -160.31 150.59 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 57.17 51.08 10.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 60.44 110.887 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.62 -35.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.153 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -149.32 155.22 40.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 75.32 110.903 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -114.17 163.25 15.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.859 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 61.04 112.534 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 136.98 34.25 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.642 2.228 . . . . 63.44 112.321 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -175.08 160.87 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 73.3 111.071 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 73.52 111.136 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.945 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 53.43 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 75.41 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.922 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -135.55 118.01 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 73.11 110.901 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.36 124.74 50.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 74.3 110.865 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.05 -35.87 59.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 75.41 110.901 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -103.14 -41.66 6.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 74.21 110.848 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 p 51.72 38.51 23.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.867 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -128.31 -179.96 5.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 74.04 110.84 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.97 69.73 2.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 75.31 110.837 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -166.99 150.26 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.923 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 pp -60.63 132.17 53.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 63.5 110.929 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -173.16 139.66 0.87 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.672 0.748 . . . . 74.32 110.964 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.53 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.55 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.44 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.14 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 74.11 111.122 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.41 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -157.44 141.37 16.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.42 110.899 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.65 134.1 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 74.22 111.093 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.99 144.68 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.02 110.949 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -112.33 -36.3 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 74.41 110.862 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -116.85 126.79 53.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 64.34 110.904 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -142.07 160.7 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 64.41 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 151.26 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.51 110.909 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 m -130.48 119.17 22.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 63.25 111.085 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 54.12 54.72 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 71.32 110.897 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.41 108.67 2.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 72.52 112.54 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.99 -55.61 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 74.24 111.065 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.15 -50.58 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.954 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 t -56.05 163.29 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 65.43 110.807 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.9 p -103.98 168.24 9.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 73.55 110.817 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.1 150.69 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.939 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.87 152.66 19.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.83 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.84 117.86 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 70.14 111.094 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -146.09 141.46 27.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.22 110.917 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.63 172.08 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 75.05 110.862 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 146.24 4.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.22 110.885 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER 52.35 62.34 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.98 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -103.38 160.32 26.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.51 112.35 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 61.34 111.109 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 72.1 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 73.4 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 74.15 111.163 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.34 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.14 110.879 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 74.51 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -152.23 115.23 4.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.944 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -100.96 117.23 34.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 62.32 110.833 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 17.4 tp -94.96 38.55 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.53 110.882 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.68 34.86 44.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 75.32 112.479 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -121.06 173.29 7.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 73.22 110.883 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.5 m -57.57 -44.04 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 53.22 110.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -100.52 155.45 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.21 110.92 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 75.3 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 74.22 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 75.21 111.101 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -145.3 132.3 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.836 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -107.47 122.74 47.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 70.44 110.934 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 56.9 mt -92.28 133.04 30.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 75.33 111.159 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -46.08 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.766 2.311 . . . . 72.31 112.354 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.4 t80 52.37 38.92 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 75.33 110.843 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 58.21 39.51 25.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 74.02 110.886 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.7 m -116.06 111.86 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 73.12 111.157 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -115.23 78.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.905 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 19.1 m -143.79 179.43 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 72.33 111.135 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 t -51.92 135.32 30.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 65.24 111.136 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.92 51.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 55.35 112.536 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.1 t -133.33 172.27 12.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 74.14 111.148 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.05 108.68 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 74.4 110.857 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.33 -75.17 0.3 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.723 . . . . 74.31 112.53 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.3 Cg_endo -69.75 -171.36 0.47 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.73 2.287 . . . . 72.1 112.333 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 182' ' ' PRO . 5.9 m 35.59 67.6 1.46 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.671 0.748 . . . . 73.32 111.162 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -171.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 73.42 112.346 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.36 93.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 74.22 111.088 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.7 m -148.84 -171.8 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 75.32 110.933 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.6 m -129.48 106.39 8.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 74.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 -176.23 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 73.14 110.905 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.2 tt -79.05 136.7 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.33 111.124 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -166.37 171.81 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 64.14 110.903 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.49 124.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.31 111.108 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -171.33 69.17 0.48 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.691 0.758 . . . . 64.11 110.908 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 142.84 48.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 71.24 112.339 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.79 173.58 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 75.13 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.913 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.891 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.947 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.44 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.12 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.53 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.02 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.05 111.126 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 67.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 74.44 110.899 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.41 -55.89 5.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 71.35 110.965 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.71 144.58 52.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 71.33 111.112 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -162.11 161.8 28.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 73.33 111.143 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.23 133.47 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 73.14 111.086 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.0 169.18 22.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 71.33 110.906 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 65.4 110.884 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.805 0.336 . . . . 63.41 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -142.81 120.28 11.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 73.43 110.855 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -91.03 138.6 31.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.887 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.27 -176.38 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 73.02 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -123.43 157.63 61.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 74.51 110.936 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 82.64 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.251 . . . . 75.31 112.324 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.26 161.56 28.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 73.43 111.162 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -103.17 108.83 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.892 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 76.7 p -110.73 67.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.839 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.76 126.94 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 72.02 111.079 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.24 178.97 43.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 63.23 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.5 92.08 3.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.873 0.368 . . . . 73.03 110.944 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -108.22 174.32 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 75.2 110.834 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 72.25 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.22 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.15 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.893 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 74.23 111.178 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.22 111.136 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.44 110.855 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.818 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 62.32 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -81.57 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 74.4 111.173 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -129.26 104.13 7.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.885 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.1 m -136.23 -179.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.519 . . . . 71.41 111.136 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.04 33.3 0.34 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.792 -0.718 . . . . 63.52 112.455 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -93.43 -37.63 11.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 64.52 110.877 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.455 ' C ' ' HG ' ' A' ' 32' ' ' LEU . 16.5 pt-20 -75.0 -40.15 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.88 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' C ' ' A' ' 31' ' ' GLU . 1.5 pp 33.55 47.69 0.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.911 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.99 -163.22 22.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 54.34 112.514 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t0 59.29 53.44 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.786 0.327 . . . . 72.32 110.828 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.42 -52.23 4.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.34 110.935 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -131.36 86.62 2.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 74.55 110.859 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.67 106.9 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 65.51 111.092 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.98 -64.61 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 75.34 112.432 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.72 -49.31 79.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.733 . . . . 73.25 112.47 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.28 128.27 8.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 72.14 112.53 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.76 36.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 62.13 111.085 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mt -83.91 159.61 59.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.721 . . . . 75.21 110.88 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.75 121.53 8.22 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.705 2.27 . . . . 71.13 112.393 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -132.32 152.89 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.853 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.03 139.98 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 63.01 111.108 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.68 149.24 28.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 72.13 110.874 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 m -127.93 166.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.424 . . . . 72.24 111.134 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -123.31 156.08 36.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 74.14 110.867 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -140.41 135.35 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 73.32 111.147 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.91 -155.36 26.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 73.31 112.471 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -122.51 117.97 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 73.4 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.51 -37.98 22.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p -57.61 143.51 40.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 73.32 111.176 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 75.4 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.13 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.24 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 74.42 111.157 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 73.42 111.098 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.11 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.14 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 74.24 111.192 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.35 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 74.12 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.869 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.54 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.2 -157.09 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.2 112.459 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.79 85.37 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.649 0.738 . . . . 72.42 111.104 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 129.99 18.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 75.55 112.341 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.19 -176.91 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.45 111.122 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.5 134.67 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 72.15 110.877 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 165.24 32.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.436 . . . . 64.54 111.131 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -88.32 152.08 22.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 74.52 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -152.08 151.01 30.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 75.41 110.846 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -146.71 137.22 23.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 62.14 110.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.86 176.49 33.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 63.2 112.549 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.8 160.57 29.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 73.41 110.935 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -137.95 67.21 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.893 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 p -166.46 177.63 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 74.34 110.832 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.0 mt -82.68 97.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.22 111.116 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.73 -176.76 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.842 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.6 p -58.88 128.39 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.821 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.37 107.07 18.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 72.53 110.901 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.3 116.72 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 62.5 112.502 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.31 -171.49 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 72.25 110.895 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 p -154.67 134.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 74.13 111.141 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.8 p -101.11 165.54 11.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.862 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.34 -171.94 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 71.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.03 104.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 52.51 111.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -176.44 173.39 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -63.2 149.44 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.5 110.885 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.98 -69.74 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.68 -0.772 . . . . 73.4 112.48 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 -170.36 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 73.42 112.369 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.06 143.96 33.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 71.54 111.044 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 72.34 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 73.44 110.93 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.12 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 70.21 110.946 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -123.5 97.37 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.65 167.24 19.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 75.3 110.846 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -77.4 61.08 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.92 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.38 -35.22 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 72.01 110.863 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 p -51.02 -35.43 34.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.2 110.753 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -82.56 -38.73 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 74.31 110.92 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 57.9 59.72 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.11 110.848 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.75 -176.01 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 71.02 110.907 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -59.1 109.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 73.22 110.91 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -161.23 160.38 24.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.72 0.771 . . . . 75.15 110.929 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 74.04 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.04 111.158 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 75.23 111.088 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.33 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.22 111.129 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.26 -177.02 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 75.24 110.852 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.65 126.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 72.45 111.059 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -139.39 150.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 73.41 110.982 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.15 163.47 38.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.804 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.3 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 64.04 110.888 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.04 -40.68 94.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 64.03 110.863 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -164.05 142.6 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.1 110.923 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.2 p -110.36 -43.81 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 71.12 111.171 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -121.1 161.29 22.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 75.05 110.873 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.67 147.43 45.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.738 . . . . 74.02 112.439 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.11 159.03 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 65.33 111.122 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.64 -41.96 83.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 71.15 110.863 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.6 t -76.54 155.0 34.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.83 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.6 m -134.03 154.63 51.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.874 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -146.64 115.13 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 75.03 110.858 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -132.32 102.62 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.33 110.882 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.8 pt -139.88 157.52 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 73.04 111.13 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 6.0 ptpt -143.04 144.88 32.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 74.5 110.892 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -118.85 172.83 7.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.15 110.854 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -102.52 159.78 15.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 75.14 110.937 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -84.43 151.16 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 73.0 110.927 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -123.24 160.0 52.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 74.14 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.1 112.312 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 73.25 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.2 111.162 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.484 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 74.12 110.931 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -127.33 178.68 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.53 110.904 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -106.67 152.01 24.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.487 . . . . 72.15 110.86 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.94 -37.37 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 72.41 110.901 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.86 4.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.671 -0.776 . . . . 63.21 112.433 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -100.62 -38.04 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 73.02 110.878 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -100.59 -56.33 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.815 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -77.39 -179.88 6.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.866 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.3 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.1 110.888 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 61.44 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -136.15 118.77 15.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.922 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -120.84 116.47 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 73.44 110.938 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 5.2 mp -103.8 133.09 20.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.621 0.724 . . . . 74.42 111.143 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 138.93 38.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.236 . . . . 72.01 112.349 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -137.6 175.16 9.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 75.31 110.918 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -61.08 109.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 72.21 110.901 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 m -87.53 129.65 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 73.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -101.64 121.16 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.15 110.913 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.54 112.6 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 74.44 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 37.6 p -78.19 137.46 38.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 74.42 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.68 48.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 70.44 112.469 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 27.1 m -72.48 99.37 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 62.12 111.163 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.8 pp -98.85 135.37 40.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 64.14 110.989 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.58 -73.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 74.45 112.412 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.7 51.75 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 75.15 112.348 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.0 p -138.75 78.01 31.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.585 0.707 . . . . 74.51 111.11 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -44.97 1.72 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.663 2.242 . . . . 73.31 112.362 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.49 145.98 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 75.34 111.188 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.3 t -63.23 133.69 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 54.01 110.84 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 4.5 t -99.65 149.37 23.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 64.24 111.125 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -67.97 177.64 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.3 pt -144.16 168.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.114 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.66 151.49 46.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 74.42 110.918 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.14 -35.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.41 111.131 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.41 73.36 0.5 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.636 0.732 . . . . 72.44 110.862 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 141.39 45.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.651 2.234 . . . . 72.12 112.387 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.43 172.4 16.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.86 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.45 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.94 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 75.43 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 74.41 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 64.45 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 71.21 111.128 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 71.42 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.915 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.12 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.62 101.16 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 73.41 110.88 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.1 -49.35 77.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 75.02 110.943 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 62.78 45.17 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 73.35 111.107 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.79 155.38 45.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 74.1 111.101 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.52 108.87 8.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.062 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -52.38 164.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.957 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.54 110.891 179.898 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.757 0.313 . . . . 70.11 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' ' 63' ' ' VAL . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.964 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.02 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.513 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.889 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 203' ' ' VAL . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.127 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 52.25 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 52.12 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.21 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 64.45 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 42.2 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 195' ' ' ILE . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 60.2 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 26' ' ' VAL . 6.9 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.24 111.147 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.863 0.363 . . . . 73.53 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.43 111.161 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 55.44 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' THR . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 72.31 111.132 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.24 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' HE1' ' A' ' 17' ' ' TRP . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 54.1 111.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 42.51 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.13 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 14' ' ' GLN . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.35 111.143 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 71.33 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 67' ' ' ILE . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 73.32 110.865 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 105' ' ' LEU . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.109 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.34 111.091 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.4 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.42 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.877 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.771 0.319 . . . . 61.11 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.506 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.54 111.125 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 67' ' ' ILE . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.904 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.685 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.973 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.938 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.699 0.761 . . . . 74.4 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' HD13 ' A' ' 153' ' ' LEU . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 45.32 112.335 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.44 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 64.21 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 149' ' ' PHE . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.05 111.113 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.31 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 147' ' ' PRO . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 61.15 111.161 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.53 112.462 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 72.51 110.857 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.676 . . . . 74.04 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.758 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 73.34 112.315 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.4 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 121' ' ' VAL . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 71.41 110.94 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.53 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.605 ' O ' HD22 ' A' ' 153' ' ' LEU . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 52.03 112.479 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 117' ' ' PRO . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 71.32 110.912 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 60.55 110.932 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.338 . . . . 74.11 110.915 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 71.43 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.847 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 51.14 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.891 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.88 0.371 . . . . 75.41 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 25' ' ' LYS . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 70.41 110.958 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.22 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.42 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 62.13 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 42.23 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 18' ' ' VAL . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.925 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.21 111.109 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.44 110.889 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.77 0.319 . . . . 51.13 110.933 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 71.33 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.54 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 74.4 111.084 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.095 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.11 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 19' ' ' ALA . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.11 110.877 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.13 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.02 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 50.33 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.133 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.369 . . . . 72.15 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.921 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.11 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 71.11 110.893 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 55.22 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 71.22 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.14 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.42 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.32 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.4 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 63.23 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.665 ' HB2' HD12 ' A' ' 67' ' ' ILE . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.1 111.198 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 55.13 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.11 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.13 110.925 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 64.5 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.21 112.448 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.752 0.311 . . . . 64.4 111.139 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.686 HG23 ' HA2' ' A' ' 124' ' ' GLY . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.44 111.119 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 50.14 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.14 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.42 110.904 -179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.656 0.741 . . . . 64.4 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.01 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.15 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.01 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.04 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 72.43 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.43 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.44 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 102' ' ' ILE . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.44 112.451 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.638 0.732 . . . . 42.02 111.069 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 64.33 112.356 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.42 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 63.24 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 167' ' ' VAL . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 34.3 111.177 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.12 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.31 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.52 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.903 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.744 0.306 . . . . 74.44 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.41 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 61.55 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.856 HG12 HD13 ' A' ' 196' ' ' LEU . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.1 111.111 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.907 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.776 0.322 . . . . 71.13 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.414 ' C ' HD22 ' A' ' 196' ' ' LEU . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.856 HD13 HG12 ' A' ' 167' ' ' VAL . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.942 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.771 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 54.03 110.938 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.54 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.12 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 31.34 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.01 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.42 110.91 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.77 0.319 . . . . 71.51 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.15 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.04 112.504 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.32 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.535 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.875 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 203' ' ' VAL . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.105 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.42 111.13 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.42 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 53.24 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.03 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.13 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 64.05 111.173 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 71.02 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 52.12 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.938 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' A' ' 17' ' ' TRP . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 53.12 111.13 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 65.32 111.116 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 70.53 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 15' ' ' GLY . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 72.33 111.105 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.03 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.3 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 67' ' ' ILE . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 63.33 110.884 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.51 111.105 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 105' ' ' LEU . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.119 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.04 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.887 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 74.54 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.42 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 64.13 112.509 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.793 0.33 . . . . 70.31 111.076 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 64.01 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 73.31 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 69' ' ' VAL . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 53.54 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.465 HE21 ' HE1' ' A' ' 118' ' ' TYR . 13.5 mm100 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.31 110.886 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.935 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.676 0.75 . . . . 72.35 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 45.42 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.465 ' HE1' HE21 ' A' ' 106' ' ' GLN . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.967 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 54.23 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.52 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 55.13 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 23.12 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 147' ' ' PRO . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.13 111.163 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.01 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.41 110.879 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 74.13 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.33 112.343 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 70.23 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.24 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 55.55 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 53.31 112.471 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.13 110.865 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 65.2 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.14 110.947 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 73.24 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.52 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 32.5 110.866 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.23 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 31.4 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 61.45 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.515 HG22 ' CD2' ' A' ' 196' ' ' LEU . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.02 111.147 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 62.25 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.929 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 60.32 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 54.12 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.34 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.31 110.955 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 18' ' ' VAL . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 65.54 111.084 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.54 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.94 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.751 0.31 . . . . 72.44 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.21 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.11 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.24 110.892 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 55.24 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 72.24 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.33 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.35 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.01 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.123 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.903 0.383 . . . . 74.04 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.15 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.55 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HE2' ' A' ' 72' ' ' PHE . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 64.2 111.142 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 63.1 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 65.53 110.935 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 58' ' ' ASP . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.1 111.154 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 51.04 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.04 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.22 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 54.13 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 52.45 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 73.13 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 54.0 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 72.0 111.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 44.34 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.11 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 63.15 110.878 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 56' ' ' THR . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.875 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.05 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.35 112.559 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.668 0.271 . . . . 44.44 111.113 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.21 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 55.33 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 67' ' ' ILE . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.52 110.932 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.43 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.914 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.585 0.707 . . . . 72.34 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.12 112.372 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 61.43 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 51.24 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 63.22 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.44 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 64.11 111.138 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 53.01 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 60.24 110.864 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.55 0.691 . . . . 73.3 111.146 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.751 ' HA ' HG12 ' A' ' 123' ' ' VAL . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 44.41 112.378 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.31 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.33 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 167' ' ' VAL . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.51 111.07 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.23 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 153' ' ' LEU . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.13 110.946 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 64.11 110.99 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.791 0.329 . . . . 74.33 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.41 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.24 110.901 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.475 ' N ' HD13 ' A' ' 163' ' ' LEU . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.91 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 61.34 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.32 111.177 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.87 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 63.33 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 63.42 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.35 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.44 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 52.14 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.03 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.3 110.927 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.779 0.323 . . . . 63.54 110.918 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.936 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.32 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 64.52 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.24 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 43.42 111.114 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.849 0.357 . . . . 45.32 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 51.11 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 59' ' ' ILE . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.14 111.103 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 73.51 111.113 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.21 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.52 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.15 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.42 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.25 110.831 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.32 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.43 112.459 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.767 0.318 . . . . 71.32 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.536 HD12 ' HA3' ' A' ' 124' ' ' GLY . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.102 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 53.04 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.961 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 50.01 110.929 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.671 0.748 . . . . 73.32 110.866 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 151' ' ' VAL . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 40.01 111.111 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.3 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 34.23 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 54.03 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 62.43 112.522 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.41 110.941 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.579 0.705 . . . . 63.22 111.134 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.2 112.369 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 65.21 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 119' ' ' VAL . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 65.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 74.02 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 63.51 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.896 -179.872 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.725 0.298 . . . . 61.31 110.975 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.35 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 196' ' ' LEU . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.43 111.071 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.876 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.736 0.303 . . . . 73.25 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.1 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.711 ' CD1' HG22 ' A' ' 167' ' ' VAL . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 60.15 110.948 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.45 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.53 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 197' ' ' SER . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.941 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.23 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 61.53 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 18' ' ' VAL . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.961 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 41.54 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 53.32 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.878 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.78 0.324 . . . . 73.13 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 24.44 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.41 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 202' ' ' TYR . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 55.13 111.157 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 42.11 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.22 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 54.34 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 195' ' ' ILE . 33.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 63.21 111.102 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.857 0.361 . . . . 71.44 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.22 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.943 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.24 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.05 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 65.23 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 53.13 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 62.23 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 73.53 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 71.44 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.23 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 63.01 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.03 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 107' ' ' TYR . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 70.23 111.094 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 52.02 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 65.41 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 71.44 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.534 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 63.22 110.876 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.1 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 63.44 112.409 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 74.52 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.22 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.42 110.966 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 63.02 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 62.34 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.645 ' HE2' HG23 ' A' ' 67' ' ' ILE . 3.5 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.676 0.75 . . . . 75.32 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.34 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 70.01 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 151' ' ' VAL . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.52 111.137 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 65.13 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 64.2 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.4 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.24 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.34 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 70.23 110.861 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.56 0.695 . . . . 71.51 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 64.25 112.351 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.11 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.21 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 119' ' ' VAL . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 44.21 111.082 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.24 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 ' OH ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 61.21 110.861 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 70.31 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.471 ' OH ' HD22 ' A' ' 153' ' ' LEU . 15.6 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.1 110.924 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.715 0.293 . . . . 74.2 110.958 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.494 HD23 ' N ' ' A' ' 164' ' ' ASN . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.494 ' N ' HD23 ' A' ' 163' ' ' LEU . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.893 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.633 ' O ' HD12 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.855 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 196' ' ' LEU . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 70.33 111.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.863 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.779 0.323 . . . . 75.31 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 26' ' ' VAL . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.33 111.157 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 166' ' ' ASP . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 71.35 110.88 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.22 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.12 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.13 110.917 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.42 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 71.34 110.897 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.746 0.308 . . . . 71.02 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HB2' HG13 ' A' ' 63' ' ' VAL . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.903 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.11 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 73.54 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 203' ' ' VAL . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.42 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 42.31 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.12 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 60.1 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 70.51 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.31 111.105 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.931 0.396 . . . . 74.24 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 55.13 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.24 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD13 ' OH ' ' A' ' 61' ' ' TYR . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.141 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.12 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 59' ' ' ILE . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.887 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 14' ' ' GLN . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 54.52 111.155 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.22 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.24 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 105' ' ' LEU . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.163 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.11 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 65.2 111.095 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.686 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 73.02 110.818 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 53.24 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.53 112.499 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.757 0.313 . . . . 73.52 111.115 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 70.24 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 70.32 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.41 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 67' ' ' ILE . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 70.02 110.908 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 119' ' ' VAL . 14.0 p90 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.948 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.671 0.748 . . . . 73.55 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 71.41 112.337 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 107' ' ' TYR . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.18 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.2 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.44 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.11 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 147' ' ' PRO . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.33 111.068 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 62.31 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.34 110.819 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.564 0.697 . . . . 73.35 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 123' ' ' VAL . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.32 112.276 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 72.13 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 72.12 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 63.15 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 64.03 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 155' ' ' TYR . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 64.35 110.914 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.535 ' CD1' HD21 ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.932 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.725 0.298 . . . . 74.12 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 164' ' ' ASN . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 52.44 110.941 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 163' ' ' LEU . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 62.05 110.914 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.44 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.846 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 70.42 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 70.1 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 163' ' ' LEU . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 61.45 110.888 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 40.43 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 71.14 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.14 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 18' ' ' VAL . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 53.14 111.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 75.35 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.3 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.11 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 203' ' ' VAL . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 71.03 111.096 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HB1' ' HZ ' ' A' ' 57' ' ' PHE . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 51.44 111.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.22 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 56' ' ' THR . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.21 110.874 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.44 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.107 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.852 0.358 . . . . 61.42 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.4 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 64.03 110.916 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' ASN . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.147 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.2 110.87 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 71.43 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.092 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 63.33 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 63.33 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.01 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.12 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 67' ' ' ILE . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.863 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.593 HG22 ' OD1' ' A' ' 66' ' ' ASN . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 62.02 111.149 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 42.11 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 51.2 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 72.13 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.53 112.52 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.749 0.309 . . . . 73.24 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.45 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.34 110.894 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.876 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.704 0.764 . . . . 72.32 110.954 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.51 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.52 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.21 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.52 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 53.44 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 65.14 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.12 111.171 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 71.3 110.923 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 121.573 0.702 . . . . 63.31 111.094 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.54 112.314 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.45 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 167' ' ' VAL . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.201 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' C ' HD13 ' A' ' 153' ' ' LEU . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 35.21 112.451 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.622 ' N ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.32 110.894 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 153' ' ' LEU . 1.1 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.947 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.82 0.343 . . . . 74.02 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.455 HD23 ' HE1' ' A' ' 155' ' ' TYR . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.918 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 50.11 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 60.5 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 196' ' ' LEU . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.136 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.896 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 65.34 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 73.12 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.571 HD22 HG23 ' A' ' 167' ' ' VAL . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 70.52 110.957 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 53.54 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 199' ' ' GLY . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 198' ' ' LEU . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 62.1 112.443 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 71.13 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 61.43 110.841 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 18' ' ' VAL . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.34 111.115 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.761 0.315 . . . . 73.1 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.32 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 202' ' ' TYR . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.21 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.14 111.147 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.861 0.363 . . . . 74.55 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.41 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 55.05 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.12 111.083 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.42 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.35 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 55.44 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.424 HG22 HD23 ' A' ' 105' ' ' LEU . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.2 111.111 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.151 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.12 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.23 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.52 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.34 112.523 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.756 0.313 . . . . 63.02 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.489 HG22 ' CA ' ' A' ' 124' ' ' GLY . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 35.32 111.152 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.13 110.886 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 67' ' ' ILE . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.32 110.883 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.989 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.655 0.741 . . . . 70.04 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.11 112.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 61.13 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.42 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 149' ' ' PHE . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.34 111.106 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 104' ' ' SER . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.43 112.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.34 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 102' ' ' ILE . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.15 110.885 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 121.622 0.725 . . . . 73.34 111.158 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 63.11 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB3' HG23 ' A' ' 121' ' ' VAL . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.904 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 167' ' ' VAL . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 63.4 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 64.14 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.14 110.857 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.662 ' CZ ' HD12 ' A' ' 163' ' ' LEU . 14.5 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.3 110.93 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.859 0.361 . . . . 74.35 110.854 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.662 HD12 ' CZ ' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 163' ' ' LEU . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.915 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.13 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 196' ' ' LEU . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.133 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 65.21 110.868 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 42.11 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.42 HG21 ' NH1' ' A' ' 168' ' ' ARG . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 65.12 111.156 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 167' ' ' VAL . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 70.45 110.951 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.32 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 54.51 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 18' ' ' VAL . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.31 111.08 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.53 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.31 110.88 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.752 0.311 . . . . 52.03 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 71.45 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 14.14 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 73.33 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.496 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.711 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.33 111.128 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 53.15 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.21 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 61.02 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 62.15 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 61.53 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 53.33 111.128 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.84 0.352 . . . . 71.14 111.117 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.438 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.31 111.219 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.43 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' A' ' 17' ' ' TRP . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.31 111.137 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.1 111.075 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.887 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.762 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 70.14 110.862 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.51 111.147 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.43 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 62.33 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 63.02 111.082 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 105' ' ' LEU . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.41 111.137 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.73 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.857 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE1' HG22 ' A' ' 56' ' ' THR . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.858 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 61.04 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.13 112.528 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.809 0.338 . . . . 62.22 111.12 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.894 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.665 0.745 . . . . 73.21 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.44 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.52 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.1 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 44.11 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.01 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 33.53 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.52 110.893 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.573 0.702 . . . . 45.23 111.086 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 72.12 112.324 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 63.14 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.2 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 167' ' ' VAL . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 63.51 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.2 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.53 110.877 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 18' ' ' VAL . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.873 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 153' ' ' LEU . 1.2 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.959 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 74.23 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 71.12 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.87 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.587 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 64.22 110.909 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.21 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.33 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 151' ' ' VAL . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.126 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.0 110.924 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.906 0.384 . . . . 71.43 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 61.42 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 61.44 110.885 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.13 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 64.1 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 18' ' ' VAL . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 65.34 111.135 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.21 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.32 110.946 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.809 0.338 . . . . 64.51 110.828 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.609 ' HB2' HG13 ' A' ' 63' ' ' VAL . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.24 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.34 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 202' ' ' TYR . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.04 111.113 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 71.13 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 63.14 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.54 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HE1' HD12 ' A' ' 55' ' ' LEU . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 56' ' ' THR . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.801 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 64.33 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 72.1 111.087 179.882 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.858 0.361 . . . . 54.42 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.34 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' HE1' ' A' ' 23' ' ' PHE . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.892 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' OG ' ' A' ' 24' ' ' SER . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 65.42 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 61' ' ' TYR . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 63.11 111.163 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 60.43 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 59' ' ' ILE . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.31 110.866 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 62.01 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 14' ' ' GLN . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.078 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.14 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 105' ' ' LEU . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 63.52 111.093 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.123 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.932 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 62.01 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 62.31 112.448 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 72.24 111.117 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.565 HD12 ' HA3' ' A' ' 124' ' ' GLY . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 62.34 111.177 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 52.34 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 67' ' ' ILE . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 64.01 110.911 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.933 -179.843 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.717 0.77 . . . . 72.22 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.35 112.327 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.815 HG22 HG13 ' A' ' 151' ' ' VAL . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.0 111.217 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.12 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 149' ' ' PHE . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.51 111.177 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 34.41 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.34 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.476 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.24 110.859 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.628 0.727 . . . . 72.42 111.107 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 51.12 112.291 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.15 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 121' ' ' VAL . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.893 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.21 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 119' ' ' VAL . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.51 111.154 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 61.24 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.11 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 71.14 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 63.32 110.936 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.727 0.298 . . . . 75.52 110.957 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.4 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.22 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.23 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.082 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.904 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 74.5 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.11 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 41.43 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.22 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 198' ' ' LEU . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 73.44 110.975 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.42 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.22 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.15 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.925 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 64.53 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.24 110.944 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.763 0.316 . . . . 70.05 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.31 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.3 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.553 ' CZ2' HD11 ' A' ' 59' ' ' ILE . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.934 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.24 111.078 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 32.51 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.05 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.21 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 74.23 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.11 111.093 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.858 0.361 . . . . 73.44 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.13 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.893 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.22 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 70.2 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 71' ' ' PHE . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.094 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 72.31 111.154 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 41.02 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 32.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 64.12 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.576 HG23 ' CE2' ' A' ' 107' ' ' TYR . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 60.5 111.204 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.099 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.616 ' HA ' HD23 ' A' ' 105' ' ' LEU . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.066 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 63.24 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' HG23 ' A' ' 59' ' ' ILE . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.875 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.03 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.21 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 33.02 112.464 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 54.53 111.074 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.739 HG23 ' CA ' ' A' ' 124' ' ' GLY . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.152 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 51.1 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 69' ' ' VAL . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.907 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.694 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 44.32 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 67' ' ' ILE . 12.9 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.924 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.727 0.775 . . . . 72.53 110.845 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 71.42 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 51.13 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 149' ' ' PHE . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 62.2 111.087 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.15 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 51.24 111.104 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.739 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 64.11 112.44 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 62.54 110.873 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.639 0.733 . . . . 53.31 111.099 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HB2' HG23 ' A' ' 121' ' ' VAL . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.881 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.32 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.509 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 70.35 110.84 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.04 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.949 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 74.02 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 162' ' ' MET . . . . . 0.404 ' O ' ' HB1' ' A' ' 200' ' ' ALA . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 62.31 110.879 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 64.25 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 64.2 110.861 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.811 0.338 . . . . 72.12 110.882 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 196' ' ' LEU . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.31 111.082 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 195' ' ' ILE . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.13 110.929 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.35 110.823 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 197' ' ' SER . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.42 110.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 54.12 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 162' ' ' MET . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.55 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.593 HG13 HG22 ' A' ' 18' ' ' VAL . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.51 111.191 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 70.22 110.943 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.757 0.313 . . . . 73.25 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' HG23 ' A' ' 63' ' ' VAL . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.947 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.42 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.02 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 53.3 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 203' ' ' VAL . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.144 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.35 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 61.25 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 73.21 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.31 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.22 111.091 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.93 0.395 . . . . 63.33 111.16 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 71.42 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 41.02 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.54 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.33 111.165 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 61.13 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.474 HG13 ' OG ' ' A' ' 64' ' ' SER . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.129 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 54.13 110.806 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.43 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.718 ' OD1' HD12 ' A' ' 67' ' ' ILE . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.35 110.866 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.718 HD12 ' OD1' ' A' ' 66' ' ' ASN . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.33 111.138 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.083 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 62.42 112.527 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 54.13 111.05 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 62.14 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 67' ' ' ILE . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.03 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.887 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 70.35 110.892 -179.837 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 121.702 0.763 . . . . 70.43 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.35 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 151' ' ' VAL . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.044 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.32 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.53 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.13 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 52.21 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.33 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.3 110.866 -179.801 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.596 0.712 . . . . 74.15 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.22 112.388 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 54.24 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 55.13 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 167' ' ' VAL . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.23 111.186 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.51 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 72.0 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.3 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.94 -179.833 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.787 0.327 . . . . 72.01 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.427 ' HB3' HD13 ' A' ' 198' ' ' LEU . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.849 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 61.42 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.03 111.079 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.25 110.911 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 196' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.875 0.369 . . . . 64.11 110.881 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 43.41 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.463 HD21 ' CE2' ' A' ' 194' ' ' PHE . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.42 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.53 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 199' ' ' GLY . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.937 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.486 ' H ' HD12 ' A' ' 198' ' ' LEU . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.14 112.51 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.23 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 72.12 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 18' ' ' VAL . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.1 111.138 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.14 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.905 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.795 0.331 . . . . 70.14 110.885 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 53.13 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.13 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.2 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.3 111.152 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 44.24 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 63.1 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 71.1 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' O ' HD23 ' A' ' 198' ' ' LEU . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.79 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.2 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 64.13 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 63.03 111.096 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 70.01 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 53.44 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 55.43 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.33 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.22 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 63.15 111.145 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 24.12 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 61.43 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.04 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.3 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 65.42 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 103' ' ' LEU . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.848 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HE2' ' HG ' ' A' ' 104' ' ' SER . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.896 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 50.24 112.418 -179.957 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.763 0.316 . . . . 63.44 111.087 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.33 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 71' ' ' PHE . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.878 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HG ' ' HE2' ' A' ' 72' ' ' PHE . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.808 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 72.44 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 54.54 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 74.14 110.932 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.624 0.726 . . . . 75.2 110.925 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 71.53 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 73.01 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 52.32 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.15 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 55.44 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 51.34 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 44.02 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 71.51 110.872 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.621 0.724 . . . . 75.3 111.072 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 62.51 112.277 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.24 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 71.12 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.702 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.35 112.533 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 152' ' ' GLY . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.92 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.755 0.312 . . . . 73.14 110.93 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 64.33 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.762 HG13 HD11 ' A' ' 196' ' ' LEU . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 65.12 111.156 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.831 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 74.01 110.868 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.42 111.112 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 167' ' ' VAL . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.44 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.15 110.918 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 53.31 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 55.2 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.44 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.547 ' C ' HG13 ' A' ' 18' ' ' VAL . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.22 110.888 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 18' ' ' VAL . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 61.41 111.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.35 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.91 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.761 0.315 . . . . 72.01 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 34.4 112.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.05 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 71.33 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 203' ' ' VAL . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 64.13 111.154 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 72.54 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.32 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 64.34 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 70.24 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.53 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 50.33 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.2 111.161 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 74.52 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 61.23 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.887 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.43 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 65.31 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 50.42 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.44 111.106 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.32 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 15' ' ' GLY . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.03 111.101 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.1 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 74.11 110.839 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.127 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 105' ' ' LEU . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.41 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 103' ' ' LEU . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.893 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 62.31 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 44.34 112.515 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.796 0.331 . . . . 74.54 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.691 HG23 ' CA ' ' A' ' 124' ' ' GLY . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.148 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 71' ' ' PHE . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.94 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.43 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 69' ' ' VAL . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.916 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.712 0.768 . . . . 62.23 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.31 112.35 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 52.21 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.21 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.13 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 71.1 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.41 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 146' ' ' ALA . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.02 111.096 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.691 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 23.3 112.519 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 73.14 110.861 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.601 0.715 . . . . 74.22 111.113 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 71.23 112.348 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.45 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.4 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 64.24 110.913 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 163' ' ' LEU . 17.9 p90 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 70.35 110.945 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.781 0.324 . . . . 73.33 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.24 110.886 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 163' ' ' LEU . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.42 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 153' ' ' LEU . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.912 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.23 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.882 HG23 HD23 ' A' ' 196' ' ' LEU . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 60.35 111.151 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.921 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 196' ' ' LEU . 13.2 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.795 0.331 . . . . 63.12 110.874 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 55.12 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.882 HD23 HG23 ' A' ' 167' ' ' VAL . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.909 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 43.53 110.875 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 197' ' ' SER . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.1 110.907 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.02 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.52 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 51.13 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 18' ' ' VAL . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 55.32 111.196 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.854 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.765 0.317 . . . . 74.23 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.455 ' HB3' HG13 ' A' ' 63' ' ' VAL . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.918 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 63' ' ' VAL . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.11 112.485 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.41 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.943 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 HG23 ' A' ' 203' ' ' VAL . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.1 111.19 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.103 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 62.5 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CE1' HD22 ' A' ' 55' ' ' LEU . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.882 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.213 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 74.34 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.31 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 62.24 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.2 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 ' HE1' ' A' ' 17' ' ' TRP . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.22 111.164 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 62.52 111.134 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' HA2' ' A' ' 15' ' ' GLY . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 60.32 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.04 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.1 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 71.43 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 50.51 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.11 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.13 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 71' ' ' PHE . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 42.33 111.067 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.54 112.501 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 64.45 111.076 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.174 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 70.41 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.99 -179.88 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.559 ' C ' HD12 ' A' ' 153' ' ' LEU . 6.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.665 0.745 . . . . 72.43 110.884 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.24 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.22 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 52.13 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.52 111.143 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 62.22 110.921 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.602 0.715 . . . . 62.54 111.164 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.652 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.4 112.361 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.33 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 63.45 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 167' ' ' VAL . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 64.03 111.102 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.03 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 116' ' ' TYR . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 54.42 110.843 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 45.35 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.15 110.875 -179.837 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 73.43 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.4 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 40.32 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.13 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 62.52 111.137 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 70.01 110.895 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.312 . . . . 73.44 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 70.33 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.1 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.55 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.54 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 18' ' ' VAL . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 73.21 111.149 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.876 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 74.53 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.1 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 62.35 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.23 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.21 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 203' ' ' VAL . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 61.11 111.106 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.45 111.111 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.13 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 55' ' ' LEU . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 56' ' ' THR . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.863 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 64.03 111.108 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 64.23 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.04 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 23' ' ' PHE . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 51.13 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.424 HG21 ' OG ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.136 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 61.34 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 71.21 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.893 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.52 111.155 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.45 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.53 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 107' ' ' TYR . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 73.43 111.143 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 61' ' ' TYR . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.41 111.071 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.24 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.54 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' A' ' 101' ' ' ALA . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 102' ' ' ILE . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 60.03 110.84 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.13 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 33.52 112.517 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.842 0.353 . . . . 74.32 111.008 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 72' ' ' PHE . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.51 111.108 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.999 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 61.34 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 119' ' ' VAL . 6.9 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.4 110.911 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.617 0.722 . . . . 63.45 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.13 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.53 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 107' ' ' TYR . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.11 111.1 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.43 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' VAL . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.35 111.146 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 63.5 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 74.34 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 63.23 110.886 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.602 0.715 . . . . 53.22 111.144 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.33 112.329 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.41 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 45.22 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 167' ' ' VAL . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.122 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.03 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 63.11 110.927 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.883 -179.812 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.73 0.3 . . . . 71.02 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.42 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 51.42 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.14 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.43 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 151' ' ' VAL . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 51.44 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.862 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 64.33 110.84 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.35 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 53.13 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.43 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 45.14 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.25 110.964 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 18' ' ' VAL . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 55.54 111.111 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.855 0.359 . . . . 73.11 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 54.11 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.12 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.726 HG22 HG23 ' A' ' 203' ' ' VAL . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 62.54 111.127 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.42 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.1 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.909 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.3 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.13 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 63.33 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.146 179.854 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 74.53 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' A' ' 57' ' ' PHE . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.896 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.21 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CE2' HD21 ' A' ' 55' ' ' LEU . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.21 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 72.23 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 64.12 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.03 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 52.31 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.492 ' ND2' HG22 ' A' ' 67' ' ' ILE . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.904 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 105' ' ' LEU . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.12 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.32 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.873 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 72.14 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 70.05 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 52.54 112.517 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.669 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.67 0.271 . . . . 53.22 111.11 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' A' ' 124' ' ' GLY . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.11 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.34 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.43 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 67' ' ' ILE . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.915 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.42 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.896 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.753 0.787 . . . . 74.32 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 72.54 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.32 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 151' ' ' VAL . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.45 111.088 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.35 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 149' ' ' PHE . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 71.11 111.083 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.21 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.34 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HG23 ' A' ' 102' ' ' ILE . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 51.05 112.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.34 110.869 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.33 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 54.14 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' VAL . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.11 111.13 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.42 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 62.1 110.97 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' CE1' HD12 ' A' ' 153' ' ' LEU . 7.5 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.14 110.978 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.338 . . . . 74.14 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 72.25 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 155' ' ' TYR . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.42 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 196' ' ' LEU . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.23 111.087 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 71.3 110.922 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 75.31 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 167' ' ' VAL . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.923 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 52.41 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 199' ' ' GLY . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 63.44 110.894 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 198' ' ' LEU . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 61.44 112.446 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 34.32 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.44 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 18' ' ' VAL . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.4 111.116 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.936 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 62.53 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 43.01 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.11 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HE1' HD12 ' A' ' 59' ' ' ILE . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.35 110.887 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.1 111.171 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 61.2 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 54.04 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.12 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 71.22 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.01 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 53.25 111.062 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.919 0.39 . . . . 65.41 111.145 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 45.1 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.53 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 73.41 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HE1' ' A' ' 17' ' ' TRP . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 54.52 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.787 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.23 111.12 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 64.13 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 60.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.22 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 106' ' ' GLN . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.058 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 55.14 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.04 110.89 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 60.42 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.41 112.476 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' HB1' ' HE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.753 0.311 . . . . 63.13 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 148' ' ' ALA . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 63.53 111.136 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 71' ' ' PHE . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.945 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 22.13 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.922 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.22 110.901 -179.803 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.672 0.748 . . . . 74.32 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.13 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.25 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.44 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.14 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 71.31 111.122 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.41 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.42 110.899 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.793 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.51 112.35 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 102' ' ' ILE . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 53.43 111.109 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.4 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 53.14 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 71.11 111.163 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.34 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.14 110.879 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.944 -179.899 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.742 0.306 . . . . 74.12 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 60.33 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 52.4 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.688 ' HB ' HD12 ' A' ' 196' ' ' LEU . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 71.5 111.101 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.836 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 72.14 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.688 HD12 ' HB ' ' A' ' 167' ' ' VAL . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.913 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' SER . . . . . 0.507 ' C ' HD12 ' A' ' 198' ' ' LEU . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.891 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.947 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.44 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.12 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.53 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.02 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 18' ' ' VAL . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.05 111.126 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.899 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.814 0.34 . . . . 75.2 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 70.21 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.22 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.15 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.545 ' HE1' HG23 ' A' ' 59' ' ' ILE . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.893 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 60' ' ' ALA . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 55.01 111.178 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.22 111.136 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 200' ' ' ALA . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.818 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 61.05 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 70.32 111.173 179.83 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.856 0.36 . . . . 73.32 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.35 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.13 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.545 HG23 ' HE1' ' A' ' 17' ' ' TRP . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.42 111.157 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.975 ' HB3' HG13 ' A' ' 18' ' ' VAL . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 50.42 111.098 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.11 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.14 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.02 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 107' ' ' TYR . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.43 111.192 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.35 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 64.32 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 103' ' ' LEU . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.869 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.54 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.2 112.459 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.782 0.325 . . . . 70.04 111.044 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 71' ' ' PHE . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.93 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.12 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.735 HD13 ' CE1' ' A' ' 107' ' ' TYR . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 63.52 110.946 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.735 ' CE1' HD13 ' A' ' 105' ' ' LEU . 5.1 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.02 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 121.72 0.771 . . . . 75.15 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 71.52 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.11 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 151' ' ' VAL . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.04 111.158 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' CD2' ' A' ' 149' ' ' PHE . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 74.13 111.088 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.33 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 147' ' ' PRO . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.22 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 63.43 110.852 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.639 0.733 . . . . 42.3 111.077 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PRO . . . . . 0.752 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.1 112.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 54.32 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 121' ' ' VAL . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.844 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 119' ' ' VAL . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.2 111.162 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.484 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 61.34 110.931 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 51.5 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.53 110.904 -179.816 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.69 0.281 . . . . 73.34 110.866 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.3 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.1 110.888 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.13 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.922 -179.944 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.839 0.352 . . . . 74.45 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.45 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 196' ' ' LEU . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.94 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.04 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 65.31 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 24.12 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 62.51 111.128 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 61.33 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.12 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.53 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 72.55 110.88 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.84 0.352 . . . . 74.2 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.42 157.59 45.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.826 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.12 144.15 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -102.8 162.02 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 70.33 110.926 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -152.38 73.43 7.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.689 0.757 . . . . 74.24 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.11 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 73.12 112.345 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.14 165.29 24.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 70.01 111.081 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -130.96 -173.71 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 73.41 110.88 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -53.11 103.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.02 110.882 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.61 -172.52 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.22 111.088 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.68 -157.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 54.11 112.459 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -175.92 140.48 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 71.41 110.888 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.41 -170.09 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 70.11 110.866 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' ' 63' ' ' VAL . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.52 110.964 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.02 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.513 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.54 110.889 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 203' ' ' VAL . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 71.21 111.127 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 52.25 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 52.12 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.21 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 64.45 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 42.2 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 195' ' ' ILE . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 60.2 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 26' ' ' VAL . 6.9 p -88.98 123.42 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.24 111.147 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.06 104.47 14.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.61 144.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 61.41 111.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.36 90.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 71.01 112.461 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -84.83 -40.84 16.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 65.34 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -52.1 -37.93 55.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 73.21 110.937 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -58.82 -44.23 90.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 64.53 110.919 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.98 3.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 63.44 112.497 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -143.49 105.75 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 62.01 110.897 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp 56.52 43.2 26.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 74.53 110.923 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -141.46 140.1 33.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.2 110.911 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.35 131.96 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 62.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.63 152.81 6.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 72.14 112.503 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.15 52.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 65.15 112.493 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.47 128.21 3.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 33.03 112.508 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.46 57.14 3.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 62.44 111.157 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -99.1 158.87 31.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 71.34 110.901 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 118.65 5.81 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 74.05 112.37 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -174.38 150.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 72.23 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 51.99 43.17 30.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.072 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.83 141.63 48.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 70.1 110.854 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.76 143.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.43 111.077 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -76.62 132.47 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.02 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 tp -54.84 137.94 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 62.32 111.159 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.15 -160.97 32.14 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.719 -0.753 . . . . 72.32 112.456 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -129.75 135.56 48.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 75.31 110.851 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -119.4 30.52 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 72.53 110.879 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -75.14 119.64 19.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 73.53 111.102 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.43 111.161 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 55.44 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' THR . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 72.31 111.132 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.43 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.24 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' HE1' ' A' ' 17' ' ' TRP . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 54.1 111.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 42.51 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.13 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.23 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 14' ' ' GLN . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.35 111.143 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.23 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 71.33 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 67' ' ' ILE . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 73.32 110.865 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 105' ' ' LEU . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.24 111.109 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.34 111.091 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.4 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.42 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.13 110.877 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.41 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.25 171.59 36.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.65 155.52 14.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.732 . . . . 71.31 111.125 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 172.7 12.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 62.52 112.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.57 158.0 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.45 111.15 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -54.95 120.52 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 73.24 110.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -173.25 174.17 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 65.32 111.14 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.93 171.77 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 62.22 110.885 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -119.91 -67.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.04 110.908 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.53 -36.26 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 70.23 110.885 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 62.08 5.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 75.2 112.482 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -174.84 145.39 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 71.15 110.874 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -63.83 122.68 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 74.21 110.9 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 t -64.89 124.28 21.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 73.4 110.87 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.91 -37.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 62.52 111.088 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 m -151.32 111.85 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.45 110.856 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 t -173.02 167.74 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 73.33 110.822 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.7 tp -170.57 126.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 71.35 110.929 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.83 -143.68 10.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.741 -0.742 . . . . 71.24 112.492 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -128.68 -41.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 73.34 110.843 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.7 t 53.17 78.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 73.12 111.073 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -86.27 167.22 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 53.42 110.844 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -114.42 71.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 62.51 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.6 m -114.76 40.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 71.01 111.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.43 135.83 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.856 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -100.52 -42.31 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 73.13 110.945 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.87 75.82 0.42 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 75.21 112.451 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.82 10.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.264 . . . . 70.12 112.374 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -149.93 130.54 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 61.11 111.113 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.506 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.54 111.125 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.55 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 67' ' ' ILE . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.14 110.904 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.685 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.24 110.973 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -132.6 133.2 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.12 110.938 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -131.07 163.45 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.22 110.874 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.5 37.23 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.919 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.25 -39.87 6.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.33 110.863 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.7 m 53.02 36.78 23.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 54.03 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -177.4 178.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 73.04 110.898 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.16 97.9 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 71.11 110.869 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 -161.89 174.31 13.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 74.33 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.0 94.58 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.05 153.4 78.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.699 0.761 . . . . 74.4 110.916 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' HD13 ' A' ' 153' ' ' LEU . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 45.32 112.335 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.11 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.44 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 64.21 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 149' ' ' PHE . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.05 111.113 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.31 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 147' ' ' PRO . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 61.15 111.161 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.53 112.462 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.28 -176.98 6.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 72.51 110.857 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.79 152.55 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 63.14 111.141 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -116.93 129.86 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.949 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.422 ' CD1' HD12 ' A' ' 127' ' ' LEU . 16.6 m-85 53.33 43.9 30.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 60.44 110.937 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.51 -36.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 65.21 110.832 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -62.12 127.8 33.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 65.4 110.881 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -92.29 178.65 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 t -113.1 73.27 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 64.43 111.106 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -154.51 147.64 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.25 110.854 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.8 80.61 1.78 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.35 112.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.15 -64.98 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 74.43 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mt -137.4 110.46 7.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 71.53 110.907 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 t -76.66 160.71 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 71.42 110.834 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t 57.53 48.43 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 71.35 110.877 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -124.46 43.53 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 74.21 110.905 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -142.33 144.05 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 62.2 110.887 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 144' ' ' LYS . 8.4 tt -110.71 150.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 72.53 111.129 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -51.95 -64.33 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 74.35 110.904 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -152.35 122.67 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.853 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.736 ' HG3' HG21 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -126.33 98.65 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.01 110.91 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -124.32 147.66 48.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 75.33 110.878 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -126.08 159.93 59.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.521 0.676 . . . . 74.04 111.148 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.758 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 73.34 112.315 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.4 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 121' ' ' VAL . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 71.41 110.94 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.23 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.53 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.605 ' O ' HD22 ' A' ' 153' ' ' LEU . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 52.03 112.479 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 117' ' ' PRO . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 71.32 110.912 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.2 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -136.02 148.0 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 60.55 110.932 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.42 110.15 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 73.05 110.882 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.44 -40.13 12.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.42 110.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -133.5 -139.17 4.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 73.44 112.477 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -111.28 -56.5 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 61.3 110.848 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.3 p -74.31 -62.96 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 45.22 110.908 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -92.13 148.14 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.11 110.915 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 71.43 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.24 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 62.23 110.847 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 51.14 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -143.98 130.31 19.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -77.16 139.71 40.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.925 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.439 HG23 ' HD2' ' A' ' 171' ' ' PRO . 48.6 mm -120.95 133.1 24.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.626 0.726 . . . . 75.41 111.111 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 170' ' ' ILE . 54.1 Cg_endo -69.79 150.08 67.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 65.14 112.355 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -114.97 118.62 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.04 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -64.5 151.88 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.21 110.89 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.4 m -61.63 109.16 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 74.24 111.129 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -171.02 150.94 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.53 110.859 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.1 p -107.35 139.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.21 111.168 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.5 p -132.6 107.09 8.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.22 111.169 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.67 -162.73 10.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 65.4 112.483 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 180' ' ' LEU . 9.2 m -133.66 153.85 51.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 70.33 111.136 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 179' ' ' THR . 1.5 pt? -54.59 162.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.02 110.871 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.49 71.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 70.22 112.495 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.89 55.31 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 74.12 112.279 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.4 156.19 70.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.671 0.748 . . . . 74.2 111.139 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -38.08 8.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.638 2.225 . . . . 74.54 112.373 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -70.05 174.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 75.51 111.148 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 36.9 m -129.28 151.35 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.31 110.843 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p -133.27 151.38 51.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.05 111.139 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -70.6 152.56 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.922 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.1 89.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.118 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -121.95 90.46 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.22 110.891 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.68 -70.42 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.42 111.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.88 71.12 1.29 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.642 0.734 . . . . 73.41 110.856 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.29 69.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.243 . . . . 64.22 112.35 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -161.38 174.76 13.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.41 110.865 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 25' ' ' LYS . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.44 111.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 70.41 110.958 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.22 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.42 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 62.13 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 42.23 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 18' ' ' VAL . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.44 110.925 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.21 111.109 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -121.33 100.34 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.44 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.456 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.3 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 63.44 110.898 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 58.81 48.71 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.31 111.095 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.28 109.12 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 61.44 111.072 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.21 149.61 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 42.35 111.12 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.95 118.6 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 61.11 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.1 110.865 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.763 0.316 . . . . 74.2 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.89 131.63 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 61.23 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -146.51 127.99 15.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 62.14 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -119.17 151.79 37.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.908 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -72.78 160.46 82.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.727 0.775 . . . . 72.41 110.899 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 98.18 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.628 2.219 . . . . 65.53 112.431 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 141.8 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 54.24 111.012 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -117.34 37.32 3.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 64.24 110.945 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -91.25 119.49 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.24 110.892 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.64 162.35 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 111.145 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.92 -155.1 6.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 73.11 112.498 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -163.91 133.51 4.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 72.54 110.921 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -158.45 158.43 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 51.13 110.933 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.34 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 71.33 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.54 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 74.4 111.084 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.35 111.095 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.11 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 19' ' ' ALA . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.11 110.877 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 64.32 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.13 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.02 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 50.33 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.18 113.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.32 111.133 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -103.76 110.64 22.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.1 110.929 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.82 149.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 74.22 111.099 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.95 70.14 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 71.41 112.448 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -87.64 -46.41 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 72.12 110.877 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.02 37.67 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 71.13 110.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.15 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 54.44 110.933 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.65 -126.59 7.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.783 -0.723 . . . . 52.11 112.522 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.31 129.34 16.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 64.31 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.16 -50.2 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.903 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -52.56 156.71 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.45 110.962 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 p -87.94 146.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.45 111.109 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.17 -122.23 0.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.803 -0.713 . . . . 73.54 112.501 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.76 -99.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 42.21 112.53 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.08 -155.03 3.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 61.15 112.522 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.89 -58.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.8 0.333 . . . . 73.5 111.059 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -110.31 91.1 11.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.666 0.746 . . . . 75.23 110.922 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.609 2.206 . . . . 73.33 112.372 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -119.43 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 73.11 110.913 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.25 136.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.35 111.069 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -119.09 -43.23 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.1 m -142.56 145.55 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.53 111.127 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.9 t -108.36 126.37 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.1 110.849 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 pp -51.96 145.67 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 53.45 111.12 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.15 4.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 63.03 112.455 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.8 146.63 35.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 71.1 110.855 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -123.4 -36.9 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.22 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -57.15 121.27 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.15 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 61.53 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 61.04 110.921 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.11 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 71.11 110.893 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 55.22 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 71.22 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.53 111.14 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.42 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.32 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.4 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 63.23 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.665 ' HB2' HD12 ' A' ' 67' ' ' ILE . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.1 111.198 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 55.13 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.11 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.44 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.13 110.925 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.55 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 64.5 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.46 -167.81 21.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.21 112.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.34 156.23 72.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 60.21 111.125 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 175.3 8.3 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.622 2.215 . . . . 63.42 112.313 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.24 168.86 9.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 72.23 111.11 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -59.68 105.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 72.31 110.897 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.55 178.16 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.33 111.165 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -143.42 121.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 73.35 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -126.79 167.59 15.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 73.33 110.881 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -154.3 -178.66 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 75.15 110.859 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.46 106.13 1.51 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 54.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.38 154.82 50.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.44 110.894 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 40.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.907 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -66.62 -175.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 73.43 110.882 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -95.07 -57.08 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.164 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 p -73.62 95.2 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 42.11 110.854 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.4 p -63.21 145.55 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.11 110.914 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.66 45.47 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.04 110.876 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.28 130.94 29.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.716 -0.754 . . . . 51.22 112.477 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 -30.14 24.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 61.21 110.849 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.74 102.43 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.43 111.154 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -170.28 119.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 63.23 110.814 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.64 -65.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 70.12 110.841 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 t -85.9 117.24 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.24 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -137.21 170.91 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 73.02 110.897 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -89.85 150.48 22.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 75.24 110.897 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.28 -170.21 26.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.771 -0.728 . . . . 61.33 112.517 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.72 135.87 31.66 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 73.22 112.366 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -143.92 131.43 21.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 64.4 111.139 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.686 HG23 ' HA2' ' A' ' 124' ' ' GLY . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.44 111.119 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.11 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 50.14 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.14 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -128.59 137.46 51.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.42 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -130.92 145.35 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 73.11 110.852 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.45 -35.75 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 52.24 110.851 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.7 -36.34 9.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.23 110.891 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.0 m 63.28 62.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.33 110.93 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -167.4 143.27 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 72.4 110.843 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -54.07 102.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 74.13 110.933 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -176.04 158.79 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.24 110.867 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD23 ' CA ' ' A' ' 155' ' ' TYR . 0.8 OUTLIER -60.59 98.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 71.11 110.871 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.26 160.53 26.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.656 0.741 . . . . 64.4 110.935 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.01 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.15 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.01 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.04 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 72.43 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.43 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.44 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 102' ' ' ILE . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.44 112.451 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -141.42 134.65 29.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.468 HG12 ' HD3' ' A' ' 144' ' ' LYS . 14.1 p -115.0 141.54 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 62.34 111.081 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.41 115.5 30.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 62.34 110.902 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -54.8 135.86 47.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.13 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -98.18 168.27 10.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.52 110.902 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 56.35 53.55 8.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.42 110.889 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -71.66 142.01 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 74.13 110.955 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.9 t -85.3 168.14 14.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 75.15 111.189 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -85.26 -52.92 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 75.31 110.932 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.2 78.33 1.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.784 . . . . 72.34 112.513 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.48 -38.88 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 70.41 111.079 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.7 mt -86.2 -69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 62.13 110.906 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 p -113.07 171.77 7.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 71.02 110.855 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 m -112.48 135.84 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 75.03 110.845 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 73.12 110.854 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -118.77 157.01 28.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.894 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tp -82.26 135.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 63.45 111.096 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -96.02 150.38 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 75.02 110.907 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -61.92 177.1 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 64.35 110.882 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HD3' HG12 ' A' ' 126' ' ' VAL . 30.1 tttt -123.02 -62.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 53.03 110.928 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.3 m95 52.03 56.05 8.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.03 110.885 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -84.42 160.47 56.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.638 0.732 . . . . 42.02 111.069 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 64.33 112.356 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.3 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.42 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 63.24 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 167' ' ' VAL . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 34.3 111.177 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.12 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.31 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.52 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.557 ' CA ' HD23 ' A' ' 115' ' ' LEU . 13.9 m-85 -131.12 105.35 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 64.34 110.903 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.52 99.98 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 75.4 110.869 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.5 -62.07 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.42 110.959 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -57.04 147.54 34.08 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 73.45 112.477 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -57.76 -36.43 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 74.13 110.875 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -110.5 -67.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 75.5 110.841 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -72.45 146.9 46.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 74.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.41 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 61.55 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.856 HG12 HD13 ' A' ' 196' ' ' LEU . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.1 111.111 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -149.58 147.62 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.32 110.907 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -114.55 127.55 55.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 61.32 110.913 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -108.74 132.1 21.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.604 0.716 . . . . 61.5 111.174 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 55.43 112.366 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -130.3 145.12 51.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.35 110.897 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -93.56 123.5 36.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 73.03 110.923 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 t -143.2 158.38 43.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.31 111.108 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.47 156.05 17.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 71.32 110.877 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.3 m -66.45 177.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.45 111.204 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.8 t -164.29 152.62 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.23 111.168 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -109.77 173.3 16.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.677 -0.773 . . . . 72.41 112.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.2 t -132.58 137.27 47.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 44.45 111.106 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -147.03 145.2 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 52.25 110.946 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.91 177.74 20.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 71.22 112.476 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 81.73 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 71.34 112.389 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.626 HG12 HG13 ' A' ' 185' ' ' VAL . 21.8 t 63.22 73.8 0.48 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.598 0.713 . . . . 54.23 111.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 92.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.709 2.273 . . . . 71.21 112.375 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 183' ' ' VAL . 25.5 m -113.95 152.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 71.43 111.097 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 83.4 p -145.51 172.48 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 61.24 110.892 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 -42.15 4.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 41.42 111.177 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -99.39 139.14 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.936 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.4 mt -123.72 110.48 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 72.23 111.113 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.14 112.96 3.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 71.35 110.882 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.05 -70.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.24 111.114 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.65 160.62 61.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 73.1 110.876 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.79 48.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.718 2.279 . . . . 64.23 112.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.09 136.56 33.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 71.13 110.908 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.414 ' C ' HD22 ' A' ' 196' ' ' LEU . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.856 HD13 HG12 ' A' ' 167' ' ' VAL . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.942 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.32 110.771 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 54.03 110.938 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.54 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.12 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 31.34 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.01 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.12 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.11 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -126.45 89.39 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.42 110.91 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.65 -44.09 14.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 73.33 110.903 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.66 91.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.44 111.125 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.64 178.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 72.15 111.128 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.29 -54.8 5.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 52.4 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.6 tp -74.4 -62.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.922 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 72.31 110.882 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.728 0.299 . . . . 71.42 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.56 136.98 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 72.53 110.911 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.01 178.16 4.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.905 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.74 171.74 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.23 110.843 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -126.87 69.18 72.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.706 0.765 . . . . 62.23 110.929 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -41.79 3.98 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 64.22 112.348 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.12 -177.93 3.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 65.41 111.106 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.08 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 75.53 110.923 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t 62.45 40.0 11.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 63.44 110.834 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.66 118.58 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.1 111.024 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.32 -161.54 18.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.77 . . . . 54.42 112.451 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -140.12 116.65 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 74.12 110.901 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.19 131.87 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 71.51 110.89 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.15 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.04 112.504 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.32 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.535 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.51 110.875 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 203' ' ' VAL . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 72.44 111.105 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.42 111.13 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.42 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 53.24 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.03 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.13 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.67 125.62 40.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 64.05 111.173 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -114.1 108.08 16.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 72.54 110.935 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.54 151.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 72.43 111.134 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.22 48.19 0.46 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.753 . . . . 65.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.32 -43.82 93.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 70.33 110.876 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 57.41 52.13 9.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.14 110.945 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -131.82 -55.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 75.14 110.936 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.94 -143.5 17.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 24.15 112.479 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' C ' HD22 ' A' ' 35' ' ' LEU . 15.3 t70 -122.21 165.04 16.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 72.53 110.829 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 34' ' ' ASP . 4.5 mm? -121.84 75.9 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 62.21 110.913 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.72 140.22 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.24 110.913 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -173.61 135.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 75.1 111.123 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.89 -43.38 8.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 71.25 112.449 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.83 47.61 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 71.22 112.454 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.83 53.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 61.04 112.495 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.31 165.86 10.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 70.3 111.046 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -104.81 159.21 30.08 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.589 0.709 . . . . 75.33 110.889 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 174.51 9.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.622 2.215 . . . . 72.34 112.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -94.99 124.29 38.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 65.24 110.956 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.84 -52.32 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 74.22 111.142 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.37 152.27 34.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.11 110.839 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.8 t -130.04 129.84 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.3 111.169 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.4 p -77.73 99.12 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.53 110.841 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -124.4 124.61 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.25 111.068 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.31 -72.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.781 -0.723 . . . . 61.32 112.508 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.26 121.72 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 45.33 110.911 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -118.41 -36.98 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 71.42 110.831 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -54.93 132.66 47.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 71.02 111.116 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 52.12 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.938 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.22 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' A' ' 17' ' ' TRP . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 53.12 111.13 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 65.32 111.116 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 70.53 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 15' ' ' GLY . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 72.33 111.105 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.03 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.3 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 67' ' ' ILE . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 63.33 110.884 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.51 111.105 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.4 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 105' ' ' LEU . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.24 111.119 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.04 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 72.34 110.887 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 74.54 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.42 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.53 -157.37 17.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 64.13 112.509 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.67 156.18 45.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.628 0.728 . . . . 75.35 111.196 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 138.26 37.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.628 2.218 . . . . 64.4 112.363 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.48 -176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 73.13 111.095 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -81.68 128.62 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.1 110.894 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.64 132.74 48.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.145 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -105.31 170.0 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 73.13 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.4 179.56 3.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.849 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -83.07 115.79 22.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 51.43 110.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -97.88 -166.25 31.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 41.3 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.42 -57.89 2.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.398 . . . . 70.34 110.897 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -103.04 39.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.51 110.929 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.3 m -125.5 176.36 6.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 71.21 110.811 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.8 pt -55.61 165.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 54.52 111.195 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 m -160.22 148.66 16.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 62.33 110.894 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -122.19 115.36 22.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 63.42 110.858 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 98.57 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.43 110.874 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.2 99.59 2.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 62.53 112.507 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 169.21 18.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 73.42 110.818 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.68 -35.59 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 70.23 111.141 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 57.44 50.13 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 53.32 110.893 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' VAL . 98.0 mt-10 -141.91 -178.08 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.31 110.885 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 95' ' ' GLU . 27.1 m 36.88 44.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 42.11 111.166 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -113.97 172.59 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 63.52 110.907 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -69.59 138.69 53.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.941 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.66 -69.93 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 51.24 112.497 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -174.43 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 53.24 112.303 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -118.32 173.01 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 70.31 111.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.33 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 64.01 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 73.31 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 69' ' ' VAL . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 53.54 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.465 HE21 ' HE1' ' A' ' 118' ' ' TYR . 13.5 mm100 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.31 110.886 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -153.23 152.36 31.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.43 110.935 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -131.01 144.7 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 73.12 110.832 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -52.33 -39.84 61.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.892 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -91.76 -37.25 13.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.04 110.826 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.1 t 61.41 52.83 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.868 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.42 179.28 4.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.863 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.09 73.09 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.14 110.923 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -170.03 -175.85 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 73.04 110.836 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 115' ' ' LEU . 0.8 OUTLIER -60.49 100.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 72.14 110.946 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.28 160.46 26.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.676 0.75 . . . . 72.35 110.988 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 45.42 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.465 ' HE1' HE21 ' A' ' 106' ' ' GLN . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.14 110.967 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 54.23 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.52 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 55.13 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 23.12 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 147' ' ' PRO . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.13 111.163 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.01 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.24 172.1 3.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.41 110.879 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.82 149.98 5.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.15 111.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.76 114.01 27.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 63.34 110.936 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -62.57 132.76 53.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.34 110.848 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -122.4 156.18 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 71.41 110.838 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -112.69 65.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.11 110.833 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.37 37.5 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 60.23 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 t -131.11 164.1 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 72.24 111.11 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -113.61 96.51 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 74.32 110.895 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.56 21.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 75.24 112.537 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.78 -42.01 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 62.22 111.141 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 mt 57.8 43.25 22.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 64.35 110.965 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m 52.36 37.58 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 63.2 110.875 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -61.2 143.59 55.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 75.23 110.855 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -137.99 141.14 40.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.53 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -118.3 143.86 46.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 64.54 110.829 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 143' ' ' ASP . 38.5 mm -82.68 142.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 32.32 111.11 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -70.71 -38.11 73.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.42 110.865 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 141' ' ' ILE . 14.8 m-20 -65.62 -69.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 63.21 110.853 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm 53.56 42.42 31.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.05 110.924 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -151.91 107.26 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.6 95.24 15.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.13 111.026 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.33 112.343 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.01 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 70.23 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.24 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 55.55 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 53.31 112.471 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.13 110.865 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 65.2 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -136.04 111.66 9.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.14 110.947 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.08 120.04 39.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.3 110.863 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 163' ' ' LEU . 7.1 mp -76.23 -47.03 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 73.44 110.899 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 151.66 41.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 62.01 112.479 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -168.2 -176.74 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 65.53 110.93 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.0 m -55.59 -46.79 77.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -78.42 135.27 37.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.94 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.52 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 157' ' ' LEU . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 32.5 110.866 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.23 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 31.4 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 61.45 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.515 HG22 ' CD2' ' A' ' 196' ' ' LEU . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.02 111.147 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.54 144.83 23.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.878 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -124.3 144.03 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 72.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -112.48 132.06 22.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.607 0.717 . . . . 73.13 111.174 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.12 1.78 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 71.23 112.392 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -131.54 -68.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.21 110.916 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -164.16 144.52 8.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 75.24 110.84 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 m -147.04 151.26 36.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 71.53 111.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.99 152.87 41.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 64.03 110.912 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.37 67.62 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 72.33 111.189 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.83 162.2 34.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 64.51 111.194 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.21 171.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 75.41 112.457 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -115.49 -41.78 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.05 111.173 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.68 119.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 73.42 110.922 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.29 174.47 27.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 23.2 112.529 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.22 17.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.664 2.243 . . . . 73.24 112.315 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t 63.72 73.93 0.46 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.62 0.724 . . . . 74.13 111.021 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -33.1 17.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.679 2.252 . . . . 63.05 112.346 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.19 -174.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 73.34 111.104 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 p -52.07 168.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 50.13 110.868 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -51.79 156.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 63.2 111.122 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -53.5 141.08 26.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.1 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.424 ' CG2' HG13 ' A' ' 191' ' ' VAL . 15.4 tt -60.33 -35.62 63.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.21 111.155 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 63.07 52.89 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 75.12 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 189' ' ' ILE . 21.8 m -61.64 171.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.32 111.171 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.24 160.05 1.8 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.576 0.703 . . . . 71.34 110.93 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.01 3.56 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.735 2.29 . . . . 65.25 112.305 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -143.8 145.63 32.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 62.25 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.1 110.929 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.21 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 60.32 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 54.12 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.34 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.31 110.955 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 18' ' ' VAL . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 65.54 111.084 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.54 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -110.59 95.82 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.55 110.94 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -33.84 38.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 41.24 110.895 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -115.46 121.44 42.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 65.41 110.997 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.69 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 53.41 111.136 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.31 178.15 10.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 54.1 111.089 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.94 84.32 5.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.43 110.853 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.45 110.92 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.848 0.356 . . . . 71.33 110.916 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.46 174.97 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 72.22 110.94 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.83 148.33 49.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 64.33 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -107.82 159.1 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 53.24 110.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -82.37 160.58 61.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.625 0.726 . . . . 53.22 110.961 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 153.17 68.73 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.631 2.221 . . . . 75.33 112.318 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.33 160.33 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 60.04 111.117 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -89.98 154.4 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.921 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -91.61 172.2 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.43 110.858 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.55 139.16 56.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 111.082 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.51 -169.54 35.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.666 -0.778 . . . . 55.14 112.5 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -161.38 125.11 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 72.23 110.927 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -140.23 155.13 47.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 72.44 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.13 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.21 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.11 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' HE1' HD22 ' A' ' 206' ' ' LEU . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.24 110.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 55.24 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 72.24 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.33 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.35 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.44 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.01 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.66 123.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.35 111.123 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -112.63 126.68 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 62.11 110.883 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.29 142.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 60.14 111.185 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.35 132.19 46.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 64.01 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -67.17 -37.34 83.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 75.33 110.878 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 189' ' ' ILE . 50.9 mm-40 -53.96 -42.22 68.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 62.41 110.929 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 mt 55.49 39.03 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 72.2 110.888 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.85 -178.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 42.13 112.499 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.09 73.25 1.44 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.86 0.362 . . . . 73.23 110.883 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -145.66 77.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 64.32 110.913 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -137.67 159.3 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.12 110.855 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.78 -70.45 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 50.14 111.095 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.9 -179.56 44.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 64.31 112.495 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.86 -172.31 45.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 31.45 112.49 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.7 -133.94 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 40.41 112.474 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.59 64.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 74.53 111.064 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.1 tp -109.84 90.98 9.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.561 0.696 . . . . 64.31 110.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 144.91 55.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.645 2.23 . . . . 74.33 112.332 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -172.1 130.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 72.11 110.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 141.71 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 73.22 111.11 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.87 176.6 7.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.25 127.41 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 73.31 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 t -115.1 118.88 34.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.8 tt -139.5 143.0 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 72.32 111.049 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.51 -117.91 0.59 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 75.2 112.526 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -106.78 115.22 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 64.4 110.932 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -111.23 30.55 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.11 110.864 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -109.8 129.59 55.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.04 111.141 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.15 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.55 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HE2' ' A' ' 72' ' ' PHE . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 64.2 111.142 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 63.1 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 65.53 110.935 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 58' ' ' ASP . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.1 111.154 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 51.04 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.04 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.22 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 54.13 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 52.45 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 73.13 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 54.0 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 72.0 111.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 44.34 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.11 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.52 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 63.15 110.878 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 56' ' ' THR . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.875 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.05 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 147.76 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.35 112.559 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.61 155.61 13.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 63.31 111.102 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 117.27 4.99 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 62.23 112.324 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.47 55.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 75.13 111.095 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -131.82 120.59 22.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.4 110.91 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.24 88.05 2.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.41 111.139 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -117.89 170.81 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.1 110.938 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -169.84 132.95 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.834 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -59.72 126.82 29.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.51 110.939 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.58 -156.96 45.5 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 53.35 112.546 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -156.41 154.59 30.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 74.42 110.87 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -131.74 162.67 29.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 73.14 110.911 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -58.81 -37.74 77.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 54.41 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.7 tt -66.37 141.87 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 52.52 111.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -99.9 176.42 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 71.12 110.87 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.79 43.12 9.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 54.44 110.854 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 mt -85.42 119.23 25.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.84 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.54 -176.92 36.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 64.33 112.492 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -110.49 170.88 7.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 74.33 110.846 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.6 m -73.03 178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 63.41 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -84.7 121.15 27.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 52.1 110.938 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -95.37 128.02 41.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 74.2 110.881 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -100.95 44.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.01 111.151 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.36 -179.55 3.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.1 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -107.33 -177.0 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.41 110.87 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.31 -71.21 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 75.22 112.567 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 145.77 58.66 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.736 2.29 . . . . 72.34 112.379 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -152.47 135.74 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 44.44 111.113 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.21 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.44 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 55.33 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 67' ' ' ILE . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.52 110.932 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.43 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -147.24 140.82 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -131.01 134.55 46.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 63.33 110.895 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -60.26 -36.09 76.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.909 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.94 -40.82 38.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.44 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.6 t 61.42 42.95 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.847 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -150.92 130.84 13.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 50.51 110.899 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.08 112.36 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.885 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -177.64 159.85 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 74.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 94.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.93 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.17 160.52 26.58 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 72.34 110.963 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.12 112.372 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 61.43 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 51.24 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 63.22 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.44 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 64.11 111.138 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 53.01 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.5 125.62 34.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 60.24 110.864 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.08 138.25 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 71.04 111.144 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -111.9 119.71 39.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 62.42 110.865 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.4 ' N ' HD13 ' A' ' 127' ' ' LEU . 7.7 t80 -86.46 128.24 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 64.41 110.884 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -95.55 151.65 19.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 73.23 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -110.05 148.75 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.15 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -129.3 115.85 18.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 72.1 110.861 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 1.4 t -129.86 -44.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 63.34 111.171 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 51.59 55.35 9.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.33 110.893 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.69 -31.26 8.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 74.2 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB3' ' OG1' ' A' ' 132' ' ' THR . . . -51.88 171.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.326 . . . . 55.33 111.092 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.89 104.71 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.02 110.919 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 t -143.4 151.75 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.855 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -140.15 117.9 11.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 72.3 110.818 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -149.66 146.26 27.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 72.02 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.43 136.55 54.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 73.24 110.823 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.82 132.37 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.13 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -100.19 161.48 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.31 96.6 8.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 71.13 110.959 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 72.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -88.62 157.88 18.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 65.03 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -123.16 160.36 50.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.55 0.691 . . . . 73.3 111.146 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.751 ' HA ' HG12 ' A' ' 123' ' ' VAL . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 44.41 112.378 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.34 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.31 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.33 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 167' ' ' VAL . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.51 111.07 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.23 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.414 ' C ' HD23 ' A' ' 153' ' ' LEU . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.13 110.946 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -137.41 135.23 36.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 64.11 110.99 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.42 105.31 17.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 64.41 110.944 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt -121.74 -58.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 73.12 110.953 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.52 -179.22 30.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 53.42 112.464 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -102.22 -38.1 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.5 110.936 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.1 m -92.26 -50.49 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 74.02 110.809 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -106.76 162.8 13.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.41 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.24 110.901 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.475 ' N ' HD13 ' A' ' 163' ' ' LEU . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.03 110.91 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 61.34 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.44 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.32 111.177 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -134.04 122.07 22.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.51 110.87 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -139.73 153.01 47.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.43 110.938 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -141.89 132.16 12.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 62.32 111.107 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 161.21 46.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 63.4 112.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -60.98 176.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.2 110.887 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -150.88 121.95 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 65.23 110.883 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.1 p 49.94 40.58 21.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 75.22 111.059 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.76 149.74 30.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 61.14 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.26 137.94 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 70.22 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.66 115.21 8.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 70.41 111.145 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.05 -142.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 71.32 112.464 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.8 m -64.63 158.26 24.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.33 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.47 136.62 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 72.14 110.94 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.53 71.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.686 -0.769 . . . . 63.24 112.514 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -179.65 3.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.647 2.231 . . . . 70.12 112.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.4 t 55.9 71.69 1.17 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 73.51 111.079 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.83 179.38 3.78 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 63.44 112.322 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.71 172.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 74.34 111.065 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 p -59.54 173.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 53.35 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.2 p -52.59 145.28 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 73.24 111.163 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -174.21 141.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.898 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 31' ' ' GLU . 15.3 pt -57.95 169.08 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.22 111.081 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -159.34 160.46 35.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 64.12 110.932 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -58.36 129.21 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 61.34 111.102 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -176.16 71.75 0.26 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.638 0.733 . . . . 71.42 110.874 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 145.0 55.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 73.43 112.285 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.24 171.41 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 63.33 110.887 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 63.42 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.35 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.14 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.22 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.44 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 52.14 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 72.24 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.03 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 97.1 4.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.3 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 17' ' ' TRP . 2.6 pt? -51.85 -33.87 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 64.34 110.899 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.98 63.58 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 73.1 111.097 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.58 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 63.33 111.087 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.29 49.25 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 73.21 111.109 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 78.4 mt -125.84 -51.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 44.13 110.963 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 63.34 110.868 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.791 0.329 . . . . 74.33 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -165.12 171.33 13.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 61.45 110.942 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.03 175.65 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.22 110.846 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 178.51 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 72.5 110.898 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.67 160.56 34.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.678 0.752 . . . . 64.23 110.96 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 156.78 62.43 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.65 2.233 . . . . 72.03 112.336 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.39 111.23 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 63.01 111.085 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -64.86 -178.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 64.01 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.8 m -103.59 -178.74 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 70.34 110.834 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.8 159.54 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 63.24 111.09 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.34 -175.65 24.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 62.31 112.467 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -157.38 117.72 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 74.55 110.875 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -136.08 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 63.54 110.918 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.2 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.42 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.713 ' CH2' HD13 ' A' ' 206' ' ' LEU . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.936 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.44 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.32 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.15 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 64.52 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.24 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.52 137.33 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 43.42 111.114 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -118.76 111.66 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 65.45 110.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 141.91 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 52.3 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.49 149.7 19.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 41.43 112.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -59.99 -41.99 93.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 63.23 110.899 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 63.17 53.48 2.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 52.55 110.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.03 -35.61 69.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.944 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.34 -151.87 8.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 64.34 112.482 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.38 52.73 5.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.902 0.382 . . . . 75.11 110.894 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.47 60.07 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 71.11 110.911 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.67 152.15 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 75.32 110.931 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.06 -35.81 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 73.31 111.105 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.54 -119.26 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 74.55 112.521 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.41 -175.94 20.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 52.41 112.54 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.78 -37.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.762 . . . . 53.01 112.453 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.29 158.21 44.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.836 0.35 . . . . 52.14 111.122 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.38 91.04 11.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.572 0.701 . . . . 71.34 110.847 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.31 47.3 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.71 2.274 . . . . 44.1 112.338 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.4 173.33 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 62.42 110.896 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.9 -178.85 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.34 111.158 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -117.72 -74.27 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 72.32 110.836 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.23 136.7 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.12 111.104 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.6 t -149.18 132.86 16.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.889 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.15 139.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 74.13 111.13 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.5 -123.95 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 40.24 112.464 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -123.42 46.78 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 70.55 110.923 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -95.26 -38.44 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 74.13 110.904 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p -51.85 121.44 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 45.32 111.181 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.14 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 73.33 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 51.11 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.13 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' ILE . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.14 111.103 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 73.51 111.113 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.21 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.43 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.52 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.51 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.15 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.42 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.25 110.831 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.24 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.32 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.28 133.57 11.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.43 112.459 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.2 p -90.59 133.22 33.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 54.31 111.13 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.87 170.62 16.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 61.04 112.313 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -164.19 125.86 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 53.24 111.074 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.87 146.59 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.826 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.47 128.97 4.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 71.25 111.089 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -81.69 151.16 27.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 63.35 110.827 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -110.18 159.31 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 73.13 110.941 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.27 137.04 9.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.876 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.32 142.4 11.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 62.11 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.48 128.11 28.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 64.13 110.965 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 55.29 40.8 31.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 64.12 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.0 m -118.5 38.34 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 51.52 110.808 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mp 54.23 79.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 74.35 111.136 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -160.64 -62.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 72.41 110.84 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.9 t -137.04 103.48 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 74.25 110.917 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -87.04 76.36 9.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 70.24 110.882 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.18 -166.12 29.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 55.54 112.499 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -130.53 58.09 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 64.42 110.89 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.46 175.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 73.04 111.193 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t 55.9 44.51 25.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 51.1 110.836 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -122.85 36.94 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 55.41 110.883 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.17 -176.43 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.3 111.061 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.44 159.92 19.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 45.41 110.846 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.88 163.41 32.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.4 110.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.03 75.74 0.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 45.55 112.421 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.66 20.9 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 75.12 112.399 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -146.23 119.28 8.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 71.32 111.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.536 HD12 ' HA3' ' A' ' 124' ' ' GLY . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.14 111.102 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 53.04 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.4 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.22 110.961 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.15 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.99 135.06 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 50.01 110.929 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -131.0 166.84 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 63.43 110.838 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -131.24 36.3 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.01 110.891 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.04 -37.67 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 42.33 110.843 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t 63.17 39.0 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 72.44 110.85 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -149.45 -178.99 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 74.2 110.891 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.45 50.44 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 63.21 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -131.54 -174.06 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 70.54 110.834 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 115.58 4.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.931 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.3 160.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.671 0.748 . . . . 73.32 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.3 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 151' ' ' VAL . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 40.01 111.111 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.3 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 34.23 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 54.03 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 62.43 112.522 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -144.7 161.89 38.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.41 110.941 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.05 142.28 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 61.45 111.137 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.2 134.37 49.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 41.52 110.983 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -102.98 125.38 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.34 110.844 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -122.16 94.31 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.22 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.17 142.91 51.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.32 110.898 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -111.15 77.95 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 71.33 110.886 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.73 150.34 47.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 73.24 111.126 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.06 129.24 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 71.42 110.821 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.32 119.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 73.51 112.415 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 136' ' ' LEU . . . -64.82 -30.24 71.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 70.13 111.143 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -154.08 33.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 51.3 110.914 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -120.18 49.19 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 53.33 110.863 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t -64.24 -69.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 62.31 110.756 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 55.45 40.17 31.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 64.44 110.862 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.06 41.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 53.42 110.908 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -121.5 82.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.54 111.158 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -155.92 162.78 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 74.12 110.965 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -103.3 137.57 41.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 75.25 110.86 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -35.98 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.971 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -54.88 115.87 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.2 110.966 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -124.25 160.39 52.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.579 0.705 . . . . 63.22 111.134 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.2 112.369 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 65.21 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.1 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 119' ' ' VAL . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 65.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.24 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 74.02 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 63.51 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.45 ' HE2' HD13 ' A' ' 157' ' ' LEU . 44.2 t80 -114.78 114.01 25.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.04 110.896 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.72 155.28 40.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 64.15 110.84 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.45 HD13 ' HE2' ' A' ' 155' ' ' TYR . 23.6 tp -162.14 116.28 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 74.32 110.896 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -84.29 69.94 3.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.14 112.526 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -141.09 -58.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 74.25 110.918 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -142.42 -74.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -123.31 178.63 5.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 61.31 110.975 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.14 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.52 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.23 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.35 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 196' ' ' LEU . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.43 111.071 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -143.44 109.54 5.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -95.56 127.66 41.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.21 110.927 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 171' ' ' PRO . 45.5 mm -82.38 133.12 50.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 72.21 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.3 Cg_endo -69.79 169.63 18.51 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 75.45 112.32 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -66.12 129.13 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 64.43 110.843 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -174.3 104.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 73.55 110.911 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p -140.53 135.93 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.143 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.75 144.88 31.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 74.14 110.819 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.22 150.83 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 72.41 111.139 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.58 108.88 9.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 73.3 111.128 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 99.5 1.94 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 40.14 112.499 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 m -137.74 136.68 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 64.44 111.131 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.527 ' H ' HD23 ' A' ' 180' ' ' LEU . 1.3 pt? -116.33 166.73 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 34.21 110.92 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.21 176.79 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.787 -0.72 . . . . 61.45 112.47 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 128.07 15.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.212 . . . . 73.21 112.372 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.7 t -131.94 71.17 80.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.596 0.712 . . . . 74.43 111.141 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -45.78 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 62.1 112.337 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.36 143.38 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.15 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 70.7 m -80.29 131.68 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.852 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 t -134.06 123.21 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.14 111.125 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -173.56 124.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 61.04 110.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.38 -35.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 63.13 111.155 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -98.91 65.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 72.14 110.866 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.81 -64.58 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 52.45 111.133 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -174.53 72.25 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.525 0.678 . . . . 51.33 110.895 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 144.6 54.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.741 2.294 . . . . 72.2 112.347 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.53 171.04 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.92 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.1 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.711 ' CD1' HG22 ' A' ' 167' ' ' VAL . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 60.15 110.948 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.45 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.53 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 197' ' ' SER . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.941 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.23 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 61.53 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.14 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 18' ' ' VAL . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.1 110.961 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 41.54 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 53.32 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.65 85.96 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.878 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.713 HD13 ' CH2' ' A' ' 17' ' ' TRP . 2.6 pt? -52.19 -33.8 42.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 74.45 110.933 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.77 59.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 24.52 111.123 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -173.31 111.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.057 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.75 144.35 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 73.45 111.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 101.31 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.949 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.925 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.814 0.34 . . . . 74.45 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -143.86 -176.92 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 70.25 110.863 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.32 161.66 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.52 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.18 -179.14 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 53.44 110.859 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -115.61 157.63 43.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.67 0.748 . . . . 61.44 110.936 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -178.15 2.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 72.3 112.354 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -176.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 65.05 111.094 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -123.03 -40.99 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 61.21 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -73.89 134.86 43.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 50.53 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.95 -178.99 7.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.43 111.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.98 -175.01 39.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 73.24 112.504 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -163.34 120.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.882 0.372 . . . . 64.33 110.944 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.17 160.31 42.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.927 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 24.44 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.41 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.45 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 202' ' ' TYR . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 55.13 111.157 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 42.11 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.02 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.22 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 54.34 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.42 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 64.2 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.15 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 195' ' ' ILE . 33.1 m -81.29 133.04 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 63.21 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.31 104.51 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 75.05 110.919 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.53 151.69 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.42 111.1 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.89 5.68 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 61.51 112.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -92.21 8.31 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 73.24 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -55.51 -41.02 72.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.2 110.913 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.07 40.57 30.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.878 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.09 149.0 35.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 53.34 112.527 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -53.61 156.15 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 71.41 110.84 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -107.38 62.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 65.02 110.867 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -82.12 62.85 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.45 110.905 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.26 162.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 64.23 111.134 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.03 87.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.68 -0.771 . . . . 62.42 112.509 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.9 157.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.728 -0.749 . . . . 75.15 112.483 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.73 161.61 37.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 43.24 112.435 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.84 54.95 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 34.34 111.108 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.7 159.22 30.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 74.41 110.875 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 173.47 10.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.67 2.246 . . . . 74.12 112.35 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.5 174.99 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 64.31 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.62 160.45 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 170.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 73.43 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.62 177.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 73.43 111.042 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 p -71.71 125.83 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 64.41 110.885 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 tt -85.82 142.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 72.23 111.148 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.35 -101.42 0.15 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.765 -0.731 . . . . 62.34 112.496 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -96.95 62.49 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 72.25 110.862 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -107.33 -37.06 6.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.902 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -70.55 143.57 51.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.156 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.22 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.23 110.943 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.24 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.05 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 65.23 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 53.13 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 62.23 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 73.53 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.42 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 71.44 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.23 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 63.01 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.03 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 107' ' ' TYR . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 70.23 111.094 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 52.02 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 65.41 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 71.44 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.534 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 63.22 110.876 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.34 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.1 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.64 138.45 6.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 63.44 112.409 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.7 p -114.02 85.6 10.25 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.626 0.727 . . . . 73.2 111.089 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.16 57.87 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.731 2.287 . . . . 71.54 112.327 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 36.73 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 72.31 111.071 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 168.81 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 73.21 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.64 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 72.24 111.058 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.01 170.74 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 73.02 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -79.01 161.67 26.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 72.11 110.955 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.56 175.55 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 64.24 110.915 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.75 -59.06 0.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 73.31 112.54 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -92.81 125.92 37.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 72.13 110.928 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -64.88 94.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.24 110.91 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.0 m -159.81 116.24 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 63.23 110.86 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 90' ' ' LEU . 63.8 mt -61.74 -50.46 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 55.41 111.076 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t 62.77 37.82 12.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.839 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 t 53.61 53.69 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 43.21 110.84 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.54 ' H ' HG22 ' A' ' 87' ' ' ILE . 1.8 tt -75.9 131.33 39.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 73.42 110.958 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -87.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 73.21 112.477 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -88.08 -73.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 72.43 110.964 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.3 t 58.05 73.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 74.44 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -100.72 138.73 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 40.15 110.841 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.83 127.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.897 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -53.08 138.63 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 42.33 111.15 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -149.3 156.04 41.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 75.24 110.826 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.6 114.86 18.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.72 165.87 52.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 41.42 112.504 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' HB3' HG23 ' A' ' 126' ' ' VAL . 54.1 Cg_endo -69.72 178.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.682 2.255 . . . . 74.4 112.4 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -158.42 122.48 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 74.52 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.22 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.414 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.42 110.966 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 63.02 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 62.34 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.645 ' HE2' HG23 ' A' ' 67' ' ' ILE . 3.5 m-85 -123.92 114.01 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 71.42 110.932 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -132.32 87.89 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 74.44 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -114.67 29.42 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.33 110.92 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.07 18.36 22.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 72.04 110.858 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 m -77.54 55.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 71.4 110.812 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -119.9 84.69 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 73.55 110.914 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.95 39.32 30.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 73.23 110.915 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.785 ' HD3' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -163.1 -173.42 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 74.5 110.894 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.785 HD23 ' HD3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -57.86 166.64 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 72.04 110.871 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -114.08 70.85 1.97 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.75 . . . . 75.32 110.95 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.34 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 70.01 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 151' ' ' VAL . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.52 111.137 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 65.13 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 64.2 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.4 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.24 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.34 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 70.23 110.861 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 100' ' ' PRO . 7.6 p -146.3 144.47 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 45.55 111.174 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.43 119.72 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 73.12 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.92 151.01 20.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.1 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.83 -176.54 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.44 110.887 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.99 144.04 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.83 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.52 -37.06 4.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.22 110.921 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 m 56.42 44.1 24.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.33 111.122 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -69.82 143.35 52.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 72.24 110.847 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.93 -95.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 63.24 112.532 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.58 43.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 62.23 111.105 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.48 176.97 6.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 74.54 110.934 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -104.07 144.28 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 70.55 110.878 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -150.92 170.15 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 51.34 110.853 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -118.65 -61.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.892 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -128.23 -62.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 50.15 110.87 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.5 tt -172.2 145.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.45 111.141 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -64.34 162.6 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 70.53 110.914 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -110.9 167.09 10.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 64.45 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -115.42 -55.25 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 60.05 110.883 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -63.4 122.03 15.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.1 110.975 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -125.74 160.44 56.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 71.51 111.155 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 64.25 112.351 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.12 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.11 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.21 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 119' ' ' VAL . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 44.21 111.082 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.24 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 ' OH ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 61.21 110.861 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 70.31 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.471 ' OH ' HD22 ' A' ' 153' ' ' LEU . 15.6 m-85 -133.68 144.7 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.1 110.924 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -104.91 104.23 13.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.55 110.935 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mp -74.46 -55.72 5.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.42 110.922 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.34 43.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 72.21 112.416 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -150.23 179.39 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 65.23 110.908 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 p -52.08 -38.64 57.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.53 110.828 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -104.04 153.08 21.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.2 110.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.42 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.494 HD23 ' N ' ' A' ' 164' ' ' ASN . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 61.22 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.494 ' N ' HD23 ' A' ' 163' ' ' LEU . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.12 110.893 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.22 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.633 ' O ' HD12 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.12 110.855 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 196' ' ' LEU . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 70.33 111.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 158.47 42.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.31 110.863 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -128.45 149.15 50.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.11 110.924 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -111.75 132.12 22.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 74.24 111.118 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 81.22 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.66 2.24 . . . . 73.4 112.355 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -88.09 -72.44 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.21 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -72.61 134.7 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.4 110.872 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.2 m -120.9 154.37 35.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 60.13 111.124 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -78.89 88.73 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 60.1 110.881 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.12 147.63 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 65.04 111.134 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -103.22 -55.64 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 73.0 111.19 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.38 52.05 7.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 60.12 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.18 169.95 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 63.54 111.076 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.12 83.5 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 70.15 110.958 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 174.76 174.48 41.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.7 -0.762 . . . . 51.54 112.495 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -174.99 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.746 2.298 . . . . 62.33 112.352 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.74 69.39 44.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.688 0.756 . . . . 73.51 111.149 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -40.92 4.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.65 2.233 . . . . 71.41 112.309 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.02 136.23 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 62.42 111.063 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 m -141.54 -176.84 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 60.55 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 p 49.84 38.6 16.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 73.34 111.114 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -126.35 55.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 43.44 110.916 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.34 114.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 71.23 111.087 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -70.55 160.63 32.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 70.21 110.935 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 m -75.35 146.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 72.1 111.119 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 156.53 36.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 62.45 110.918 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 148.77 65.72 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.716 2.278 . . . . 75.21 112.318 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.18 150.02 52.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 75.31 110.888 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 26' ' ' VAL . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.33 111.157 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 166' ' ' ASP . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 71.35 110.88 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.22 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.12 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 60.35 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.13 110.917 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.42 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.04 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm -117.62 69.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 71.34 110.897 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.449 ' O ' HD23 ' A' ' 206' ' ' LEU . 2.7 tt -65.42 -36.82 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.908 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -82.73 83.83 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 62.12 111.134 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.09 103.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 71.44 111.11 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.01 77.84 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.51 111.098 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 19.6 tp -137.31 126.45 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 71.03 110.882 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.892 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.828 0.347 . . . . 73.42 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -54.79 136.52 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 74.04 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.43 -60.11 2.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 72.33 110.891 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -150.68 147.76 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 61.12 110.903 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -51.72 156.91 2.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 75.12 111.003 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 140.28 42.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.734 2.289 . . . . 63.22 112.335 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.26 171.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 55.22 111.092 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -75.83 -175.97 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.33 110.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -69.33 133.45 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 62.52 110.865 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.55 118.02 8.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 71.51 111.095 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.71 -150.71 8.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 63.1 112.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -129.73 115.15 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 73.3 110.973 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -118.92 168.44 10.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 71.02 110.927 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HB2' HG13 ' A' ' 63' ' ' VAL . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.903 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.11 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 73.54 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.04 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 203' ' ' VAL . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.33 111.153 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.42 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 42.31 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.4 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.12 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 60.1 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.23 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 70.51 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.9 129.77 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.31 111.105 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -137.45 143.56 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.859 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.4 137.91 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 71.21 111.13 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.806 -0.712 . . . . 72.22 112.552 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -83.47 -47.33 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 65.04 110.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -126.1 -54.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.21 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mt 60.56 39.23 18.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.51 110.876 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.09 51.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 73.41 112.485 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -127.47 139.48 52.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 74.13 110.855 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.97 35.84 25.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.9 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.34 69.81 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 72.21 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.57 -35.49 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.138 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.93 141.64 3.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 34.52 112.538 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.9 106.58 0.37 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.674 -0.774 . . . . 33.53 112.476 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' CA ' HG21 ' A' ' 187' ' ' THR . . . 104.34 132.98 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 63.4 112.452 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.21 -62.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.325 . . . . 75.35 111.087 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 4.4 mm? -110.11 91.03 10.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.612 0.72 . . . . 74.04 110.888 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 53.8 Cg_endo -69.81 129.32 17.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.644 2.229 . . . . 75.33 112.345 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -138.55 121.03 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 63.21 110.897 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.02 115.09 29.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 43.43 111.085 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -132.84 167.56 19.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.878 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.26 171.12 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 72.32 111.079 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.4 p -158.41 123.93 4.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 71.24 110.841 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.44 111.174 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.96 95.35 2.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 50.0 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.3 m120 58.9 45.83 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 73.1 110.88 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.54 -37.54 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 62.44 110.853 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -102.9 138.95 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.24 111.092 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 55.13 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.24 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.44 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.44 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD13 ' OH ' ' A' ' 61' ' ' TYR . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.141 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.12 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 59' ' ' ILE . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.33 110.887 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 14' ' ' GLN . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 54.52 111.155 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.22 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.24 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 105' ' ' LEU . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.12 111.163 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.11 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 65.2 111.095 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.686 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 73.02 110.818 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.14 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 53.24 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.31 158.98 27.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.53 112.499 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.7 p -116.36 85.62 16.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.32 111.164 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.9 64.68 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 63.15 112.336 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.36 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.03 111.061 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm-85 -66.31 143.46 57.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 50.12 110.827 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.54 168.55 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 51.12 111.068 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -119.2 46.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.3 110.894 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 61.17 53.28 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.861 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.65 148.04 32.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 72.42 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.67 -145.47 18.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 42.41 112.487 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -157.92 150.74 22.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 73.44 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 164.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 t -168.77 155.9 7.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 61.14 110.836 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 pt -67.29 159.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.176 -0.465 . . . . 61.31 111.203 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 p -109.15 178.43 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 34.35 110.909 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 p -103.63 176.67 5.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 71.2 110.843 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.4 pt? -53.09 145.5 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 71.43 110.985 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.05 -164.92 48.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 53.33 112.477 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -75.6 -175.16 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 73.43 110.881 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 t -136.48 130.74 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 61.55 111.192 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -70.73 117.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.31 110.846 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.33 -61.09 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 70.21 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.55 139.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 72.21 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.26 112.66 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.41 110.926 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.0 -51.7 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 72.12 110.964 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.53 73.91 0.45 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 35.43 112.454 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -179.55 3.01 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.696 2.264 . . . . 74.15 112.294 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -159.6 120.56 3.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 73.52 111.115 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 70.24 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 70.32 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.41 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 67' ' ' ILE . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 70.02 110.908 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.32 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 119' ' ' VAL . 14.0 p90 -153.26 150.55 29.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.948 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -131.03 96.3 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 74.22 110.837 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -111.75 32.78 5.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.54 110.926 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -93.97 -36.76 12.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 74.12 110.945 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.9 t -143.47 -74.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 62.11 110.834 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.36 -169.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.34 110.838 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -74.99 72.17 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 62.33 110.871 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -153.51 -175.91 5.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.52 110.897 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.429 ' H ' HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -60.54 95.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.854 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.77 160.91 22.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 73.55 110.897 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 71.41 112.337 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 107' ' ' TYR . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.18 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.2 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.44 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.11 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 147' ' ' PRO . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.33 111.068 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 62.31 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.96 177.02 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.34 110.819 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.9 p -129.35 137.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 74.33 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 119.74 25.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -81.73 93.16 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 54.13 110.894 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -86.77 131.84 34.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 65.04 110.828 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.55 160.39 23.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 72.34 110.798 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -121.27 -51.39 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 64.11 110.905 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.3 m -119.31 142.9 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 64.13 111.184 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -66.93 171.28 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 54.41 110.923 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.59 -119.21 5.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 64.45 112.432 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.05 44.62 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 53.23 111.082 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.9 -38.54 73.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 62.41 110.958 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -118.29 69.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 53.32 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 t -138.37 -178.67 5.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 72.11 110.84 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.13 169.4 9.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 74.02 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.8 131.0 40.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 73.11 110.949 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.99 108.95 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 61.42 111.131 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.38 42.81 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.11 110.896 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -130.38 65.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.02 110.827 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -115.63 36.48 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 75.51 110.849 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -62.43 135.84 57.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.451 . . . . 75.45 110.955 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -132.14 95.14 22.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.564 0.697 . . . . 73.35 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 123' ' ' VAL . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.32 112.276 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.31 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 72.13 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 72.12 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 63.15 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 64.03 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 155' ' ' TYR . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 64.35 110.914 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.535 ' CD1' HD21 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -140.18 116.29 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.22 110.932 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -106.52 94.84 5.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 71.11 110.875 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.51 -71.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 62.23 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -65.48 -168.89 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 70.55 112.497 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -115.82 -36.16 4.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 52.54 110.842 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 t -56.54 -60.56 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 70.42 110.859 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -134.43 170.63 15.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 74.12 110.954 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 164' ' ' ASN . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 52.44 110.941 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 163' ' ' LEU . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 62.05 110.914 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.44 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.31 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -148.29 153.54 38.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.43 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.99 135.58 53.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 72.15 110.874 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 tp -109.66 131.54 21.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 73.15 111.125 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -45.09 1.69 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.245 . . . . 73.04 112.4 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -161.18 147.79 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 74.52 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -117.61 129.12 55.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 75.42 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.4 m -76.94 81.33 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 62.12 111.085 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -93.04 179.21 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.873 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.61 145.27 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.33 111.153 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 18.4 p -69.72 158.53 35.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 43.24 111.208 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.91 155.12 11.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 61.51 112.514 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 73.1 p -66.11 -174.92 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 65.04 111.163 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 184' ' ' PRO . 1.7 pt? -131.07 -176.39 3.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.34 110.942 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.28 -177.35 40.37 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 32.3 112.457 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 162.44 42.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 75.41 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 185' ' ' VAL . 33.7 t 51.72 68.25 3.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.614 0.721 . . . . 52.04 111.134 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.736 ' HB3' HD11 ' A' ' 180' ' ' LEU . 54.2 Cg_endo -69.76 98.72 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 75.13 112.353 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 183' ' ' VAL . 21.9 t -125.64 67.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 75.13 111.095 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 161.78 31.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 53.5 110.869 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.479 HG21 ' CA ' ' A' ' 40' ' ' GLY . 10.1 p -129.96 -62.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 53.13 111.112 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -128.15 70.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 70.44 110.874 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.09 -34.48 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.095 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -141.17 134.92 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.21 110.861 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.79 -58.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.101 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -126.65 69.92 71.35 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.607 0.718 . . . . 71.4 110.894 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 142.94 48.77 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 75.11 112.333 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.65 153.81 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 70.42 110.906 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 70.1 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.35 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 163' ' ' LEU . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 61.45 110.888 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.41 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 40.43 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 71.14 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.14 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 18' ' ' VAL . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 53.14 111.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.13 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 63.04 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.24 110.911 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -52.41 28.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 43.01 110.889 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.67 111.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 13.21 111.125 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -110.47 92.68 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 65.13 111.072 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.43 92.42 4.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 73.03 111.124 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.44 85.56 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 65.25 110.88 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 74.2 110.843 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.841 0.353 . . . . 62.45 110.871 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -143.95 147.08 33.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.888 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -127.9 141.26 51.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 72.1 110.875 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -132.48 137.21 47.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 63.42 110.962 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -168.41 68.24 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.728 . . . . 74.21 110.902 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.72 113.53 3.4 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 74.43 112.328 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.33 109.1 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 42.2 111.07 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -64.79 163.64 13.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 71.32 110.894 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -129.68 156.48 44.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 70.42 110.906 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.63 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 54.41 111.143 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.92 -170.54 32.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 54.22 112.462 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -172.08 129.42 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 65.24 110.943 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -134.96 166.51 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 75.35 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.3 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.11 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.52 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 203' ' ' VAL . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 71.03 111.096 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HB1' ' HZ ' ' A' ' 57' ' ' PHE . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 51.44 111.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.22 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.02 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 56' ' ' THR . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.21 110.874 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.32 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.44 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 72.32 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -81.39 114.91 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.23 111.107 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 196' ' ' LEU . 8.1 t80 -114.06 144.46 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.51 110.948 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.14 148.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.44 111.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.31 160.64 44.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.829 -0.701 . . . . 75.21 112.495 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -79.62 -48.55 13.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 71.02 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.55 50.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.15 110.903 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 mt 53.82 43.09 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 73.23 110.9 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.88 -123.54 4.89 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 52.3 112.509 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -71.29 178.44 3.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.36 . . . . 74.32 110.829 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.11 66.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.31 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -105.67 105.8 16.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 65.23 110.915 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.56 128.96 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.05 111.152 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.52 68.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 62.04 112.534 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.5 71.41 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 72.13 112.499 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.39 -141.21 9.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 64.45 112.494 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 143.71 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 63.03 111.083 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.35 160.68 70.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 72.42 110.875 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 129.42 17.6 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.695 2.264 . . . . 61.33 112.375 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -134.89 170.68 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.45 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.46 117.04 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 71.4 111.052 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 47' ' ' VAL . 81.4 m-20 -102.96 -45.18 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 51.01 110.844 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ASP . 27.0 m 37.05 44.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 72.2 111.082 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 p -117.56 75.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.15 110.858 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.24 107.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 51.4 111.148 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.65 -143.66 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 64.22 112.516 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -75.65 75.65 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 74.11 110.858 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -92.51 -36.38 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 65.3 110.847 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m -60.17 102.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 61.42 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.4 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 64.03 110.916 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' ASN . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.12 111.147 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.2 110.87 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 71.43 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.13 111.092 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 63.33 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 63.33 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.01 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.12 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 67' ' ' ILE . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.32 110.863 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.593 HG22 ' OD1' ' A' ' 66' ' ' ASN . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 62.02 111.149 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.23 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 42.11 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 51.2 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.41 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 72.13 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.72 177.75 36.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.53 112.52 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.46 155.54 13.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 70.34 111.173 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 139.17 39.4 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 62.35 112.374 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.83 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 42.34 111.079 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -171.78 112.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 62.14 110.822 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.65 169.76 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 64.44 111.071 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -118.23 169.87 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 71.03 110.917 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -149.3 164.75 33.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 72.33 110.905 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.35 172.03 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 61.23 110.926 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.05 166.39 3.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.75 . . . . 60.25 112.47 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -117.23 161.44 19.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 73.21 110.852 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -61.23 -71.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.934 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -174.8 122.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 70.42 110.82 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 90' ' ' LEU . 63.2 mt -89.24 -53.56 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 71.13 111.135 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 t 61.5 38.88 15.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 72.25 110.908 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 t 52.53 50.21 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.513 . . . . 52.43 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 87' ' ' ILE . 2.1 tt -109.79 109.07 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 75.31 110.998 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.66 146.43 0.51 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 30.35 112.512 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -99.32 -61.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 74.52 110.883 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 m -148.94 142.1 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 61.3 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 p -104.77 -72.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 70.22 110.853 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -151.06 159.75 44.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.24 110.877 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.4 133.81 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -148.86 110.29 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.854 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -103.71 85.87 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.23 68.74 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.719 . . . . 40.53 112.522 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 178.37 4.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 60.43 112.377 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -171.88 148.82 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 73.24 111.155 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.45 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.34 110.894 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -148.65 129.77 14.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.42 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -131.49 167.09 19.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 74.34 110.892 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -82.25 89.45 6.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 74.24 110.938 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.92 17.48 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.32 110.911 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.7 m -53.71 -36.33 62.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 52.24 110.921 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -136.14 -173.91 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 64.33 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.44 90.62 3.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 63.11 110.919 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -173.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 73.21 110.87 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.7 139.18 58.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 62.31 110.943 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -157.13 158.78 31.25 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.704 0.764 . . . . 72.32 110.954 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.51 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.52 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.21 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.52 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 53.44 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 65.14 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.12 111.171 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.24 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -125.73 127.6 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 71.3 110.923 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.0 p -121.73 139.61 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 64.53 111.144 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 119.35 21.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 63.42 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -109.84 164.96 12.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.23 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -67.46 104.73 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.31 110.882 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.59 109.24 19.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 75.51 110.825 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -106.96 91.56 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.928 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -164.19 136.35 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 44.3 111.163 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.59 -71.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.192 -0.458 . . . . 60.22 110.91 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.97 148.19 4.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.757 -0.735 . . . . 71.35 112.462 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.64 171.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.339 . . . . 75.11 111.097 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.95 75.13 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 63.12 110.939 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -148.96 179.42 7.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 71.22 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -68.34 152.59 45.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.44 110.876 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.65 151.58 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 55.24 110.929 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.63 147.65 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 61.54 110.783 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.2 mt -63.22 134.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.09 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -103.63 144.51 31.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 54.53 110.877 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -165.13 -176.49 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 71.23 110.859 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -140.19 122.73 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.31 110.865 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.458 ' CZ3' HG11 ' A' ' 123' ' ' VAL . 25.3 p-90 -118.72 131.07 56.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 62.14 110.983 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -127.8 159.96 63.58 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.573 0.702 . . . . 63.31 111.094 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.54 112.314 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.45 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.51 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.23 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 167' ' ' VAL . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.45 111.201 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' C ' HD13 ' A' ' 153' ' ' LEU . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 35.21 112.451 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.622 ' N ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.32 110.894 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.43 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 153' ' ' LEU . 1.1 p90 -152.35 153.08 32.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.02 110.947 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.36 144.44 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 72.52 110.855 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.1 93.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 72.54 110.878 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.71 -159.61 22.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 75.51 112.446 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.95 125.91 50.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 62.34 110.871 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.5 m 51.74 35.23 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.14 110.838 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -159.97 142.56 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 74.02 110.88 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.455 HD23 ' HE1' ' A' ' 155' ' ' TYR . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.42 110.918 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.23 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 50.11 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 60.5 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 196' ' ' LEU . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.43 111.136 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -146.05 146.2 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -112.07 131.98 55.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 63.13 110.969 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 171' ' ' PRO . 67.5 mt -68.35 133.12 91.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.753 . . . . 72.33 111.082 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.8 Cg_endo -69.8 -44.9 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.669 2.246 . . . . 71.24 112.31 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.09 123.99 31.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 71.52 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -173.08 104.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 62.14 110.922 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.8 t -141.15 150.12 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 54.22 111.14 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -169.03 117.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 75.23 110.847 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.97 134.15 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 65.12 111.131 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -172.04 129.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 54.55 111.23 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.04 52.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.692 -0.766 . . . . 41.42 112.414 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.7 p -85.49 60.21 6.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 71.34 111.153 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 181' ' ' GLY . 2.3 tt -175.19 146.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 72.34 110.865 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.591 ' N ' HD23 ' A' ' 180' ' ' LEU . . . 171.74 174.87 39.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.793 -0.718 . . . . 54.21 112.535 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -45.88 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 75.21 112.333 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.95 156.24 74.29 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.643 0.735 . . . . 75.11 111.14 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 110.99 2.72 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.633 2.222 . . . . 73.41 112.335 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.25 176.72 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 65.25 111.128 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 t -52.38 118.6 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 62.53 110.842 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -116.45 -38.78 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 63.05 111.198 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 136.43 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.15 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -118.39 -35.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 61.14 111.147 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.13 131.01 53.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 64.11 110.838 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.74 -36.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 72.44 111.129 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.65 73.33 0.95 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.698 0.761 . . . . 71.2 110.879 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.22 59.33 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.619 2.213 . . . . 74.43 112.355 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -116.8 146.42 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 65.34 110.894 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 73.12 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.571 HD22 HG23 ' A' ' 167' ' ' VAL . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 70.52 110.957 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 53.54 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 199' ' ' GLY . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 198' ' ' LEU . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 62.1 112.443 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 71.13 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 61.43 110.841 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 18' ' ' VAL . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.34 111.115 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.44 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 67.28 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.876 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.09 -58.72 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.989 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -112.74 134.85 54.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 73.11 111.149 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.63 161.87 36.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 60.44 111.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.31 84.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.126 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 pp -165.28 175.23 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 75.1 110.972 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 43.24 110.849 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.748 0.308 . . . . 72.12 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -131.23 86.12 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -113.34 133.33 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 73.23 110.835 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.88 154.13 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 62.23 110.861 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.09 160.51 56.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.724 0.773 . . . . 72.13 110.884 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 132.57 23.7 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 74.41 112.346 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.45 176.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 64.15 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 161.28 28.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 73.31 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -160.15 160.93 33.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 70.21 110.862 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.82 114.11 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 64.14 111.084 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.94 47.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 43.41 112.449 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -117.58 103.83 10.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 74.02 110.92 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -103.99 164.27 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 73.1 110.882 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.42 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.32 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 202' ' ' TYR . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.21 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.43 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.22 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.22 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.53 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -85.96 135.77 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.14 111.147 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -132.26 141.04 48.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.13 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -122.26 139.19 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 74.12 111.148 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -129.68 0.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 75.21 112.527 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.44 -40.34 78.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.336 . . . . 70.01 110.904 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 62.48 38.18 12.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.907 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.35 -61.32 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 53.35 110.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.49 -103.94 1.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 62.42 112.526 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.4 t70 -127.11 166.15 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 72.34 110.88 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 34' ' ' ASP . 4.6 mm? -121.07 74.24 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 72.33 110.952 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.13 170.15 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 71.11 110.916 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.72 160.43 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.187 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.61 -99.3 0.38 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.757 -0.735 . . . . 65.25 112.462 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.41 91.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 65.21 112.505 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.4 129.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.662 -0.78 . . . . 73.5 112.477 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.98 -71.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 52.51 111.05 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.15 160.68 29.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 70.4 110.902 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 104.49 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.709 2.273 . . . . 73.03 112.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -169.62 125.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.853 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.49 113.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.4 111.106 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.5 115.45 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 73.05 110.89 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.17 138.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.4 111.132 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -172.84 115.34 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.881 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 tp -169.04 135.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 73.45 111.11 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.27 175.38 14.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 71.3 112.497 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.35 87.06 2.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 64.35 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.24 30.58 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -104.19 134.25 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 74.55 111.141 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.41 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 55.05 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 72.34 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.53 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.54 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.12 111.083 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.42 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.33 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.35 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 55.44 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.1 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.424 HG22 HD23 ' A' ' 105' ' ' LEU . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.2 111.111 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.151 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.12 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.23 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.34 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.52 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.8 176.25 39.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.34 112.523 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.09 85.36 15.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 74.3 111.09 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 173.64 10.7 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 74.41 112.403 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -37.51 85.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.22 111.107 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -84.33 77.71 9.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 64.21 110.852 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 98' ' ' TYR . . . -111.1 -37.59 5.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 74.44 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -126.25 58.75 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 62.43 110.929 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -126.16 71.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.54 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.27 -64.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.01 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.72 128.49 42.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 75.33 112.444 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -127.6 -40.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 72.44 110.934 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -105.56 -74.42 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.881 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -164.08 160.4 21.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 64.22 110.86 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.07 68.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.41 111.14 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 t -125.3 44.12 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 62.14 110.823 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 t -118.29 -179.81 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.922 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.1 mt -124.78 65.24 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.888 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.92 -108.24 0.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 70.43 112.456 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.47 93.42 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 72.41 110.919 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.54 167.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 72.54 111.105 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -73.21 -176.73 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.874 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.3 167.61 29.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 71.44 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.84 -35.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 72.21 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -52.06 157.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.4 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.749 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 40.7 p90 -149.02 168.21 23.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 75.03 110.891 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.16 72.29 1.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 65.34 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.87 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.656 2.238 . . . . 53.42 112.37 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -163.93 140.95 6.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 63.02 111.094 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.489 HG22 ' CA ' ' A' ' 124' ' ' GLY . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 35.32 111.152 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 72.31 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.13 110.886 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 67' ' ' ILE . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.32 110.883 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 70.14 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -153.26 137.29 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.989 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -130.92 88.01 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 71.12 110.845 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -106.66 37.42 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.931 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.18 -40.16 15.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 70.44 110.835 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -142.47 -74.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 73.34 110.873 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -174.61 -176.65 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 74.24 110.931 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.52 95.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 64.02 110.817 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.51 -173.72 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 75.41 110.925 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 98.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 74.13 110.919 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -161.17 161.0 24.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.655 0.741 . . . . 70.04 110.945 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.11 112.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 61.13 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.42 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 149' ' ' PHE . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.34 111.106 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 104' ' ' SER . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.43 112.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.34 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 102' ' ' ILE . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -145.1 164.39 31.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.15 110.885 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.48 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.31 111.072 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 130' ' ' ASP . 15.9 tp -86.39 146.53 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 45.42 110.915 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -123.52 -36.31 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 73.02 110.893 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.08 86.22 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 74.23 110.898 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' HB2' HD23 ' A' ' 127' ' ' LEU . 25.8 t0 -115.33 -61.82 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 75.33 110.812 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -151.47 146.25 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.43 110.844 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.6 p -105.89 85.22 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 75.11 111.157 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.94 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 72.04 110.856 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.43 -62.67 1.26 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 62.11 112.501 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.46 43.55 19.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 64.02 111.147 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 tt -72.54 91.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.888 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.7 m 53.84 40.62 31.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.25 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -122.84 71.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.11 110.88 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -113.16 42.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 74.14 110.844 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.422 ' O ' HD13 ' A' ' 141' ' ' ILE . 53.6 t0 -172.24 109.78 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.12 110.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 140' ' ' ASP . 30.6 mm -121.6 124.97 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.117 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -90.61 154.34 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.919 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -88.63 133.65 34.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.435 . . . . 60.13 110.855 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -118.08 72.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 74.41 110.949 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -53.68 139.32 32.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 74.51 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -137.03 95.04 12.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 73.34 111.158 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 63.11 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB3' HG23 ' A' ' 121' ' ' VAL . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.44 110.904 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.24 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 167' ' ' VAL . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 63.4 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 64.14 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.14 110.857 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.42 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.662 ' CZ ' HD12 ' A' ' 163' ' ' LEU . 14.5 p90 -152.65 141.31 20.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.3 110.93 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.98 155.38 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.661 HD13 ' N ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -125.45 37.59 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.41 110.951 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.65 82.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 43.43 112.453 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -175.81 169.72 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 74.42 110.997 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.6 m -56.05 -36.31 67.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 65.13 110.783 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -108.65 164.47 12.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 74.35 110.854 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.662 HD12 ' CZ ' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 163' ' ' LEU . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.915 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.42 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.13 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 196' ' ' LEU . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.133 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -152.55 165.63 34.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 65.21 110.868 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -142.08 152.34 43.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 72.41 110.913 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 55.3 mt -120.5 130.0 25.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.743 . . . . 73.53 111.073 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 -36.83 10.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 73.22 112.392 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.68 179.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.874 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.11 91.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.32 110.909 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -172.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 63.33 111.133 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.641 ' OD2' HG22 ' A' ' 191' ' ' VAL . 3.0 t70 -101.79 102.86 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.04 110.876 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.7 p -89.45 133.25 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 72.42 111.121 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 72.4 p -91.8 146.91 23.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.55 111.149 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.31 83.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.659 -0.782 . . . . 74.21 112.459 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.6 m -156.59 122.5 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 71.45 111.172 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 mt -69.67 -57.48 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 73.4 110.973 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 133.55 -74.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 74.33 112.524 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 149.31 66.4 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.714 2.276 . . . . 62.4 112.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG12 HG23 ' A' ' 185' ' ' VAL . 38.2 t 61.39 69.89 0.97 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.665 0.745 . . . . 64.12 111.148 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 88.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 72.14 112.361 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 183' ' ' VAL . 41.0 t -102.35 -70.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 43.41 111.054 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.9 t -139.16 151.69 46.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 33.21 110.8 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.4 t -171.94 142.57 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 54.15 111.186 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -133.79 147.35 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.24 110.901 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.14 132.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 64.33 111.062 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -100.14 113.73 26.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 53.42 110.918 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.641 HG22 ' OD2' ' A' ' 175' ' ' ASP . 22.3 t -113.18 88.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.3 111.136 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.2 t0 52.88 74.59 0.75 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 63.42 110.816 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 148.7 65.61 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 72.51 112.325 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.53 144.27 48.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 42.11 110.861 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.42 HG21 ' NH1' ' A' ' 168' ' ' ARG . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 65.12 111.156 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 167' ' ' VAL . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 70.45 110.951 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.01 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.21 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.32 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 54.51 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.924 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 18' ' ' VAL . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.31 111.08 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.53 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.05 68.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.31 110.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -96.49 -37.37 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 74.03 110.945 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 57.23 46.59 18.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 53.41 111.12 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.57 ' HB3' HD12 ' A' ' 206' ' ' LEU . . . -101.32 83.36 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 64.14 111.081 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.66 168.98 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 54.41 111.092 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.4 109.97 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.42 110.903 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 73.44 110.897 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.803 0.335 . . . . 72.31 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -161.93 159.49 26.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 60.02 110.858 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -129.12 125.1 36.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 71.31 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -121.24 143.23 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 70.54 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -143.93 157.56 57.51 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.627 0.727 . . . . 74.34 110.957 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.16 34.7 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.701 2.267 . . . . 74.52 112.347 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.5 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 71.1 111.094 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -119.39 -38.69 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.908 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -138.54 138.66 38.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 74.3 110.823 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.8 140.67 32.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 63.01 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.93 -152.28 9.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.723 . . . . 60.42 112.529 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -145.5 119.15 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 74.13 110.947 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -149.96 149.77 30.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 52.03 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 71.45 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 14.14 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 73.33 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.496 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.711 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.33 111.128 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 53.15 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.13 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.21 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 61.02 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 62.15 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 61.53 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.83 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 53.33 111.128 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' HD23 ' A' ' 196' ' ' LEU . 13.5 m-85 -123.92 148.93 46.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.931 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.01 -179.52 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 45.44 111.114 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.78 -162.22 18.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 71.3 112.44 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' CG ' HD23 ' A' ' 32' ' ' LEU . 1.3 tp10 -52.27 -40.9 62.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.778 0.323 . . . . 74.13 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 32' ' ' LEU . 36.8 tt0 64.38 57.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.11 110.864 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD23 ' CG ' ' A' ' 30' ' ' GLU . 4.5 mm? -116.83 34.49 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.87 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.59 119.69 19.69 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 74.42 112.468 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.41 169.19 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 73.24 110.831 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 tp 60.11 36.71 21.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.907 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.52 -38.03 11.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.42 110.948 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.97 132.98 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.25 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -86.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.768 -0.729 . . . . 61.21 112.418 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 160.46 40.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.761 . . . . 50.41 112.526 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.52 82.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 44.42 112.457 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.5 70.76 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 63.35 111.074 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.2 159.19 32.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.554 0.692 . . . . 74.35 110.946 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 169.86 17.88 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 75.22 112.358 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -156.08 120.08 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 72.32 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.65 47.86 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 63.14 111.04 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.67 150.48 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 71.03 110.82 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.94 147.13 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 74.23 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -169.06 132.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 63.12 110.88 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 tp -119.97 134.7 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.093 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.75 142.3 13.78 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 75.42 112.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -81.11 100.9 9.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 71.23 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.4 30.56 7.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 70.33 110.872 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -67.42 126.02 27.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 71.14 111.117 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.438 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.31 111.219 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.43 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.13 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' A' ' 17' ' ' TRP . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.31 111.137 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.1 111.075 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.43 110.887 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.762 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 70.14 110.862 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 63' ' ' VAL . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.51 111.147 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.43 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.12 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.31 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 62.33 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 63.02 111.082 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 105' ' ' LEU . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.41 111.137 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.43 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.73 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.857 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE1' HG22 ' A' ' 56' ' ' THR . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.858 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 61.04 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.97 -154.64 7.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.13 112.528 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.06 155.88 42.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.622 0.725 . . . . 75.13 111.125 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 174.5 9.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.679 2.253 . . . . 73.04 112.334 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.21 77.67 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 71.13 111.095 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -52.59 -37.37 57.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.24 110.918 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.71 -55.52 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.22 111.146 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -76.91 133.36 39.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 71.45 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.82 160.88 39.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.55 110.889 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -172.7 150.88 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.986 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.45 153.28 5.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 44.44 112.506 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.3 -37.63 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 74.32 110.838 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.65 149.0 19.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.43 110.93 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 p -162.05 108.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 65.21 110.897 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.73 94.78 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 62.31 111.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 p -159.35 179.63 8.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 63.33 110.914 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -164.75 139.7 5.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 62.3 110.913 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 90' ' ' LEU . 0.8 OUTLIER -146.53 163.91 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.957 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.31 77.51 0.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 71.32 112.512 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.39 41.59 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 73.44 110.843 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 p -144.52 139.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.02 111.131 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -132.16 -61.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.86 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.61 -69.23 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.22 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.5 140.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 70.31 111.17 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -117.06 137.31 52.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 63.22 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -74.1 -67.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.24 110.958 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.73 -167.96 28.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.33 112.446 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 141.48 45.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.658 2.238 . . . . 63.13 112.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -139.82 137.68 35.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 62.22 111.12 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.4 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.13 110.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -153.49 157.42 39.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.31 110.894 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -121.98 143.28 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 73.33 110.803 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -49.37 -46.82 47.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.923 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.4 -41.9 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 51.41 110.898 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 t 50.43 64.42 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 75.23 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.34 23.26 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.11 110.9 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 48.54 85.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.34 110.91 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -173.44 173.31 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 70.42 110.874 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.34 96.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.24 110.862 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -162.87 161.07 19.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.665 0.745 . . . . 73.21 110.952 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.44 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 72.12 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.52 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.12 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.1 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 44.11 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.01 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 33.53 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -171.52 156.72 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.52 110.893 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.25 136.92 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.43 111.132 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.98 111.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 75.15 110.898 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -52.68 145.04 12.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 71.42 110.916 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -100.0 97.72 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 70.22 110.909 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -59.74 168.89 1.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 63.25 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -74.33 -175.26 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.846 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.45 163.77 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 53.04 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.03 38.95 13.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.913 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.95 -174.64 6.59 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.518 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.19 36.33 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 51.32 111.106 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 tp 59.43 37.72 23.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.99 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 t -96.52 164.42 12.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 73.41 110.821 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 p -141.34 174.59 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 71.34 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -168.96 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 65.54 110.853 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.73 145.9 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 54.41 110.933 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.2 mt -116.26 132.08 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 53.32 111.135 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -123.01 60.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.14 110.892 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.58 -176.98 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.05 110.882 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -140.27 170.31 16.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 74.42 110.826 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -65.87 152.22 44.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 65.22 110.907 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -110.31 160.4 28.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 45.23 111.086 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 72.12 112.324 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.11 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 63.14 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.2 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 167' ' ' VAL . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 63.51 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.2 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.53 110.877 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 18' ' ' VAL . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.34 110.873 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 153' ' ' LEU . 1.2 m-85 -118.73 115.17 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.54 110.959 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.3 96.09 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.841 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.72 HD22 ' CH2' ' A' ' 161' ' ' TRP . 4.6 tp -60.27 -36.04 76.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 53.42 110.926 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 139.45 -47.68 0.89 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 73.13 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.23 174.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 70.42 110.937 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.0 p -52.35 -36.81 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 60.21 110.931 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.72 ' CH2' HD22 ' A' ' 157' ' ' LEU . 69.1 p-90 -87.61 150.2 23.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.09 -0.505 . . . . 74.23 110.975 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 71.12 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.87 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.587 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 64.22 110.909 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.21 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.33 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 151' ' ' VAL . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.3 111.126 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -149.44 135.41 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -141.71 139.96 33.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.42 110.941 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.6 153.11 81.01 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.64 0.733 . . . . 64.04 111.123 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 132.91 24.2 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.683 2.255 . . . . 65.1 112.355 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -143.88 131.34 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.924 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -139.46 140.35 37.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 61.33 110.903 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.2 m -148.2 144.53 27.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 72.31 111.159 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.37 98.36 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.13 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.73 109.98 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 65.35 111.099 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.3 t -56.47 -35.31 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 71.1 111.105 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.51 172.79 38.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 43.25 112.493 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.7 t -98.73 145.26 27.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 72.31 111.169 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.7 tt -112.35 93.36 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 71.11 110.91 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.43 175.14 20.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 61.34 112.453 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 126.01 12.83 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.729 2.286 . . . . 74.44 112.326 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 184' ' ' PRO . 58.3 t -134.11 133.22 21.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 72.24 111.127 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 183' ' ' VAL . 53.8 Cg_endo -69.66 -48.35 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.673 2.249 . . . . 53.11 112.381 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.6 t -148.09 139.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 55.44 111.19 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -172.39 113.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.24 110.943 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 68.6 p -118.85 107.67 13.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 74.01 111.144 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -89.64 -64.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 72.33 110.841 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.2 tt -167.32 137.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.14 111.117 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -52.74 163.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 74.32 110.921 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.19 -55.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 53.33 111.091 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -153.55 71.54 6.75 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.64 0.733 . . . . 73.24 110.867 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 134.13 27.27 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.666 2.244 . . . . 64.13 112.367 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -98.53 141.91 30.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 71.43 110.812 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 61.42 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.607 HD23 ' CD2' ' A' ' 27' ' ' TYR . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 61.44 110.885 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.22 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.33 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.13 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 64.1 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.34 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.2 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 18' ' ' VAL . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 65.34 111.135 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.21 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -115.04 84.13 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.32 110.946 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.83 -62.04 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.975 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.09 16.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.32 111.105 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -169.11 165.55 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 62.31 111.047 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.62 96.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 73.54 111.165 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.27 65.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.12 110.928 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 60.15 110.893 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.754 0.312 . . . . 50.44 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -140.43 151.4 44.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.929 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -119.07 179.8 4.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 71.12 110.89 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -141.7 165.71 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 61.42 110.917 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -150.39 72.2 9.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.74 0.781 . . . . 74.01 110.929 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 149.41 67.24 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.632 2.222 . . . . 72.01 112.378 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.44 160.45 31.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.24 111.079 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.42 58.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 50.45 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -81.88 157.87 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 64.3 110.867 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 171.31 11.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 64.11 111.095 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.45 163.78 27.8 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.75 . . . . 70.32 112.441 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -140.65 117.55 11.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.392 . . . . 70.3 110.98 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -152.79 173.41 15.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 64.51 110.828 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.609 ' HB2' HG13 ' A' ' 63' ' ' VAL . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.45 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.24 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.34 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 202' ' ' TYR . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.04 111.113 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 71.13 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 63.14 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.54 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HE1' HD12 ' A' ' 55' ' ' LEU . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.1 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 56' ' ' THR . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.32 110.801 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 64.33 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -84.87 132.61 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 72.1 111.087 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -129.08 154.21 46.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 72.2 110.919 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -138.51 142.85 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 73.14 111.14 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.98 133.19 11.2 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 65.41 112.486 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.57 -42.67 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 74.05 110.883 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 63.2 45.97 4.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 70.31 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 tp -99.94 36.29 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.71 135.04 13.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 73.41 112.484 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -163.76 166.33 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.333 . . . . 73.14 110.881 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.27 -47.06 83.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.929 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -151.94 122.58 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.22 110.897 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.07 -36.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 65.31 111.114 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.88 -176.61 42.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.791 -0.719 . . . . 60.44 112.506 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.06 -133.24 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 71.14 112.533 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.33 -158.75 26.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 44.22 112.405 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.72 -68.56 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 73.14 111.124 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.64 160.68 58.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.647 0.737 . . . . 75.33 110.874 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 113.68 3.45 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 71.24 112.336 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -108.84 105.65 15.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 64.34 110.886 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.17 110.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.33 111.044 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.51 149.86 28.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 64.12 110.863 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 49' ' ' ILE . 10.4 p -139.5 137.14 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.3 111.18 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.7 m -125.63 39.72 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.504 ' H ' HG22 ' A' ' 47' ' ' VAL . 8.4 pt -142.56 -178.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 65.34 111.068 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.39 -137.2 4.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 61.25 112.502 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 53.62 45.83 27.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 63.5 110.883 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.05 -37.32 5.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 73.11 110.83 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t -57.76 138.27 55.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.42 111.14 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.34 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' HE1' ' A' ' 23' ' ' PHE . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.892 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' OG ' ' A' ' 24' ' ' SER . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 65.42 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.43 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 61' ' ' TYR . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 63.11 111.163 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 60.43 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 59' ' ' ILE . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.31 110.866 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 62.01 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 14' ' ' GLN . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.078 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.13 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.43 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.14 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 105' ' ' LEU . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 63.52 111.093 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.42 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.51 111.123 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.03 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.21 110.932 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.33 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 62.01 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.76 -157.04 27.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 62.31 112.448 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 76' ' ' PRO . 59.0 t -89.27 133.3 35.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 72.12 111.187 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.7 166.72 26.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 75.12 112.308 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.56 -59.82 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 42.35 111.18 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 -178.84 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.34 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.21 148.71 41.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.02 111.1 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -159.55 137.64 10.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.21 110.931 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.33 -39.66 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 73.3 110.905 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -114.15 -68.21 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.882 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.05 -79.16 0.25 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 72.52 112.478 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -94.07 66.5 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 62.12 110.906 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -162.44 135.42 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 71.05 110.901 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -52.67 160.87 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.819 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 pt -54.94 173.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 54.3 111.134 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -131.8 -60.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 64.01 110.87 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 p -170.47 172.29 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 61.31 110.909 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.82 146.43 54.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 70.4 110.916 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.04 140.08 3.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.752 . . . . 74.22 112.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -172.45 127.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.377 . . . . 75.24 110.894 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.23 176.28 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 73.41 111.125 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 p -131.49 -175.44 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 74.42 110.844 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -161.5 121.56 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 70.43 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.89 43.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.41 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 150.58 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 65.01 110.87 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -54.56 145.21 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 73.44 110.909 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.4 -71.87 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.664 -0.779 . . . . 74.22 112.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 154.75 67.1 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.702 2.268 . . . . 74.12 112.332 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -171.51 166.86 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 72.24 111.117 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.565 HD12 ' HA3' ' A' ' 124' ' ' GLY . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 62.34 111.177 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 52.34 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 67' ' ' ILE . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 64.01 110.911 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -132.3 144.32 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.4 110.933 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -112.6 150.83 30.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.32 110.913 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -47.58 64.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 75.32 110.889 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.13 -41.76 5.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 73.42 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 35.78 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.811 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.31 33.18 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.21 110.86 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 51.55 59.03 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 75.24 110.935 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.8 mtp85 -137.65 165.92 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 71.13 110.876 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 155' ' ' TYR . 2.0 mp -68.75 98.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.32 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -160.33 160.6 26.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.717 0.77 . . . . 72.22 110.894 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.35 112.327 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.21 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.815 HG22 HG13 ' A' ' 151' ' ' VAL . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.0 111.217 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.12 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 149' ' ' PHE . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.51 111.177 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 34.41 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.34 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.34 112.476 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.16 110.38 14.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.24 110.859 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' C ' HD13 ' A' ' 127' ' ' LEU . 22.7 t -140.39 134.46 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.23 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.699 ' N ' HD13 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.68 157.18 45.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.04 110.864 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.78 55.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 64.3 110.817 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -52.18 140.94 19.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 65.03 110.839 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -160.68 130.84 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 63.4 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -151.98 133.77 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.88 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 p -84.11 69.72 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 53.35 111.106 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -158.54 151.3 22.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.33 110.89 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.03 56.24 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 62.11 112.535 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.07 53.36 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.32 111.115 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tp 52.54 37.0 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 61.14 110.933 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 p 51.88 37.66 21.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 44.14 110.87 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.6 p -84.59 -179.19 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 72.03 110.891 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 56.91 50.27 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.88 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.4 61.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.825 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.4 pt -95.96 45.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 63.44 111.106 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.22 132.61 43.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.877 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.83 164.4 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.51 110.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -160.45 152.94 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 75.03 110.862 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -152.96 160.66 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.31 110.989 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -161.65 160.44 22.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 72.42 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 51.12 112.291 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.15 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 121' ' ' VAL . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.13 110.893 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.21 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 119' ' ' VAL . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.51 111.154 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 61.24 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.11 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 71.14 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.769 ' HB2' HD23 ' A' ' 115' ' ' LEU . 6.4 p90 -152.31 131.59 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 63.32 110.936 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.26 127.13 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.22 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.535 ' HB3' HD12 ' A' ' 163' ' ' LEU . 5.8 tt -170.16 119.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 72.31 110.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 147.26 -120.03 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 44.34 112.484 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -114.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 71.42 110.925 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.6 p -120.62 -48.86 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.45 110.898 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -72.33 172.26 10.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 75.52 110.957 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.4 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 157' ' ' LEU . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.914 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.34 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.22 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.23 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.082 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -149.27 129.25 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 71.35 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.29 127.45 35.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 70.41 110.903 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 170' ' ' ILE . 3.3 tp -143.83 96.55 5.54 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.65 0.738 . . . . 63.5 111.158 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 91.44 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 70.02 112.308 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -81.89 100.9 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 71.35 110.871 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -70.65 158.34 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 63.03 110.945 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p -111.51 164.65 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 62.4 111.155 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -125.59 101.37 6.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 64.22 110.88 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.41 136.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 73.14 111.122 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.2 m -56.61 145.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 73.35 111.173 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.61 94.4 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 24.43 112.467 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.473 ' O ' HD22 ' A' ' 180' ' ' LEU . 63.1 p -128.95 126.95 40.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 41.04 111.169 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 179' ' ' THR . 4.4 mm? -123.66 90.01 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 63.4 110.916 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 177.93 -74.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.709 . . . . 55.22 112.493 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -173.66 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.247 . . . . 72.14 112.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.68 70.19 11.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.568 0.699 . . . . 71.32 111.121 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -179.77 3.11 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.754 2.303 . . . . 64.02 112.396 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.17 102.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 54.35 111.151 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 187' ' ' THR . 3.1 p -83.07 -60.51 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.833 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 186' ' ' SER . 10.1 t 37.39 43.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.54 111.188 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -128.67 72.82 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.882 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.74 -63.27 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 75.31 111.087 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -67.74 96.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 70.31 110.888 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.35 108.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.23 111.133 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -164.69 73.18 1.55 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.609 0.718 . . . . 73.31 110.869 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 146.78 60.97 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.651 2.234 . . . . 70.02 112.325 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -133.05 156.2 47.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.845 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.11 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 41.43 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.22 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 198' ' ' LEU . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 73.44 110.975 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.42 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.22 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.15 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.35 110.925 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 64.53 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 61.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.24 110.944 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 207' ' ' ALA . 4.1 pp -52.14 -36.19 50.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.35 110.866 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.423 ' N ' HD12 ' A' ' 206' ' ' LEU . . . -80.17 127.61 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 64.13 111.045 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -108.87 -51.49 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 111.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.43 128.71 48.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.42 111.171 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.0 pp -129.15 -176.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 54.03 110.907 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.2 110.89 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.726 0.298 . . . . 75.35 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -136.73 -179.77 5.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 71.15 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.82 176.01 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.49 111.01 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.27 159.43 29.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.69 0.757 . . . . 74.11 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.84 107.76 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.683 2.255 . . . . 62.33 112.343 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.48 155.99 38.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.02 111.038 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 159.61 33.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 70.12 110.909 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -143.37 169.68 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 54.23 110.811 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.42 179.33 4.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 62.44 111.079 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.65 -174.0 27.8 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 61.15 112.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -150.1 124.08 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 70.11 110.904 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -153.98 -176.26 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 70.05 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.24 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.31 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.3 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.553 ' CZ2' HD11 ' A' ' 59' ' ' ILE . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.42 110.934 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.24 111.078 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 32.51 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 62.51 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.05 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.21 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 74.23 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.03 135.48 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.11 111.093 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -122.74 115.49 22.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 75.34 111.001 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.54 152.68 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 63.3 111.192 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.77 -39.45 5.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 63.42 112.491 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -34.7 41.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 73.41 110.831 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.19 -44.72 75.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.902 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.38 -36.12 68.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.53 110.889 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 168.45 36.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 64.33 112.475 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -83.32 89.71 7.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 73.52 110.91 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.64 -51.11 71.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 64.23 110.873 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -142.58 174.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 75.52 110.939 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.62 -36.53 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.4 111.115 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -149.72 37.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 61.24 112.484 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.92 166.78 17.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.748 . . . . 63.53 112.556 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.02 174.59 31.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 63.41 112.431 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.18 68.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 61.03 111.153 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.71 159.25 72.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.24 110.907 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 169.97 17.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 60.14 112.363 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -78.94 88.63 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 70.13 110.935 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' O ' HG13 ' A' ' 47' ' ' VAL . . . -136.8 143.27 43.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 74.11 111.072 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 41.82 39.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.885 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 45' ' ' ALA . 27.8 m -106.01 -35.79 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.02 111.067 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -52.08 -61.51 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 64.15 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.9 mm -91.28 102.78 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 71.3 111.185 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.36 136.57 30.24 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.735 -0.745 . . . . 72.53 112.493 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -88.7 74.14 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 74.12 110.907 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -98.69 30.56 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 64.42 110.932 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -60.61 128.0 34.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 73.44 111.183 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.13 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.893 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.22 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 70.2 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 71' ' ' PHE . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.53 111.094 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 72.31 111.154 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.02 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 41.02 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 32.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.53 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 64.12 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.576 HG23 ' CE2' ' A' ' 107' ' ' TYR . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 60.5 111.204 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.099 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.616 ' HA ' HD23 ' A' ' 105' ' ' LEU . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.43 111.066 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 63.24 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' HG23 ' A' ' 59' ' ' ILE . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.31 110.875 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.03 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.21 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.67 -178.01 32.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 33.02 112.464 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -113.8 85.28 9.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.651 0.739 . . . . 74.24 111.138 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 132.17 22.78 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.274 . . . . 73.41 112.335 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.86 86.63 6.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 72.32 111.115 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -107.53 149.6 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.14 110.889 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.1 101.19 5.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.2 111.032 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -171.0 156.93 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.898 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -112.39 178.63 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.24 110.91 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -88.79 175.67 7.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 53.43 110.953 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.9 76.2 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 51.14 112.504 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.51 84.48 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 73.52 110.895 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -100.07 142.89 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 63.03 110.884 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.0 m -94.7 -42.36 8.8 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 52.4 110.838 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -51.78 -35.55 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 74.4 111.135 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.3 m -120.88 85.45 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.873 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 t -149.72 145.02 26.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 62.05 110.959 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 -40.4 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.67 -119.57 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.764 . . . . 55.42 112.492 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -111.16 96.16 5.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 74.14 110.896 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.81 91.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 73.31 111.087 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -99.49 53.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 65.11 110.804 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.35 104.96 13.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.832 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.17 136.55 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 63.31 111.121 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.35 165.75 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 74.13 110.856 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.26 -36.82 20.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 74.34 110.909 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.25 -167.78 22.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 40.3 112.481 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 138.73 38.48 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.733 2.289 . . . . 74.44 112.35 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -176.33 164.7 2.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 54.53 111.074 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.739 HG23 ' CA ' ' A' ' 124' ' ' GLY . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.152 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 51.1 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.43 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 69' ' ' VAL . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.22 110.907 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.694 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 44.32 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 67' ' ' ILE . 12.9 m-85 -143.36 140.7 30.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 73.12 110.924 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.02 166.83 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.04 110.819 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -132.33 36.03 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.935 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.11 -41.57 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 74.05 110.854 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.62 55.49 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 74.41 110.881 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.37 174.0 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 74.53 110.867 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.06 94.78 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 72.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -174.58 -173.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.942 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.763 HD12 ' CE2' ' A' ' 155' ' ' TYR . 1.8 pt? -81.0 134.01 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 75.14 110.877 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -173.05 157.02 3.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.727 0.775 . . . . 72.53 110.845 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 71.42 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.3 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 51.13 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 149' ' ' PHE . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 62.2 111.087 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.15 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 145' ' ' TRP . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 51.24 111.104 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.739 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 64.11 112.44 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -139.08 123.93 18.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 62.54 110.873 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.92 133.95 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 64.33 111.119 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.9 tp -130.91 139.49 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.12 110.936 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.08 127.69 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.879 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -102.48 90.64 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 73.33 110.846 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.37 124.66 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 72.04 110.856 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -136.73 150.02 48.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 74.13 110.925 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 t -163.81 135.57 4.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 75.53 111.117 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.45 121.63 29.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 63.01 110.902 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -175.37 -119.38 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 71.23 112.482 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 73.42 111.077 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 128.0 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.0 110.937 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 p -89.78 -44.39 10.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 74.02 110.886 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 m -120.93 108.24 13.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 73.21 110.875 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -118.38 37.39 4.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 70.42 110.842 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.29 68.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 73.14 110.913 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -159.98 144.57 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 74.52 111.081 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' N ' HD13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -168.69 165.47 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 62.53 110.915 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.42 116.15 31.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 74.32 110.848 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -100.6 -43.94 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.873 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.516 ' CG ' HG21 ' A' ' 123' ' ' VAL . 15.5 t-105 -106.47 81.23 1.57 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 64.25 110.894 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' PRO . . . -106.33 95.67 12.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 53.31 111.099 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.21 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HB2' HG23 ' A' ' 121' ' ' VAL . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.881 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.13 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.32 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.509 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 70.35 110.84 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.04 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.763 ' CE2' HD12 ' A' ' 115' ' ' LEU . 12.1 m-85 -130.49 129.07 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.53 110.949 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -103.53 122.53 45.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 74.05 110.853 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.5 mt -140.99 -179.89 6.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.34 110.89 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.31 -125.99 29.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 64.3 112.497 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -127.73 -52.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 53.42 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 m -114.95 -44.52 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 70.23 110.827 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -71.23 124.14 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 74.02 110.934 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' MET . . . . . 0.404 ' O ' ' HB1' ' A' ' 200' ' ' ALA . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 62.31 110.879 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 64.25 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.44 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -130.98 123.99 30.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 64.2 110.861 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -140.6 126.86 19.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 75.5 110.915 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 170' ' ' ILE . 5.2 mp -85.14 133.11 43.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 73.11 111.141 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 170' ' ' ILE . 54.1 Cg_endo -69.79 140.0 41.5 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.718 2.279 . . . . 44.53 112.389 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -114.18 149.21 36.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 73.45 110.915 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 135.58 38.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 71.51 110.921 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 77.9 p -70.26 168.19 16.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.32 111.167 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.98 143.1 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 71.45 110.867 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.54 141.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.22 111.128 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.5 p -121.18 155.26 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 73.24 111.218 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.43 158.69 19.34 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 41.42 112.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -118.2 74.59 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 73.02 111.123 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.3 137.24 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.1 110.986 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.35 -174.61 55.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 71.02 112.511 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -33.93 15.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 71.41 112.347 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.2 156.12 72.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 63.34 111.164 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 114.93 3.86 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.71 2.273 . . . . 63.43 112.318 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.15 105.14 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 61.35 111.127 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.1 t -164.33 149.23 10.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 72.41 110.812 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.46 75.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 74.54 111.154 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -103.16 86.27 2.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.856 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.1 mt -107.03 106.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 44.33 111.107 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.06 105.67 8.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 62.33 110.951 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.31 -38.18 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.22 111.181 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.14 160.54 0.12 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 74.42 110.916 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 148.78 66.38 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.716 2.278 . . . . 75.11 112.349 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.47 177.47 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 72.12 110.882 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 196' ' ' LEU . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.31 111.082 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 195' ' ' ILE . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.13 110.929 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.35 110.823 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 197' ' ' SER . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.42 110.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 54.12 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 162' ' ' MET . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.55 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.593 HG13 HG22 ' A' ' 18' ' ' VAL . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.51 111.191 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -116.91 70.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 70.22 110.943 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.8 -60.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.34 110.903 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.46 93.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.14 111.107 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -123.26 177.63 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 75.4 111.052 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.06 98.88 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.43 111.151 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 tp -83.77 138.35 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 74.31 110.908 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 71.33 110.927 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.82 0.343 . . . . 71.3 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -144.5 106.2 4.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 65.2 110.867 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.68 123.0 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 53.44 110.819 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -147.19 128.69 15.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.33 110.902 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -115.87 160.63 34.4 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.712 0.768 . . . . 72.43 110.87 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 145.37 57.36 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.708 2.272 . . . . 74.31 112.354 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.2 121.61 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 73.11 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -93.05 106.17 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 70.03 110.908 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.4 t -171.08 131.14 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 51.24 110.844 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 97.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 64.21 111.109 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.5 -172.11 38.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.772 . . . . 50.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -129.17 102.13 6.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.389 . . . . 75.24 110.935 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.3 175.07 6.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' HG23 ' A' ' 63' ' ' VAL . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.42 110.947 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.42 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.02 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 53.3 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 203' ' ' VAL . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.04 111.144 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.35 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 61.25 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 73.21 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.12 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 61.35 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.31 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.44 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.07 134.18 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.22 111.091 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.614 ' CD2' HD12 ' A' ' 196' ' ' LEU . 64.8 m-85 -132.39 108.19 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 73.11 110.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 193' ' ' PRO . 18.1 m -135.44 -179.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 64.54 111.099 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.95 -165.56 25.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 51.12 112.454 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -93.4 8.5 40.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 72.13 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -63.65 -37.75 88.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 73.42 110.891 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.8 61.91 0.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.953 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.3 -155.88 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 74.42 112.473 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -122.36 116.0 23.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 51.13 110.858 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.76 53.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 60.54 110.901 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -52.74 123.09 10.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 53.41 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.14 -36.29 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 65.55 111.146 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.47 155.98 5.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.81 -0.71 . . . . 61.32 112.437 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.5 142.15 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 73.14 112.53 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.3 34.19 5.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 71.01 112.537 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 52.33 36.75 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 60.23 111.147 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.41 159.64 33.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.699 0.762 . . . . 72.41 110.866 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 130.33 19.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.693 2.262 . . . . 70.22 112.394 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -141.21 118.83 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.13 110.905 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.69 168.5 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 73.12 111.131 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -77.19 135.79 38.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.417 . . . . 75.43 110.872 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -106.52 116.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 74.23 111.151 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.5 t -108.65 113.93 27.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.24 110.883 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 pt -67.52 169.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.21 111.109 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.35 -57.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 64.32 112.527 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -58.71 117.89 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.801 0.334 . . . . 74.33 110.857 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -119.36 30.64 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.34 110.839 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p -144.42 117.84 9.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.33 111.16 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 71.42 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 41.02 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.42 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.54 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.33 111.165 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.24 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 61.13 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.474 HG13 ' OG ' ' A' ' 64' ' ' SER . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.129 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 54.13 110.806 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.43 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.718 ' OD1' HD12 ' A' ' 67' ' ' ILE . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.35 110.866 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.718 HD12 ' OD1' ' A' ' 66' ' ' ASN . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.33 111.138 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.33 111.083 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.03 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.22 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.62 -174.86 16.22 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 62.42 112.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.52 155.55 13.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.594 0.712 . . . . 60.02 111.133 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.64 3.45 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.239 . . . . 74.23 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.31 165.46 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.24 111.1 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.08 133.97 45.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 55.53 110.848 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -133.84 179.27 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 53.42 111.068 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -89.49 156.32 18.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 75.23 110.936 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -97.29 45.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 73.52 110.913 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -112.64 137.52 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 75.14 110.866 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.08 -152.54 12.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 61.31 112.506 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 141' ' ' ILE . 11.8 tt0 -121.63 120.45 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 61.34 110.883 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.67 151.82 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.2 110.855 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.8 t -142.36 134.16 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 64.2 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -91.67 -70.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 74.5 111.102 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -63.82 147.98 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.913 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 p -172.42 161.8 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 73.22 110.871 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.95 133.32 53.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.959 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.04 131.4 3.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.753 . . . . 64.44 112.493 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -117.5 -44.43 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 73.35 110.914 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.49 130.44 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 54.41 111.141 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.4 p -104.8 116.28 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.889 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.03 155.96 49.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.888 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.9 41.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 63.13 111.126 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.63 67.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.874 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' HD23 ' A' ' 127' ' ' LEU . 34.0 m-85 -149.17 137.91 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.14 110.901 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 -167.6 11.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.794 -0.717 . . . . 73.05 112.514 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 166.35 27.92 Favored 'Trans proline' 0 N--CA 1.466 -0.137 0 C-N-CA 122.706 2.27 . . . . 72.2 112.324 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -159.27 140.71 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 54.13 111.05 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 62.14 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.05 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.12 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 67' ' ' ILE . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.03 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.41 110.887 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HH ' ' HE1' ' A' ' 109' ' ' TYR . 13.0 t80 -138.4 108.77 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 70.35 110.892 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -130.86 166.81 20.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.429 ' HE1' ' HH ' ' A' ' 107' ' ' TYR . 23.4 m-85 -113.09 87.1 2.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.42 110.96 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -51.93 -41.74 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 63.21 110.874 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.8 t 51.5 36.03 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 73.11 110.873 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 t80 62.92 63.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.15 110.885 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 63.27 95.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.3 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.0 ttt85 -179.17 137.47 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 72.04 110.869 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.22 131.86 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 53.45 110.966 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.57 160.43 23.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.702 0.763 . . . . 70.43 110.848 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.35 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.43 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 151' ' ' VAL . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.044 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.32 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.53 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.13 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 52.21 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.33 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -152.83 165.06 36.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.3 110.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.6 m -130.14 138.47 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.03 111.149 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 98' ' ' TYR . 6.6 tp -108.27 136.22 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 73.43 110.892 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -168.23 130.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 74.14 110.828 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -79.18 172.28 14.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.35 110.786 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.97 162.03 33.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 75.22 110.858 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -96.07 52.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 61.13 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -96.3 143.82 27.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.1 111.124 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.03 157.72 15.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 55.41 110.866 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.69 80.08 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.804 -0.712 . . . . 64.11 112.546 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.89 109.68 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 60.21 111.101 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 52.69 36.04 19.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 73.11 110.949 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.7 m -152.48 159.38 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 65.13 110.809 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.8 t -131.66 -47.22 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 62.43 110.789 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.72 155.28 25.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 74.15 110.926 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -88.42 -73.27 0.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 74.4 110.849 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 84' ' ' GLU . 32.0 pt -148.96 140.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 71.34 111.148 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -123.87 -40.35 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 70.22 110.911 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -80.03 108.32 13.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 73.34 110.905 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -171.68 123.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -179.03 153.72 0.64 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 71.51 110.923 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -140.84 160.34 58.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 74.15 111.071 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.22 112.388 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 54.24 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 55.13 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 167' ' ' VAL . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.23 111.186 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.51 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 72.0 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.3 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.76 105.35 10.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.24 110.94 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -79.76 96.93 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 71.13 110.884 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.513 ' O ' HD23 ' A' ' 157' ' ' LEU . 2.3 tt -179.4 122.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.51 110.945 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.28 176.01 30.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 45.22 112.467 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -74.57 84.98 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 63.04 110.934 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.1 t 65.84 29.83 10.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.04 110.927 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -162.79 164.66 26.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 72.01 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.2 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.4 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.427 ' HB3' HD13 ' A' ' 198' ' ' LEU . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.34 110.849 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 61.42 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.03 111.079 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -151.95 144.42 24.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.25 110.911 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -141.88 153.28 44.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.936 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.8 tt -67.65 132.04 92.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.575 0.703 . . . . 63.11 111.127 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 82.1 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 74.13 112.302 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.65 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 75.15 110.808 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 153.19 27.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.12 110.954 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.8 m -142.94 148.34 36.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 75.41 111.159 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -128.35 149.77 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 61.13 110.913 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.01 127.87 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.21 111.113 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -56.59 166.79 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 73.51 111.187 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.01 89.66 0.88 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.704 -0.76 . . . . 65.02 112.522 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.464 ' C ' ' HG ' ' A' ' 180' ' ' LEU . 60.8 m -71.99 -36.0 69.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 63.43 111.095 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 179' ' ' THR . 1.5 pp 33.58 47.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 72.34 110.891 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.27 -169.98 14.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 44.03 112.53 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 112.95 3.23 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.668 2.245 . . . . 75.22 112.292 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 183' ' ' VAL . 4.0 p -160.32 77.96 2.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 44.24 111.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -45.17 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 73.23 112.3 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.5 p -99.66 141.88 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.24 111.1 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 66.5 m -127.43 57.01 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.806 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.2 p -115.84 38.13 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.51 111.177 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -127.61 77.66 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.13 110.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 -66.91 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 54.21 111.12 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 54.42 51.54 13.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.804 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.1 -70.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.42 111.14 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.05 160.59 57.42 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 73.01 110.88 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' A' ' 28' ' ' VAL . 53.8 Cg_endo -69.75 126.83 13.78 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.701 2.267 . . . . 64.33 112.351 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -140.0 122.61 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 64.11 110.881 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 43.41 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.614 HD12 ' CD2' ' A' ' 27' ' ' TYR . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.42 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.53 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 199' ' ' GLY . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.937 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.486 ' H ' HD12 ' A' ' 198' ' ' LEU . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.14 112.51 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.23 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 72.12 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 18' ' ' VAL . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.1 111.138 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.14 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -94.86 74.72 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.12 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.0 tp -52.06 -44.01 64.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 62.45 110.953 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.85 108.4 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 75.21 111.119 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -100.58 50.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.25 111.083 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.449 ' C ' HD22 ' A' ' 210' ' ' LEU . . . -148.94 150.33 32.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 44.41 111.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 209' ' ' ALA . 4.6 mm? -120.25 173.25 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.892 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 71.02 110.933 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.785 0.326 . . . . 55.24 110.835 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.51 155.17 31.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.925 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -57.96 167.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.932 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -141.29 173.84 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 62.15 110.906 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -117.17 157.63 46.41 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.755 0.788 . . . . 64.14 110.903 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.99 69.59 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.716 2.278 . . . . 72.51 112.323 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -178.95 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.32 111.106 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -96.34 141.24 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 63.42 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -74.96 159.08 32.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 60.14 110.844 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -157.12 145.89 19.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.52 111.05 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -150.08 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 54.12 112.498 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -166.87 135.62 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.371 . . . . 51.35 110.931 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -115.65 175.33 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.14 110.885 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 53.13 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.31 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.13 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.2 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.3 111.152 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 44.24 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 63.1 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 71.1 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' O ' HD23 ' A' ' 198' ' ' LEU . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.42 110.79 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.2 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 64.13 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m -89.37 139.33 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 63.03 111.096 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.18 131.61 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 70.42 111.026 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' GLU . 7.4 p -151.88 141.69 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.41 111.112 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.92 -33.51 36.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 71.35 112.463 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 28' ' ' VAL . 7.2 mt-10 -51.98 -45.69 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 63.51 110.911 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 58.78 52.72 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.0 tp -65.31 -37.53 87.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.2 110.917 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.67 -123.83 8.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 45.23 112.509 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -168.97 162.17 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 73.44 110.864 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.54 89.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.919 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.5 167.75 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 71.01 110.902 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.92 144.46 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 62.15 111.174 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.22 167.56 28.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 35.14 112.449 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.11 -146.44 17.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 71.11 112.522 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.53 81.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.687 -0.768 . . . . 62.41 112.528 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.67 -176.6 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 64.14 111.089 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.61 159.28 1.75 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 62.22 110.897 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 125.7 12.4 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 54.23 112.316 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -144.26 168.23 20.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.5 110.897 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.82 143.31 37.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -136.57 159.19 42.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 73.12 110.855 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.47 141.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.144 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -104.67 145.59 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 63.43 110.841 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.7 mt -90.38 121.24 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 44.54 111.097 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.18 -33.45 2.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 73.34 112.427 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.02 77.48 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 73.15 110.897 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -97.76 30.54 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 71.14 110.883 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -128.62 153.25 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 70.01 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 53.44 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 64.31 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 55.43 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.33 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 50.01 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.22 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 63.15 111.145 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.11 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.14 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 24.12 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.3 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.21 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 61.43 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.04 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.3 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 65.42 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 103' ' ' LEU . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.848 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HE2' ' HG ' ' A' ' 104' ' ' SER . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.896 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.79 -179.33 16.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 50.24 112.418 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -101.7 133.27 20.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 63.12 111.078 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.79 150.73 68.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.686 2.258 . . . . 64.3 112.331 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.16 86.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 65.31 111.087 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -66.92 126.55 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 63.21 110.904 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.12 91.36 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 70.34 111.083 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -100.36 117.67 35.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.853 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -128.2 154.51 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 70.41 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -55.51 122.11 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 75.24 110.823 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.71 92.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.715 -0.755 . . . . 64.33 112.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.24 142.63 51.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.913 0.387 . . . . 72.5 110.928 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -85.58 -45.73 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.43 110.927 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.7 p -53.09 121.27 7.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.53 110.879 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.04 -35.8 74.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 72.23 111.122 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 t -77.59 139.78 39.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 73.11 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -93.38 108.66 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 74.33 110.888 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.83 178.03 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 72.53 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.89 150.05 22.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 22.13 112.475 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.7 174.05 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 72.52 110.861 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.44 139.08 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 64.14 111.121 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 p -77.01 134.34 38.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 70.31 110.82 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -154.0 171.51 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.861 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.61 133.37 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 54.41 111.182 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -109.46 127.26 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 74.52 110.888 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -105.88 151.59 24.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 71.23 110.91 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.27 -74.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 64.32 112.456 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 147.56 63.31 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.242 . . . . 73.33 112.376 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -175.42 161.0 2.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 63.44 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.33 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 71' ' ' PHE . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.878 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HG ' ' HE2' ' A' ' 72' ' ' PHE . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.24 110.808 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 72.44 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 54.54 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -129.65 133.81 47.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 74.14 110.932 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -129.15 136.63 50.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 65.34 110.811 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -66.32 -33.32 75.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.11 110.965 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.51 -35.64 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.01 110.806 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 t 63.36 56.81 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.4 110.874 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -155.97 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 53.55 110.918 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.45 101.83 14.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 64.2 110.877 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.59 169.73 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.34 110.859 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 155' ' ' TYR . 4.2 mp -86.43 103.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.53 110.982 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -166.34 163.07 11.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 75.2 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 71.53 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 73.01 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 52.32 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.15 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 55.44 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 51.34 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 44.02 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -141.22 117.09 10.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 71.51 110.872 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.75 151.32 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 42.05 111.156 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 91.74 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 63.03 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -76.56 -43.3 39.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 55.55 110.846 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.47 77.32 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 72.24 110.889 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -91.35 -53.91 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 73.02 110.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 58.77 43.29 18.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 75.13 110.849 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.1 m -52.68 -40.7 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 73.22 111.178 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -69.21 170.79 9.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.25 110.829 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.92 -179.7 19.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 55.04 112.451 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.58 -53.6 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.41 111.1 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.93 115.32 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.882 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 t -157.67 140.7 15.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.44 110.865 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 t -168.79 115.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 62.31 110.892 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.14 165.45 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.843 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -102.64 167.03 10.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 62.41 110.831 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.68 120.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 52.41 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -100.14 53.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.894 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.77 53.93 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.864 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -90.3 96.81 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 75.14 110.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -169.9 165.42 9.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 71.34 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -158.07 160.4 29.83 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.621 0.724 . . . . 75.3 111.072 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 62.51 112.277 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.24 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.41 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 71.12 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.21 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.702 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.35 112.533 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 152' ' ' GLY . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.11 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 115' ' ' LEU . 7.7 m-85 -120.85 178.59 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.92 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -106.8 135.75 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 72.24 110.816 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.91 -68.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 45.22 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -136.27 -85.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 63.44 112.498 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.51 -40.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.11 110.888 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.29 -53.72 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 65.34 110.948 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 151.22 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.506 . . . . 73.14 110.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.43 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 64.33 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.762 HG13 HD11 ' A' ' 196' ' ' LEU . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 65.12 111.156 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -137.86 141.42 40.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.21 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -130.99 118.01 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.35 110.944 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 tp -75.04 131.57 78.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.727 . . . . 73.23 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.5 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.72 2.28 . . . . 51.42 112.342 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.73 56.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 61.23 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -169.45 147.81 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.913 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.1 p -91.86 89.41 7.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 74.45 111.111 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.56 170.74 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 32.1 110.889 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 169.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 62.22 111.136 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -115.34 153.2 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 71.3 111.102 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.01 -99.8 2.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.693 -0.765 . . . . 62.35 112.541 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.5 p -128.27 99.38 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 72.53 111.174 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.63 159.16 11.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.909 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 139.33 179.09 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.496 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -173.14 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.678 2.252 . . . . 71.41 112.334 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.4 t 61.12 68.74 1.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 64.32 111.148 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 149.11 66.53 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.638 2.225 . . . . 62.12 112.343 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -125.74 135.25 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 63.01 111.12 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -82.7 107.63 15.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.23 110.857 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.1 t -104.22 159.68 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.51 111.161 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.06 154.11 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 62.32 110.859 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.2 tt -125.99 142.32 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 70.34 111.084 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.15 143.82 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.33 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.9 t 56.51 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 72.53 111.127 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.46 73.5 9.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 75.44 110.812 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 130.15 18.97 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.732 2.288 . . . . 73.22 112.421 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.07 178.19 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 74.01 110.868 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.42 111.112 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 167' ' ' VAL . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.12 110.897 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.44 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.509 ' H ' HD23 ' A' ' 198' ' ' LEU . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.15 110.918 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 53.31 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 55.2 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.44 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.547 ' C ' HG13 ' A' ' 18' ' ' VAL . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.22 110.888 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 18' ' ' VAL . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 61.41 111.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.35 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -118.14 101.94 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.03 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.72 -45.7 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 53.23 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.56 40.36 8.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.088 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -122.33 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 71.31 111.15 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.47 121.39 11.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.32 111.048 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.44 43.36 2.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.891 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.891 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.758 0.313 . . . . 73.34 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -58.44 155.91 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 65.41 110.838 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -108.82 178.6 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.12 110.856 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -130.39 32.68 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 75.13 110.875 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 145.04 47.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.676 0.75 . . . . 72.34 110.908 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.81 52.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.653 2.235 . . . . 64.21 112.323 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.19 151.77 20.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.44 111.02 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -88.45 176.57 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 63.41 110.924 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 t -130.45 145.74 51.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 33.23 110.88 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.1 -53.46 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 64.42 111.091 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.64 -153.21 27.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 63.31 112.49 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -136.69 116.94 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 73.15 110.91 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.49 -170.59 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 72.01 110.882 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 34.4 112.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.05 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 71.33 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 203' ' ' VAL . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 64.13 111.154 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 72.54 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.32 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 74.12 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 64.34 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 70.24 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.53 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 50.33 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -87.7 138.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.2 111.161 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -131.55 137.06 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 65.44 110.945 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 30' ' ' GLU . 46.7 t -120.44 132.25 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 71.22 111.129 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.44 -33.61 40.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 62.25 112.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HG2' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -52.22 -46.89 65.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 71.25 110.91 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 60.72 47.67 7.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.883 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 30' ' ' GLU . 17.5 mt -103.58 -42.86 5.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 61.15 110.941 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.79 75.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 74.43 112.441 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.7 106.87 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 71.03 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.97 48.72 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.13 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -165.35 161.51 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.922 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.45 111.134 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.34 178.36 44.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 75.21 112.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.92 -135.85 7.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.768 -0.73 . . . . 73.43 112.574 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.39 -141.56 9.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 65.21 112.514 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.39 -45.77 4.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 23.35 111.12 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.01 159.21 73.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.667 0.746 . . . . 74.4 110.911 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.07 2.46 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.21 112.379 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -164.49 151.18 11.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.15 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.46 112.78 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 45.1 111.116 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -94.39 102.12 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 63.44 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 t -85.89 86.97 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 73.15 111.095 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -136.22 116.37 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.23 110.836 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -147.2 131.63 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 61.53 111.154 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.59 -175.91 14.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 65.31 112.523 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -60.82 156.16 17.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 63.22 110.871 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -123.62 30.6 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 62.11 110.814 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t -106.75 163.19 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 74.52 111.177 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 61.23 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' H ' HD23 ' A' ' 55' ' ' LEU . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.22 110.887 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.43 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 65.31 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 50.42 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.44 111.106 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.33 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.32 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 15' ' ' GLY . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.03 111.101 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.04 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.1 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 74.11 110.839 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.45 111.127 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 105' ' ' LEU . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.32 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.41 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 103' ' ' LEU . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.14 110.893 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 62.31 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.22 -159.94 35.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 44.34 112.515 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 76' ' ' PRO . 58.7 t -76.55 133.29 70.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.736 . . . . 61.12 111.12 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.75 155.71 65.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 64.44 112.371 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.7 70.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.02 111.074 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -137.06 141.7 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 64.11 110.836 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.55 156.37 47.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 72.04 111.104 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.66 38.46 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.34 110.894 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -98.96 104.59 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 72.52 110.92 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -109.0 155.85 20.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 65.15 110.895 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.89 147.87 16.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 71.45 112.487 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.44 120.99 29.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.924 0.393 . . . . 70.03 110.92 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -109.37 135.28 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 71.43 110.985 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 p -79.37 164.85 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 62.43 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.99 -35.82 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.13 111.154 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 m -80.68 160.29 25.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 71.14 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.5 t -156.9 115.71 3.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.71 -54.19 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 73.24 110.869 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.5 40.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 60.01 112.512 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -157.22 133.9 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.2 110.911 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.34 169.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 75.21 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.7 p -156.72 123.55 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 62.41 110.885 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.4 171.45 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.912 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.03 129.29 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.145 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.06 136.89 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 71.31 110.827 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -129.48 99.38 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 74.43 110.935 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.57 -165.86 39.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.424 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.68 45.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 64.2 112.403 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -178.0 -177.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.54 111.046 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.691 HG23 ' CA ' ' A' ' 124' ' ' GLY . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.41 111.148 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 71' ' ' PHE . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.54 110.94 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.43 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 69' ' ' VAL . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.32 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.2 110.916 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -153.32 156.24 38.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -131.57 163.84 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 60.12 110.854 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.47 -41.76 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 65.12 110.97 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -104.81 -41.82 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 74.34 110.842 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.89 75.05 0.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.14 110.842 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.97 144.2 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.45 110.931 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.05 107.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 64.21 110.894 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.71 -172.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.46 98.41 9.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 64.01 110.927 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -160.55 162.18 23.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.712 0.768 . . . . 62.23 110.909 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.31 112.35 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 52.21 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.21 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.13 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 71.1 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.41 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 146' ' ' ALA . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.02 111.096 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.691 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 23.3 112.519 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -141.23 112.54 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 73.14 110.861 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 m -122.23 149.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 74.43 111.183 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.51 146.86 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.877 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 54.61 36.13 25.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.872 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -51.92 -37.4 52.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 62.22 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -150.53 169.35 21.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 52.02 110.865 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -113.94 150.9 33.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 70.34 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.3 m -114.05 -67.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 50.32 111.157 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -170.71 164.73 8.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.885 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.56 44.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.23 112.527 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.84 -175.68 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 73.41 111.036 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.76 41.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.44 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.65 162.55 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.889 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 p -124.61 141.34 52.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 72.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.97 -176.93 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.4 110.901 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 141' ' ' ILE . 6.3 m-20 -81.25 -74.36 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 73.53 110.882 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.414 ' C ' ' O ' ' A' ' 140' ' ' ASP . 41.3 pt 36.74 44.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 65.0 111.097 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -58.83 -74.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 74.14 110.831 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.08 43.27 30.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 64.41 110.887 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -67.86 -49.94 59.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 72.33 110.957 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -139.26 125.27 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.24 110.949 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -113.94 160.28 32.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.601 0.715 . . . . 74.22 111.113 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 71.23 112.348 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.45 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.11 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.42 111.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.4 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 64.24 110.913 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.23 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 163' ' ' LEU . 17.9 p90 -152.41 132.54 13.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 70.35 110.945 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.52 154.19 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 63.54 110.862 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.6 tp -150.54 -74.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 73.5 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.59 175.84 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 72.22 112.497 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -79.21 135.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 63.11 110.886 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.4 m 51.32 34.41 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.05 110.885 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -162.22 131.84 4.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 73.33 110.906 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.14 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.24 110.886 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 163' ' ' LEU . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.42 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 153' ' ' LEU . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.23 110.912 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.23 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.882 HG23 HD23 ' A' ' 196' ' ' LEU . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 60.35 111.151 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -132.89 116.43 16.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -103.86 153.32 20.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 61.05 110.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 46.9 mt -106.43 96.55 14.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.655 0.74 . . . . 74.14 111.092 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' ILE . 54.4 Cg_endo -69.64 -172.2 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 72.54 112.398 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -169.02 162.87 11.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 75.51 110.888 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.81 120.55 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 75.51 110.909 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.7 m -113.85 135.97 53.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 73.21 111.206 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.68 174.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 71.12 110.816 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.6 p -80.25 142.17 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.31 111.135 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.3 t -71.12 148.73 47.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 65.21 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.16 140.28 17.52 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 65.4 112.439 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.7 -48.66 80.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 51.31 111.168 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 181' ' ' GLY . 1.4 tt -139.99 154.6 47.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.948 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.635 ' N ' HD23 ' A' ' 180' ' ' LEU . . . 168.41 -171.61 42.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 62.11 112.471 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -38.77 7.16 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.671 2.247 . . . . 74.33 112.296 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 183' ' ' VAL . 3.9 p -155.24 77.96 4.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.622 0.725 . . . . 74.4 111.109 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -47.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 72.33 112.343 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.01 131.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 72.15 111.137 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.581 ' HB3' HD11 ' A' ' 189' ' ' ILE . 2.6 t -125.65 174.49 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 63.33 110.853 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -98.66 -39.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 72.15 111.22 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -148.4 120.57 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 72.54 110.91 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 186' ' ' SER . 3.8 mp -120.82 63.12 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.22 111.142 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -176.15 148.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 72.44 110.83 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.96 88.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 62.11 111.106 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -150.57 160.51 32.58 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.683 . . . . 74.05 110.893 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 169.01 19.84 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.752 2.302 . . . . 74.13 112.371 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 196' ' ' LEU . 13.2 p90 -157.18 168.51 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 63.12 110.874 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 55.12 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.882 HD23 HG23 ' A' ' 167' ' ' VAL . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.42 110.909 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 43.53 110.875 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 197' ' ' SER . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.1 110.907 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.02 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.52 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 51.13 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 71.31 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 18' ' ' VAL . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 55.32 111.196 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.23 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -112.85 97.78 6.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.854 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.89 -36.24 11.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 64.23 110.941 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.36 120.78 6.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 60.13 111.1 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 149.21 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 62.1 111.099 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.15 169.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 51.44 111.049 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.61 166.43 18.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.33 110.954 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.11 110.955 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.786 0.327 . . . . 73.43 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -99.45 170.96 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 63.23 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.13 159.18 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 61.14 110.884 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.97 173.3 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.918 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -126.65 160.5 58.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.637 0.732 . . . . 74.43 110.972 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 162.02 43.68 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.674 2.249 . . . . 64.44 112.32 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.27 168.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 53.11 111.118 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -117.55 153.75 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 m -68.77 -177.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.7 153.85 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 73.51 111.176 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.5 -150.81 5.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 42.41 112.424 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.9 118.82 8.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 75.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -116.82 171.27 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.943 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.455 ' HB3' HG13 ' A' ' 63' ' ' VAL . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.45 110.918 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 63' ' ' VAL . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.11 112.485 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.41 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.24 110.943 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 HG23 ' A' ' 203' ' ' VAL . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.1 111.19 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.103 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 62.5 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CE1' HD22 ' A' ' 55' ' ' LEU . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 72.22 110.882 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.11 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.33 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.53 134.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.41 111.213 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -128.68 116.17 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 64.41 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 193' ' ' PRO . 93.0 t -140.08 144.23 28.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 72.32 111.152 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.1 -172.75 0.48 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 72.24 112.456 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -90.44 -36.16 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 74.12 110.883 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -52.18 -36.17 51.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 71.24 110.867 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 28' ' ' VAL . 13.8 tp -91.92 46.92 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 61.51 110.888 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.49 33.53 2.27 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.682 -0.77 . . . . 35.31 112.447 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 70.03 110.892 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tp -99.7 49.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 75.31 110.911 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.75 54.71 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 60.23 110.89 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.72 142.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.139 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.53 -87.47 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 74.35 112.478 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.84 175.16 30.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.76 . . . . 44.22 112.437 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.53 57.12 2.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 73.31 112.485 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.63 146.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 73.23 111.127 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 163.1 20.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.564 0.697 . . . . 75.01 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 119.82 6.71 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.705 2.27 . . . . 75.11 112.31 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -170.18 130.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 72.2 110.913 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -177.44 137.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 75.24 111.121 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -144.8 171.99 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 72.15 110.875 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 t -111.97 68.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 53.23 111.145 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.3 p -115.47 36.35 3.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.498 . . . . 55.31 110.886 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.23 142.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.064 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.06 155.85 13.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 74.14 112.447 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 62.21 38.71 13.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 64.42 110.895 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -114.49 30.5 7.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.33 110.869 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -69.98 136.71 50.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.34 111.156 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.31 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.33 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 62.24 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.2 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.12 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 ' HE1' ' A' ' 17' ' ' TRP . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.22 111.164 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 62.52 111.134 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.51 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.01 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' HA2' ' A' ' 15' ' ' GLY . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 60.32 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.04 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.1 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 71.43 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 50.51 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.11 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 71.12 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.41 110.876 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.13 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 71' ' ' PHE . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 42.33 111.067 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.6 -166.85 35.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.54 112.501 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -63.66 133.2 95.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.596 0.712 . . . . 74.4 111.168 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.69 141.1 44.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.763 2.309 . . . . 71.22 112.338 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.52 -74.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.081 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 140.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 73.02 110.802 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.41 156.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 75.21 111.101 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.59 134.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 63.22 110.897 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.46 165.29 26.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 75.13 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -69.34 147.14 51.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.921 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.08 -157.77 13.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.789 -0.719 . . . . 74.35 112.477 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.67 -36.73 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 73.31 110.847 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -62.3 -176.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.875 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 p -52.47 134.35 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 52.23 110.854 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.02 -177.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 54.32 111.185 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 p 51.91 37.54 21.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 74.54 110.847 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t -114.31 64.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 54.22 110.797 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 tp -169.72 131.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.924 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.05 123.09 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 73.21 112.474 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 164.26 38.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 64.51 110.848 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.99 -36.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 63.45 111.149 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -159.17 124.97 4.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.31 110.881 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -169.93 175.95 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 61.31 110.919 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.65 150.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.17 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.46 173.48 11.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.01 110.871 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -119.33 -67.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.968 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.09 75.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.787 -0.721 . . . . 64.34 112.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.508 ' CB ' HG12 ' A' ' 126' ' ' VAL . 54.0 Cg_endo -69.82 162.2 43.03 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.663 2.242 . . . . 74.11 112.337 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -164.71 151.39 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 64.45 111.076 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.174 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.43 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 70.41 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.857 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -153.13 148.49 27.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.99 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -130.98 166.88 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.21 110.892 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -130.29 35.32 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 73.31 110.888 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.15 -41.61 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 64.21 110.877 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t 54.77 65.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 75.05 110.872 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -152.36 -177.52 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 62.44 110.855 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.29 36.12 4.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 55.03 110.79 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.31 -179.32 5.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 73.52 110.922 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.02 131.44 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 74.5 110.969 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.559 ' C ' HD12 ' A' ' 153' ' ' LEU . 6.1 m-85 -161.51 160.45 23.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.665 0.745 . . . . 72.43 110.884 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.24 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.41 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 64.12 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.22 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 52.13 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.52 111.143 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.43 112.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -154.0 151.92 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 62.22 110.921 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.508 HG12 ' CB ' ' A' ' 100' ' ' PRO . 32.8 m -133.23 134.99 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 73.42 111.128 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 tp -92.28 136.91 32.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 71.3 110.895 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -106.59 162.39 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.52 110.924 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -135.57 105.87 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.41 110.95 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.4 150.45 31.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 73.35 110.914 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -133.45 145.2 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.24 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 m -56.02 133.52 51.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 53.2 111.173 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.52 173.91 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 60.43 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.74 -64.95 3.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 70.35 112.495 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.78 122.33 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 64.24 111.164 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 137' ' ' SER . 0.3 OUTLIER -172.66 121.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 73.04 110.919 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 136' ' ' LEU . 3.3 t -149.29 113.39 5.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.457 . . . . 51.14 110.851 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -173.65 147.47 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.91 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -81.51 153.35 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 74.12 110.893 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -118.67 170.85 8.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 75.44 110.869 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.7 pt -150.52 150.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 54.41 111.145 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -116.51 -179.18 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 62.02 110.869 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 52.33 44.81 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 63.41 110.875 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.56 104.07 13.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 70.14 110.908 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.532 ' CZ3' HG11 ' A' ' 123' ' ' VAL . 64.1 p-90 -124.96 151.78 45.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 74.52 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -135.6 160.39 67.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 62.54 111.164 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.652 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.4 112.361 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.33 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 63.45 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 167' ' ' VAL . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 64.03 111.102 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.03 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 116' ' ' TYR . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 54.42 110.843 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 45.35 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -140.14 110.31 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.15 110.875 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -106.5 155.04 20.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.854 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.91 -63.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.26 -126.48 0.91 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.768 -0.73 . . . . 41.54 112.465 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -81.93 57.0 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 73.53 110.858 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.4 m -160.96 -172.85 3.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.24 110.852 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -70.81 135.92 48.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 73.43 110.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.4 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.33 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 40.32 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.13 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 62.52 111.137 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.7 135.68 26.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 70.01 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -94.6 140.62 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 64.41 110.912 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 171' ' ' PRO . 67.5 mt -129.64 133.12 24.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.669 0.747 . . . . 72.54 111.128 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.6 Cg_endo -69.8 173.75 10.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.717 2.278 . . . . 74.12 112.365 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -153.71 143.14 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 73.35 110.861 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -127.9 89.41 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 64.11 110.842 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 p -84.19 -179.54 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 55.35 111.107 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -112.51 130.37 56.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 61.42 110.845 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.1 t -80.32 135.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 63.22 111.128 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m 54.55 43.63 29.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 64.03 111.142 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.8 -95.43 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 64.23 112.517 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 71.33 111.124 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.0 mt -130.18 -49.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 63.14 110.943 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.57 176.97 3.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 70.0 112.476 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 135.11 29.54 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 60.23 112.328 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 156.15 49.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 63.11 111.142 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.16 64.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 63.15 112.337 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 185' ' ' VAL . 13.0 p 39.68 38.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 51.13 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.7 t -167.58 148.35 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.04 110.838 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.1 m 65.17 48.72 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 61.11 111.161 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 189' ' ' ILE . 5.8 mptp? -110.73 35.19 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.955 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 188' ' ' LYS . 25.7 mm -133.48 66.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 71.41 111.159 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -154.05 118.62 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 74.15 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.39 -70.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 73.45 111.087 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.2 144.87 0.5 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.65 0.738 . . . . 62.42 110.852 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.6 ' CB ' HG22 ' A' ' 28' ' ' VAL . 53.3 Cg_endo -69.78 133.6 25.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 64.4 112.299 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -153.55 175.1 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.44 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 70.33 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.1 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.35 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.55 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.54 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.12 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.43 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 18' ' ' VAL . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 73.21 111.149 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -91.65 83.83 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.876 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -34.83 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 73.01 110.869 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 64.13 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 61.24 111.117 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -51.78 164.16 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.53 111.069 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.35 -176.42 5.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.115 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 210' ' ' LEU . 5.0 tt -51.85 -37.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.32 110.89 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.868 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.733 0.302 . . . . 63.13 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -173.48 128.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.11 110.915 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -125.36 -178.09 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.824 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -130.01 177.6 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.86 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -145.28 157.59 52.8 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 74.41 110.981 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 154.39 67.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.261 . . . . 73.04 112.417 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.3 140.55 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 63.23 111.119 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -85.55 172.02 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.15 110.917 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 p -84.51 170.62 13.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 72.12 110.943 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.81 144.72 37.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 62.24 111.055 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.78 -177.09 15.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 73.55 112.499 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -47.43 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 74.43 110.928 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -114.86 -175.81 2.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 74.53 110.937 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.1 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 62.35 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.23 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.21 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 203' ' ' VAL . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 61.11 111.106 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.45 111.111 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.31 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.13 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.34 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 55' ' ' LEU . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 56' ' ' THR . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.44 110.863 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.13 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.73 131.81 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 64.03 111.108 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.15 140.9 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.44 110.913 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.22 123.28 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.01 111.175 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.51 51.52 0.41 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.733 . . . . 71.44 112.506 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.57 -38.86 65.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.752 0.31 . . . . 74.21 110.803 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.07 -36.3 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.33 110.894 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.43 -58.95 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 62.3 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.08 -106.2 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 74.41 112.5 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -150.31 141.74 23.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.89 0.376 . . . . 71.15 110.858 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -126.77 74.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.4 110.91 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -124.79 -44.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 73.05 110.878 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -118.25 36.82 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.181 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.41 -130.09 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 62.14 112.539 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.04 175.03 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 73.4 112.419 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.11 -179.45 16.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 62.51 112.497 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.3 105.06 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 73.13 111.132 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.85 160.68 26.46 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.566 0.698 . . . . 73.42 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 131.64 21.59 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.64 2.226 . . . . 75.44 112.364 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -98.14 167.96 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.05 110.922 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.11 118.9 10.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 62.32 111.053 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -56.48 167.39 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.867 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.8 p -157.44 143.85 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 75.21 111.164 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -99.47 55.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.866 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -53.42 146.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 74.01 111.183 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.35 -90.82 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 64.24 112.436 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -163.0 115.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.85 0.357 . . . . 65.42 110.896 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.68 30.5 7.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.842 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -60.32 128.39 36.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.23 111.169 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.04 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 23' ' ' PHE . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 51.13 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.424 HG21 ' OG ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.24 111.136 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.23 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 61.34 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 71.21 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.2 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.24 110.893 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 64.44 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 63' ' ' VAL . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.52 111.155 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.41 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.45 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.53 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 107' ' ' TYR . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 73.43 111.143 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 61' ' ' TYR . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.41 111.071 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.24 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.54 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' A' ' 101' ' ' ALA . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.14 110.87 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 102' ' ' ILE . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 60.03 110.84 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.13 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.0 -173.32 19.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 33.52 112.517 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -86.87 133.24 39.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 71.2 111.136 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.79 128.41 15.96 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 71.03 112.336 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.66 37.56 4.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 73.11 111.133 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 55.41 51.32 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 74.02 110.896 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.17 142.64 20.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 43.22 111.035 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.85 164.87 21.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.43 110.893 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -108.12 -175.18 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.892 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -124.27 162.99 22.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 61.01 110.935 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.18 -123.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 74.13 112.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -160.66 139.06 10.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 72.42 110.85 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -144.3 138.83 28.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 72.34 110.888 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -70.38 97.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.45 110.764 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -145.25 137.91 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.44 111.088 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.2 m -57.85 173.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.907 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.8 m -81.42 64.18 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.13 110.891 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.32 125.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 74.42 110.919 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.36 174.8 37.97 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 51.14 112.512 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.52 91.29 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 73.52 110.914 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 p -175.83 137.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 73.41 111.17 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 p -105.08 142.56 34.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 73.11 110.913 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -82.35 177.34 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 70.52 110.844 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.11 57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 73.42 111.108 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.7 173.63 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 64.2 110.866 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -95.26 -63.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.882 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.67 68.61 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 70.54 112.475 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.509 ' HB3' HG12 ' A' ' 126' ' ' VAL . 53.5 Cg_endo -69.84 -170.96 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 75.12 112.268 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 71' ' ' PHE . . . -132.6 125.85 31.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 74.32 111.008 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 72' ' ' PHE . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.51 111.108 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 65.42 110.999 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 61.34 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 119' ' ' VAL . 6.9 m-85 -120.26 114.34 21.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.4 110.911 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.16 166.87 20.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 74.33 110.838 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -124.09 80.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 74.11 110.896 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.29 17.69 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 65.32 110.84 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -95.15 36.39 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 53.21 110.803 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -161.95 151.83 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.43 110.894 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 87.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.899 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -179.83 -173.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 62.45 110.826 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.621 HD23 HD12 ' A' ' 153' ' ' LEU . 6.8 mp -59.43 165.54 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 65.23 110.892 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.29 70.46 2.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 63.45 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.13 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.53 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 107' ' ' TYR . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.11 111.1 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.43 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' VAL . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.35 111.146 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 63.5 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 74.34 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.42 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -143.89 165.9 26.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 63.23 110.886 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 100' ' ' PRO . 28.6 m -110.34 156.52 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 74.34 111.112 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -133.49 143.72 48.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.91 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -152.75 175.49 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 70.35 110.866 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -139.56 133.48 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 64.42 110.977 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.92 102.98 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 63.22 110.808 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -77.65 171.41 14.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 34.3 110.896 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 69.67 3.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 63.42 111.143 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.53 80.61 8.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.14 110.846 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.59 -109.73 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.753 . . . . 62.44 112.542 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -129.25 41.49 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 71.03 111.055 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.95 120.0 37.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.55 110.892 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -157.8 122.3 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.53 110.877 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 t -173.64 164.18 4.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 63.24 110.909 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -98.27 147.2 24.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 62.31 110.897 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -127.51 126.88 43.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 70.14 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.7 tt -118.96 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.35 111.089 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -151.76 178.96 8.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 72.41 110.819 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -80.89 64.18 5.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 61.04 110.863 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -76.05 -38.35 57.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 73.15 110.912 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -55.14 119.89 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.51 110.904 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -131.73 160.41 67.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 53.22 111.144 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.33 112.329 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.41 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 72.42 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 45.22 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 167' ' ' VAL . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.122 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.03 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.621 HD12 HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 63.11 110.927 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.2 132.91 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.33 110.883 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -58.47 111.6 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 72.3 110.93 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 HD12 ' A' ' 163' ' ' LEU . 6.5 tt -151.51 104.35 3.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 74.12 110.916 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 130.68 -139.43 10.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.689 -0.767 . . . . 52.52 112.501 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -112.13 -65.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 72.54 110.85 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.2 m -108.0 -46.79 3.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 72.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -80.76 141.56 34.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 71.02 110.911 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.42 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 157' ' ' LEU . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 51.42 110.914 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.23 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.14 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.43 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 151' ' ' VAL . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 51.44 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -146.26 145.05 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.11 110.862 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.551 ' O ' HD13 ' A' ' 170' ' ' ILE . 10.1 t80 -131.75 112.59 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.31 110.916 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 169' ' ' TYR . 50.2 mm -130.49 133.07 24.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.699 . . . . 72.42 111.129 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.6 Cg_endo -69.72 132.59 23.72 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.713 2.275 . . . . 71.3 112.342 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -83.98 154.07 23.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 53.14 110.865 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -87.19 -42.02 13.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 75.21 110.909 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 t -170.72 161.82 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.24 111.176 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.41 173.11 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.23 110.842 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.1 142.81 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.01 111.143 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.0 m -79.83 142.19 35.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.23 111.172 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.38 -134.41 4.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 62.03 112.473 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.0 t -138.96 149.2 44.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 73.23 111.128 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -133.17 163.85 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.94 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.63 -73.64 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 43.34 112.483 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.24 14.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 72.13 112.41 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 184' ' ' PRO . 58.1 t -121.65 133.33 24.22 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.642 0.734 . . . . 75.01 111.088 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 183' ' ' VAL . 53.6 Cg_endo -69.78 135.26 29.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 53.53 112.328 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.09 121.87 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 71.45 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.9 t -76.43 -176.93 3.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.05 110.832 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -53.3 120.3 5.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 54.45 111.104 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -82.4 93.17 7.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.908 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.58 145.14 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 65.35 111.14 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -52.04 139.75 22.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.878 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.87 139.88 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 63.23 111.083 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.12 73.51 2.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 75.12 110.864 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 140.31 42.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.77 2.313 . . . . 73.21 112.33 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -104.59 162.88 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 64.33 110.84 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.45 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.35 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 53.13 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.43 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 45.14 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 65.34 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.25 110.964 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 18' ' ' VAL . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 55.54 111.111 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -106.43 76.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.32 110.87 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 208' ' ' ALA . 0.2 OUTLIER -68.13 -50.17 56.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 64.14 110.939 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 53.44 53.44 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 60.3 111.077 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.723 ' HB2' HD12 ' A' ' 206' ' ' LEU . . . -82.85 161.99 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.2 111.09 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.43 129.03 34.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.24 111.061 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mt -123.28 138.21 54.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 70.11 110.929 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.21 110.881 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.847 0.356 . . . . 54.41 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -154.72 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.44 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.25 174.35 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 61.23 110.872 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -114.89 141.31 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 63.41 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -87.21 161.01 47.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 74.13 110.92 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 157.34 60.83 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.655 2.237 . . . . 71.25 112.334 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.76 -177.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 51.11 111.098 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -118.77 160.64 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 74.35 110.906 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -103.93 158.61 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.02 110.836 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.47 -175.54 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 70.55 111.039 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.4 -175.81 49.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 73.4 112.495 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -173.28 129.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 62.23 110.925 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -133.18 163.48 29.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 73.11 110.837 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 54.11 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.12 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.726 HG22 HG23 ' A' ' 203' ' ' VAL . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 62.54 111.127 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.42 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.1 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.44 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.909 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.3 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.13 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 63.33 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.31 129.54 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.12 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -119.82 107.05 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 71.02 110.916 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -134.61 145.35 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 61.5 111.145 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.44 138.48 10.23 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.699 -0.763 . . . . 73.23 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.88 -44.0 17.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 60.15 110.851 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 53.54 48.12 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.926 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.5 36.29 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 60.31 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.67 -124.49 29.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 74.24 112.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -129.83 177.19 7.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.362 . . . . 62.11 110.842 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mt -107.56 61.07 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 73.43 110.922 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.74 119.9 10.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 62.32 110.971 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -169.08 148.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 52.42 111.098 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.18 106.15 2.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 32.41 112.485 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.13 -110.66 3.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 65.21 112.481 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.89 -133.59 7.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 71.34 112.483 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.59 -50.8 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 71.33 111.111 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -108.67 90.93 7.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 71.21 110.952 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 54.6 Cg_endo -69.64 135.53 30.96 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.721 2.281 . . . . 73.4 112.381 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -148.15 113.94 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.22 110.916 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.4 134.82 20.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 43.02 111.088 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -160.53 106.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 64.2 110.929 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -174.44 138.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 54.42 111.086 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -162.74 136.15 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 53.31 110.822 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -136.56 124.68 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 62.24 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.36 70.68 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.738 . . . . 61.33 112.487 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -120.86 79.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 74.05 110.89 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.67 30.54 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.12 110.807 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p -65.32 96.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.53 111.102 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.32 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.896 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.21 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CE2' HD21 ' A' ' 55' ' ' LEU . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 74.04 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.11 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.34 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.21 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 72.23 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 64.12 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.03 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 52.31 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.492 ' ND2' HG22 ' A' ' 67' ' ' ILE . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.31 110.904 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 105' ' ' LEU . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 65.12 111.12 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 72.43 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.32 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.873 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 72.14 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 70.05 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.03 170.09 24.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 52.54 112.517 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 55' ' ' LEU . 58.4 t -57.34 133.26 81.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 60.04 111.172 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 75' ' ' VAL . 54.1 Cg_endo -69.71 -177.37 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.675 2.25 . . . . 65.51 112.374 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.77 45.17 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 72.22 111.093 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -62.34 116.05 4.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.24 110.874 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.32 95.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.41 111.132 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -128.91 166.96 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.43 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -69.59 173.11 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 75.13 110.861 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -75.41 -71.27 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 71.35 110.885 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.45 -45.38 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 73.53 112.468 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 53.24 44.82 29.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 73.04 110.894 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -116.27 133.85 55.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 73.14 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t 58.02 50.81 9.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 23.22 110.836 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.41 142.38 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 72.11 111.153 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -151.57 148.15 27.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.21 110.884 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -99.82 148.85 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 45.14 110.869 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.86 38.29 24.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.21 110.985 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.76 53.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 74.53 112.529 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -117.98 61.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 65.13 110.885 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG11 ' OD2' ' A' ' 133' ' ' ASP . 60.4 t -93.82 96.8 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.129 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 p -119.22 42.55 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 75.12 110.801 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -55.98 -37.41 69.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 62.4 110.852 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.76 179.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 74.24 111.153 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -136.3 179.29 6.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.53 110.814 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.26 149.74 44.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 71.45 110.969 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.23 76.03 0.3 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 73.34 112.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.605 2.203 . . . . 43.2 112.4 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.669 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -136.67 135.87 38.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 53.22 111.11 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' A' ' 124' ' ' GLY . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 71.12 111.11 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.34 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.43 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 67' ' ' ILE . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.44 110.915 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.42 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -141.22 143.01 33.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.44 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -130.97 103.8 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 72.12 110.869 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -51.66 -35.13 41.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.922 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.83 -41.54 18.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 72.35 110.891 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t 52.41 39.39 27.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 70.43 110.946 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -102.34 176.11 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 64.41 110.916 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -105.1 39.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 73.31 110.886 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -144.39 -175.87 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 63.14 110.86 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 155' ' ' TYR . 1.5 pp -60.09 116.48 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 52.2 110.866 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.29 160.53 26.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.753 0.787 . . . . 74.32 110.866 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 72.54 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.32 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 151' ' ' VAL . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.45 111.088 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.35 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 149' ' ' PHE . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 71.11 111.083 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.21 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.34 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HG23 ' A' ' 102' ' ' ILE . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 51.05 112.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -160.83 -175.18 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.34 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.55 101.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.01 111.231 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 128' ' ' PHE . 1.6 tt -89.14 155.08 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 60.33 110.976 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 127' ' ' LEU . 36.7 p90 -116.05 138.4 51.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.01 110.842 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.17 169.76 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 75.24 110.91 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -136.7 154.66 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.13 110.855 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.03 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.22 110.852 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -71.73 91.03 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 63.44 111.176 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 93' ' ' VAL . 10.5 t70 -157.05 151.35 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.814 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.41 135.91 29.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.767 -0.73 . . . . 74.13 112.42 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.585 ' C ' HD23 ' A' ' 136' ' ' LEU . . . -124.98 -45.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 71.24 111.145 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER 41.44 37.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.951 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 p -117.31 143.19 46.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 75.22 110.85 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 t -145.85 172.1 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.54 110.859 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 54.97 48.62 19.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.25 153.03 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 71.42 110.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.7 mm -82.8 145.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.13 111.128 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.22 174.84 6.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.864 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.99 171.25 8.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 73.4 110.839 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -112.45 178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.45 110.835 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -97.05 149.78 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.33 110.935 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -125.83 95.15 40.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.33 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 54.14 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.13 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' VAL . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.11 111.13 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.42 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 62.1 110.97 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.704 ' CE2' HD13 ' A' ' 115' ' ' LEU . 7.5 m-85 -126.79 150.71 49.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.14 110.978 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -104.46 95.12 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.12 110.877 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.36 -74.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 72.4 110.942 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.34 -160.41 12.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 50.21 112.512 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -110.81 -36.4 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 54.53 110.898 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.1 m -60.43 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 54.15 110.873 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -128.95 171.87 11.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.954 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 72.25 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 155' ' ' TYR . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.42 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.33 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.13 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 196' ' ' LEU . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.23 111.087 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.57 160.79 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 71.3 110.922 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -124.41 98.28 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 70.03 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 171' ' ' PRO . 64.3 mt -70.9 133.07 86.36 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.635 0.731 . . . . 71.2 111.148 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.9 Cg_endo -69.76 95.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.615 2.21 . . . . 74.5 112.344 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -62.49 171.17 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -153.14 113.46 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 75.41 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 p -152.1 170.63 19.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.22 111.109 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -80.33 -179.87 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.53 110.86 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -58.27 160.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 54.45 111.183 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.0 p -117.72 -55.06 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.126 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.26 -168.14 28.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 74.53 112.509 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.5 ' C ' HD12 ' A' ' 180' ' ' LEU . 8.9 t -119.66 165.46 14.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 64.3 111.093 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 179' ' ' THR . 4.4 mp -149.19 138.95 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 65.23 110.869 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.92 166.06 24.14 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.759 -0.734 . . . . 61.2 112.512 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -47.64 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.695 2.263 . . . . 70.13 112.354 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.6 73.42 12.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 52.51 111.1 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 130.46 19.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.658 2.239 . . . . 62.33 112.408 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.85 -36.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.31 111.1 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.5 p -132.35 48.89 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.34 110.813 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.7 p -127.41 83.06 2.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.25 111.133 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 151.34 36.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 72.31 110.931 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -33.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.53 111.145 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -53.17 156.23 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.04 110.863 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.814 HG12 ' HD3' ' A' ' 193' ' ' PRO . 21.7 t -124.05 102.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 61.54 111.152 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.85 73.51 2.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.551 0.691 . . . . 74.32 110.815 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 191' ' ' VAL . 54.3 Cg_endo -69.76 142.28 47.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.687 2.258 . . . . 71.31 112.334 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.3 152.75 34.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 75.31 110.862 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.23 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 167' ' ' VAL . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.21 110.923 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 52.41 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 199' ' ' GLY . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 63.44 110.894 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 198' ' ' LEU . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 61.44 112.446 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 34.32 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.44 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 73.54 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 18' ' ' VAL . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.4 111.116 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.34 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.03 77.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.32 110.936 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.28 -36.72 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.34 110.921 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.35 107.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 60.44 111.035 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -119.84 177.32 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 43.34 111.091 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.93 157.4 20.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 63.1 111.113 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -62.49 135.46 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.882 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 74.12 110.862 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.78 0.324 . . . . 73.13 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.09 89.22 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.34 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -114.25 178.06 4.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 72.12 110.915 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.08 78.28 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 73.02 110.841 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.65 160.48 68.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 65.51 110.966 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 97.45 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 70.11 112.314 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 133.59 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.11 111.111 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -143.85 136.25 26.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 70.34 110.9 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 t -119.17 142.27 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 60.44 110.935 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.92 -56.85 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 74.11 111.029 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.44 -154.36 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 53.03 112.495 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -119.99 102.89 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.345 . . . . 64.02 110.898 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.07 155.96 17.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 62.53 110.911 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.12 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 43.01 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.11 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HE1' HD12 ' A' ' 59' ' ' ILE . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.35 110.887 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.1 111.171 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 61.2 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 54.04 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.43 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.12 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 71.22 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.01 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.29 132.89 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 53.25 111.062 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -125.02 105.87 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 64.44 110.918 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 193' ' ' PRO . 19.0 m -133.44 -179.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.35 111.173 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.67 34.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 64.3 112.499 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.89 -40.35 96.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.14 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 63.29 47.97 3.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.31 110.889 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.75 -43.69 22.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 63.33 110.907 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.05 -169.52 34.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 74.53 112.452 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.33 90.29 4.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 74.12 110.91 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -48.32 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.873 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -86.28 146.06 26.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 65.43 110.945 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.23 147.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 72.13 111.153 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.05 116.75 7.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 71.34 112.541 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 108.2 0.86 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.744 -0.741 . . . . 45.32 112.541 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.72 172.54 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.705 -0.76 . . . . 64.5 112.503 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.76 -67.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 63.31 111.085 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 7.6 mt -111.49 91.05 13.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.632 0.73 . . . . 54.32 110.864 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 53.6 Cg_endo -69.84 102.6 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.678 2.252 . . . . 73.1 112.357 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -171.33 140.29 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 74.12 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.17 169.07 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 51.23 111.102 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.71 -48.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 74.42 110.878 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.99 127.72 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.02 111.131 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -151.01 104.4 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.1 110.875 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.97 122.46 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.45 111.101 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.38 -159.61 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.718 . . . . 42.52 112.544 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -129.39 56.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 75.35 110.834 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.96 30.58 7.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 63.24 110.915 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -86.19 131.44 34.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 65.41 111.145 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 45.1 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.53 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 73.41 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.22 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HE1' ' A' ' 17' ' ' TRP . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 54.52 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.787 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.23 111.12 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.22 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 64.13 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 60.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.04 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.22 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 106' ' ' GLN . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.44 111.058 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 55.14 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.41 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 73.41 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.04 110.89 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 60.42 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.79 -157.25 7.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.41 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -117.06 133.27 23.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 74.42 111.091 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.76 138.64 38.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.731 2.288 . . . . 73.0 112.294 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.81 -175.77 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 50.32 111.113 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -67.9 139.77 56.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 65.32 110.879 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.82 106.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 65.03 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.39 120.46 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.892 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -129.64 -42.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.21 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -111.71 142.15 44.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 64.5 110.917 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.72 109.07 2.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.22 112.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -95.83 128.54 42.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 61.12 110.935 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -115.2 73.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 61.52 110.903 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.5 t -80.44 174.07 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.897 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.49 -36.91 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.32 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 p -152.0 126.15 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 62.55 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 p -168.62 107.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 63.12 110.853 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.18 -65.54 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.43 110.921 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.2 137.87 1.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.21 112.478 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -122.54 75.93 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 64.54 110.867 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.96 124.94 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.44 111.151 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 t -160.31 150.59 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 57.17 51.08 10.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 60.44 110.887 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.62 -35.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.31 111.153 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -149.32 155.22 40.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 60.31 110.903 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -114.17 163.25 15.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 54.11 110.859 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 61.04 112.534 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 136.98 34.25 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.642 2.228 . . . . 60.14 112.321 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' HB1' ' HE2' ' A' ' 71' ' ' PHE . . . -175.08 160.87 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 63.13 111.071 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 148' ' ' ALA . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 63.53 111.136 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 71' ' ' PHE . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.52 110.945 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 22.13 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 70.14 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 67' ' ' ILE . 0.2 OUTLIER -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.922 179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -135.55 118.01 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.22 110.901 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.36 124.74 50.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 74.3 110.865 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.05 -35.87 59.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 75.41 110.901 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -103.14 -41.66 6.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 73.11 110.848 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 p 51.72 38.51 23.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.867 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -128.31 -179.96 5.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 74.04 110.84 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.97 69.73 2.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 63.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -166.99 150.26 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.33 110.923 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.437 HD22 ' CE1' ' A' ' 155' ' ' TYR . 3.0 pp -60.63 132.17 53.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 63.42 110.929 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -173.16 139.66 0.87 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.672 0.748 . . . . 74.32 110.964 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.13 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.12 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.25 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.44 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.14 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.23 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 71.31 111.122 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.41 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -157.44 141.37 16.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.42 110.899 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.65 134.1 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.54 111.093 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 127' ' ' LEU . 4.3 pp -130.99 144.68 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.02 110.949 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -112.33 -36.3 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.35 110.862 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -116.85 126.79 53.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 52.25 110.904 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -142.07 160.7 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 52.22 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 151.26 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.44 110.909 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 m -130.48 119.17 22.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 52.14 111.085 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 54.12 54.72 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 64.11 110.897 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.41 108.67 2.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 72.52 112.54 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.99 -55.61 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 74.24 111.065 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.15 -50.58 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.21 110.954 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 t -56.05 163.29 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 65.43 110.807 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.9 p -103.98 168.24 9.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 64.5 110.817 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.1 150.69 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.518 . . . . 75.52 110.939 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.87 152.66 19.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.83 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.84 117.86 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 64.02 111.094 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -146.09 141.46 27.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 71.5 110.917 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.63 172.08 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 75.05 110.862 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 146.24 4.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.01 110.885 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.49 ' CE2' HG21 ' A' ' 123' ' ' VAL . 0.9 OUTLIER 52.35 62.34 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.43 110.98 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -103.38 160.32 26.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.793 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.51 112.35 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 102' ' ' ILE . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 53.43 111.109 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.4 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 53.14 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 71.11 111.163 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.34 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.14 110.879 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.437 ' CE1' HD22 ' A' ' 115' ' ' LEU . 75.1 t80 -152.23 115.23 4.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.944 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -100.96 117.23 34.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 62.32 110.833 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 17.4 tp -94.96 38.55 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.53 110.882 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.68 34.86 44.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 60.14 112.479 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -121.06 173.29 7.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 50.42 110.883 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.5 m -57.57 -44.04 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 53.22 110.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -100.52 155.45 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.12 110.92 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 60.33 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 52.4 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.13 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.33 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.688 ' HB ' HD12 ' A' ' 196' ' ' LEU . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 71.5 111.101 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -145.3 132.3 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.11 110.836 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -107.47 122.74 47.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.54 110.934 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.435 HG23 ' HD2' ' A' ' 171' ' ' PRO . 56.9 mt -92.28 133.04 30.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 70.35 111.159 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.4 Cg_endo -69.75 -46.08 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.766 2.311 . . . . 72.31 112.354 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.4 t80 52.37 38.92 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.843 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 58.21 39.51 25.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 62.2 110.886 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.613 HG22 HG22 ' A' ' 176' ' ' VAL . 23.7 m -116.06 111.86 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 73.12 111.157 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -115.23 78.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 75.51 110.905 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 174' ' ' THR . 19.1 m -143.79 179.43 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.23 111.135 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 t -51.92 135.32 30.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 65.24 111.136 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.92 51.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 55.35 112.536 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.1 t -133.33 172.27 12.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 74.14 111.148 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.05 108.68 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 71.24 110.857 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.33 -75.17 0.3 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.723 . . . . 74.31 112.53 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.3 Cg_endo -69.75 -171.36 0.47 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.73 2.287 . . . . 64.45 112.333 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 182' ' ' PRO . 5.9 m 35.59 67.6 1.46 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.671 0.748 . . . . 50.51 111.162 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -171.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 73.42 112.346 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.36 93.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 73.32 111.088 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.7 m -148.84 -171.8 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 75.32 110.933 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.6 m -129.48 106.39 8.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 65.14 111.129 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 -176.23 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 71.34 110.905 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.2 tt -79.05 136.7 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.33 111.124 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -166.37 171.81 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 61.41 110.903 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.49 124.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.32 111.108 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -171.33 69.17 0.48 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.691 0.758 . . . . 52.14 110.908 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.605 ' HB3' HG12 ' A' ' 28' ' ' VAL . 54.6 Cg_endo -69.78 142.84 48.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 71.24 112.339 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.79 173.58 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.14 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 72.22 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.688 HD12 ' HB ' ' A' ' 167' ' ' VAL . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.913 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.507 ' C ' HD12 ' A' ' 198' ' ' LEU . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.891 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.31 110.947 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.44 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.12 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.53 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.02 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 18' ' ' VAL . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.05 111.126 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 67.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.44 110.899 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.41 -55.89 5.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.53 110.965 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.71 144.58 52.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 62.51 111.112 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -162.11 161.8 28.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 65.52 111.143 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.23 133.47 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 72.33 111.086 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.0 169.18 22.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 71.24 110.906 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 65.4 110.884 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.805 0.336 . . . . 60.24 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -142.81 120.28 11.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 65.42 110.855 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -91.03 138.6 31.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 71.34 110.887 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.27 -176.38 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 53.22 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -123.43 157.63 61.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 74.51 110.936 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 82.64 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.251 . . . . 73.41 112.324 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.26 161.56 28.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 63.24 111.162 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -103.17 108.83 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 75.33 110.892 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 76.7 p -110.73 67.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 65.51 110.839 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.76 126.94 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 54.33 111.079 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.24 178.97 43.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 63.21 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.5 92.08 3.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.873 0.368 . . . . 73.03 110.944 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -108.22 174.32 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 75.2 110.834 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 70.21 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.22 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.15 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.545 ' HE1' HG23 ' A' ' 59' ' ' ILE . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.24 110.893 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 60' ' ' ALA . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 55.01 111.178 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.22 111.136 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 200' ' ' ALA . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.44 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.03 110.818 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 61.05 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -81.57 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 70.32 111.173 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -129.26 104.13 7.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 60.22 110.885 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.668 HG12 ' CB ' ' A' ' 193' ' ' PRO . 19.1 m -136.23 -179.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.519 . . . . 63.44 111.136 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.04 33.3 0.34 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.792 -0.718 . . . . 63.52 112.455 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -93.43 -37.63 11.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 64.52 110.877 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' C ' ' HG ' ' A' ' 32' ' ' LEU . 16.5 pt-20 -75.0 -40.15 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.01 110.88 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 31' ' ' GLU . 1.5 pp 33.55 47.69 0.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.169 -0.469 . . . . 73.33 110.911 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.99 -163.22 22.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 54.34 112.514 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t0 59.29 53.44 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.786 0.327 . . . . 61.43 110.828 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.42 -52.23 4.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.34 110.935 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -131.36 86.62 2.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.21 110.859 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.67 106.9 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 65.51 111.092 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.98 -64.61 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 64.5 112.432 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.72 -49.31 79.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.733 . . . . 73.25 112.47 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.28 128.27 8.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 52.04 112.53 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.76 36.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 62.13 111.085 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD23 ' HD2' ' A' ' 43' ' ' PRO . 1.1 mt -83.91 159.61 59.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.721 . . . . 73.41 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' HD23 ' A' ' 42' ' ' LEU . 54.6 Cg_endo -69.75 121.53 8.22 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.705 2.27 . . . . 70.34 112.393 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -132.32 152.89 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 73.13 110.853 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.03 139.98 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 63.01 111.108 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.68 149.24 28.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 62.15 110.874 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 m -127.93 166.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.424 . . . . 72.12 111.134 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -123.31 156.08 36.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 71.52 110.867 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -140.41 135.35 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 73.32 111.147 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.91 -155.36 26.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 73.31 112.471 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -122.51 117.97 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 73.4 110.893 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.51 -37.98 22.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 75.02 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p -57.61 143.51 40.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 73.32 111.176 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.35 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.13 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.21 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.11 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.545 HG23 ' HE1' ' A' ' 17' ' ' TRP . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.42 111.157 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.975 ' HB3' HG13 ' A' ' 18' ' ' VAL . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 50.42 111.098 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.11 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.14 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.02 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.44 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 107' ' ' TYR . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.43 111.192 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.35 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 64.32 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.33 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 103' ' ' LEU . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.869 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.31 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.54 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.2 -157.09 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.2 112.459 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.79 85.37 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.649 0.738 . . . . 72.42 111.104 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 129.99 18.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 70.23 112.341 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.19 -176.91 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.45 111.122 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.5 134.67 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.31 110.877 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 165.24 32.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.436 . . . . 64.42 111.131 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -88.32 152.08 22.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 65.13 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -152.08 151.01 30.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 73.1 110.846 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -146.71 137.22 23.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 62.14 110.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.86 176.49 33.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 52.21 112.549 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.8 160.57 29.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 73.41 110.935 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -137.95 67.21 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.893 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 p -166.46 177.63 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 74.34 110.832 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.0 mt -82.68 97.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.22 111.116 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.73 -176.76 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.842 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.6 p -58.88 128.39 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 74.05 110.821 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -89.37 107.07 18.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 72.53 110.901 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.3 116.72 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 54.32 112.502 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.31 -171.49 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 72.25 110.895 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 p -154.67 134.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 62.33 111.141 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.8 p -101.11 165.54 11.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.862 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.34 -171.94 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 71.14 110.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.03 104.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 52.14 111.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -176.44 173.39 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.22 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -63.2 149.44 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.35 110.885 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.98 -69.74 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.68 -0.772 . . . . 70.3 112.48 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 -170.36 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 64.44 112.369 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.06 143.96 33.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 70.04 111.044 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.44 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 71' ' ' PHE . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.93 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.12 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.735 HD13 ' CE1' ' A' ' 107' ' ' TYR . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 63.52 110.946 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.55 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.735 ' CE1' HD13 ' A' ' 105' ' ' LEU . 5.1 m-85 -123.5 97.37 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.02 110.888 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.65 167.24 19.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 63.3 110.846 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -77.4 61.08 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.92 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.38 -35.22 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 72.01 110.863 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 p -51.02 -35.43 34.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.2 110.753 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -82.56 -38.73 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 71.34 110.92 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 57.9 59.72 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 63.43 110.848 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.75 -176.01 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 71.02 110.907 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.674 HD23 ' CD2' ' A' ' 155' ' ' TYR . 6.4 mp -59.1 109.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 55.3 110.91 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -161.23 160.38 24.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.72 0.771 . . . . 75.15 110.929 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 71.52 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.11 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 151' ' ' VAL . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.04 111.158 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' CD2' ' A' ' 149' ' ' PHE . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 74.13 111.088 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.33 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 147' ' ' PRO . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.22 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.04 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.26 -177.02 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 63.43 110.852 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.65 126.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 72.45 111.059 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' H ' HD23 ' A' ' 127' ' ' LEU . 2.2 pt? -139.39 150.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 73.41 110.982 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.15 163.47 38.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 72.12 110.804 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.3 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 64.04 110.888 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.04 -40.68 94.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 62.53 110.863 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -164.05 142.6 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 42.43 110.923 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.2 p -110.36 -43.81 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 71.11 111.171 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -121.1 161.29 22.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.23 110.873 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.67 147.43 45.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.738 . . . . 73.32 112.439 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.11 159.03 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 64.5 111.122 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.64 -41.96 83.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 45.44 110.863 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.6 t -76.54 155.0 34.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 63.42 110.83 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.6 m -134.03 154.63 51.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.874 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -146.64 115.13 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 75.03 110.858 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -132.32 102.62 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.01 110.882 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.8 pt -139.88 157.52 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 72.53 111.13 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.0 ptpt -143.04 144.88 32.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 63.22 110.892 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -118.85 172.83 7.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.15 110.854 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -102.52 159.78 15.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.937 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -84.43 151.16 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 73.0 110.927 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -123.24 160.0 52.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 42.3 111.077 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PRO . . . . . 0.752 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.1 112.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 54.32 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 121' ' ' VAL . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.53 110.844 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.44 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 119' ' ' VAL . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.2 111.162 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.484 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 61.34 110.931 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 51.5 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.674 ' CD2' HD23 ' A' ' 115' ' ' LEU . 11.7 m-85 -127.33 178.68 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.53 110.904 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -106.67 152.01 24.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.487 . . . . 72.15 110.86 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -125.94 -37.37 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.01 110.901 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.86 4.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.671 -0.776 . . . . 63.21 112.433 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -100.62 -38.04 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 72.35 110.878 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -100.59 -56.33 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 74.42 110.815 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -77.39 -179.88 6.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.168 -0.469 . . . . 73.34 110.866 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.3 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 157' ' ' LEU . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.1 110.888 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 52.42 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.54 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.13 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -136.15 118.77 15.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.44 110.922 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -120.84 116.47 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 73.44 110.938 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 171' ' ' PRO . 5.2 mp -103.8 133.09 20.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.621 0.724 . . . . 60.22 111.143 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.8 Cg_endo -69.77 138.93 38.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.236 . . . . 64.31 112.349 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -137.6 175.16 9.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.918 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -61.08 109.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 72.21 110.901 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 m -87.53 129.65 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 73.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -101.64 121.16 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.15 110.913 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.54 112.6 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.53 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 37.6 p -78.19 137.46 38.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 71.32 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.68 48.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 70.44 112.469 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 27.1 m -72.48 99.37 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 62.12 111.163 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.8 pp -98.85 135.37 40.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 63.1 110.989 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.58 -73.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 74.45 112.412 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.7 51.75 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 65.04 112.348 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 183' ' ' VAL . 4.0 p -138.75 78.01 31.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.585 0.707 . . . . 74.14 111.11 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -44.97 1.72 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.663 2.242 . . . . 72.51 112.362 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.49 145.98 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 75.34 111.188 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.3 t -63.23 133.69 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 54.01 110.84 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 4.5 t -99.65 149.37 23.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 64.24 111.125 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -67.97 177.64 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 70.45 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.3 pt -144.16 168.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.14 111.114 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.66 151.49 46.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 70.11 110.918 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 193' ' ' PRO . 27.2 m -122.14 -35.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.12 111.131 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.41 73.36 0.5 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.636 0.732 . . . . 72.44 110.862 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . 0.668 ' CB ' HG12 ' A' ' 28' ' ' VAL . 54.3 Cg_endo -69.68 141.39 45.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.651 2.234 . . . . 72.12 112.387 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.43 172.4 16.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 74.45 110.86 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.45 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 196' ' ' LEU . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.94 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.04 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 65.31 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 24.12 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 62.51 111.128 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 61.33 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.12 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.53 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.62 101.16 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 72.55 110.88 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.1 -49.35 77.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.5 110.943 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 62.78 45.17 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 55.04 111.107 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.79 155.38 45.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 71.41 111.101 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.52 108.87 8.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 64.42 111.062 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 210' ' ' LEU . 1.7 pt? -52.38 164.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 74.21 110.957 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.54 110.891 179.898 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.757 0.313 . . . . 70.109999999999999 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' ' 63' ' ' VAL . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 110.964 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.019999999999996 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.513 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.540000000000006 110.889 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 203' ' ' VAL . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.127 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 52.25 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 52.119999999999997 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.209999999999994 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 64.450000000000003 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 42.200000000000003 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 195' ' ' ILE . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 60.200000000000003 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 26' ' ' VAL . 6.9 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 111.147 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.863 0.363 . . . . 73.530000000000001 111.102 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 111.161 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 55.439999999999998 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' THR . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 111.132 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.239999999999995 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' HE1' ' A' ' 17' ' ' TRP . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 54.100000000000001 111.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 42.509999999999998 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.129999999999995 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.230000000000004 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 14' ' ' GLN . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.349999999999994 111.143 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 71.329999999999998 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 67' ' ' ILE . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 73.319999999999993 110.865 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 105' ' ' LEU . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.109 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.340000000000003 111.091 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.400000000000006 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.877 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.771 0.319 . . . . 61.109999999999999 111.113 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.506 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.125 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.549999999999997 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.439999999999998 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 67' ' ' ILE . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 110.904 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.685 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.973 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 110.938 -179.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.699 0.761 . . . . 74.400000000000006 110.916 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' HD13 ' A' ' 153' ' ' LEU . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 45.32 112.335 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.439999999999998 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 64.209999999999994 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 149' ' ' PHE . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.049999999999997 111.113 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.310000000000002 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 147' ' ' PRO . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 61.149999999999999 111.161 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.530000000000001 112.462 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 72.510000000000005 110.857 -179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.521 0.676 . . . . 74.040000000000006 111.148 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.758 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 73.340000000000003 112.315 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.400000000000006 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 121' ' ' VAL . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.94 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.530000000000001 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.605 ' O ' HD22 ' A' ' 153' ' ' LEU . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 52.030000000000001 112.479 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 117' ' ' PRO . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 71.319999999999993 110.912 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 60.549999999999997 110.932 -179.857 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.811 0.338 . . . . 74.109999999999999 110.915 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 110.847 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 51.140000000000001 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.891 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.88 0.371 . . . . 75.409999999999997 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 25' ' ' LYS . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.439999999999998 111.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 70.409999999999997 110.958 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.219999999999999 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.420000000000002 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 62.130000000000003 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 42.229999999999997 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 18' ' ' VAL . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.439999999999998 110.925 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.209999999999994 111.109 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.439999999999998 110.889 179.999 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.77 0.319 . . . . 51.130000000000003 110.933 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 71.329999999999998 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.540000000000006 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 74.400000000000006 111.084 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.095 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.109999999999999 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 19' ' ' ALA . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 110.877 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.019999999999996 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 50.329999999999998 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 111.133 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.874 0.369 . . . . 72.150000000000006 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 61.530000000000001 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 61.039999999999999 110.921 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.109999999999999 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.893 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 55.219999999999999 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 71.219999999999999 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.14 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.420000000000002 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.319999999999993 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.400000000000006 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 63.229999999999997 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.665 ' HB2' HD12 ' A' ' 67' ' ' ILE . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.319999999999993 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 111.198 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 55.130000000000003 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.109999999999999 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.439999999999998 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.129999999999995 110.925 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 64.5 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.209999999999994 112.448 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.752 0.311 . . . . 64.400000000000006 111.139 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.686 HG23 ' HA2' ' A' ' 124' ' ' GLY . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.439999999999998 111.119 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 50.140000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.140000000000001 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.319999999999993 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.904 -179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.656 0.741 . . . . 64.400000000000006 110.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.010000000000005 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.150000000000006 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.010000000000005 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.040000000000006 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.430000000000007 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.439999999999998 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 102' ' ' ILE . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.439999999999998 112.451 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.903 -179.867 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.638 0.732 . . . . 42.020000000000003 111.069 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 64.329999999999998 112.356 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 63.240000000000002 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 167' ' ' VAL . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 34.299999999999997 111.177 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.120000000000005 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.310000000000002 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.520000000000003 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 64.340000000000003 110.903 -179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.744 0.306 . . . . 74.439999999999998 110.943 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 73.129999999999995 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.140000000000001 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.409999999999997 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 61.549999999999997 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.856 HG12 HD13 ' A' ' 196' ' ' LEU . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.111 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.907 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.776 0.322 . . . . 71.129999999999995 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.414 ' C ' HD22 ' A' ' 196' ' ' LEU . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.856 HD13 HG12 ' A' ' 167' ' ' VAL . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.942 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.771 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 54.030000000000001 110.938 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.540000000000006 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.120000000000005 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 31.34 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.010000000000005 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.120000000000005 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.420000000000002 110.91 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.77 0.319 . . . . 71.510000000000005 110.89 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.149999999999999 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.040000000000006 112.504 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.319999999999993 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.535 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.875 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 203' ' ' VAL . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 111.105 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.420000000000002 111.13 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.420000000000002 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 53.240000000000002 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.030000000000001 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 64.049999999999997 111.173 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 71.019999999999996 111.116 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 52.119999999999997 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.329999999999998 110.938 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' A' ' 17' ' ' TRP . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 53.119999999999997 111.13 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 65.319999999999993 111.116 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 70.530000000000001 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 15' ' ' GLY . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 72.329999999999998 111.105 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.030000000000001 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.299999999999997 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 67' ' ' ILE . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 63.329999999999998 110.884 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 111.105 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 105' ' ' LEU . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.239999999999995 111.119 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.040000000000006 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.887 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 74.540000000000006 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.420000000000002 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 64.129999999999995 112.509 -179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.793 0.33 . . . . 70.310000000000002 111.076 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 64.010000000000005 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 73.310000000000002 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 69' ' ' VAL . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 53.539999999999999 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.886 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 110.935 -179.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.676 0.75 . . . . 72.349999999999994 110.988 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 45.420000000000002 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.967 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 54.229999999999997 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.519999999999996 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 55.130000000000003 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 23.120000000000001 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 147' ' ' PRO . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.129999999999995 111.163 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.010000000000005 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 110.879 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.614 0.721 . . . . 74.129999999999995 111.026 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.329999999999998 112.343 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.010000000000005 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 70.230000000000004 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.239999999999995 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 55.549999999999997 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 53.310000000000002 112.471 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.129999999999995 110.865 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 65.200000000000003 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.140000000000001 110.947 -179.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.776 0.322 . . . . 73.239999999999995 110.94 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.519999999999996 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 32.5 110.866 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 31.399999999999999 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 61.450000000000003 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.515 HG22 ' CD2' ' A' ' 196' ' ' LEU . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.019999999999996 111.147 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.878 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.787 0.327 . . . . 62.25 110.854 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.929 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 60.32 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 54.119999999999997 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.340000000000003 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.450000000000003 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.310000000000002 110.955 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 18' ' ' VAL . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 65.540000000000006 111.084 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.540000000000006 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.549999999999997 110.94 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.751 0.31 . . . . 72.439999999999998 110.868 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.129999999999995 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.210000000000001 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.239999999999995 110.892 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 55.240000000000002 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.329999999999998 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.349999999999994 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 61.439999999999998 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.010000000000005 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.349999999999994 111.123 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.903 0.383 . . . . 74.040000000000006 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.150000000000006 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.549999999999997 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HE2' ' A' ' 72' ' ' PHE . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 64.200000000000003 111.142 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 63.100000000000001 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 65.530000000000001 110.935 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 58' ' ' ASP . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 111.154 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 51.039999999999999 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.040000000000006 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.219999999999999 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 52.450000000000003 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 54.0 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 72.0 111.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 44.340000000000003 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 63.149999999999999 110.878 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 56' ' ' THR . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.875 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.049999999999997 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.349999999999994 112.559 179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.668 0.271 . . . . 44.439999999999998 111.113 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.209999999999994 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 55.329999999999998 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 67' ' ' ILE . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.519999999999996 110.932 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.914 -179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.585 0.707 . . . . 72.340000000000003 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.120000000000005 112.372 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 61.43 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 51.240000000000002 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 63.219999999999999 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.439999999999998 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 64.109999999999999 111.138 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 53.009999999999998 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 60.240000000000002 110.864 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.55 0.691 . . . . 73.299999999999997 111.146 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.751 ' HA ' HG12 ' A' ' 123' ' ' VAL . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 44.409999999999997 112.378 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.310000000000002 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.329999999999998 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 167' ' ' VAL . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.510000000000005 111.07 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.229999999999997 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 153' ' ' LEU . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.129999999999995 110.946 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.99 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.791 0.329 . . . . 74.329999999999998 110.913 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.239999999999995 110.901 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.475 ' N ' HD13 ' A' ' 163' ' ' LEU . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.030000000000001 110.91 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 61.340000000000003 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.319999999999993 111.177 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 110.87 -179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.837 0.351 . . . . 63.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 63.420000000000002 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.349999999999994 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.140000000000001 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.439999999999998 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 52.140000000000001 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.030000000000001 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.927 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.779 0.323 . . . . 63.539999999999999 110.918 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.200000000000003 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.420000000000002 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.936 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.319999999999993 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 64.519999999999996 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.239999999999995 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 43.420000000000002 111.114 179.877 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.849 0.357 . . . . 45.32 111.181 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 51.109999999999999 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.416 ' O ' HG23 ' A' ' 59' ' ' ILE . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 111.103 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 73.510000000000005 111.113 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.210000000000001 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.519999999999996 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.510000000000005 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.149999999999999 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.25 110.831 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.239999999999995 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.430000000000007 112.459 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.767 0.318 . . . . 71.319999999999993 111.09 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.536 HD12 ' HA3' ' A' ' 124' ' ' GLY . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 111.102 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 53.039999999999999 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.444 HD12 ' H ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.219999999999999 110.961 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 50.009999999999998 110.929 -179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.671 0.748 . . . . 73.319999999999993 110.866 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 151' ' ' VAL . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 40.009999999999998 111.111 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.329999999999998 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.299999999999997 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 34.229999999999997 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 54.030000000000001 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 62.43 112.522 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.409999999999997 110.941 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 121.579 0.705 . . . . 63.219999999999999 111.134 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.200000000000003 112.369 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.099999999999994 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 119' ' ' VAL . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 65.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.239999999999995 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 74.019999999999996 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 63.509999999999998 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.2 t80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.896 -179.872 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.725 0.298 . . . . 61.310000000000002 110.975 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.349999999999994 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 196' ' ' LEU . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.430000000000007 111.071 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.876 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.736 0.303 . . . . 73.25 110.92 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.099999999999994 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.711 ' CD1' HG22 ' A' ' 167' ' ' VAL . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 60.149999999999999 110.948 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.45 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.530000000000001 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 197' ' ' SER . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.941 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.229999999999997 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 61.530000000000001 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.140000000000001 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 18' ' ' VAL . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.961 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 41.539999999999999 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 53.32 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.878 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.78 0.324 . . . . 73.129999999999995 110.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 24.440000000000001 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.409999999999997 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 202' ' ' TYR . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 55.130000000000003 111.157 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 42.109999999999999 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.019999999999996 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.219999999999999 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 54.340000000000003 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.420000000000002 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 64.200000000000003 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.150000000000006 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 195' ' ' ILE . 33.1 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 63.210000000000001 111.102 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.857 0.361 . . . . 71.439999999999998 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.230000000000004 110.943 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.240000000000002 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.049999999999997 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 65.230000000000004 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 53.130000000000003 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 62.229999999999997 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 73.530000000000001 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 71.439999999999998 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 63.009999999999998 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.030000000000001 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 107' ' ' TYR . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 70.230000000000004 111.094 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 52.020000000000003 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.534 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.876 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.099999999999994 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 63.439999999999998 112.409 179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.803 0.335 . . . . 74.519999999999996 111.121 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.219999999999999 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 103' ' ' LEU . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.420000000000002 110.966 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 63.020000000000003 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 72.209999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 62.340000000000003 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.645 ' HE2' HG23 ' A' ' 67' ' ' ILE . 3.5 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.932 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.676 0.75 . . . . 75.319999999999993 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.340000000000003 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 70.010000000000005 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 151' ' ' VAL . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.520000000000003 111.137 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 65.129999999999995 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 64.200000000000003 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.400000000000006 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.340000000000003 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 70.230000000000004 110.861 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 121.56 0.695 . . . . 71.510000000000005 111.155 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 64.25 112.351 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.120000000000005 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.109999999999999 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.209999999999994 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 119' ' ' VAL . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 44.210000000000001 111.082 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.240000000000002 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 ' OH ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 61.210000000000001 110.861 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 70.310000000000002 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.471 ' OH ' HD22 ' A' ' 153' ' ' LEU . 15.6 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.099999999999994 110.924 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.715 0.293 . . . . 74.200000000000003 110.958 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.494 HD23 ' N ' ' A' ' 164' ' ' ASN . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 61.219999999999999 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.494 ' N ' HD23 ' A' ' 163' ' ' LEU . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.120000000000005 110.893 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.219999999999999 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.633 ' O ' HD12 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.855 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 196' ' ' LEU . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 70.329999999999998 111.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.863 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.779 0.323 . . . . 75.310000000000002 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 26' ' ' VAL . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 111.157 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 166' ' ' ASP . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 71.349999999999994 110.88 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.219999999999999 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.119999999999997 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 60.350000000000001 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.129999999999995 110.917 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.420000000000002 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 71.340000000000003 110.897 179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 . . . . . 0 CA--C 1.526 0.045 0 CA-C-O 120.746 0.308 . . . . 71.019999999999996 110.927 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HB2' HG13 ' A' ' 63' ' ' VAL . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 110.903 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.109999999999999 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 73.540000000000006 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.040000000000006 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 203' ' ' VAL . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.329999999999998 111.153 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 42.310000000000002 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.400000000000006 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.119999999999997 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 60.100000000000001 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.230000000000004 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 70.510000000000005 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.310000000000002 111.105 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.931 0.396 . . . . 74.239999999999995 111.092 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 55.130000000000003 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.239999999999995 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.439999999999998 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.219999999999999 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.454 HD13 ' OH ' ' A' ' 61' ' ' TYR . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.141 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.120000000000005 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 59' ' ' ILE . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 110.887 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 14' ' ' GLN . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 54.520000000000003 111.155 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.219999999999999 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.239999999999995 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 105' ' ' LEU . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 111.163 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.405 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 65.200000000000003 111.095 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.686 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 73.019999999999996 110.818 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.140000000000001 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 53.240000000000002 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.530000000000001 112.499 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.757 0.313 . . . . 73.519999999999996 111.115 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 70.239999999999995 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 70.319999999999993 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.409999999999997 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 67' ' ' ILE . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 70.019999999999996 110.908 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 119' ' ' VAL . 14.0 p90 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.019999999999996 110.948 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.039 0 CA-C-O 121.671 0.748 . . . . 73.549999999999997 110.897 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 71.409999999999997 112.337 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 107' ' ' TYR . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.329999999999998 111.18 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.200000000000003 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.439999999999998 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.109999999999999 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 147' ' ' PRO . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.329999999999998 111.068 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 62.310000000000002 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.340000000000003 110.819 -179.827 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.564 0.697 . . . . 73.349999999999994 111.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 123' ' ' VAL . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.319999999999993 112.276 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 72.120000000000005 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 63.149999999999999 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 64.030000000000001 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 155' ' ' TYR . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 64.349999999999994 110.914 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.230000000000004 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.535 ' CD1' HD21 ' A' ' 153' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.932 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.725 0.298 . . . . 74.120000000000005 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 164' ' ' ASN . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 52.439999999999998 110.941 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 163' ' ' LEU . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 62.049999999999997 110.914 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.439999999999998 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.310000000000002 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 110.846 -179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 70.420000000000002 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 70.099999999999994 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.349999999999994 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 163' ' ' LEU . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 61.450000000000003 110.888 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.409999999999997 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 40.43 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 71.140000000000001 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.140000000000001 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 18' ' ' VAL . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 111.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.239999999999995 110.911 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.775 0.321 . . . . 75.349999999999994 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.299999999999997 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 203' ' ' VAL . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 71.030000000000001 111.096 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HB1' ' HZ ' ' A' ' 57' ' ' PHE . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 51.439999999999998 111.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.219999999999999 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 56' ' ' THR . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.209999999999994 110.874 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.230000000000004 111.107 179.899 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.852 0.358 . . . . 61.420000000000002 111.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.400000000000006 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 64.030000000000001 110.916 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' ASN . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.147 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.200000000000003 110.87 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.092 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 63.329999999999998 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 63.329999999999998 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 63.539999999999999 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.120000000000005 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 67' ' ' ILE . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.863 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.593 HG22 ' OD1' ' A' ' 66' ' ' ASN . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.149 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 42.109999999999999 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.409999999999997 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 72.129999999999995 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.530000000000001 112.52 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.749 0.309 . . . . 73.239999999999995 111.155 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.450000000000003 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.340000000000003 110.894 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 110.876 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.704 0.764 . . . . 72.319999999999993 110.954 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.510000000000005 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.520000000000003 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.210000000000001 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.519999999999996 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 53.439999999999998 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 65.140000000000001 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.120000000000005 111.171 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.239999999999995 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 71.299999999999997 110.923 -179.849 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.066 0 CA-C-O 121.573 0.702 . . . . 63.310000000000002 111.094 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.540000000000006 112.314 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.450000000000003 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 167' ' ' VAL . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 111.201 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.603 ' C ' HD13 ' A' ' 153' ' ' LEU . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 35.210000000000001 112.451 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.319999999999993 110.894 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 153' ' ' LEU . 1.1 p90 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.947 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.82 0.343 . . . . 74.019999999999996 110.88 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.455 HD23 ' HE1' ' A' ' 155' ' ' TYR . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.918 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.230000000000004 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 50.109999999999999 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 60.5 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 196' ' ' LEU . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.430000000000007 111.136 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.896 -179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.88 0.371 . . . . 65.340000000000003 110.894 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 73.120000000000005 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.571 HD22 HG23 ' A' ' 167' ' ' VAL . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 70.519999999999996 110.957 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 53.539999999999999 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 199' ' ' GLY . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 198' ' ' LEU . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 62.100000000000001 112.443 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 71.129999999999995 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 61.43 110.841 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 18' ' ' VAL . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 111.115 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.876 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.761 0.315 . . . . 73.099999999999994 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.319999999999993 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 202' ' ' TYR . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.219999999999999 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.099999999999994 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.140000000000001 111.147 179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.861 0.363 . . . . 74.549999999999997 111.141 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 55.049999999999997 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 72.340000000000003 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.530000000000001 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.119999999999997 111.083 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.420000000000002 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.349999999999994 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 55.439999999999998 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.099999999999994 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.424 HG22 HD23 ' A' ' 105' ' ' LEU . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.200000000000003 111.111 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.151 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.119999999999997 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.230000000000004 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.340000000000003 112.523 179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.756 0.313 . . . . 63.020000000000003 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.489 HG22 ' CA ' ' A' ' 124' ' ' GLY . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 35.32 111.152 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.130000000000003 110.886 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 67' ' ' ILE . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.319999999999993 110.883 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 70.140000000000001 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 110.989 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.655 0.741 . . . . 70.040000000000006 110.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.109999999999999 112.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.420000000000002 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 149' ' ' PHE . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.340000000000003 111.106 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 104' ' ' SER . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.430000000000007 112.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.340000000000003 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 102' ' ' ILE . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.150000000000006 110.885 -179.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.101 0 CA-C-O 121.622 0.725 . . . . 73.340000000000003 111.158 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 63.109999999999999 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB3' HG23 ' A' ' 121' ' ' VAL . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.439999999999998 110.904 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 167' ' ' VAL . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 63.399999999999999 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 64.140000000000001 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 110.857 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.662 ' CZ ' HD12 ' A' ' 163' ' ' LEU . 14.5 p90 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.299999999999997 110.93 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 . . . . . 0 C--O 1.23 0.049 0 CA-C-O 120.859 0.361 . . . . 74.349999999999994 110.854 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 65.209999999999994 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.662 HD12 ' CZ ' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 163' ' ' LEU . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.915 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.130000000000003 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 196' ' ' LEU . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 62.420000000000002 111.133 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.868 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 42.109999999999999 110.861 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.42 HG21 ' NH1' ' A' ' 168' ' ' ARG . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 65.120000000000005 111.156 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 167' ' ' VAL . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 70.450000000000003 110.951 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.209999999999994 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.319999999999993 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 54.509999999999998 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.924 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 18' ' ' VAL . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 111.08 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.530000000000001 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 110.88 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.752 0.311 . . . . 52.030000000000001 110.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 71.450000000000003 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 14.140000000000001 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 73.329999999999998 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.496 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.711 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.329999999999998 111.128 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 53.149999999999999 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.129999999999995 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.209999999999994 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 61.020000000000003 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 62.149999999999999 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 61.530000000000001 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 53.329999999999998 111.128 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.84 0.352 . . . . 71.140000000000001 111.117 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.438 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 111.219 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.430000000000007 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' A' ' 17' ' ' TRP . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.310000000000002 111.137 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.100000000000001 111.075 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.887 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.762 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 70.140000000000001 110.862 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.510000000000005 111.147 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.43 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 63.020000000000003 111.082 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 105' ' ' LEU . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.409999999999997 111.137 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.73 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 110.857 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE1' HG22 ' A' ' 56' ' ' THR . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.349999999999994 110.858 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 61.039999999999999 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.130000000000003 112.528 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.809 0.338 . . . . 62.219999999999999 111.12 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.400000000000006 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 110.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 73.230000000000004 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.310000000000002 110.894 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 121.665 0.745 . . . . 73.209999999999994 110.952 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.439999999999998 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.519999999999996 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.099999999999994 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 44.109999999999999 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.010000000000005 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 33.530000000000001 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.893 -179.868 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 121.573 0.702 . . . . 45.229999999999997 111.086 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 72.120000000000005 112.324 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.109999999999999 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 63.140000000000001 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.200000000000003 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 167' ' ' VAL . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 63.509999999999998 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.200000000000003 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.530000000000001 110.877 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 18' ' ' VAL . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.873 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 153' ' ' LEU . 1.2 m-85 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.540000000000006 110.959 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 74.230000000000004 110.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 71.120000000000005 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.87 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.587 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 64.219999999999999 110.909 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.210000000000001 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.329999999999998 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 151' ' ' VAL . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.126 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.0 110.924 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.906 0.384 . . . . 71.430000000000007 110.812 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 61.420000000000002 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 61.439999999999998 110.885 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.129999999999995 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 64.099999999999994 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 18' ' ' VAL . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 65.340000000000003 111.135 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.946 179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 CA--C 1.526 0.056 0 CA-C-O 120.809 0.338 . . . . 64.510000000000005 110.828 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.609 ' HB2' HG13 ' A' ' 63' ' ' VAL . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.239999999999995 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.340000000000003 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 202' ' ' TYR . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.040000000000006 111.113 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 71.129999999999995 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 63.140000000000001 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.540000000000006 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HE1' HD12 ' A' ' 55' ' ' LEU . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 56' ' ' THR . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.319999999999993 110.801 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 64.329999999999998 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 72.099999999999994 111.087 179.882 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.858 0.361 . . . . 54.420000000000002 111.14 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.340000000000003 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' HE1' ' A' ' 23' ' ' PHE . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 63.340000000000003 110.892 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' OG ' ' A' ' 24' ' ' SER . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 65.420000000000002 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 61' ' ' TYR . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 63.109999999999999 111.163 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 60.43 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 59' ' ' ILE . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.310000000000002 110.866 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 62.009999999999998 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 14' ' ' GLN . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 111.078 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 105' ' ' LEU . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 63.520000000000003 111.093 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.420000000000002 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 111.123 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.932 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 62.310000000000002 112.448 179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 111.117 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.565 HD12 ' HA3' ' A' ' 124' ' ' GLY . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 111.177 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 52.340000000000003 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 67' ' ' ILE . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 64.010000000000005 110.911 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.439999999999998 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.933 -179.843 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.717 0.77 . . . . 72.219999999999999 110.894 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.349999999999994 112.327 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.815 HG22 HG13 ' A' ' 151' ' ' VAL . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.0 111.217 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.119999999999997 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 149' ' ' PHE . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.510000000000005 111.177 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 34.409999999999997 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.340000000000003 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.340000000000003 112.476 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.239999999999995 110.859 -179.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.628 0.727 . . . . 72.420000000000002 111.107 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 51.119999999999997 112.291 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 121' ' ' VAL . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 110.893 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.209999999999994 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 119' ' ' VAL . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.509999999999998 111.154 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 61.240000000000002 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 63.32 110.936 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.727 0.298 . . . . 75.519999999999996 110.957 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.400000000000006 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.219999999999999 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.230000000000004 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.082 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 71.349999999999994 110.904 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 74.5 110.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.109999999999999 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 41.43 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.219999999999999 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 198' ' ' LEU . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 110.975 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.420000000000002 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.219999999999999 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.150000000000006 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.349999999999994 110.925 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 64.530000000000001 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.219999999999999 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.239999999999995 110.944 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.763 0.316 . . . . 70.049999999999997 110.907 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.310000000000002 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.299999999999997 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.553 ' CZ2' HD11 ' A' ' 59' ' ' ILE . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.420000000000002 110.934 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.078 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 32.509999999999998 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.049999999999997 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.210000000000001 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 74.230000000000004 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.109999999999999 111.093 179.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.457 -0.109 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 111.183 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.893 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 70.200000000000003 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 71' ' ' PHE . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 72.310000000000002 111.154 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.019999999999996 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 41.020000000000003 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 32.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.530000000000001 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.576 HG23 ' CE2' ' A' ' 107' ' ' TYR . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 60.5 111.204 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.219999999999999 111.099 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.616 ' HA ' HD23 ' A' ' 105' ' ' LEU . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.066 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' HG23 ' A' ' 59' ' ' ILE . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.875 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.030000000000001 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 33.020000000000003 112.464 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 54.530000000000001 111.074 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.739 HG23 ' CA ' ' A' ' 124' ' ' GLY . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.152 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 51.100000000000001 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 69' ' ' VAL . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 110.907 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.694 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 44.32 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 67' ' ' ILE . 12.9 m-85 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.924 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.727 0.775 . . . . 72.530000000000001 110.845 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 71.420000000000002 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 51.130000000000003 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 149' ' ' PHE . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 62.200000000000003 111.087 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.149999999999999 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 51.240000000000002 111.104 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.739 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 64.109999999999999 112.44 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 . . . . . 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 62.539999999999999 110.873 -179.854 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.639 0.733 . . . . 53.310000000000002 111.099 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HB2' HG23 ' A' ' 121' ' ' VAL . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.150000000000006 110.881 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.319999999999993 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.509 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 70.349999999999994 110.84 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.949 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.741 0.305 . . . . 74.019999999999996 110.934 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . 0.404 ' O ' ' HB1' ' A' ' 200' ' ' ALA . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 62.310000000000002 110.879 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 64.25 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.299999999999997 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 64.200000000000003 110.861 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.811 0.338 . . . . 72.120000000000005 110.882 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 196' ' ' LEU . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.310000000000002 111.082 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 195' ' ' ILE . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.130000000000003 110.929 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.349999999999994 110.823 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 197' ' ' SER . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.420000000000002 110.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 54.119999999999997 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 162' ' ' MET . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.549999999999997 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.593 HG13 HG22 ' A' ' 18' ' ' VAL . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.510000000000005 111.191 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 70.219999999999999 110.943 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.757 0.313 . . . . 73.25 110.891 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' HG23 ' A' ' 63' ' ' VAL . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.947 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.420000000000002 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.020000000000003 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 53.299999999999997 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 203' ' ' VAL . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.144 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.350000000000001 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 61.25 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 61.350000000000001 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.310000000000002 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.091 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.93 0.395 . . . . 63.329999999999998 111.16 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 41.020000000000003 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.540000000000006 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.329999999999998 111.165 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.474 HG13 ' OG ' ' A' ' 64' ' ' SER . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.129999999999995 111.129 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 54.130000000000003 110.806 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.430000000000007 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.718 ' OD1' HD12 ' A' ' 67' ' ' ILE . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.349999999999994 110.866 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.718 HD12 ' OD1' ' A' ' 66' ' ' ASN . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 111.138 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.083 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.030000000000001 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.219999999999999 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.527 179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.803 0.335 . . . . 54.130000000000003 111.05 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 62.140000000000001 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 67' ' ' ILE . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.030000000000001 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.887 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 13.0 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 70.349999999999994 110.892 -179.837 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 121.702 0.763 . . . . 70.430000000000007 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.349999999999994 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 151' ' ' VAL . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.230000000000004 111.044 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.319999999999993 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.530000000000001 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.129999999999995 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 52.210000000000001 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.329999999999998 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.299999999999997 110.866 -179.801 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 111.071 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 112.388 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 54.240000000000002 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 55.130000000000003 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 167' ' ' VAL . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.186 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.509999999999998 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 72.0 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.299999999999997 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.239999999999995 110.94 -179.833 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.787 0.327 . . . . 72.010000000000005 110.915 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.200000000000003 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.230000000000004 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.427 ' HB3' HD13 ' A' ' 198' ' ' LEU . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.849 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 61.420000000000002 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 111.079 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.25 110.911 -179.962 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 196' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.875 0.369 . . . . 64.109999999999999 110.881 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 43.409999999999997 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.463 HD21 ' CE2' ' A' ' 194' ' ' PHE . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.420000000000002 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.530000000000001 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 199' ' ' GLY . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.329999999999998 110.937 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.486 ' H ' HD12 ' A' ' 198' ' ' LEU . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.140000000000001 112.51 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.230000000000004 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 18' ' ' VAL . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.099999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.140000000000001 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.905 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.795 0.331 . . . . 70.140000000000001 110.885 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 53.130000000000003 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.310000000000002 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.129999999999995 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.200000000000003 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.299999999999997 111.152 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 44.240000000000002 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 63.100000000000001 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 71.099999999999994 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' O ' HD23 ' A' ' 198' ' ' LEU . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.79 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.200000000000003 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 64.129999999999995 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 63.030000000000001 111.096 179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.826 0.346 . . . . 70.010000000000005 111.166 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 53.439999999999998 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 55.43 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.329999999999998 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 50.009999999999998 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.219999999999999 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 63.149999999999999 111.145 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.140000000000001 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 24.120000000000001 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.209999999999994 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 61.43 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.040000000000006 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.299999999999997 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 65.420000000000002 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 103' ' ' LEU . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.530000000000001 110.848 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HE2' ' HG ' ' A' ' 104' ' ' SER . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.310000000000002 110.896 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 50.240000000000002 112.418 -179.957 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.763 0.316 . . . . 63.439999999999998 111.087 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 71' ' ' PHE . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.878 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.538 ' HG ' ' HE2' ' A' ' 72' ' ' PHE . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.808 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 72.439999999999998 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 54.539999999999999 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 110.932 -179.879 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.624 0.726 . . . . 75.200000000000003 110.925 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 71.530000000000001 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 73.010000000000005 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 52.32 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 55.439999999999998 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 51.340000000000003 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 44.020000000000003 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 71.510000000000005 110.872 -179.881 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.621 0.724 . . . . 75.299999999999997 111.072 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 62.509999999999998 112.277 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.702 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.349999999999994 112.533 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 152' ' ' GLY . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.92 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.755 0.312 . . . . 73.140000000000001 110.93 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 64.329999999999998 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.329999999999998 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.762 HG13 HD11 ' A' ' 196' ' ' LEU . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 65.120000000000005 111.156 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.831 -179.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.837 0.351 . . . . 74.010000000000005 110.868 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.420000000000002 111.112 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 167' ' ' VAL . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.897 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.439999999999998 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.918 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 53.310000000000002 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 55.200000000000003 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.439999999999998 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.547 ' C ' HG13 ' A' ' 18' ' ' VAL . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.219999999999999 110.888 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 18' ' ' VAL . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 61.409999999999997 111.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 110.91 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.761 0.315 . . . . 72.010000000000005 110.882 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 34.399999999999999 112.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.049999999999997 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 71.329999999999998 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 203' ' ' VAL . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 64.129999999999995 111.154 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 72.540000000000006 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.319999999999993 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 70.239999999999995 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 50.329999999999998 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.200000000000003 111.161 179.882 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.888 0.375 . . . . 74.519999999999996 111.177 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 61.229999999999997 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.219999999999999 110.887 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.43 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 50.420000000000002 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.439999999999998 111.106 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.319999999999993 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 15' ' ' GLY . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.030000000000001 111.101 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.099999999999994 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 74.109999999999999 110.839 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 111.127 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 105' ' ' LEU . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.409999999999997 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 103' ' ' LEU . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.893 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.010000000000005 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 62.310000000000002 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 44.340000000000003 112.515 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.796 0.331 . . . . 74.540000000000006 111.046 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.691 HG23 ' CA ' ' A' ' 124' ' ' GLY . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 111.148 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 71' ' ' PHE . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.540000000000006 110.94 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 69' ' ' VAL . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.916 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 121.712 0.768 . . . . 62.229999999999997 110.909 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.310000000000002 112.35 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 52.210000000000001 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.209999999999994 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.129999999999995 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 71.099999999999994 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.409999999999997 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 146' ' ' ALA . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.019999999999996 111.096 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.691 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 23.300000000000001 112.519 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 73.140000000000001 110.861 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.23 0.074 0 CA-C-O 121.601 0.715 . . . . 74.219999999999999 111.113 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 71.230000000000004 112.348 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.450000000000003 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.400000000000006 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 64.239999999999995 110.913 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.230000000000004 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 163' ' ' LEU . 17.9 p90 . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 70.349999999999994 110.945 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.781 0.324 . . . . 73.329999999999998 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 110.886 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 163' ' ' LEU . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.420000000000002 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 153' ' ' LEU . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.230000000000004 110.912 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.230000000000004 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.882 HG23 HD23 ' A' ' 196' ' ' LEU . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 60.350000000000001 111.151 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.921 -179.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 196' ' ' LEU . 13.2 p90 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.795 0.331 . . . . 63.119999999999997 110.874 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 55.119999999999997 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.882 HD23 HG23 ' A' ' 167' ' ' VAL . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.909 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.875 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 197' ' ' SER . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.099999999999994 110.907 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.020000000000003 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.519999999999996 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 51.130000000000003 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 71.310000000000002 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 18' ' ' VAL . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 55.32 111.196 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.230000000000004 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.854 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.765 0.317 . . . . 74.230000000000004 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.455 ' HB3' HG13 ' A' ' 63' ' ' VAL . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.450000000000003 110.918 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 63' ' ' VAL . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.109999999999999 112.485 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.409999999999997 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 110.943 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 HG23 ' A' ' 203' ' ' VAL . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 111.19 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 111.103 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 62.5 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CE1' HD22 ' A' ' 55' ' ' LEU . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 110.882 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.213 179.819 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.928 0.394 . . . . 74.340000000000003 111.156 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.200000000000003 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 ' HE1' ' A' ' 17' ' ' TRP . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 111.164 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.134 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.010000000000005 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' HA2' ' A' ' 15' ' ' GLY . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 60.32 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.040000000000006 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.099999999999994 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 71.430000000000007 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 50.509999999999998 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.109999999999999 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.876 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 71' ' ' PHE . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 42.329999999999998 111.067 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.540000000000006 112.501 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.791 0.329 . . . . 64.450000000000003 111.076 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.174 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 70.409999999999997 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.857 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.99 -179.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.559 ' C ' HD12 ' A' ' 153' ' ' LEU . 6.1 m-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.665 0.745 . . . . 72.430000000000007 110.884 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.239999999999995 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.409999999999997 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 64.120000000000005 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.219999999999999 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 52.130000000000003 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.519999999999996 111.143 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 62.219999999999999 110.921 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.602 0.715 . . . . 62.539999999999999 111.164 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.652 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.400000000000006 112.361 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.329999999999998 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 63.450000000000003 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 167' ' ' VAL . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 64.030000000000001 111.102 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.030000000000001 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 116' ' ' TYR . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 110.843 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 45.350000000000001 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.149999999999999 110.875 -179.837 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.7 0.286 . . . . 73.430000000000007 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.400000000000006 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.329999999999998 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 40.32 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.420000000000002 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 62.520000000000003 111.137 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 70.010000000000005 110.895 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.312 . . . . 73.439999999999998 110.944 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 70.329999999999998 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.099999999999994 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.349999999999994 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.549999999999997 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.540000000000006 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.120000000000005 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 18' ' ' VAL . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 73.209999999999994 111.149 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.876 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.811 0.338 . . . . 74.530000000000001 110.937 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.099999999999994 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 62.350000000000001 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.230000000000004 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 203' ' ' VAL . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 61.109999999999999 111.106 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.129999999999995 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 55' ' ' LEU . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 56' ' ' THR . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.439999999999998 110.863 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.108 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 64.230000000000004 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 23' ' ' PHE . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 51.130000000000003 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.424 HG21 ' OG ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 111.136 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 61.340000000000003 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 71.209999999999994 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.42 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.893 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 64.439999999999998 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.519999999999996 111.155 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.450000000000003 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.530000000000001 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 107' ' ' TYR . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 73.430000000000007 111.143 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 61' ' ' TYR . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.409999999999997 111.071 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.540000000000006 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' A' ' 101' ' ' ALA . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.87 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 102' ' ' ILE . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 60.030000000000001 110.84 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.130000000000003 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 33.520000000000003 112.517 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.842 0.353 . . . . 74.319999999999993 111.008 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 72' ' ' PHE . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.108 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.999 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.409999999999997 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 61.340000000000003 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.439999999999998 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 119' ' ' VAL . 6.9 m-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.400000000000006 110.911 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.617 0.722 . . . . 63.450000000000003 110.925 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.129999999999995 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.530000000000001 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 107' ' ' TYR . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.109999999999999 111.1 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.430000000000007 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' VAL . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.349999999999994 111.146 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 63.5 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 74.340000000000003 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.420000000000002 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 63.229999999999997 110.886 -179.924 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.602 0.715 . . . . 53.219999999999999 111.144 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.329999999999998 112.329 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 45.219999999999999 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 167' ' ' VAL . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.409999999999997 111.122 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.030000000000001 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 63.109999999999999 110.927 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.883 -179.812 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.73 0.3 . . . . 71.019999999999996 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.420000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.914 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.430000000000007 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 151' ' ' VAL . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 51.439999999999998 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.109999999999999 110.862 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.808 0.337 . . . . 64.329999999999998 110.84 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.450000000000003 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.349999999999994 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 53.130000000000003 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 45.140000000000001 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.25 110.964 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 18' ' ' VAL . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 55.539999999999999 111.111 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.855 0.359 . . . . 73.109999999999999 110.837 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 54.109999999999999 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.120000000000005 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.726 HG22 HG23 ' A' ' 203' ' ' VAL . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 62.539999999999999 111.127 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.099999999999994 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.909 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.299999999999997 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.129999999999995 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.146 179.854 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.866 0.365 . . . . 74.530000000000001 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD21 ' CE2' ' A' ' 57' ' ' PHE . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.896 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.210000000000001 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CE2' HD21 ' A' ' 55' ' ' LEU . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.209999999999994 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 72.230000000000004 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 64.120000000000005 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.030000000000001 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 52.310000000000002 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.492 ' ND2' HG22 ' A' ' 67' ' ' ILE . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.310000000000002 110.904 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 105' ' ' LEU . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 65.120000000000005 111.12 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.669 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.873 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 72.140000000000001 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 52.539999999999999 112.517 180.0 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.669 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.67 0.271 . . . . 53.219999999999999 111.11 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' A' ' 124' ' ' GLY . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 111.11 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.340000000000003 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 67' ' ' ILE . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.439999999999998 110.915 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.420000000000002 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.896 -179.843 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 121.753 0.787 . . . . 74.319999999999993 110.866 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 72.540000000000006 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.319999999999993 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 151' ' ' VAL . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.450000000000003 111.088 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.349999999999994 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 149' ' ' PHE . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.083 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.209999999999994 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.340000000000003 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HG23 ' A' ' 102' ' ' ILE . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 51.049999999999997 112.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.869 -179.898 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.329999999999998 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 54.140000000000001 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' VAL . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.109999999999999 111.13 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.420000000000002 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 62.100000000000001 110.97 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 71.420000000000002 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.61 ' CE1' HD12 ' A' ' 153' ' ' LEU . 7.5 m-85 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.140000000000001 110.978 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.338 . . . . 74.140000000000001 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 72.25 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 155' ' ' TYR . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.420000000000002 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 196' ' ' LEU . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.230000000000004 111.087 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 71.299999999999997 110.922 -179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.817 0.341 . . . . 75.310000000000002 110.862 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 167' ' ' VAL . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.923 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 52.409999999999997 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 199' ' ' GLY . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 63.439999999999998 110.894 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 198' ' ' LEU . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 61.439999999999998 112.446 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 34.32 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.439999999999998 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 18' ' ' VAL . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.400000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 110.936 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.798 0.332 . . . . 62.530000000000001 110.911 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.120000000000005 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 43.009999999999998 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.109999999999999 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HE1' HD12 ' A' ' 59' ' ' ILE . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.349999999999994 110.887 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.099999999999994 111.171 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 61.200000000000003 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 54.039999999999999 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.430000000000007 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.119999999999997 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 71.219999999999999 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 53.25 111.062 179.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.919 0.39 . . . . 65.409999999999997 111.145 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 45.100000000000001 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.530000000000001 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HE1' ' A' ' 17' ' ' TRP . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 54.520000000000003 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.787 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.230000000000004 111.12 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.219999999999999 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.400000000000006 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 64.129999999999995 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 60.439999999999998 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.219999999999999 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 106' ' ' GLN . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.439999999999998 111.058 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 55.140000000000001 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.040000000000006 110.89 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 60.420000000000002 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.409999999999997 112.476 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.453 ' HB1' ' HE2' ' A' ' 71' ' ' PHE . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.753 0.311 . . . . 63.130000000000003 111.071 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 148' ' ' ALA . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.136 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 71' ' ' PHE . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 110.945 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 22.129999999999999 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 70.140000000000001 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 67' ' ' ILE . 3.4 tp60 -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.922 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.219999999999999 110.901 -179.803 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.672 0.748 . . . . 74.319999999999993 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.129999999999995 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.120000000000005 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.25 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.439999999999998 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.140000000000001 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.230000000000004 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 71.310000000000002 111.122 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.409999999999997 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 . . . . . 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.420000000000002 110.899 -179.875 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.793 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.510000000000005 112.35 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 102' ' ' ILE . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 53.43 111.109 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.400000000000006 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 53.140000000000001 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 71.109999999999999 111.163 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.340000000000003 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.879 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 64.230000000000004 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.944 -179.899 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.742 0.306 . . . . 74.120000000000005 110.92 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 60.329999999999998 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 52.399999999999999 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.129999999999995 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.329999999999998 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.688 ' HB ' HD12 ' A' ' 196' ' ' LEU . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 71.5 111.101 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.109999999999999 110.836 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.801 0.334 . . . . 72.140000000000001 110.931 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 72.219999999999999 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.688 HD12 ' HB ' ' A' ' 167' ' ' VAL . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.913 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . 0.507 ' C ' HD12 ' A' ' 198' ' ' LEU . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.891 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.310000000000002 110.947 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.439999999999998 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.120000000000005 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.530000000000001 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.019999999999996 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 18' ' ' VAL . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.049999999999997 111.126 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.899 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.814 0.34 . . . . 75.200000000000003 110.834 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 70.209999999999994 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.219999999999999 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.150000000000006 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.545 ' HE1' HG23 ' A' ' 59' ' ' ILE . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.239999999999995 110.893 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 60' ' ' ALA . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 55.009999999999998 111.178 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.219999999999999 111.136 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 200' ' ' ALA . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.439999999999998 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.030000000000001 110.818 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 61.049999999999997 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 70.319999999999993 111.173 179.83 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.856 0.36 . . . . 73.319999999999993 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.349999999999994 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.329999999999998 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.130000000000003 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.109999999999999 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.545 HG23 ' HE1' ' A' ' 17' ' ' TRP . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 111.157 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.975 ' HB3' HG13 ' A' ' 18' ' ' VAL . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 50.420000000000002 111.098 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.109999999999999 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.140000000000001 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.019999999999996 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 107' ' ' TYR . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 111.192 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 64.319999999999993 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 103' ' ' LEU . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.869 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.540000000000006 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.200000000000003 112.459 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.782 0.325 . . . . 70.040000000000006 111.044 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.439999999999998 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 71' ' ' PHE . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.93 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.120000000000005 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.735 HD13 ' CE1' ' A' ' 107' ' ' TYR . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 63.520000000000003 110.946 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.735 ' CE1' HD13 ' A' ' 105' ' ' LEU . 5.1 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.019999999999996 110.888 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 121.72 0.771 . . . . 75.150000000000006 110.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 71.519999999999996 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.109999999999999 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 151' ' ' VAL . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.040000000000006 111.158 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' CD2' ' A' ' 149' ' ' PHE . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 74.129999999999995 111.088 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.329999999999998 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 147' ' ' PRO . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.219999999999999 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 63.43 110.852 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 121.639 0.733 . . . . 42.299999999999997 111.077 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PRO . . . . . 0.752 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.099999999999994 112.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 54.32 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 121' ' ' VAL . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.844 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.439999999999998 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 119' ' ' VAL . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 111.162 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.484 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 61.340000000000003 110.931 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 51.5 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.530000000000001 110.904 -179.816 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.69 0.281 . . . . 73.340000000000003 110.866 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.299999999999997 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.888 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.540000000000006 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 110.922 -179.944 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.839 0.352 . . . . 74.450000000000003 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.450000000000003 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 196' ' ' LEU . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.310000000000002 110.94 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 65.310000000000002 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 24.120000000000001 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 62.509999999999998 111.128 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 61.329999999999998 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.530000000000001 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 72.549999999999997 110.88 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mmt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.84 0.352 . . . . 74.200000000000003 110.894 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -139.42 157.59 45.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.826 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.12 144.15 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.400000000000006 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -102.8 162.02 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 70.329999999999998 110.926 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -152.38 73.43 7.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.689 0.757 . . . . 74.239999999999995 110.912 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.11 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.683 2.255 . . . . 73.120000000000005 112.345 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.14 165.29 24.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 70.010000000000005 111.081 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -130.96 -173.71 3.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 73.409999999999997 110.88 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 96.1 p -53.11 103.02 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.882 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -135.61 -172.52 3.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.219999999999999 111.088 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.68 -157.23 1.11 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.778 -0.725 . . . . 54.109999999999999 112.459 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -175.92 140.48 0.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.903 0.382 . . . . 71.409999999999997 110.888 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.41 -170.09 2.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 70.109999999999999 110.866 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.542 ' HB2' HG13 ' A' ' 63' ' ' VAL . 18.0 pt20 -51.94 142.93 14.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 110.964 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.3 7.46 34.95 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.789 -0.72 . . . . 61.25 112.47 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.34 146.23 53.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 73.019999999999996 110.829 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.513 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.4 t90 -125.19 107.48 10.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 73.540000000000006 110.889 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.61 HG22 HG23 ' A' ' 203' ' ' VAL . 25.1 t -105.98 128.41 60.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 71.209999999999994 111.127 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.62 113.25 23.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 52.25 111.088 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.16 129.76 51.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 52.119999999999997 110.808 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -138.0 125.45 21.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.095 -0.502 . . . . 74.209999999999994 110.892 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -156.72 158.5 37.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.146 -0.479 . . . . 64.450000000000003 110.88 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -104.36 139.59 39.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.893 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.4 m -90.9 151.84 20.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 42.200000000000003 110.857 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.59 ' O ' HD12 ' A' ' 195' ' ' ILE . 5.6 mtpm? -141.7 135.99 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 60.200000000000003 110.898 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 26' ' ' VAL . 6.9 p -88.98 123.42 41.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 73.239999999999995 111.147 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -107.06 104.47 14.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.911 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -156.61 144.75 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 61.409999999999997 111.136 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.36 90.25 0.44 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.748 -0.739 . . . . 71.010000000000005 112.461 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -84.83 -40.84 16.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 65.340000000000003 110.9 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -52.1 -37.93 55.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 73.209999999999994 110.937 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 40.2 mt -58.82 -44.23 90.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 64.530000000000001 110.919 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -178.37 136.98 3.12 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.721 -0.752 . . . . 63.439999999999998 112.497 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -143.49 105.75 4.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.825 0.345 . . . . 62.009999999999998 110.897 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 tp 56.52 43.2 26.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.196 -0.456 . . . . 74.530000000000001 110.923 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -141.46 140.1 33.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 75.200000000000003 110.911 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.0 t -94.35 131.96 39.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 62.0 111.123 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 161.63 152.81 6.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.776 -0.726 . . . . 72.140000000000001 112.503 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -112.15 52.24 0.65 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.745 -0.74 . . . . 65.150000000000006 112.493 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.47 128.21 3.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 33.030000000000001 112.508 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -89.46 57.14 3.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.824 0.345 . . . . 62.439999999999998 111.157 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.7 mt -99.1 158.87 31.52 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 71.340000000000003 110.901 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 118.65 5.81 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 74.049999999999997 112.37 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -174.38 150.3 1.44 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 72.230000000000004 110.938 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 51.99 43.17 30.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.25 111.072 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.83 141.63 48.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.22 -0.446 . . . . 70.099999999999994 110.854 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.76 143.94 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 111.077 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.0 p -76.62 132.47 39.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 62.020000000000003 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.4 tp -54.84 137.94 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 62.32 111.159 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.15 -160.97 32.14 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.719 -0.753 . . . . 72.319999999999993 112.456 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -129.75 135.56 48.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.858 0.361 . . . . 75.310000000000002 110.851 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -119.4 30.52 7.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 72.530000000000001 110.879 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 34.6 p -75.14 119.64 19.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.2 -0.455 . . . . 73.530000000000001 111.102 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.694 ' O ' HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -98.76 100.74 11.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 111.161 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.8 mp -57.27 115.91 2.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 55.439999999999998 110.892 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.694 HG23 ' O ' ' A' ' 54' ' ' THR . 20.4 p -126.0 142.21 51.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 111.132 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -112.86 150.73 31.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 74.430000000000007 110.902 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -147.78 142.32 26.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 64.239999999999995 110.864 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 ' HE1' ' A' ' 17' ' ' TRP . 5.4 mp -107.55 121.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.453 . . . . 54.100000000000001 111.141 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.04 110.91 22.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 42.509999999999998 111.127 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -100.17 116.1 31.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 70.129999999999995 110.94 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -89.96 110.84 21.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 73.230000000000004 110.9 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG13 ' HB2' ' A' ' 14' ' ' GLN . 38.2 t -121.93 -35.93 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 74.349999999999994 111.143 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.52 150.04 52.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 65.230000000000004 110.852 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.0 m -75.58 -36.63 60.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 71.329999999999998 110.815 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 67' ' ' ILE . 8.0 p30 -74.1 -36.97 64.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.145 -0.479 . . . . 73.319999999999993 110.865 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.55 HD11 HD13 ' A' ' 105' ' ' LEU . 9.5 tt -140.68 141.06 32.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.239999999999995 111.109 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.685 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -126.93 158.83 35.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 61.340000000000003 111.091 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.1 141.38 14.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 72.400000000000006 111.12 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -138.93 143.91 38.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 62.420000000000002 110.893 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.69 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.7 t80 -136.18 132.02 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.877 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -105.44 136.71 44.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.906 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 69.4 t -148.37 124.79 2.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 111.152 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.25 171.59 36.6 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.676 -0.773 . . . . 54.25 112.46 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.65 155.52 14.25 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.636 0.732 . . . . 71.310000000000002 111.125 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.82 172.7 12.21 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 62.520000000000003 112.31 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -168.57 158.0 9.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 65.450000000000003 111.15 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -54.95 120.52 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 73.239999999999995 110.886 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -173.25 174.17 3.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 65.319999999999993 111.14 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -59.93 171.77 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 62.219999999999999 110.885 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -119.91 -67.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 73.040000000000006 110.908 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -124.53 -36.26 2.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 70.230000000000004 110.885 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 63.77 62.08 5.6 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 75.200000000000003 112.482 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -174.84 145.39 0.86 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.959 0.409 . . . . 71.150000000000006 110.874 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -63.83 122.68 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 110.9 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.3 t -64.89 124.28 21.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 110.87 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 74.2 mt -101.91 -37.95 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 62.520000000000003 111.088 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.9 m -151.32 111.85 4.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 63.450000000000003 110.856 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.6 t -173.02 167.74 4.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.101 -0.5 . . . . 73.329999999999998 110.822 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.7 tp -170.57 126.17 0.74 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 71.349999999999994 110.929 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.83 -143.68 10.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.741 -0.742 . . . . 71.239999999999995 112.492 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.5 tpp180 -128.68 -41.69 1.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.82 0.343 . . . . 73.340000000000003 110.843 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.7 t 53.17 78.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 73.120000000000005 111.073 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -86.27 167.22 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 53.420000000000002 110.844 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -114.42 71.95 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 62.509999999999998 110.882 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.6 m -114.76 40.24 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.147 -0.478 . . . . 71.010000000000005 111.141 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -81.43 135.83 35.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 110.856 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -100.52 -42.31 6.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.188 -0.46 . . . . 73.129999999999995 110.945 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -131.87 75.82 0.42 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.739 -0.743 . . . . 75.209999999999994 112.451 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 173.82 10.41 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.264 . . . . 70.120000000000005 112.374 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.69 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -149.93 130.54 14.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 61.109999999999999 111.113 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.506 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -123.26 137.02 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.540000000000006 111.125 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.1 pp -121.69 125.23 46.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.549999999999997 110.904 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.1 p -155.7 159.68 39.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 64.439999999999998 110.892 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.55 HD13 HD11 ' A' ' 67' ' ' ILE . 1.8 mt -102.22 146.61 27.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 110.904 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.685 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 7.4 pt20 -110.17 143.76 39.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 74.239999999999995 110.973 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -132.6 133.2 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 73.120000000000005 110.938 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -131.07 163.45 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 63.219999999999999 110.874 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -136.5 37.23 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 73.349999999999994 110.919 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -103.25 -39.87 6.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 71.329999999999998 110.863 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.7 m 53.02 36.78 23.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 54.030000000000001 110.847 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -177.4 178.98 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 73.040000000000006 110.898 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -97.16 97.9 9.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 71.109999999999999 110.869 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.1 mtt85 -161.89 174.31 13.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 74.329999999999998 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.6 tt -75.0 94.58 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 74.430000000000007 110.91 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.05 153.4 78.41 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.699 0.761 . . . . 74.400000000000006 110.916 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.7 ' HA ' HD13 ' A' ' 153' ' ' LEU . 54.0 Cg_endo -69.78 171.05 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.684 2.256 . . . . 45.32 112.335 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.51 134.33 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 73.109999999999999 110.877 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.0 t -105.92 145.93 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.439999999999998 111.103 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.23 130.77 4.11 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.746 -0.74 . . . . 64.209999999999994 112.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 149' ' ' PHE . 16.6 m -141.56 141.93 29.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.911 0.386 . . . . 75.049999999999997 111.113 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 171.05 -153.94 21.67 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.702 -0.761 . . . . 71.310000000000002 112.454 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' A' ' 147' ' ' PRO . 35.5 m -131.47 156.33 42.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.885 0.374 . . . . 61.149999999999999 111.161 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -128.36 157.86 21.45 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.789 -0.719 . . . . 71.530000000000001 112.462 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -157.28 -176.98 6.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.868 0.366 . . . . 72.510000000000005 110.857 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.9 m -104.79 152.55 6.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 63.140000000000001 111.141 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.422 HD12 ' CD1' ' A' ' 128' ' ' PHE . 0.1 OUTLIER -116.93 129.86 56.32 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.204 -0.453 . . . . 70.329999999999998 110.949 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.422 ' CD1' HD12 ' A' ' 127' ' ' LEU . 16.6 m-85 53.33 43.9 30.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 60.439999999999998 110.937 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -55.51 -36.43 66.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 65.209999999999994 110.832 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -62.12 127.8 33.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 65.400000000000006 110.881 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -92.29 178.65 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.918 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.9 t -113.1 73.27 0.81 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 64.430000000000007 111.106 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -154.51 147.64 24.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 63.25 110.854 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -85.8 80.61 1.78 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.753 -0.737 . . . . 71.349999999999994 112.521 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.15 -64.98 1.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.059 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 mt -137.4 110.46 7.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.249 -0.432 . . . . 71.530000000000001 110.907 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 6.0 t -76.66 160.71 29.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 71.420000000000002 110.834 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t 57.53 48.43 14.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 71.349999999999994 110.877 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -124.46 43.53 2.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 74.209999999999994 110.905 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -142.33 144.05 33.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.116 -0.493 . . . . 62.200000000000003 110.887 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.736 HG21 ' HG3' ' A' ' 144' ' ' LYS . 8.4 tt -110.71 150.55 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 72.530000000000001 111.129 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -51.95 -64.33 0.85 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 74.349999999999994 110.904 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -152.35 122.67 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.853 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.736 ' HG3' HG21 ' A' ' 141' ' ' ILE . 0.5 OUTLIER -126.33 98.65 5.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 73.010000000000005 110.91 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -124.32 147.66 48.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 75.329999999999998 110.878 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.566 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -126.08 159.93 59.65 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.521 0.676 . . . . 74.040000000000006 111.148 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.758 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.77 155.36 66.1 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.671 2.247 . . . . 73.340000000000003 112.315 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.98 149.39 0.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.466 . . . . 71.400000000000006 111.078 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.515 ' CD1' HG12 ' A' ' 121' ' ' VAL . 10.4 m-85 -131.91 166.4 21.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 71.409999999999997 110.94 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -165.59 154.31 11.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 64.230000000000004 110.893 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 37.9 t -130.67 117.38 38.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.530000000000001 111.103 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.605 ' O ' HD22 ' A' ' 153' ' ' LEU . . . -110.82 -173.85 20.09 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.746 -0.74 . . . . 52.030000000000001 112.479 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.7 HD13 ' HA ' ' A' ' 117' ' ' PRO . 3.0 mm? -129.26 149.7 50.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.816 0.341 . . . . 71.319999999999993 110.912 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -123.86 119.82 30.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 74.200000000000003 110.888 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -136.02 148.0 48.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 60.549999999999997 110.932 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.42 110.15 22.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 73.049999999999997 110.882 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.9 tp -90.44 -40.13 12.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 73.420000000000002 110.914 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -133.5 -139.17 4.14 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.749 -0.739 . . . . 73.439999999999998 112.477 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -111.28 -56.5 2.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.848 0.356 . . . . 61.299999999999997 110.848 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.3 p -74.31 -62.96 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 45.219999999999999 110.908 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 17.5 p90 -92.13 148.14 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.109999999999999 110.915 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 4.8 mtp -122.48 176.5 5.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 71.430000000000007 110.87 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 9.3 tp -107.42 132.73 52.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.239999999999995 110.964 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -129.89 144.51 51.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 62.229999999999997 110.847 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.43 160.39 36.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 51.140000000000001 110.86 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -137.49 133.56 34.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.135 -0.484 . . . . 72.409999999999997 110.894 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.1 t -131.63 127.25 58.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 61.32 111.138 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 43.3 ttp85 -143.98 130.31 19.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.891 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -77.16 139.71 40.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 110.925 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.439 HG23 ' HD2' ' A' ' 171' ' ' PRO . 48.6 mm -120.95 133.1 24.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.626 0.726 . . . . 75.409999999999997 111.111 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 170' ' ' ILE . 54.1 Cg_endo -69.79 150.08 67.55 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 65.140000000000001 112.355 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -114.97 118.62 33.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 75.040000000000006 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.5 tptt -64.5 151.88 43.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 73.209999999999994 110.89 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 71.4 m -61.63 109.16 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 74.239999999999995 111.129 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -171.02 150.94 3.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 74.530000000000001 110.859 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.1 p -107.35 139.49 28.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 71.209999999999994 111.168 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 82.5 p -132.6 107.09 8.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 111.169 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.67 -162.73 10.8 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.749 -0.739 . . . . 65.400000000000006 112.483 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.631 HG22 HD23 ' A' ' 180' ' ' LEU . 9.2 m -133.66 153.85 51.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.842 0.353 . . . . 70.329999999999998 111.136 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.631 HD23 HG22 ' A' ' 179' ' ' THR . 1.5 pt? -54.59 162.54 1.14 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.019999999999996 110.871 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.49 71.95 1.07 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.717 -0.754 . . . . 70.219999999999999 112.495 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 144.89 55.31 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.673 2.249 . . . . 74.120000000000005 112.279 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.4 156.19 70.6 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.671 0.748 . . . . 74.200000000000003 111.139 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -38.08 8.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.638 2.225 . . . . 74.540000000000006 112.373 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -70.05 174.65 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 75.510000000000005 111.148 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 36.9 m -129.28 151.35 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.462 . . . . 73.310000000000002 110.843 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.3 p -133.27 151.38 51.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.049999999999997 111.139 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -70.6 152.56 43.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.922 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 53.8 mt -129.1 89.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.262 -0.427 . . . . 63.43 111.118 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -121.95 90.46 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.219999999999999 110.891 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.68 -70.42 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 74.420000000000002 111.13 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 55.88 71.12 1.29 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.642 0.734 . . . . 73.409999999999997 110.856 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 153.29 69.15 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.665 2.243 . . . . 64.219999999999999 112.35 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -161.38 174.76 13.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.409999999999997 110.865 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.59 HD12 ' O ' ' A' ' 25' ' ' LYS . 6.9 tp -116.9 135.64 56.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.439999999999998 111.139 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.558 HD23 ' O ' ' A' ' 25' ' ' LYS . 2.1 pt? -139.85 133.87 30.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 70.409999999999997 110.958 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.1 m -120.53 152.28 38.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 73.219999999999999 110.838 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 14.5 tp -143.59 144.24 31.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.485 . . . . 75.219999999999999 110.938 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -178.15 -150.06 8.43 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.739 -0.743 . . . . 63.420000000000002 112.46 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -136.3 168.2 19.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 62.130000000000003 111.135 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.0 m -141.89 157.85 44.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 42.229999999999997 110.863 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.542 ' C ' HG13 ' A' ' 18' ' ' VAL . 26.0 t80 -141.51 123.93 15.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 75.439999999999998 110.925 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 18' ' ' VAL . 7.2 p -77.96 135.15 26.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.209999999999994 111.109 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.09 157.51 45.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.876 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? -121.33 100.34 6.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 72.439999999999998 110.889 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.456 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.3 OUTLIER -53.51 -36.19 61.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 63.439999999999998 110.898 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 58.81 48.71 10.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 71.310000000000002 111.095 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -146.28 109.12 4.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 61.439999999999998 111.072 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -145.21 149.61 35.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 42.350000000000001 111.12 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.4 tt -133.95 118.6 18.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 61.109999999999999 110.918 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 73.099999999999994 110.865 179.958 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.5 mtt . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.763 0.316 . . . . 74.200000000000003 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -118.89 131.63 56.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 61.229999999999997 110.882 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -146.51 127.99 15.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 62.140000000000001 110.913 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -119.17 151.79 37.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 61.310000000000002 110.908 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -72.78 160.46 82.8 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.727 0.775 . . . . 72.409999999999997 110.899 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 98.18 0.67 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.628 2.219 . . . . 65.530000000000001 112.431 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.87 141.8 57.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 54.240000000000002 111.012 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -117.34 37.32 3.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 64.239999999999995 110.945 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -91.25 119.49 31.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.239999999999995 110.892 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.64 162.35 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.109999999999999 111.145 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.92 -155.1 6.97 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.7 -0.762 . . . . 73.109999999999999 112.498 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -163.91 133.51 4.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.869 0.366 . . . . 72.540000000000006 110.921 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -158.45 158.43 34.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 51.130000000000003 110.933 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -59.28 136.02 57.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.340000000000003 110.912 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.02 7.31 38.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.71 -0.757 . . . . 71.329999999999998 112.529 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.07 153.89 36.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.829 0.347 . . . . 73.540000000000006 110.888 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 4.9 m0 -131.54 134.41 46.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.182 -0.463 . . . . 75.5 110.902 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.69 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 32.3 m -130.83 129.38 63.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 74.400000000000006 111.084 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' A' ' 21' ' ' PHE . . . -97.64 115.88 28.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 72.349999999999994 111.095 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.2 t -114.34 112.02 22.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 71.109999999999999 110.824 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' A' ' 19' ' ' ALA . 10.5 m-85 -116.07 123.96 49.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 110.877 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -154.02 159.91 41.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 110.864 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -110.74 147.09 35.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.129999999999995 110.884 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.7 t -105.55 154.68 20.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.069 -0.514 . . . . 74.019999999999996 110.869 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.2 mtpt -144.18 135.72 25.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 50.329999999999998 110.912 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.2 t -89.18 113.05 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 64.319999999999993 111.133 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -103.76 110.64 22.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 73.099999999999994 110.929 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.2 p -149.82 149.4 14.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 74.219999999999999 111.099 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.95 70.14 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.706 -0.759 . . . . 71.409999999999997 112.448 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -87.64 -46.41 9.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.874 0.368 . . . . 72.120000000000005 110.877 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 62.02 37.67 14.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 71.129999999999995 110.872 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.15 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.119 -0.491 . . . . 54.439999999999998 110.933 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.65 -126.59 7.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.783 -0.723 . . . . 52.109999999999999 112.522 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -146.31 129.34 16.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 64.310000000000002 110.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -121.16 -50.2 2.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 110.903 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -52.56 156.71 1.75 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 110.962 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.9 p -87.94 146.09 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 72.450000000000003 111.109 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -167.17 -122.23 0.6 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.803 -0.713 . . . . 73.540000000000006 112.501 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.76 -99.32 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 42.210000000000001 112.53 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.08 -155.03 3.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.753 . . . . 61.149999999999999 112.522 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -126.89 -58.93 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.8 0.333 . . . . 73.5 111.059 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 mt -110.31 91.1 11.0 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.666 0.746 . . . . 75.230000000000004 110.922 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.609 2.206 . . . . 73.329999999999998 112.372 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -119.43 87.36 2.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 73.109999999999999 110.913 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -174.25 136.63 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 75.349999999999994 111.069 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -119.09 -43.23 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.1 m -142.56 145.55 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 72.530000000000001 111.127 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.9 t -108.36 126.37 52.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 74.099999999999994 110.849 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.7 pp -51.96 145.67 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 53.450000000000003 111.12 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 162.25 146.15 4.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 63.030000000000001 112.455 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.8 146.63 35.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.885 0.374 . . . . 71.099999999999994 110.855 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -123.4 -36.9 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 110.859 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 5.0 t -57.15 121.27 9.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 72.150000000000006 111.154 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.0 m -125.58 111.72 15.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.225 -0.443 . . . . 61.530000000000001 111.136 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.622 HD13 ' CZ ' ' A' ' 57' ' ' PHE . 4.2 pp -67.6 134.8 51.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 61.039999999999999 110.921 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.7 146.03 43.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.109999999999999 111.139 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.622 ' CZ ' HD13 ' A' ' 55' ' ' LEU . 9.2 m-85 -120.94 131.22 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 71.109999999999999 110.893 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.58 138.42 47.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 55.219999999999999 110.896 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.8 pt -115.78 126.85 73.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 71.219999999999999 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.69 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -109.93 143.86 39.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 74.530000000000001 111.14 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.85 120.92 41.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.467 . . . . 75.420000000000002 110.885 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.52 100.83 13.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 74.319999999999993 110.895 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.08 -35.8 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 73.400000000000006 111.122 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.6 m -124.62 149.61 46.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 73.0 110.885 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -79.29 -36.32 39.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 63.229999999999997 110.874 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.665 ' HB2' HD12 ' A' ' 67' ' ' ILE . 27.1 m-80 -66.95 -41.78 86.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 71.319999999999993 110.897 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.665 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -140.45 145.99 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 111.198 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.33 159.04 24.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 55.130000000000003 111.095 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.71 142.3 13.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 65.109999999999999 111.161 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.45 130.55 23.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 63.439999999999998 110.901 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.705 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.2 t80 -126.26 120.08 29.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 72.129999999999995 110.925 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -95.22 134.46 37.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 73.549999999999997 110.77 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -138.45 125.58 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.495 . . . . 64.5 111.1 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.46 -167.81 21.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.715 -0.755 . . . . 74.209999999999994 112.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.34 156.23 72.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.611 0.719 . . . . 60.210000000000001 111.125 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 175.3 8.3 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.622 2.215 . . . . 63.420000000000002 112.313 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.24 168.86 9.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 111.11 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -59.68 105.06 0.33 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 72.310000000000002 110.897 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.55 178.16 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 111.165 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -143.42 121.44 12.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 73.349999999999994 110.892 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -126.79 167.59 15.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 73.329999999999998 110.881 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -154.3 -178.66 7.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 75.150000000000006 110.859 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -66.46 106.13 1.51 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 54.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -133.38 154.82 50.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.888 0.375 . . . . 74.439999999999998 110.894 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.43 40.53 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 73.409999999999997 110.907 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.5 t -66.62 -175.61 0.4 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 110.882 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.1 mp -95.07 -57.08 4.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 72.409999999999997 111.164 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.4 p -73.62 95.2 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 42.109999999999999 110.854 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 32.4 p -63.21 145.55 55.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 71.109999999999999 110.914 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.66 45.47 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.040000000000006 110.876 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.28 130.94 29.78 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.716 -0.754 . . . . 51.219999999999999 112.477 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.04 -30.14 24.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 61.210000000000001 110.849 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 36.0 t -74.74 102.43 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.430000000000007 111.154 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.9 t -170.28 119.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 63.229999999999997 110.814 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -76.64 -65.01 0.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.487 . . . . 70.120000000000005 110.841 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 t -85.9 117.24 30.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 64.239999999999995 111.149 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -137.21 170.91 15.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 73.019999999999996 110.897 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -89.85 150.48 22.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 75.239999999999995 110.897 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 144.28 -170.21 26.11 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.771 -0.728 . . . . 61.329999999999998 112.517 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.72 135.87 31.66 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.699 2.266 . . . . 73.219999999999999 112.366 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.705 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -143.92 131.43 21.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.416 . . . . 64.400000000000006 111.139 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.686 HG23 ' HA2' ' A' ' 124' ' ' GLY . 27.5 mt -124.98 135.6 63.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 62.439999999999998 111.119 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.55 118.9 34.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 73.109999999999999 110.865 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.2 p -152.05 162.82 40.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 50.140000000000001 110.9 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 1.8 mp -108.91 151.91 25.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 64.140000000000001 110.887 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -108.96 143.49 38.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 72.319999999999993 110.896 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -128.59 137.46 51.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.268 -0.423 . . . . 73.420000000000002 110.904 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -130.92 145.35 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.037 -0.529 . . . . 73.109999999999999 110.852 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.45 -35.75 81.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 52.240000000000002 110.851 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -100.7 -36.34 9.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.230000000000004 110.891 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.0 m 63.28 62.68 0.96 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 62.329999999999998 110.93 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -167.4 143.27 4.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 72.400000000000006 110.843 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -54.07 102.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 74.129999999999995 110.933 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -176.04 158.79 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.239999999999995 110.867 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.557 HD23 ' CA ' ' A' ' 155' ' ' TYR . 0.8 OUTLIER -60.59 98.58 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.173 -0.467 . . . . 71.109999999999999 110.871 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.26 160.53 26.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.656 0.741 . . . . 64.400000000000006 110.935 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 165.76 29.94 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.691 2.261 . . . . 73.010000000000005 112.31 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -155.98 138.56 15.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.150000000000006 110.871 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 23.1 t -111.51 142.98 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.089 -0.505 . . . . 75.010000000000005 111.115 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.06 131.71 7.58 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.772 -0.727 . . . . 72.040000000000006 112.474 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.66 142.94 31.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.091 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.13 -154.2 23.95 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 74.430000000000007 112.461 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.5 m -128.87 146.69 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.849 0.357 . . . . 74.439999999999998 111.176 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.686 ' HA2' HG23 ' A' ' 102' ' ' ILE . . . -110.36 158.42 14.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.77 -0.729 . . . . 70.439999999999998 112.451 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -141.42 134.65 29.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.903 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.468 HG12 ' HD3' ' A' ' 144' ' ' LYS . 14.1 p -115.0 141.54 31.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 62.340000000000003 111.081 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.41 115.5 30.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 62.340000000000003 110.902 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -54.8 135.86 47.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.902 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -98.18 168.27 10.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.519999999999996 110.902 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 56.35 53.55 8.65 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 72.420000000000002 110.889 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -71.66 142.01 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 74.129999999999995 110.955 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.9 t -85.3 168.14 14.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 75.150000000000006 111.189 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -85.26 -52.92 5.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 75.310000000000002 110.932 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 104.2 78.33 1.24 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.655 -0.784 . . . . 72.340000000000003 112.513 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -103.48 -38.88 6.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.814 0.34 . . . . 70.409999999999997 111.079 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 33.7 mt -86.2 -69.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 62.130000000000003 110.906 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 p -113.07 171.77 7.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 71.019999999999996 110.855 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 m -112.48 135.84 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 75.030000000000001 110.845 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -162.67 134.29 5.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 73.120000000000005 110.854 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -118.77 157.01 28.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 110.894 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 9.5 tp -82.26 135.81 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 63.450000000000003 111.096 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -96.02 150.38 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 75.019999999999996 110.907 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 39.1 p30 -61.92 177.1 0.47 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 64.349999999999994 110.882 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HD3' HG12 ' A' ' 126' ' ' VAL . 30.1 tttt -123.02 -62.34 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.206 -0.452 . . . . 53.030000000000001 110.928 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.3 m95 52.03 56.05 8.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.282 -0.417 . . . . 71.030000000000001 110.885 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -84.42 160.47 56.69 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.638 0.732 . . . . 42.020000000000003 111.069 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.9 Cg_endo -69.8 131.31 20.91 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 64.329999999999998 112.356 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -134.89 131.74 37.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 111.099 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -162.19 126.96 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 75.420000000000002 110.852 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -149.67 163.6 37.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.478 . . . . 63.240000000000002 110.911 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 167' ' ' VAL . 8.5 p -124.99 134.03 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 34.299999999999997 111.177 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -139.12 177.29 20.39 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.781 -0.723 . . . . 71.120000000000005 112.495 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.7 141.12 51.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.812 0.339 . . . . 62.310000000000002 110.914 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.2 mtp85 -112.21 123.22 49.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 62.520000000000003 110.851 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.557 ' CA ' HD23 ' A' ' 115' ' ' LEU . 13.9 m-85 -131.12 105.35 7.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 64.340000000000003 110.903 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -90.52 99.98 12.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 75.400000000000006 110.869 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.5 -62.07 1.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 70.420000000000002 110.959 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -57.04 147.54 34.08 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 73.450000000000003 112.477 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -57.76 -36.43 72.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.364 . . . . 74.129999999999995 110.875 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.1 t -110.5 -67.12 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 75.5 110.841 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -72.45 146.9 46.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 74.439999999999998 110.943 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 15.2 mmt -124.28 166.06 16.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 73.129999999999995 110.86 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.8 tp -102.54 125.42 49.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.427 . . . . 74.140000000000001 110.91 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -131.53 128.37 39.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.874 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.93 150.81 49.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 55.409999999999997 110.812 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -142.19 152.2 42.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.067 -0.515 . . . . 61.549999999999997 110.872 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.856 HG12 HD13 ' A' ' 196' ' ' LEU . 29.4 m -150.63 146.03 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.111 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -149.58 147.62 28.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 73.319999999999993 110.907 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -114.55 127.55 55.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.256 -0.429 . . . . 61.32 110.913 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -108.74 132.1 21.37 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.604 0.716 . . . . 61.5 111.174 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.74 116.73 4.7 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.708 2.272 . . . . 55.43 112.366 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -130.3 145.12 51.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.897 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 23.0 tptt -93.56 123.5 36.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 73.030000000000001 110.923 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 t -143.2 158.38 43.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 75.310000000000002 111.108 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -99.47 156.05 17.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 71.319999999999993 110.877 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.3 m -66.45 177.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 74.450000000000003 111.204 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.8 t -164.29 152.62 12.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 111.168 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -109.77 173.3 16.68 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.677 -0.773 . . . . 72.409999999999997 112.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 5.2 t -132.58 137.27 47.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 44.450000000000003 111.106 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 28.6 tp -147.03 145.2 29.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 52.25 110.946 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.91 177.74 20.84 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.746 . . . . 71.219999999999999 112.476 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 81.73 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 71.340000000000003 112.389 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.626 HG12 HG13 ' A' ' 185' ' ' VAL . 21.8 t 63.22 73.8 0.48 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.598 0.713 . . . . 54.229999999999997 111.151 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.65 92.71 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.709 2.273 . . . . 71.209999999999994 112.375 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.626 HG13 HG12 ' A' ' 183' ' ' VAL . 25.5 m -113.95 152.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 71.430000000000007 111.097 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 83.4 p -145.51 172.48 13.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 61.240000000000002 110.892 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 81.3 p -108.37 -42.15 4.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 41.420000000000002 111.177 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -99.39 139.14 35.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.936 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 60.4 mt -123.72 110.48 25.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.439 . . . . 72.230000000000004 111.113 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -154.14 112.96 3.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 71.349999999999994 110.882 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 44.2 t -91.05 -70.17 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.114 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.65 160.62 61.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.603 0.716 . . . . 73.099999999999994 110.876 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.79 48.59 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.718 2.279 . . . . 64.230000000000004 112.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -140.09 136.56 33.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.244 -0.435 . . . . 71.129999999999995 110.908 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.414 ' C ' HD22 ' A' ' 196' ' ' LEU . 55.2 mt -88.39 113.28 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.25 111.121 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.856 HD13 HG12 ' A' ' 167' ' ' VAL . 4.6 mm? -116.07 114.55 24.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.444 . . . . 61.43 110.942 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.504 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.4 m -120.12 146.35 46.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 74.319999999999993 110.771 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.504 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -156.25 152.64 28.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 54.030000000000001 110.938 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.65 -150.88 10.74 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 72.540000000000006 112.524 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.24 170.77 13.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 72.120000000000005 111.121 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 73.4 m -146.49 171.98 14.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 31.34 110.884 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -148.69 141.59 24.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 64.010000000000005 110.934 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 59.0 t -95.35 140.11 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 71.120000000000005 111.101 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -139.64 124.28 18.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.109999999999999 110.832 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -126.45 89.39 3.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.512 . . . . 75.420000000000002 110.91 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.4 tt -83.65 -44.09 14.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.303 -0.408 . . . . 73.329999999999998 110.903 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -65.66 91.29 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 111.125 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.64 178.62 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 72.150000000000006 111.128 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -80.29 -54.8 5.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 52.399999999999999 111.091 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.6 tp -74.4 -62.09 1.64 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 71.540000000000006 110.922 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 72.310000000000002 110.882 179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.728 0.299 . . . . 71.420000000000002 110.9 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -158.56 136.98 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 72.530000000000001 110.911 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.01 178.16 4.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 74.310000000000002 110.905 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -61.74 171.74 1.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 74.230000000000004 110.843 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -126.87 69.18 72.06 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.706 0.765 . . . . 62.229999999999997 110.929 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -41.79 3.98 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 64.219999999999999 112.348 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.12 -177.93 3.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 65.409999999999997 111.106 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -36.08 4.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 75.530000000000001 110.923 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t 62.45 40.0 11.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.254 -0.43 . . . . 63.439999999999998 110.834 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -81.66 118.58 22.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 74.099999999999994 111.024 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -168.32 -161.54 18.45 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.684 -0.77 . . . . 54.420000000000002 112.451 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -140.12 116.65 10.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 74.120000000000005 110.901 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.19 131.87 10.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.489 . . . . 71.510000000000005 110.89 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -55.92 143.11 33.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 62.149999999999999 110.9 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.26 7.37 26.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.715 -0.755 . . . . 75.040000000000006 112.504 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.51 147.0 38.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.774 0.321 . . . . 73.319999999999993 110.862 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.535 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.1 t90 -115.07 115.31 26.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.179 -0.464 . . . . 74.510000000000005 110.875 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.807 HG22 HG23 ' A' ' 203' ' ' VAL . 25.4 t -111.67 129.89 66.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 111.105 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -100.85 115.72 31.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 41.420000000000002 111.13 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -116.0 115.74 26.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 53.420000000000002 110.887 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -115.12 124.78 52.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 53.240000000000002 110.876 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -146.75 166.96 25.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 64.030000000000001 110.901 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -114.06 137.75 51.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.88 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.6 p -96.45 148.21 23.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 65.129999999999995 110.846 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 tppt? -134.61 126.27 28.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 110.835 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.1 t -84.67 125.62 40.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 64.049999999999997 111.173 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -114.1 108.08 16.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 72.540000000000006 110.935 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.0 p -156.54 151.44 9.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 72.430000000000007 111.134 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.22 48.19 0.46 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.72 -0.753 . . . . 65.0 112.516 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -64.32 -43.82 93.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.811 0.339 . . . . 70.329999999999998 110.876 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 57.41 52.13 9.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 110.945 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -131.82 -55.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 75.140000000000001 110.936 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 111.94 -143.5 17.45 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.75 -0.738 . . . . 24.149999999999999 112.479 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.421 ' C ' HD22 ' A' ' 35' ' ' LEU . 15.3 t70 -122.21 165.04 16.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.917 0.389 . . . . 72.530000000000001 110.829 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.421 HD22 ' C ' ' A' ' 34' ' ' ASP . 4.5 mm? -121.84 75.9 1.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 62.210000000000001 110.913 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -130.72 140.22 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.463 . . . . 73.239999999999995 110.913 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -173.61 135.08 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 75.099999999999994 111.123 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -80.89 -43.38 8.95 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.715 -0.755 . . . . 71.25 112.449 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.83 47.61 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.717 -0.754 . . . . 71.219999999999999 112.454 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 164.83 53.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 61.039999999999999 112.495 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.31 165.86 10.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.862 0.363 . . . . 70.299999999999997 111.046 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.4 mt -104.81 159.21 30.08 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.589 0.709 . . . . 75.329999999999998 110.889 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 174.51 9.46 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.622 2.215 . . . . 72.340000000000003 112.352 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -94.99 124.29 38.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 65.239999999999995 110.956 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -95.84 -52.32 4.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 111.142 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.37 152.27 34.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.206 -0.452 . . . . 71.109999999999999 110.839 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.8 t -130.04 129.84 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 71.299999999999997 111.169 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.4 p -77.73 99.12 5.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 52.530000000000001 110.841 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -124.4 124.61 68.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 73.25 111.068 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -145.31 -72.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.781 -0.723 . . . . 61.32 112.508 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -113.26 121.72 45.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 45.329999999999998 110.911 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -118.41 -36.98 3.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 71.420000000000002 110.831 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 t -54.93 132.66 47.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 71.019999999999996 111.116 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.9 t -142.38 133.42 25.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 52.119999999999997 111.14 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.17 151.75 45.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.887 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.0 t -154.25 143.25 21.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 74.530000000000001 111.128 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 4.7 t80 -111.3 158.17 19.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 72.329999999999998 110.938 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.45 134.16 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.893 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' A' ' 17' ' ' TRP . 31.5 mm -103.64 108.88 25.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 53.119999999999997 111.13 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -102.28 109.83 21.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 65.319999999999993 111.116 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.77 120.73 36.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.931 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -93.85 114.13 26.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 70.530000000000001 110.876 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 15' ' ' GLY . 12.7 m -129.38 -39.44 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 72.329999999999998 111.105 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 m -125.34 149.69 47.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 54.030000000000001 110.848 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.2 t -77.75 -36.26 50.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 65.299999999999997 110.781 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.613 ' HB2' HD12 ' A' ' 67' ' ' ILE . 31.2 m-20 -70.58 -39.13 74.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 63.329999999999998 110.884 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.613 HD12 ' HB2' ' A' ' 66' ' ' ASN . 4.0 mp -139.79 149.29 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 111.105 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.64 161.98 28.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.400000000000006 111.089 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD13 ' A' ' 105' ' ' LEU . 92.0 t -96.73 136.88 26.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.19 -0.459 . . . . 71.239999999999995 111.119 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.63 131.17 35.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 64.040000000000006 110.83 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.451 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 9.8 t80 -126.46 115.95 20.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 72.340000000000003 110.887 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.78 131.65 34.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 74.540000000000006 110.821 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 m -146.0 123.12 3.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.489 . . . . 73.420000000000002 111.207 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -109.53 -157.37 17.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 64.129999999999995 112.509 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 m -114.67 156.18 45.15 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.628 0.728 . . . . 75.349999999999994 111.196 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 138.26 37.49 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.628 2.218 . . . . 64.400000000000006 112.363 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.48 -176.95 3.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.437 . . . . 73.129999999999995 111.095 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -81.68 128.62 34.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 75.099999999999994 110.894 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -128.64 132.74 48.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 73.099999999999994 111.145 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -105.31 170.0 8.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 73.129999999999995 110.887 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -113.4 179.56 3.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.196 -0.456 . . . . 72.439999999999998 110.849 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -83.07 115.79 22.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 51.43 110.837 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -97.88 -166.25 31.75 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.729 -0.748 . . . . 41.299999999999997 112.487 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -112.42 -57.89 2.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.935 0.398 . . . . 70.340000000000003 110.897 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.3 tptm -103.04 39.98 1.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.510000000000005 110.929 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.3 m -125.5 176.36 6.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 71.209999999999994 110.811 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.8 pt -55.61 165.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 54.520000000000003 111.195 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.9 m -160.22 148.66 16.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 62.329999999999998 110.894 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.9 m -122.19 115.36 22.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 63.420000000000002 110.858 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.13 98.57 5.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 70.430000000000007 110.874 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 109.2 99.59 2.59 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.72 -0.752 . . . . 62.530000000000001 112.507 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.14 169.21 18.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 73.420000000000002 110.818 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.68 -35.59 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 70.230000000000004 111.141 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m 57.44 50.13 11.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 53.32 110.893 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 96' ' ' VAL . 98.0 mt-10 -141.91 -178.08 5.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 110.885 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 95' ' ' GLU . 27.1 m 36.88 44.25 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 42.109999999999999 111.166 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -113.97 172.59 6.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 63.520000000000003 110.907 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -69.59 138.69 53.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.941 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.66 -69.93 0.52 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 51.240000000000002 112.497 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -174.43 0.9 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.742 2.295 . . . . 53.240000000000002 112.303 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -118.32 173.01 7.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 70.310000000000002 111.076 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 29.1 mt -141.47 132.46 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 111.071 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.96 124.09 48.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 64.010000000000005 110.956 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 38.1 m -153.98 164.57 38.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 73.310000000000002 110.838 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.412 HD13 ' HA ' ' A' ' 69' ' ' VAL . 3.7 mm? -106.85 143.17 35.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 53.539999999999999 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -103.07 140.81 36.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 72.310000000000002 110.886 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -153.23 152.36 31.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.430000000000007 110.935 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -131.01 144.7 51.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.478 . . . . 73.120000000000005 110.832 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -52.33 -39.84 61.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.175 -0.466 . . . . 74.150000000000006 110.892 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -91.76 -37.25 13.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.040000000000006 110.826 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.1 t 61.41 52.83 3.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.868 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -105.42 179.28 4.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 75.329999999999998 110.863 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -117.09 73.09 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 71.140000000000001 110.923 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -170.03 -175.85 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 73.040000000000006 110.836 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 115' ' ' LEU . 0.8 OUTLIER -60.49 100.78 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 72.140000000000001 110.946 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.28 160.46 26.35 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.676 0.75 . . . . 72.349999999999994 110.988 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 171.1 15.09 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.72 2.28 . . . . 45.420000000000002 112.309 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.15 146.29 5.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.225 -0.443 . . . . 75.140000000000001 110.967 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.3 m -115.93 161.23 14.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.161 -0.472 . . . . 54.229999999999997 111.11 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.68 13.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.717 -0.754 . . . . 75.519999999999996 112.431 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.88 134.97 42.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 55.130000000000003 111.139 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 177.52 -153.71 14.0 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 23.120000000000001 112.509 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 147' ' ' PRO . 17.4 m -133.95 171.29 18.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 73.129999999999995 111.163 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -131.68 165.36 23.36 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.777 -0.725 . . . . 70.010000000000005 112.525 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.24 172.1 3.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.881 0.372 . . . . 72.409999999999997 110.879 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.82 149.98 5.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 65.150000000000006 111.189 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.76 114.01 27.91 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.201 -0.454 . . . . 63.340000000000003 110.936 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -62.57 132.76 53.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 70.340000000000003 110.848 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -122.4 156.18 34.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 71.409999999999997 110.838 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -112.69 65.09 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 75.109999999999999 110.833 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.37 37.5 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.448 . . . . 60.229999999999997 110.914 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.6 t -131.11 164.1 26.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 72.239999999999995 111.11 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -113.61 96.51 5.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 74.319999999999993 110.895 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.75 178.56 21.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 75.239999999999995 112.537 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -94.78 -42.01 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.814 0.34 . . . . 62.219999999999999 111.141 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 mt 57.8 43.25 22.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 64.349999999999994 110.965 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.5 m 52.36 37.58 22.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 63.200000000000003 110.875 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -61.2 143.59 55.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 75.230000000000004 110.855 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.4 t80 -137.99 141.14 40.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 72.530000000000001 110.912 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -118.3 143.86 46.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.139 -0.482 . . . . 64.540000000000006 110.829 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 143' ' ' ASP . 38.5 mm -82.68 142.95 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 32.32 111.11 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 pttt -70.71 -38.11 73.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 110.865 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 141' ' ' ILE . 14.8 m-20 -65.62 -69.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 63.210000000000001 110.853 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.2 ttmm 53.56 42.42 31.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 73.049999999999997 110.924 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.6 m0 -151.91 107.26 3.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.854 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -108.6 95.24 15.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.614 0.721 . . . . 74.129999999999995 111.026 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.636 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.81 136.87 33.97 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.766 2.31 . . . . 74.329999999999998 112.343 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -176.87 177.5 1.31 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.226 -0.443 . . . . 71.010000000000005 111.137 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -141.42 170.69 15.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.415 . . . . 70.230000000000004 110.894 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -153.74 159.7 42.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.488 . . . . 75.239999999999995 110.833 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.04 150.5 12.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.163 -0.471 . . . . 55.549999999999997 111.075 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -155.75 165.05 32.44 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.731 -0.747 . . . . 53.310000000000002 112.471 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.2 mt -134.08 130.71 37.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.832 0.348 . . . . 72.129999999999995 110.865 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -105.32 130.37 53.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 65.200000000000003 110.859 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -136.04 111.66 9.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 75.140000000000001 110.947 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -103.08 120.04 39.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 73.299999999999997 110.863 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.539 ' CD1' HD13 ' A' ' 163' ' ' LEU . 7.1 mp -76.23 -47.03 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.283 -0.417 . . . . 73.439999999999998 110.899 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 151.66 41.68 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.779 -0.724 . . . . 62.009999999999998 112.479 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -168.2 -176.74 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.856 0.36 . . . . 65.530000000000001 110.93 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 20.0 m -55.59 -46.79 77.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 71.25 110.784 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -78.42 135.27 37.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.94 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 39.7 mtm -141.09 166.42 24.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.257 -0.429 . . . . 75.519999999999996 110.889 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.539 HD13 ' CD1' ' A' ' 157' ' ' LEU . 6.8 mp -92.05 137.52 32.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 32.5 110.866 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -135.04 133.24 39.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 72.230000000000004 110.907 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.0 t -119.96 143.67 47.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 31.399999999999999 110.856 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.19 140.75 51.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.051 -0.522 . . . . 61.450000000000003 110.863 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.515 HG22 ' CD2' ' A' ' 196' ' ' LEU . 39.9 t -143.33 126.06 12.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 71.019999999999996 111.147 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.54 144.83 23.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 70.5 110.878 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -124.3 144.03 50.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 72.0 110.888 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -112.48 132.06 22.35 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.607 0.717 . . . . 73.129999999999995 111.174 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 107.12 1.78 Allowed 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.651 2.234 . . . . 71.230000000000004 112.392 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -131.54 -68.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 74.209999999999994 110.916 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -164.16 144.52 8.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 75.239999999999995 110.84 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.0 m -147.04 151.26 36.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 71.530000000000001 111.156 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -143.99 152.87 41.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.458 . . . . 64.030000000000001 110.912 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.37 67.62 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.975 0.417 . . . . 72.329999999999998 111.189 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.83 162.2 34.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.154 -0.476 . . . . 64.510000000000005 111.194 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -52.21 171.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.783 -0.722 . . . . 75.409999999999997 112.457 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -115.49 -41.78 3.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.049999999999997 111.173 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.68 119.19 0.16 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 73.420000000000002 110.922 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 102.29 174.47 27.45 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.734 -0.746 . . . . 23.199999999999999 112.529 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -33.22 17.11 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.664 2.243 . . . . 73.239999999999995 112.315 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 21.9 t 63.72 73.93 0.46 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.62 0.724 . . . . 74.129999999999995 111.021 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -33.1 17.16 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.679 2.252 . . . . 63.049999999999997 112.346 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.2 m -59.19 -174.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 73.340000000000003 111.104 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 p -52.07 168.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.094 -0.503 . . . . 50.130000000000003 110.868 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -51.79 156.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 63.200000000000003 111.122 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.9 pttt -53.5 141.08 26.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.099999999999994 110.962 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.424 ' CG2' HG13 ' A' ' 191' ' ' VAL . 15.4 tt -60.33 -35.62 63.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.209999999999994 111.155 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 63.07 52.89 2.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.143 -0.481 . . . . 75.120000000000005 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 189' ' ' ILE . 21.8 m -61.64 171.99 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 73.319999999999993 111.171 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -176.24 160.05 1.8 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.576 0.703 . . . . 71.340000000000003 110.93 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 114.01 3.56 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.735 2.29 . . . . 65.25 112.305 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -143.8 145.63 32.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 62.25 110.854 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.5 114.93 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 111.139 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.515 ' CD2' HG22 ' A' ' 167' ' ' VAL . 0.2 OUTLIER -117.15 120.02 37.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 73.099999999999994 110.929 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.76 152.26 34.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 74.209999999999994 110.899 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.0 tp -154.22 149.02 26.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.123 -0.489 . . . . 60.32 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.91 -143.6 6.14 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.772 -0.727 . . . . 54.119999999999997 112.514 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.52 167.48 22.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.845 0.355 . . . . 64.340000000000003 111.047 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 53.8 p -149.5 164.43 35.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 74.450000000000003 110.831 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 17.6 p90 -149.65 131.92 15.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.156 -0.475 . . . . 72.310000000000002 110.955 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 18' ' ' VAL . 7.3 p -84.23 134.73 26.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.109 -0.496 . . . . 65.540000000000006 111.084 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -139.71 163.02 33.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.112 -0.494 . . . . 75.540000000000006 110.854 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -110.59 95.82 5.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 74.549999999999997 110.94 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -51.92 -33.84 38.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 41.240000000000002 110.895 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -115.46 121.44 42.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 65.409999999999997 110.997 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -57.44 -38.69 74.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 53.409999999999997 111.136 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -153.31 178.15 10.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 54.100000000000001 111.089 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 15.5 tp -90.94 84.32 5.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 110.853 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 71.450000000000003 110.92 179.871 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.848 0.356 . . . . 71.329999999999998 110.916 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.46 174.97 5.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 72.219999999999999 110.94 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.83 148.33 49.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 64.329999999999998 110.971 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -107.82 159.1 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 53.240000000000002 110.906 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -82.37 160.58 61.95 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.625 0.726 . . . . 53.219999999999999 110.961 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.87 153.17 68.73 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.631 2.221 . . . . 75.329999999999998 112.318 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.33 160.33 10.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 60.039999999999999 111.117 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -89.98 154.4 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 74.150000000000006 110.921 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.1 t -91.61 172.2 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 110.858 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.55 139.16 56.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.310000000000002 111.082 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.51 -169.54 35.78 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.666 -0.778 . . . . 55.140000000000001 112.5 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -161.38 125.11 3.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.894 0.378 . . . . 72.230000000000004 110.927 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -140.23 155.13 47.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.106 -0.497 . . . . 72.439999999999998 110.868 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -64.07 143.02 58.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 74.129999999999995 110.887 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.66 7.48 53.52 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 62.210000000000001 112.521 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.68 147.8 48.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.827 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' HE1' HD22 ' A' ' 206' ' ' LEU . 20.4 m95 -117.55 129.48 55.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.24 -0.437 . . . . 75.239999999999995 110.892 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -123.39 116.1 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 55.240000000000002 111.099 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.4 108.16 19.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 72.239999999999995 111.094 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.69 122.92 45.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 72.25 110.844 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -129.2 122.6 30.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 75.329999999999998 110.881 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.45 178.33 9.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 74.349999999999994 110.835 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -118.27 131.83 56.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 61.439999999999998 110.908 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 63.3 p -96.29 156.78 16.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 110.867 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -157.48 147.66 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 73.010000000000005 110.904 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.66 123.17 37.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 75.349999999999994 111.123 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -112.63 126.68 55.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 62.109999999999999 110.883 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.9 p -155.29 142.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 60.140000000000001 111.185 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.35 132.19 46.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.777 -0.725 . . . . 64.010000000000005 112.464 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -67.17 -37.34 83.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.757 0.313 . . . . 75.329999999999998 110.878 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.568 ' HG3' HD11 ' A' ' 189' ' ' ILE . 50.9 mm-40 -53.96 -42.22 68.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 62.409999999999997 110.929 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 31.2 mt 55.49 39.03 31.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 72.200000000000003 110.888 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 56.85 -178.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.728 -0.749 . . . . 42.130000000000003 112.499 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -137.09 73.25 1.44 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.86 0.362 . . . . 73.230000000000004 110.883 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.1 mt -145.66 77.89 1.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.219 -0.446 . . . . 64.319999999999993 110.913 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -137.67 159.3 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.120000000000005 110.855 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.78 -70.45 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 50.140000000000001 111.095 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 172.9 -179.56 44.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 64.310000000000002 112.495 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.86 -172.31 45.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 31.449999999999999 112.49 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.7 -133.94 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 40.409999999999997 112.474 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.02 -43.59 64.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 74.530000000000001 111.064 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.1 tp -109.84 90.98 9.94 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.561 0.696 . . . . 64.310000000000002 110.953 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 144.91 55.42 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.645 2.23 . . . . 74.329999999999998 112.332 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -172.1 130.42 0.62 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 72.109999999999999 110.882 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -121.79 141.71 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 73.219999999999999 111.11 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -128.87 176.6 7.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 74.129999999999995 110.856 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.25 127.41 19.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.454 . . . . 73.310000000000002 111.179 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 5.1 t -115.1 118.88 34.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.9 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.8 tt -139.5 143.0 31.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 72.319999999999993 111.049 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.51 -117.91 0.59 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 75.200000000000003 112.526 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -106.78 115.22 29.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.823 0.344 . . . . 64.400000000000006 110.932 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -111.23 30.55 6.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 110.864 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -109.8 129.59 55.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 111.141 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.3 m -121.91 144.74 48.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.201 -0.454 . . . . 73.150000000000006 111.078 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.32 124.06 21.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 63.549999999999997 110.919 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 ' HE2' ' A' ' 72' ' ' PHE . 96.0 m -121.96 119.77 32.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 64.200000000000003 111.142 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -108.26 141.27 40.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 63.100000000000001 110.804 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.607 ' O ' HD13 ' A' ' 59' ' ' ILE . 3.5 m-20 -145.35 148.29 33.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 65.530000000000001 110.935 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.607 HD13 ' O ' ' A' ' 58' ' ' ASP . 35.4 mm -136.09 111.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.241 -0.436 . . . . 72.099999999999994 111.154 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.0 126.22 50.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 51.039999999999999 111.086 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -105.45 122.4 45.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 73.040000000000006 110.924 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -92.32 106.47 18.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 72.219999999999999 110.875 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.2 p -120.09 -35.82 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 111.095 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.2 m -125.63 149.23 48.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 52.450000000000003 110.911 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.4 t -77.18 -37.61 53.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.144 -0.48 . . . . 73.129999999999995 110.844 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -70.58 -40.11 73.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.114 -0.494 . . . . 54.0 110.814 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.915 HD11 HD13 ' A' ' 105' ' ' LEU . 15.5 tt -140.77 148.87 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 72.0 111.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.06 164.14 23.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 44.340000000000003 111.056 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.7 t -97.77 144.49 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 73.109999999999999 111.107 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -139.17 134.32 32.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 110.848 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.443 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 8.9 t80 -117.89 130.23 56.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 63.149999999999999 110.878 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.437 ' HE2' HG23 ' A' ' 56' ' ' THR . 10.0 t80 -114.25 126.27 54.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.136 -0.484 . . . . 72.25 110.875 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.8 p -147.52 130.1 7.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 75.049999999999997 111.1 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.33 147.76 16.76 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.796 -0.716 . . . . 72.349999999999994 112.559 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.61 155.61 13.91 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.654 0.74 . . . . 63.310000000000002 111.102 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.85 117.27 4.99 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.669 2.246 . . . . 62.229999999999997 112.324 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.47 55.48 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 75.129999999999995 111.095 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.5 tpm_? -131.82 120.59 22.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 74.400000000000006 110.91 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.24 88.05 2.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 53.409999999999997 111.139 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -117.89 170.81 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 73.099999999999994 110.938 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -169.84 132.95 1.18 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 74.230000000000004 110.834 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -59.72 126.82 29.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 71.510000000000005 110.939 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.58 -156.96 45.5 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 53.350000000000001 112.546 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -156.41 154.59 30.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.35 . . . . 74.420000000000002 110.87 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -131.74 162.67 29.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 110.911 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.1 m -58.81 -37.74 77.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 54.409999999999997 110.888 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 14.7 tt -66.37 141.87 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 52.520000000000003 111.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -99.9 176.42 5.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.453 . . . . 71.120000000000005 110.87 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t 61.79 43.12 9.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 54.439999999999998 110.854 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 25.1 mt -85.42 119.23 25.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.84 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 159.54 -176.92 36.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.773 -0.727 . . . . 64.329999999999998 112.492 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -110.49 170.88 7.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 74.329999999999998 110.846 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.6 m -73.03 178.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 63.409999999999997 111.125 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.7 p -84.7 121.15 27.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 52.100000000000001 110.938 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -95.37 128.02 41.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.089 -0.505 . . . . 74.200000000000003 110.881 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.5 m -100.95 44.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.484 . . . . 75.010000000000005 111.151 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -107.36 -179.55 3.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 73.099999999999994 110.882 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -107.33 -177.0 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 62.409999999999997 110.87 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.31 -71.21 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 75.219999999999999 112.567 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.68 145.77 58.66 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.736 2.29 . . . . 72.340000000000003 112.379 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.443 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -152.47 135.74 15.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 44.439999999999998 111.113 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 mp -121.42 138.83 50.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.445 . . . . 65.209999999999994 111.172 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.71 137.83 54.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 110.981 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 26.8 m -160.35 -178.86 7.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 55.329999999999998 110.792 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.915 HD13 HD11 ' A' ' 67' ' ' ILE . 4.3 pp -130.46 144.24 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 73.519999999999996 110.932 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -103.21 149.5 24.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 72.430000000000007 110.93 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -147.24 140.82 25.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.914 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -131.01 134.55 46.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 63.329999999999998 110.895 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -60.26 -36.09 76.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.909 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -77.94 -40.82 38.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.439999999999998 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.6 t 61.42 42.95 10.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 73.409999999999997 110.847 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -150.92 130.84 13.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.117 -0.492 . . . . 50.509999999999998 110.899 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -52.08 112.36 0.78 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.885 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -177.64 159.85 1.5 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.082 -0.508 . . . . 74.0 110.863 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 94.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.93 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -160.17 160.52 26.58 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.585 0.707 . . . . 72.340000000000003 110.963 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.74 170.2 17.11 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.679 2.253 . . . . 65.120000000000005 112.372 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -146.35 143.33 29.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.904 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 34.5 t -103.7 129.02 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 61.43 111.128 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.36 133.87 9.77 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.735 -0.745 . . . . 51.240000000000002 112.489 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 36.7 t -141.73 138.84 31.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 63.219999999999999 111.159 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.94 16.71 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.783 -0.723 . . . . 73.439999999999998 112.475 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.7 m -132.84 158.39 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.871 0.367 . . . . 64.109999999999999 111.138 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -122.72 154.6 17.01 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 53.009999999999998 112.469 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.5 125.62 34.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 60.240000000000002 110.864 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.08 138.25 51.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 71.040000000000006 111.144 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.4 HD13 ' N ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -111.9 119.71 39.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.265 -0.425 . . . . 62.420000000000002 110.865 179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.4 ' N ' HD13 ' A' ' 127' ' ' LEU . 7.7 t80 -86.46 128.24 34.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 110.884 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -95.55 151.65 19.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.479 . . . . 73.230000000000004 110.932 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -110.05 148.75 31.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 73.150000000000006 110.889 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 29.8 tttm -129.3 115.85 18.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 72.099999999999994 110.861 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.415 ' OG1' ' HB3' ' A' ' 135' ' ' ALA . 1.4 t -129.86 -44.76 1.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.148 -0.478 . . . . 63.340000000000003 111.171 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 51.59 55.35 9.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 72.329999999999998 110.893 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 97.69 -31.26 8.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.736 -0.745 . . . . 74.200000000000003 112.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HB3' ' OG1' ' A' ' 132' ' ' THR . . . -51.88 171.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.786 0.326 . . . . 55.329999999999998 111.092 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.89 104.71 13.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 72.019999999999996 110.919 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 31.5 t -143.4 151.75 40.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.442 . . . . 74.25 110.855 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -140.15 117.9 11.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 72.299999999999997 110.818 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -149.66 146.26 27.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 72.019999999999996 110.888 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.43 136.55 54.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.823 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.0 tt -139.82 132.37 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 64.129999999999995 111.137 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -100.19 161.48 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 110.941 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.31 96.6 8.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.259 -0.428 . . . . 71.129999999999995 110.959 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -128.66 125.36 37.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 72.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 2.3 p90 -88.62 157.88 18.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 65.030000000000001 110.913 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -123.16 160.36 50.25 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.55 0.691 . . . . 73.299999999999997 111.146 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.751 ' HA ' HG12 ' A' ' 123' ' ' VAL . 54.6 Cg_endo -69.74 150.16 67.98 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.691 2.261 . . . . 44.409999999999997 112.378 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.54 146.26 3.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 111.114 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -130.94 130.05 42.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 71.310000000000002 110.854 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -125.26 151.22 46.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 61.329999999999998 110.83 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 167' ' ' VAL . 92.4 t -113.65 119.61 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 75.510000000000005 111.07 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -111.15 -176.87 20.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 62.229999999999997 112.46 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.414 HD23 ' C ' ' A' ' 153' ' ' LEU . 10.2 tt -162.47 137.35 6.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.793 0.33 . . . . 74.129999999999995 110.946 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -118.86 130.43 55.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.819 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -137.41 135.23 36.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 64.109999999999999 110.99 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -88.42 105.31 17.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.174 -0.466 . . . . 64.409999999999997 110.944 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 9.5 mt -121.74 -58.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 110.953 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -71.52 -179.22 30.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.815 -0.707 . . . . 53.420000000000002 112.464 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -102.22 -38.1 7.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.843 0.354 . . . . 73.5 110.936 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 58.1 m -92.26 -50.49 5.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.45 . . . . 74.019999999999996 110.809 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 5.9 m0 -106.76 162.8 13.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.913 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 31.7 mtt -111.91 149.8 31.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 110.858 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.475 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.3 OUTLIER -69.87 124.09 23.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 75.239999999999995 110.901 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.475 ' N ' HD13 ' A' ' 163' ' ' LEU . 61.1 t30 -120.29 129.78 54.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 71.030000000000001 110.91 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 30.6 t -130.96 141.31 50.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.454 . . . . 61.340000000000003 110.898 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -140.58 145.38 36.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.105 -0.498 . . . . 64.439999999999998 110.847 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 16.4 m -146.89 140.62 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 74.319999999999993 111.177 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -134.04 122.07 22.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 74.510000000000005 110.87 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -139.73 153.01 47.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 73.430000000000007 110.938 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.6 tt -141.89 132.16 12.76 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.644 0.735 . . . . 62.32 111.107 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.72 161.21 46.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.685 2.257 . . . . 63.399999999999999 112.404 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -60.98 176.47 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 75.200000000000003 110.887 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 33.7 mtmm -150.88 121.95 7.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.174 -0.466 . . . . 65.230000000000004 110.883 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 14.1 p 49.94 40.58 21.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.295 -0.411 . . . . 75.219999999999999 111.059 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.76 149.74 30.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 61.140000000000001 110.842 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 9.6 p -75.26 137.94 21.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 70.219999999999999 111.152 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.66 115.21 8.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 70.409999999999997 111.145 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -74.05 -142.65 0.71 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.778 -0.725 . . . . 71.319999999999993 112.464 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.8 m -64.63 158.26 24.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.82 0.343 . . . . 74.329999999999998 111.135 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 8.5 mp -53.47 136.62 37.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 72.140000000000001 110.94 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -129.53 71.58 0.49 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.686 -0.769 . . . . 63.240000000000002 112.514 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -179.65 3.05 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.647 2.231 . . . . 70.120000000000005 112.34 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.4 t 55.9 71.69 1.17 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 73.510000000000005 111.079 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.83 179.38 3.78 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.707 2.271 . . . . 63.439999999999998 112.322 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.8 m -107.71 172.47 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 111.065 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 6.2 p -59.54 173.49 0.54 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.068 -0.515 . . . . 53.350000000000001 110.877 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.2 p -52.59 145.28 12.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 111.163 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 tptp -174.21 141.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.898 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' A' ' 31' ' ' GLU . 15.3 pt -57.95 169.08 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 72.219999999999999 111.081 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -159.34 160.46 35.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 64.120000000000005 110.932 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 45.2 t -58.36 129.21 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 61.340000000000003 111.102 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -176.16 71.75 0.26 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.638 0.733 . . . . 71.420000000000002 110.874 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 145.0 55.45 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.702 2.268 . . . . 73.430000000000007 112.285 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -155.24 171.41 19.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 63.329999999999998 110.887 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 72.2 mt -96.46 131.24 43.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.124 -0.489 . . . . 63.420000000000002 111.13 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 6.6 tt -128.1 124.57 37.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.105 -0.498 . . . . 71.349999999999994 110.887 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -124.5 144.63 50.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 61.140000000000001 110.857 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 11.1 mt -145.92 146.64 31.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 75.25 110.882 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.67 -134.04 2.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 62.219999999999999 112.52 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -149.9 175.59 11.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 63.439999999999998 111.057 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 24.5 p -146.62 168.77 20.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 52.140000000000001 110.907 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -139.25 141.19 37.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.159 -0.473 . . . . 72.239999999999995 110.962 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.1 p -103.48 136.63 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 71.030000000000001 111.18 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -137.87 133.83 34.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.986 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 97.1 4.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 73.299999999999997 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.424 HD22 ' HE1' ' A' ' 17' ' ' TRP . 2.6 pt? -51.85 -33.87 38.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 64.340000000000003 110.899 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.98 63.58 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 73.099999999999994 111.097 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.58 102.41 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 63.329999999999998 111.087 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.29 49.25 0.83 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 111.109 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 78.4 mt -125.84 -51.09 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 44.130000000000003 110.963 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.138 -0.483 . . . . 63.340000000000003 110.868 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.791 0.329 . . . . 74.329999999999998 110.837 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -165.12 171.33 13.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 61.450000000000003 110.942 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.03 175.65 5.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 74.219999999999999 110.846 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.9 178.51 4.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.478 . . . . 72.5 110.898 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -92.67 160.56 34.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.678 0.752 . . . . 64.230000000000004 110.96 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 156.78 62.43 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.65 2.233 . . . . 72.030000000000001 112.336 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.39 111.23 3.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 63.009999999999998 111.085 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -64.86 -178.15 0.4 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 64.010000000000005 110.888 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.8 m -103.59 -178.74 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 70.340000000000003 110.834 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.8 159.54 15.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 111.09 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.34 -175.65 24.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.759 -0.734 . . . . 62.310000000000002 112.467 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -157.38 117.72 3.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.868 0.366 . . . . 74.549999999999997 110.875 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -136.08 173.36 11.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.078 -0.51 . . . . 63.539999999999999 110.918 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -55.28 139.45 42.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 75.200000000000003 110.839 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.44 7.39 37.26 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.752 -0.737 . . . . 71.420000000000002 112.469 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.79 154.93 35.93 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.838 0.351 . . . . 72.25 110.841 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.713 ' CH2' HD13 ' A' ' 206' ' ' LEU . 43.3 m0 -123.39 130.31 52.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.184 -0.462 . . . . 74.140000000000001 110.936 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 35.8 t -117.85 138.73 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 55.43 111.063 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.14 117.89 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.148 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -129.65 155.85 45.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 74.319999999999993 110.872 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -143.45 131.57 21.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.86 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -147.89 159.04 44.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 110.836 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -103.23 142.78 33.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 110.922 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.08 147.62 22.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.11 -0.495 . . . . 64.519999999999996 110.921 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -150.22 147.76 28.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 65.239999999999995 110.861 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.1 p -85.52 137.33 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 43.420000000000002 111.114 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -118.76 111.66 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 65.450000000000003 110.909 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.3 p -139.6 141.91 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 52.299999999999997 111.105 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.49 149.7 19.57 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.771 -0.728 . . . . 41.43 112.533 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -59.99 -41.99 93.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.878 0.371 . . . . 63.229999999999997 110.899 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 63.17 53.48 2.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 52.549999999999997 110.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tt -57.03 -35.61 69.48 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.944 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -124.34 -151.87 8.23 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.751 -0.738 . . . . 64.340000000000003 112.482 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 59.38 52.73 5.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.902 0.382 . . . . 75.109999999999999 110.894 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.47 60.07 5.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.132 -0.485 . . . . 71.109999999999999 110.911 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -107.67 152.15 24.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 75.319999999999993 110.931 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -52.06 -35.81 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 111.105 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.54 -119.26 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.691 -0.766 . . . . 74.549999999999997 112.521 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -147.41 -175.94 20.66 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.781 -0.723 . . . . 52.409999999999997 112.54 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.78 -37.27 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.701 -0.762 . . . . 53.009999999999998 112.453 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.29 158.21 44.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.836 0.35 . . . . 52.140000000000001 111.122 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 tt -110.38 91.04 11.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.572 0.701 . . . . 71.340000000000003 110.847 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 142.31 47.3 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.71 2.274 . . . . 44.100000000000001 112.338 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.4 173.33 12.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 62.420000000000002 110.896 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.9 -178.85 5.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 65.340000000000003 111.158 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -117.72 -74.27 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 72.319999999999993 110.836 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -137.23 136.7 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.120000000000005 111.104 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.6 t -149.18 132.86 16.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.889 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.3 tt -173.15 139.23 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 74.129999999999995 111.13 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.5 -123.95 1.2 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.71 -0.757 . . . . 40.240000000000002 112.464 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -123.42 46.78 2.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.796 0.331 . . . . 70.549999999999997 110.923 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -95.26 -38.44 10.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.148 -0.478 . . . . 74.129999999999995 110.904 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.1 p -51.85 121.44 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.164 -0.471 . . . . 45.32 111.181 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.57 110.93 17.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 111.152 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -61.84 133.08 55.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 73.329999999999998 110.842 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.85 137.11 34.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 51.109999999999999 111.118 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -106.21 134.94 48.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 74.319999999999993 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -127.12 131.73 50.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.878 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 59' ' ' ILE . 14.3 tt -119.29 122.32 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 111.103 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.518 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -109.67 167.39 10.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 73.510000000000005 111.113 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -140.2 131.37 26.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.210000000000001 110.956 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -98.23 102.35 14.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.118 -0.492 . . . . 74.430000000000007 110.859 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.69 -35.74 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.519999999999996 111.147 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.1 m -122.98 149.23 44.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 110.866 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.1 t -80.46 -35.97 34.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 73.25 110.869 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -68.75 -41.66 78.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.471 . . . . 73.510000000000005 110.944 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.4 mt -141.94 148.66 20.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.149999999999999 111.112 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.77 169.42 9.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.127 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.76 141.54 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 111.116 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -141.28 135.77 30.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.948 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 2.9 t80 -128.24 131.73 48.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 71.25 110.831 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -110.02 129.43 55.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 72.239999999999995 110.916 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.1 m -144.44 142.69 23.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 111.178 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -107.28 133.57 11.73 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.762 -0.732 . . . . 71.430000000000007 112.459 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.2 p -90.59 133.22 33.13 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.62 0.724 . . . . 54.310000000000002 111.13 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.419 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.87 170.62 16.27 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 61.039999999999999 112.313 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -164.19 125.86 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 53.240000000000002 111.074 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.87 146.59 52.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.826 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.47 128.97 4.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 71.25 111.089 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -81.69 151.16 27.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 63.350000000000001 110.827 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -110.18 159.31 17.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.941 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -160.27 137.04 9.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 110.876 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 104.32 142.4 11.61 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.713 -0.756 . . . . 62.109999999999999 112.48 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -136.48 128.11 28.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 64.129999999999995 110.965 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt 55.29 40.8 31.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 64.120000000000005 110.896 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.0 m -118.5 38.34 3.77 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 51.520000000000003 110.808 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.3 mp 54.23 79.32 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 74.349999999999994 111.136 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 58.1 m -160.64 -62.92 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 72.409999999999997 110.84 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.9 t -137.04 103.48 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 74.25 110.917 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 tt -87.04 76.36 9.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 70.239999999999995 110.882 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 149.18 -166.12 29.45 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.757 -0.735 . . . . 55.539999999999999 112.499 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -130.53 58.09 1.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.818 0.342 . . . . 64.420000000000002 110.89 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.46 175.19 5.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 73.040000000000006 111.193 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.2 t 55.9 44.51 25.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 51.100000000000001 110.836 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -122.85 36.94 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 55.409999999999997 110.883 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.17 -176.43 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.299999999999997 111.061 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -85.44 159.92 19.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 45.409999999999997 110.846 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -142.88 163.41 32.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.174 -0.466 . . . . 72.400000000000006 110.929 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.03 75.74 0.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.726 -0.749 . . . . 45.549999999999997 112.421 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 168.66 20.9 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.693 2.262 . . . . 75.120000000000005 112.399 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.481 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -146.23 119.28 8.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.283 -0.417 . . . . 71.319999999999993 111.09 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.536 HD12 ' HA3' ' A' ' 124' ' ' GLY . 22.7 mm -117.76 129.12 74.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 111.102 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.97 124.12 46.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.103 -0.498 . . . . 53.039999999999999 110.932 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 t -155.82 159.84 39.73 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 74.400000000000006 110.878 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -105.51 146.23 29.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 62.219999999999999 110.961 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -103.09 138.61 39.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 75.150000000000006 110.871 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -133.99 135.06 43.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 50.009999999999998 110.929 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -131.0 166.84 20.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 63.43 110.838 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -131.24 36.3 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.010000000000005 110.891 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.04 -37.67 7.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 42.329999999999998 110.843 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 t 63.17 39.0 10.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 72.439999999999998 110.85 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -149.45 -178.99 6.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.077 -0.511 . . . . 74.200000000000003 110.891 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -120.45 50.44 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 63.210000000000001 110.848 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -131.54 -174.06 3.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 70.540000000000006 110.834 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.64 115.58 4.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.931 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.3 160.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.671 0.748 . . . . 73.319999999999993 110.866 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 171.15 15.0 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 71.25 112.312 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -164.6 135.1 4.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.299999999999997 110.904 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.768 HG13 HG12 ' A' ' 151' ' ' VAL . 39.1 t -105.93 144.34 15.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 40.009999999999998 111.111 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -126.46 131.87 7.54 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 74.329999999999998 112.48 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.3 t -136.33 141.62 40.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 75.299999999999997 111.126 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.77 -153.61 21.23 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 34.229999999999997 112.504 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -127.21 150.59 33.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.85 0.357 . . . . 54.030000000000001 111.15 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -121.38 148.88 17.35 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 62.43 112.522 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -144.7 161.89 38.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.845 0.355 . . . . 72.409999999999997 110.941 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.05 142.28 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 61.450000000000003 111.137 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -106.2 134.37 49.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 41.520000000000003 110.983 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -102.98 125.38 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 74.340000000000003 110.844 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -122.16 94.31 4.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.105 -0.498 . . . . 74.219999999999999 110.874 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -128.17 142.91 51.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 75.319999999999993 110.898 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -111.15 77.95 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.476 . . . . 71.329999999999998 110.886 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.73 150.34 47.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.277 -0.42 . . . . 73.239999999999995 111.126 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.06 129.24 56.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 71.420000000000002 110.821 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -144.32 119.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.635 -0.793 . . . . 73.510000000000005 112.415 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.66 ' HB3' HD13 ' A' ' 136' ' ' LEU . . . -64.82 -30.24 71.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.832 0.349 . . . . 70.129999999999995 111.143 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.66 HD13 ' HB3' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -154.08 33.37 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 51.299999999999997 110.914 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 22.6 t -120.18 49.19 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 53.329999999999998 110.863 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t -64.24 -69.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 62.310000000000002 110.756 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 55.45 40.17 31.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 64.439999999999998 110.862 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -104.06 41.75 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 53.420000000000002 110.908 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.3 mt -121.5 82.25 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.158 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -155.92 162.78 40.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 74.120000000000005 110.965 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -103.3 137.57 41.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.287 -0.415 . . . . 75.25 110.86 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.23 -35.98 2.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 43.32 110.971 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -54.88 115.87 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 72.200000000000003 110.966 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -124.25 160.39 52.78 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.579 0.705 . . . . 63.219999999999999 111.134 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.73 143.84 52.26 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.667 2.244 . . . . 74.200000000000003 112.369 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -123.58 128.32 49.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 65.209999999999994 111.115 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -162.4 120.67 2.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.896 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -148.65 163.64 36.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 71.099999999999994 110.923 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.768 HG12 HG13 ' A' ' 119' ' ' VAL . 21.3 m -132.17 123.59 50.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.434 . . . . 65.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -135.9 -169.14 11.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 64.239999999999995 112.459 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -146.54 150.42 35.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.753 0.311 . . . . 74.019999999999996 110.93 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.41 133.36 54.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 63.509999999999998 110.902 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.45 ' HE2' HD13 ' A' ' 157' ' ' LEU . 44.2 t80 -114.78 114.01 25.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.040000000000006 110.896 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -71.72 155.28 40.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.124 -0.489 . . . . 64.150000000000006 110.84 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.45 HD13 ' HE2' ' A' ' 155' ' ' TYR . 23.6 tp -162.14 116.28 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 74.319999999999993 110.896 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -84.29 69.94 3.24 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.140000000000001 112.526 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -141.09 -58.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 74.25 110.918 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 41.9 t -142.42 -74.06 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 63.219999999999999 110.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.7 p90 -123.31 178.63 5.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.145 -0.48 . . . . 61.310000000000002 110.975 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.9 mmt -102.95 162.7 12.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 110.912 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.81 132.36 45.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 73.519999999999996 110.955 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -125.19 127.66 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 74.230000000000004 110.911 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 22.0 t -132.02 138.24 48.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.349999999999994 110.916 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -128.62 139.84 52.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.876 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.711 HG22 ' CD1' ' A' ' 196' ' ' LEU . 21.9 t -132.43 139.61 49.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.147 -0.478 . . . . 73.430000000000007 111.071 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 27.7 ttt180 -143.44 109.54 5.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.876 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -95.56 127.66 41.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 110.927 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 171' ' ' PRO . 45.5 mm -82.38 133.12 50.81 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.629 0.728 . . . . 72.209999999999994 111.104 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.3 Cg_endo -69.79 169.63 18.51 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.251 . . . . 75.450000000000003 112.32 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -66.12 129.13 38.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 64.430000000000007 110.843 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -174.3 104.35 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 73.549999999999997 110.911 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 p -140.53 135.93 32.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 52.32 111.143 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -80.75 144.88 31.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 110.819 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 11.2 p -55.22 150.83 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 111.139 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.58 108.88 9.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 73.299999999999997 111.128 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 99.5 1.94 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.717 -0.754 . . . . 40.140000000000001 112.499 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.3 m -137.74 136.68 37.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 64.439999999999998 111.131 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 180' ' ' LEU . 1.3 pt? -116.33 166.73 11.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.25 -0.432 . . . . 34.210000000000001 110.92 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.21 176.79 20.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.787 -0.72 . . . . 61.450000000000003 112.47 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 128.07 15.44 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.619 2.212 . . . . 73.209999999999994 112.372 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 23.7 t -131.94 71.17 80.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.596 0.712 . . . . 74.430000000000007 111.141 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -45.78 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.682 2.255 . . . . 62.100000000000001 112.337 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -91.36 143.38 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.150000000000006 111.14 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 70.7 m -80.29 131.68 35.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 71.230000000000004 110.852 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.2 t -134.06 123.21 24.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 111.125 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.5 pttt -173.56 124.31 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.253 -0.431 . . . . 61.039999999999999 110.907 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 14.9 pt -117.38 -35.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 63.130000000000003 111.155 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -98.91 65.65 1.52 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.195 -0.457 . . . . 72.140000000000001 110.866 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 37.7 t -83.81 -64.58 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 52.450000000000003 111.133 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -174.53 72.25 0.31 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.525 0.678 . . . . 51.329999999999998 110.895 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 144.6 54.69 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.741 2.294 . . . . 72.200000000000003 112.347 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.53 171.04 7.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.92 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 75.1 mt -120.74 127.51 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.099999999999994 111.124 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.711 ' CD1' HG22 ' A' ' 167' ' ' VAL . 4.9 tp -140.05 130.64 25.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.455 . . . . 60.149999999999999 110.948 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.45 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.6 m -120.36 152.28 38.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 63.530000000000001 110.861 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 197' ' ' SER . 3.8 mp -145.34 147.62 32.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 62.32 110.941 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 176.5 -146.44 7.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.696 -0.764 . . . . 52.229999999999997 112.481 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -131.92 170.8 14.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.741 0.305 . . . . 61.530000000000001 111.164 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.6 t -140.25 154.4 46.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 74.140000000000001 110.824 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.448 ' O ' HG13 ' A' ' 18' ' ' VAL . 8.1 t80 -139.65 144.15 37.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 110.961 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.3 m -108.16 145.56 15.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.131 -0.486 . . . . 41.539999999999999 111.071 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -139.68 124.27 18.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 53.32 110.926 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.65 85.96 2.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.878 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.713 HD13 ' CH2' ' A' ' 17' ' ' TRP . 2.6 pt? -52.19 -33.8 42.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.285 -0.416 . . . . 74.450000000000003 110.933 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.77 59.16 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 24.52 111.123 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -173.31 111.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 111.057 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.75 144.35 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 73.450000000000003 111.119 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.53 101.31 4.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 73.420000000000002 110.949 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.925 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 mmt . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.814 0.34 . . . . 74.450000000000003 110.923 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -143.86 -176.92 5.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 70.25 110.863 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -173.32 161.66 4.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 74.519999999999996 110.928 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.18 -179.14 4.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 53.439999999999998 110.859 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -115.61 157.63 43.86 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.67 0.748 . . . . 61.439999999999998 110.936 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 -178.15 2.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 72.299999999999997 112.354 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.63 -176.49 1.3 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.456 . . . . 65.049999999999997 111.094 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -123.03 -40.99 2.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 61.210000000000001 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -73.89 134.86 43.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 50.530000000000001 110.856 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.95 -178.99 7.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.430000000000007 111.024 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 162.98 -175.01 39.37 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.504 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -163.34 120.89 1.89 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.882 0.372 . . . . 64.329999999999998 110.944 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -146.17 160.31 42.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.129999999999995 110.927 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -58.23 132.4 53.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.884 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.2 7.56 28.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.774 -0.726 . . . . 24.440000000000001 112.527 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -75.89 158.08 32.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.828 0.347 . . . . 64.409999999999997 110.869 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -128.39 131.89 48.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 74.450000000000003 110.901 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 202' ' ' TYR . 37.7 t -127.98 124.69 63.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 55.130000000000003 111.157 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.59 112.96 25.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 42.109999999999999 111.128 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 38.1 m -111.42 129.52 55.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 73.019999999999996 110.922 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.5 p90 -134.58 132.89 39.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 65.219999999999999 110.894 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -155.9 157.81 36.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.475 . . . . 54.340000000000003 110.895 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -101.82 131.25 48.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.420000000000002 110.852 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.0 t -82.14 140.43 33.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 64.200000000000003 110.845 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -126.64 117.54 22.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 73.150000000000006 110.931 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG12 HD12 ' A' ' 195' ' ' ILE . 33.1 m -81.29 133.04 30.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 63.210000000000001 111.102 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -125.31 104.51 8.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 75.049999999999997 110.919 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.9 p -155.53 151.69 9.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 73.420000000000002 111.1 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.37 33.89 5.68 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 61.509999999999998 112.507 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -92.21 8.31 38.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 110.861 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 -55.51 -41.02 72.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.200000000000003 110.913 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 mt 56.07 40.57 30.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.878 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.09 149.0 35.49 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.771 -0.728 . . . . 53.340000000000003 112.527 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -53.61 156.15 2.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.877 0.37 . . . . 71.409999999999997 110.84 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 12.6 mt -107.38 62.36 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 65.019999999999996 110.867 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -82.12 62.85 6.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.905 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.26 162.96 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 64.230000000000004 111.134 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.03 87.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.68 -0.771 . . . . 62.420000000000002 112.509 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 65.9 157.44 0.43 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.728 -0.749 . . . . 75.150000000000006 112.483 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.73 161.61 37.08 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.747 -0.739 . . . . 43.240000000000002 112.435 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -118.84 54.95 0.94 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.806 0.336 . . . . 34.340000000000003 111.108 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.2 mt -100.7 159.22 30.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.662 0.744 . . . . 74.409999999999997 110.875 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 173.47 10.88 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.67 2.246 . . . . 74.120000000000005 112.35 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -110.5 174.99 5.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 64.310000000000002 110.867 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.62 160.45 3.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.09 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 170.77 0.18 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 73.430000000000007 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -114.62 177.33 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 111.042 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.4 p -71.71 125.83 28.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.131 -0.486 . . . . 64.409999999999997 110.885 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.5 tt -85.82 142.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 72.230000000000004 111.148 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -172.35 -101.42 0.15 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.765 -0.731 . . . . 62.340000000000003 112.496 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -96.95 62.49 1.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 72.25 110.862 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -107.33 -37.06 6.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 62.43 110.902 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.4 p -70.55 143.57 51.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 111.156 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -105.33 101.06 10.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.439 . . . . 75.219999999999999 111.169 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.1 pp -55.73 131.02 45.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 72.230000000000004 110.943 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.96 141.82 46.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.240000000000002 111.16 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -113.85 156.63 23.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 74.049999999999997 110.837 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -163.75 128.87 2.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 65.230000000000004 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.0 pt -108.36 128.07 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.458 . . . . 53.130000000000003 111.154 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.45 124.5 52.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 62.229999999999997 111.094 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.35 121.75 40.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 73.530000000000001 110.902 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.16 102.0 12.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 71.420000000000002 110.912 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.1 m -113.84 -35.52 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 71.439999999999998 111.145 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.63 148.95 36.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 72.230000000000004 110.821 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -71.91 -35.88 69.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 63.009999999999998 110.871 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -80.08 -36.05 36.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 74.030000000000001 110.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 107' ' ' TYR . 82.9 mt -132.98 123.83 49.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 70.230000000000004 111.094 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.8 158.67 23.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 52.020000000000003 111.161 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 98.2 t -95.79 139.23 19.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 65.409999999999997 111.14 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -137.51 138.91 40.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 71.439999999999998 110.836 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.534 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -139.32 106.58 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 63.219999999999999 110.876 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -88.79 149.0 23.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 110.839 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.0 p -162.41 148.08 4.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.083 -0.508 . . . . 74.099999999999994 111.09 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.64 138.45 6.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 63.439999999999998 112.409 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 75' ' ' VAL . 2.7 p -114.02 85.6 10.25 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.626 0.727 . . . . 73.200000000000003 111.089 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 158.16 57.87 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.731 2.287 . . . . 71.540000000000006 112.327 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 36.73 3.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 72.310000000000002 111.071 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.29 168.81 16.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.269 -0.423 . . . . 73.209999999999994 110.846 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -82.64 179.69 7.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.495 . . . . 72.239999999999995 111.058 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.01 170.74 15.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 110.888 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -79.01 161.67 26.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 72.109999999999999 110.955 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.56 175.55 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 64.239999999999995 110.915 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -107.75 -59.06 0.56 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 73.310000000000002 112.54 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -92.81 125.92 37.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 72.129999999999995 110.928 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -64.88 94.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 72.239999999999995 110.91 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.0 m -159.81 116.24 2.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 63.229999999999997 110.86 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.54 HG22 ' H ' ' A' ' 90' ' ' LEU . 63.8 mt -61.74 -50.46 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 55.409999999999997 111.076 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.0 t 62.77 37.82 12.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.839 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 t 53.61 53.69 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 43.210000000000001 110.84 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.54 ' H ' HG22 ' A' ' 87' ' ' ILE . 1.8 tt -75.9 131.33 39.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 73.420000000000002 110.958 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -139.38 -87.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.711 -0.757 . . . . 73.209999999999994 112.477 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -88.08 -73.89 0.47 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.883 0.373 . . . . 72.430000000000007 110.964 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 41.3 t 58.05 73.1 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 74.439999999999998 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -100.72 138.73 37.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.474 . . . . 40.149999999999999 110.841 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -151.83 127.17 9.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 64.140000000000001 110.897 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 22.0 m -53.08 138.63 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 42.329999999999998 111.15 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -149.3 156.04 41.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 75.239999999999995 110.826 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -79.6 114.86 18.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.165 -0.471 . . . . 72.25 110.948 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.72 165.87 52.84 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 41.420000000000002 112.504 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.543 ' HB3' HG23 ' A' ' 126' ' ' VAL . 54.1 Cg_endo -69.72 178.43 4.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.682 2.255 . . . . 74.400000000000006 112.4 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.534 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -158.42 122.48 4.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 74.519999999999996 111.121 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.1 mt -118.42 112.85 39.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 71.219999999999999 111.039 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 103' ' ' LEU . 3.2 pp -101.84 127.21 48.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 71.420000000000002 110.966 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.8 p -160.57 159.56 30.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 63.020000000000003 110.916 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.7 mp -99.68 136.06 40.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 72.209999999999994 110.841 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -103.07 135.41 44.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 62.340000000000003 110.911 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.645 ' HE2' HG23 ' A' ' 67' ' ' ILE . 3.5 m-85 -123.92 114.01 19.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 71.420000000000002 110.932 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -132.32 87.89 2.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 74.439999999999998 110.85 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -114.67 29.42 8.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 63.329999999999998 110.92 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.07 18.36 22.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.123 -0.49 . . . . 72.040000000000006 110.858 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.5 m -77.54 55.39 1.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 71.400000000000006 110.812 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -119.9 84.69 2.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.134 -0.485 . . . . 73.549999999999997 110.914 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 53.95 39.32 30.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.101 -0.499 . . . . 73.230000000000004 110.915 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.785 ' HD3' HD23 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -163.1 -173.42 3.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 74.5 110.894 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.785 HD23 ' HD3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -57.86 166.64 1.38 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 72.040000000000006 110.871 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -114.08 70.85 1.97 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.676 0.75 . . . . 75.319999999999993 110.95 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 121.35 8.05 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 65.340000000000003 112.363 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -112.88 133.96 54.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 70.010000000000005 110.95 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 151' ' ' VAL . 7.9 m -109.58 120.95 61.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 53.520000000000003 111.137 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -101.02 128.46 9.58 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.711 -0.757 . . . . 65.129999999999995 112.465 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.76 124.79 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.941 0.401 . . . . 64.200000000000003 111.09 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.54 -153.33 12.56 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.727 -0.749 . . . . 75.400000000000006 112.447 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.99 153.48 36.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.944 0.402 . . . . 73.239999999999995 111.096 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.21 153.49 25.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.744 -0.741 . . . . 65.340000000000003 112.476 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.01 147.48 51.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.883 0.373 . . . . 70.230000000000004 110.861 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 100' ' ' PRO . 7.6 p -146.3 144.47 20.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.46 . . . . 45.549999999999997 111.174 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.43 119.72 21.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.223 -0.444 . . . . 73.120000000000005 110.897 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -91.92 151.01 20.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 74.099999999999994 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -93.83 -176.54 4.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 64.439999999999998 110.887 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -65.99 144.04 57.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.83 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.7 ttmt -114.52 -37.06 4.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.48 . . . . 74.219999999999999 110.921 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 m 56.42 44.1 24.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 75.329999999999998 111.122 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -69.82 143.35 52.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.278 -0.419 . . . . 72.239999999999995 110.847 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.93 -95.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.771 -0.728 . . . . 63.240000000000002 112.532 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -117.05 146.58 43.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.859 0.361 . . . . 62.229999999999997 111.105 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -166.48 176.97 6.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 74.540000000000006 110.934 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 4.7 m -104.07 144.28 31.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 70.549999999999997 110.878 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.3 m -150.92 170.15 20.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 51.340000000000003 110.853 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -118.65 -61.76 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 75.510000000000005 110.892 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -128.23 -62.39 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.477 . . . . 50.149999999999999 110.87 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.5 tt -172.2 145.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 111.141 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -64.34 162.6 14.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 70.530000000000001 110.914 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -110.9 167.09 10.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 64.450000000000003 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -115.42 -55.25 2.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 60.049999999999997 110.883 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -63.4 122.03 15.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 110.975 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.586 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -125.74 160.44 56.25 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.56 0.695 . . . . 71.510000000000005 111.155 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.586 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.2 Cg_endo -69.78 142.38 47.69 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.657 2.238 . . . . 64.25 112.351 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -125.65 129.49 49.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 72.120000000000005 111.093 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -156.19 127.56 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.262 -0.426 . . . . 75.109999999999999 110.847 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.48 163.54 40.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.467 . . . . 65.209999999999994 110.867 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.014 HG12 HG12 ' A' ' 119' ' ' VAL . 24.5 m -130.86 123.93 55.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 44.210000000000001 111.082 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -119.74 171.6 14.48 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.796 -0.716 . . . . 63.240000000000002 112.536 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD22 ' OH ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -125.78 125.76 43.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.863 0.363 . . . . 61.210000000000001 110.861 -179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -108.22 136.34 48.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.111 -0.495 . . . . 70.310000000000002 110.912 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.471 ' OH ' HD22 ' A' ' 153' ' ' LEU . 15.6 m-85 -133.68 144.7 49.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 74.099999999999994 110.924 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -104.91 104.23 13.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 73.549999999999997 110.935 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.3 mp -74.46 -55.72 5.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 110.922 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 143.34 43.97 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.693 -0.765 . . . . 72.209999999999994 112.416 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -150.23 179.39 8.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.804 0.335 . . . . 65.230000000000004 110.908 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 p -52.08 -38.64 57.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 73.530000000000001 110.828 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.8 p90 -104.04 153.08 21.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 74.200000000000003 110.958 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 55.5 mtt -121.4 160.12 24.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.868 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.494 HD23 ' N ' ' A' ' 164' ' ' ASN . 2.5 tt -68.47 126.97 31.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 61.219999999999999 110.915 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.494 ' N ' HD23 ' A' ' 163' ' ' LEU . 21.3 t-20 -126.47 109.9 12.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 71.120000000000005 110.893 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.2 m -115.59 148.24 39.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 65.219999999999999 110.964 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.633 ' O ' HD12 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -130.87 139.27 50.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 110.855 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.463 HG22 HD13 ' A' ' 196' ' ' LEU . 30.8 t -136.62 121.7 26.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 70.329999999999998 111.177 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 158.47 42.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 73.310000000000002 110.863 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -128.45 149.15 50.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.227 -0.442 . . . . 72.109999999999999 110.924 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 9.5 tt -111.75 132.12 22.07 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.642 0.734 . . . . 74.239999999999995 111.118 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 81.22 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.66 2.24 . . . . 73.400000000000006 112.355 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -88.09 -72.44 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 72.209999999999994 110.887 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -72.61 134.7 45.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.400000000000006 110.872 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.2 m -120.9 154.37 35.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 60.130000000000003 111.124 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -78.89 88.73 4.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 60.100000000000001 110.881 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.12 147.63 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 65.040000000000006 111.134 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.2 m -103.22 -55.64 2.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 73.0 111.19 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.38 52.05 7.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.735 -0.745 . . . . 60.119999999999997 112.494 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.18 169.95 20.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.852 0.358 . . . . 63.539999999999999 111.076 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 29.6 mt -102.12 83.5 2.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 70.150000000000006 110.958 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 174.76 174.48 41.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.7 -0.762 . . . . 51.539999999999999 112.495 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -174.99 1.01 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.746 2.298 . . . . 62.329999999999998 112.352 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 8.4 m -138.74 69.39 44.24 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.688 0.756 . . . . 73.510000000000005 111.149 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 -40.92 4.6 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.65 2.233 . . . . 71.409999999999997 112.309 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.02 136.23 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 62.420000000000002 111.063 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 33.5 m -141.54 -176.84 4.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.177 -0.465 . . . . 60.549999999999997 110.84 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 13.7 p 49.84 38.6 16.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.122 -0.49 . . . . 73.340000000000003 111.114 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -126.35 55.27 1.51 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.236 -0.438 . . . . 43.439999999999998 110.916 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 5.3 mp -94.34 114.03 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 71.230000000000004 111.087 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -70.55 160.63 32.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 70.209999999999994 110.935 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 m -75.35 146.39 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 72.099999999999994 111.119 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.0 156.53 36.56 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 62.450000000000003 110.918 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.77 148.77 65.72 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.716 2.278 . . . . 75.209999999999994 112.318 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -133.18 150.02 52.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 75.310000000000002 110.888 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 26' ' ' VAL . 42.2 mm -118.67 120.87 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 111.157 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 166' ' ' ASP . 20.9 tp -127.83 120.18 27.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.465 . . . . 71.349999999999994 110.88 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.34 151.7 25.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 72.140000000000001 110.852 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 4.2 mp -141.51 138.82 33.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.898 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.99 -148.89 7.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.732 -0.747 . . . . 75.219999999999999 112.455 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -143.03 169.31 17.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 62.119999999999997 111.081 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.6 p -135.21 159.14 42.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 60.350000000000001 110.85 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.488 ' O ' HG13 ' A' ' 18' ' ' VAL . 2.6 t80 -133.98 125.35 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 74.129999999999995 110.917 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -85.91 136.78 22.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.096 -0.502 . . . . 72.420000000000002 111.134 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -139.66 131.63 27.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 74.040000000000006 110.911 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 9.2 pttm -117.62 69.7 0.78 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 71.340000000000003 110.897 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 206' ' ' LEU . 2.7 tt -65.42 -36.82 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.908 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -82.73 83.83 7.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 62.119999999999997 111.134 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.09 103.93 1.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 71.439999999999998 111.11 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -73.01 77.84 1.19 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.510000000000005 111.098 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 19.6 tp -137.31 126.45 24.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 71.030000000000001 110.882 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.892 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.828 0.347 . . . . 73.420000000000002 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -54.79 136.52 46.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 74.040000000000006 110.893 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.43 -60.11 2.05 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 72.329999999999998 110.891 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -150.68 147.76 27.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 61.119999999999997 110.903 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -51.72 156.91 2.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.691 0.758 . . . . 75.120000000000005 111.003 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 140.28 42.48 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.734 2.289 . . . . 63.219999999999999 112.335 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.26 171.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 55.219999999999999 111.092 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -75.83 -175.97 3.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 110.911 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -69.33 133.45 47.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 62.520000000000003 110.865 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.55 118.02 8.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.469 . . . . 71.510000000000005 111.095 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.71 -150.71 8.16 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.703 -0.761 . . . . 63.100000000000001 112.508 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -129.73 115.15 16.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.976 0.417 . . . . 73.299999999999997 110.973 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -118.92 168.44 10.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.106 -0.497 . . . . 71.019999999999996 110.927 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.592 ' HB2' HG13 ' A' ' 63' ' ' VAL . 4.1 pt20 -58.95 143.05 49.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 71.150000000000006 110.903 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.4 7.33 54.38 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.737 -0.744 . . . . 70.109999999999999 112.464 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.42 146.59 19.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 73.540000000000006 110.909 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 15.9 t90 -116.0 115.3 25.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 74.040000000000006 110.933 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 203' ' ' VAL . 93.7 t -115.05 120.58 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.422 . . . . 74.329999999999998 111.153 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.21 109.14 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 73.420000000000002 111.083 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.4 151.72 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 42.310000000000002 110.925 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -155.22 122.77 5.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.400000000000006 110.922 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -149.57 159.28 44.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 43.119999999999997 110.901 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -108.63 140.33 42.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 60.100000000000001 110.947 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.5 p -103.92 161.26 14.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.469 . . . . 72.230000000000004 110.862 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -158.59 145.66 17.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 70.510000000000005 110.923 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.9 t -87.9 129.77 38.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.209 -0.451 . . . . 72.310000000000002 111.105 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -137.45 143.56 41.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 110.859 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -146.4 137.91 19.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 71.209999999999994 111.13 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.28 0.15 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.806 -0.712 . . . . 72.219999999999999 112.552 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -83.47 -47.33 11.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.802 0.334 . . . . 65.040000000000006 110.886 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -126.1 -54.25 1.5 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 73.209999999999994 110.872 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 mt 60.56 39.23 18.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 71.510000000000005 110.876 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -147.09 51.02 0.58 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 73.409999999999997 112.485 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -127.47 139.48 52.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.906 0.384 . . . . 74.129999999999995 110.855 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 54.97 35.84 25.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.9 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -83.34 69.81 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 72.209999999999994 110.904 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.57 -35.49 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 64.340000000000003 111.138 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.93 141.64 3.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 34.520000000000003 112.538 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 149.9 106.58 0.37 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.674 -0.774 . . . . 33.530000000000001 112.476 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.479 ' CA ' HG21 ' A' ' 187' ' ' THR . . . 104.34 132.98 7.66 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.677 -0.773 . . . . 63.399999999999999 112.452 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.21 -62.45 1.56 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.784 0.325 . . . . 75.349999999999994 111.087 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 4.4 mm? -110.11 91.03 10.49 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.612 0.72 . . . . 74.040000000000006 110.888 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 53.8 Cg_endo -69.81 129.32 17.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.644 2.229 . . . . 75.329999999999998 112.345 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -138.55 121.03 16.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 63.210000000000001 110.897 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.02 115.09 29.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 43.43 111.085 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -132.84 167.56 19.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 62.43 110.878 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.1 m -125.26 171.12 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 72.319999999999993 111.079 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.4 p -158.41 123.93 4.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.121 -0.49 . . . . 71.239999999999995 110.841 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.45 178.76 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.137 -0.483 . . . . 75.439999999999998 111.174 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.96 95.35 2.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 50.0 112.541 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.3 m120 58.9 45.83 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 73.099999999999994 110.88 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.54 -37.54 8.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 62.439999999999998 110.853 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.9 t -102.9 138.95 39.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 111.092 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p -133.0 133.44 43.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.49 . . . . 55.130000000000003 111.153 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.4 pp -76.93 138.08 39.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.468 . . . . 73.239999999999995 110.915 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 19.7 p -137.95 145.55 42.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 71.439999999999998 111.124 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -106.21 151.58 24.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 63.219999999999999 110.887 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.53 141.23 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 110.876 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.454 HD13 ' OH ' ' A' ' 61' ' ' TYR . 13.9 tt -120.27 122.24 67.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.141 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -115.12 145.78 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.101 -0.499 . . . . 75.120000000000005 111.048 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 59' ' ' ILE . 17.0 m-85 -118.92 126.15 51.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 110.887 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -93.35 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.863 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 14' ' ' GLN . 22.4 t -121.42 -35.7 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 54.520000000000003 111.155 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.2 t -132.1 150.94 52.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 64.219999999999999 110.85 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -77.25 -36.25 54.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.079 -0.51 . . . . 73.239999999999995 110.893 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -66.61 -41.28 88.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HB2' ' A' ' 105' ' ' LEU . 12.5 tt -141.66 150.79 19.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 74.120000000000005 111.163 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.05 160.99 34.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.076 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.405 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.8 t -93.77 143.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 65.200000000000003 111.095 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -148.19 130.55 15.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.837 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.686 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 3.4 t80 -122.93 125.39 45.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 73.019999999999996 110.818 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -98.07 136.9 37.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.089 -0.505 . . . . 75.140000000000001 110.887 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.4 t -147.79 111.45 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 53.240000000000002 111.148 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.31 158.98 27.88 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.715 -0.755 . . . . 65.530000000000001 112.499 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 75' ' ' VAL . 2.7 p -116.36 85.62 16.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.644 0.735 . . . . 74.319999999999993 111.164 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.9 64.68 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.677 2.251 . . . . 63.149999999999999 112.336 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.48 178.36 6.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.030000000000001 111.061 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.0 mtm-85 -66.31 143.46 57.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.229 -0.441 . . . . 50.119999999999997 110.827 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.54 168.55 3.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 51.119999999999997 111.068 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 35.9 mttm -119.2 46.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 64.299999999999997 110.894 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 61.17 53.28 3.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 110.861 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -109.65 148.04 32.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 72.420000000000002 110.867 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.67 -145.47 18.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 42.409999999999997 112.487 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -157.92 150.74 22.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.896 0.379 . . . . 73.439999999999998 110.849 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 164.72 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 110.922 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.1 t -168.77 155.9 7.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.433 . . . . 61.140000000000001 110.836 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 36.1 pt -67.29 159.5 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.176 -0.465 . . . . 61.310000000000002 111.203 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.5 p -109.15 178.43 4.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 34.350000000000001 110.909 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 11.9 p -103.63 176.67 5.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.162 -0.472 . . . . 71.200000000000003 110.843 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.4 pt? -53.09 145.5 13.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.089 -0.505 . . . . 71.430000000000007 110.985 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.05 -164.92 48.52 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 53.329999999999998 112.477 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -75.6 -175.16 2.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.813 0.339 . . . . 73.430000000000007 110.881 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 33.9 t -136.48 130.74 47.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 61.549999999999997 111.192 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -70.73 117.36 12.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.846 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -113.33 -61.09 1.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 70.209999999999994 110.836 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.6 p -53.55 139.3 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 72.209999999999994 111.088 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -145.26 112.66 6.18 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 110.926 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -129.0 -51.7 1.21 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 110.964 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.53 73.91 0.45 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.79 -0.719 . . . . 35.43 112.454 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 -179.55 3.01 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.696 2.264 . . . . 74.150000000000006 112.294 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -159.6 120.56 3.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 73.519999999999996 111.115 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.4 mt -118.66 135.84 57.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 70.239999999999995 111.139 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.24 128.37 51.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.163 -0.471 . . . . 70.319999999999993 110.975 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 35.4 p -159.45 165.27 33.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 63.409999999999997 110.811 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 67' ' ' ILE . 6.6 mt -110.22 133.03 53.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 70.019999999999996 110.908 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 pp0? -103.07 148.78 25.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 110.858 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.567 ' CE1' HG13 ' A' ' 119' ' ' VAL . 14.0 p90 -153.26 150.55 29.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 75.019999999999996 110.948 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -131.03 96.3 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -111.75 32.78 5.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.540000000000006 110.926 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -93.97 -36.76 12.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 74.120000000000005 110.945 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.9 t -143.47 -74.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.487 . . . . 62.109999999999999 110.834 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.36 -169.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 74.340000000000003 110.838 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -74.99 72.17 2.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.115 -0.493 . . . . 62.329999999999998 110.871 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 44.8 mtm180 -153.51 -175.91 5.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.519999999999996 110.897 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.429 HD23 ' H ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -60.54 95.91 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.854 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.77 160.91 22.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.671 0.748 . . . . 73.549999999999997 110.897 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.4 Cg_endo -69.73 146.45 60.43 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.634 2.222 . . . . 71.409999999999997 112.337 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -137.47 168.76 19.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 73.140000000000001 110.938 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.567 HG13 ' CE1' ' A' ' 107' ' ' TYR . 11.2 p -139.05 147.78 24.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.329999999999998 111.18 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.62 162.36 24.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.677 -0.773 . . . . 74.200000000000003 112.46 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.9 t -142.33 149.89 19.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.894 0.378 . . . . 73.439999999999998 111.09 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.96 -154.04 19.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.766 -0.73 . . . . 65.109999999999999 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 147' ' ' PRO . 24.6 m -128.5 160.51 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 72.329999999999998 111.068 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -129.21 152.14 19.38 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 62.310000000000002 112.503 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 46.8 mtm180 -146.96 177.02 9.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 75.340000000000003 110.819 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.9 p -129.35 137.89 55.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.453 . . . . 74.329999999999998 111.119 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.42 119.74 25.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.911 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -81.73 93.16 6.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 54.130000000000003 110.894 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -86.77 131.84 34.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 65.040000000000006 110.828 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -81.55 160.39 23.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 72.340000000000003 110.798 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -121.27 -51.39 2.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.131 -0.486 . . . . 64.109999999999999 110.905 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.3 m -119.31 142.9 47.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 64.129999999999995 111.184 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -66.93 171.28 5.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 54.409999999999997 110.923 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.59 -119.21 5.04 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.702 -0.761 . . . . 64.450000000000003 112.432 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 61.05 44.62 10.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 53.229999999999997 111.082 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.2 tp -70.9 -38.54 73.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 62.409999999999997 110.958 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 1.7 m -118.29 69.88 0.8 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 53.32 110.825 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.4 t -138.37 -178.67 5.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 72.109999999999999 110.84 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -117.13 169.4 9.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 74.019999999999996 110.878 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -132.8 131.0 40.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.949 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -138.99 108.95 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 61.420000000000002 111.131 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.38 42.81 2.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 75.109999999999999 110.896 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -130.38 65.18 1.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.019999999999996 110.827 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -115.63 36.48 3.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 75.510000000000005 110.849 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 4.5 p-90 -62.43 135.84 57.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.451 . . . . 75.450000000000003 110.955 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -132.14 95.14 22.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.564 0.697 . . . . 73.349999999999994 111.128 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.496 ' HA ' HG12 ' A' ' 123' ' ' VAL . 52.9 Cg_endo -69.84 139.78 40.8 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.673 2.249 . . . . 75.319999999999993 112.276 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.1 178.62 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 111.055 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -126.64 150.41 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 72.129999999999995 110.885 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.63 156.83 46.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 72.120000000000005 110.917 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.0 t -111.01 155.99 12.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.181 -0.463 . . . . 63.149999999999999 111.153 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -162.12 -168.14 23.59 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.77 -0.728 . . . . 64.030000000000001 112.512 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 155' ' ' TYR . 2.4 tt -163.08 142.99 8.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.767 0.318 . . . . 64.349999999999994 110.914 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -118.88 133.0 56.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.230000000000004 110.844 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.535 ' CD1' HD21 ' A' ' 153' ' ' LEU . 0.7 OUTLIER -140.18 116.29 10.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 72.219999999999999 110.932 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -106.52 94.84 5.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.13 -0.486 . . . . 71.109999999999999 110.875 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.51 -71.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.165 -0.471 . . . . 62.229999999999997 110.983 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -65.48 -168.89 2.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.773 -0.727 . . . . 70.549999999999997 112.497 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -115.82 -36.16 4.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.848 0.356 . . . . 52.539999999999999 110.842 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.9 t -56.54 -60.56 3.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 70.420000000000002 110.859 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 2.4 p90 -134.43 170.63 15.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 74.120000000000005 110.954 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 57.2 ttp -111.67 151.81 28.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.84 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 164' ' ' ASN . 3.4 tt -87.02 133.05 33.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 52.439999999999998 110.941 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.603 ' N ' HD23 ' A' ' 163' ' ' LEU . 25.5 t-20 -136.14 134.43 38.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 62.049999999999997 110.914 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -125.59 143.33 51.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 51.439999999999998 110.86 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -133.24 147.54 51.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.119 -0.491 . . . . 62.310000000000002 110.907 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.26 138.95 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 74.0 111.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -148.29 153.54 38.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 71.430000000000007 110.846 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -123.99 135.58 53.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 72.150000000000006 110.874 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.9 tp -109.66 131.54 21.86 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.676 0.75 . . . . 73.150000000000006 111.125 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -45.09 1.69 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.668 2.245 . . . . 73.040000000000006 112.4 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -161.18 147.79 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 74.519999999999996 110.835 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -117.61 129.12 55.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.226 -0.443 . . . . 75.420000000000002 110.875 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 4.4 m -76.94 81.33 3.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 62.119999999999997 111.085 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -93.04 179.21 5.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.873 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 60.3 t -112.61 145.27 18.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.329999999999998 111.153 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 18.4 p -69.72 158.53 35.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.122 -0.49 . . . . 43.240000000000002 111.208 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.91 155.12 11.04 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.737 -0.744 . . . . 61.509999999999998 112.514 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 73.1 p -66.11 -174.92 0.28 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 65.040000000000006 111.163 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.736 HD11 ' HB3' ' A' ' 184' ' ' PRO . 1.7 pt? -131.07 -176.39 3.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 110.942 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.28 -177.35 40.37 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.817 -0.706 . . . . 32.299999999999997 112.457 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 162.44 42.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.723 2.282 . . . . 75.409999999999997 112.314 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.492 HG12 HG23 ' A' ' 185' ' ' VAL . 33.7 t 51.72 68.25 3.41 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.614 0.721 . . . . 52.039999999999999 111.134 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.736 ' HB3' HD11 ' A' ' 180' ' ' LEU . 54.2 Cg_endo -69.76 98.72 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.669 2.246 . . . . 75.129999999999995 112.353 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.492 HG23 HG12 ' A' ' 183' ' ' VAL . 21.9 t -125.64 67.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.158 -0.474 . . . . 75.129999999999995 111.095 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.4 m -160.98 161.78 31.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 53.5 110.869 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.479 HG21 ' CA ' ' A' ' 40' ' ' GLY . 10.1 p -129.96 -62.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 53.130000000000003 111.112 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -128.15 70.22 1.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 70.439999999999998 110.874 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 7.9 tp -58.09 -34.48 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 63.32 111.095 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -141.17 134.92 30.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.861 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.5 t -131.79 -58.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 111.101 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -126.65 69.92 71.35 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.607 0.718 . . . . 71.400000000000006 110.894 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.87 142.94 48.77 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.683 2.255 . . . . 75.109999999999999 112.333 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -115.65 153.81 30.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 70.420000000000002 110.906 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.12 119.32 54.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 70.099999999999994 111.119 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 19.5 tp -120.5 131.17 54.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.5 110.876 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.99 152.23 51.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 75.349999999999994 110.825 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.474 HD11 HD21 ' A' ' 163' ' ' LEU . 37.3 tp -152.36 151.48 30.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.06 -0.518 . . . . 61.450000000000003 110.888 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.31 -148.09 8.3 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 74.409999999999997 112.515 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.3 -178.48 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.361 . . . . 40.43 111.029 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -156.75 172.48 18.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 71.140000000000001 110.833 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -144.62 127.31 16.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 75.140000000000001 110.823 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 18' ' ' VAL . 47.9 t -87.85 135.16 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.045 -0.525 . . . . 53.140000000000001 111.097 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -139.73 150.33 44.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 74.129999999999995 110.893 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.17 63.04 1.01 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.484 . . . . 74.239999999999995 110.911 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.05 -52.41 28.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 43.009999999999998 110.889 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -51.67 111.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 13.210000000000001 111.125 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -110.47 92.68 4.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 65.129999999999995 111.072 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -103.43 92.42 4.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 73.030000000000001 111.124 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 9.0 tp -83.44 85.56 7.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 65.25 110.88 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 74.200000000000003 110.843 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.841 0.353 . . . . 62.450000000000003 110.871 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -143.95 147.08 33.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 73.299999999999997 110.888 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -127.9 141.26 51.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 72.099999999999994 110.875 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -132.48 137.21 47.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.493 . . . . 63.420000000000002 110.962 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -168.41 68.24 0.76 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.63 0.728 . . . . 74.209999999999994 110.902 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.72 113.53 3.4 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.668 2.246 . . . . 74.430000000000007 112.328 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.33 109.1 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 42.200000000000003 111.07 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -64.79 163.64 13.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 71.319999999999993 110.894 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.9 t -129.68 156.48 44.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.275 -0.42 . . . . 70.420000000000002 110.906 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.12 133.63 49.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 54.409999999999997 111.143 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.92 -170.54 32.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.732 -0.747 . . . . 54.219999999999999 112.462 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.4 p90 -172.08 129.42 0.61 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 65.239999999999995 110.943 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -134.96 166.51 22.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.129 -0.487 . . . . 75.349999999999994 110.865 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -69.43 143.24 53.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.892 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.29 57.46 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.736 -0.745 . . . . 74.299999999999997 112.521 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -75.41 146.32 40.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.848 0.356 . . . . 74.109999999999999 110.867 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -113.83 124.83 53.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 74.519999999999996 110.887 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.836 HG22 HG23 ' A' ' 203' ' ' VAL . 21.2 t -121.23 133.94 66.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.162 -0.472 . . . . 71.030000000000001 111.096 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.573 ' HB1' ' HZ ' ' A' ' 57' ' ' PHE . . . -103.27 121.66 43.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 51.439999999999998 111.119 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.0 t -117.43 113.51 22.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.219999999999999 110.845 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -116.74 124.87 50.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 75.019999999999996 110.819 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.408 ' O ' HG22 ' A' ' 56' ' ' THR . 4.6 p30 -153.44 178.25 10.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 75.209999999999994 110.874 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -133.47 143.12 48.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 75.319999999999993 110.934 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.2 p -98.67 155.87 17.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 73.439999999999998 110.794 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.9 pttt -152.33 155.22 37.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 72.319999999999993 110.886 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -81.39 114.91 23.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 74.230000000000004 111.107 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB3' HD23 ' A' ' 196' ' ' LEU . 8.1 t80 -114.06 144.46 43.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 71.510000000000005 110.948 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.14 148.23 22.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 111.132 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.31 160.64 44.24 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.829 -0.701 . . . . 75.209999999999994 112.495 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -79.62 -48.55 13.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 71.019999999999996 110.912 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -108.55 50.55 0.77 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.150000000000006 110.903 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.9 mt 53.82 43.09 31.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 73.230000000000004 110.9 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 125.88 -123.54 4.89 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 52.299999999999997 112.509 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -71.29 178.44 3.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.36 . . . . 74.319999999999993 110.829 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -103.11 66.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 110.883 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -105.67 105.8 16.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 65.230000000000004 110.915 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.56 128.96 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 75.049999999999997 111.152 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 157.52 68.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.702 -0.761 . . . . 62.039999999999999 112.534 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 68.5 71.41 0.97 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.742 . . . . 72.129999999999995 112.499 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.39 -141.21 9.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 64.450000000000003 112.494 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -112.4 143.71 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 63.030000000000001 111.083 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.35 160.68 70.26 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.617 0.722 . . . . 72.420000000000002 110.875 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.73 129.42 17.6 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.695 2.264 . . . . 61.329999999999998 112.375 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -134.89 170.68 15.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 73.450000000000003 110.888 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -130.46 117.04 19.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 71.400000000000006 111.052 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 47' ' ' VAL . 81.4 m-20 -102.96 -45.18 5.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 51.009999999999998 110.844 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ASP . 27.0 m 37.05 44.14 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 72.200000000000003 111.082 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 p -117.56 75.81 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.149999999999999 110.858 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.24 107.88 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 51.399999999999999 111.148 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -106.65 -143.66 11.41 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.75 -0.738 . . . . 64.219999999999999 112.516 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 36.2 t30 -75.65 75.65 2.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 74.109999999999999 110.858 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -92.51 -36.38 13.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 65.299999999999997 110.847 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 17.2 m -60.17 102.27 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 61.420000000000002 111.127 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 m -108.76 101.21 10.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 70.400000000000006 111.144 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.3 pt? -56.98 144.49 33.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 64.030000000000001 110.916 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 22' ' ' ASN . 10.9 t -160.77 143.34 12.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.147 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.573 ' HZ ' ' HB1' ' A' ' 19' ' ' ALA . 8.0 t80 -115.02 158.84 21.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 61.200000000000003 110.87 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -148.95 140.24 23.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 73.340000000000003 110.836 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.2 mm -103.61 110.87 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 71.430000000000007 111.114 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.717 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -98.07 109.44 22.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 111.092 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -95.83 119.28 34.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.468 . . . . 63.329999999999998 110.905 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 109.22 21.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.5 . . . . 63.329999999999998 110.85 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 95.6 t -121.93 -35.47 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.036 -0.529 . . . . 75.010000000000005 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.41 149.37 48.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 63.539999999999999 110.826 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -78.5 -35.4 46.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 64.120000000000005 110.834 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.593 ' OD1' HG22 ' A' ' 67' ' ' ILE . 4.2 p30 -68.2 -42.01 80.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 75.319999999999993 110.863 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.593 HG22 ' OD1' ' A' ' 66' ' ' ASN . 10.1 tp -142.17 144.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 62.020000000000003 111.149 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -119.69 162.56 18.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.173 -0.467 . . . . 74.230000000000004 111.083 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.51 146.21 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 42.109999999999999 111.107 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -148.73 135.36 19.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 51.200000000000003 110.816 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -121.46 125.39 46.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 73.310000000000002 110.882 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -88.77 135.62 33.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.409999999999997 110.899 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.5 t -148.67 113.97 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.077 -0.511 . . . . 72.129999999999995 111.078 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.72 177.75 36.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.753 -0.737 . . . . 72.530000000000001 112.52 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.1 m -56.46 155.54 13.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.625 0.726 . . . . 70.340000000000003 111.173 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 139.17 39.4 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.658 2.239 . . . . 62.350000000000001 112.374 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.83 -65.32 1.2 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 42.340000000000003 111.079 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -171.78 112.18 0.32 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 62.140000000000001 110.822 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.65 169.76 8.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 64.439999999999998 111.071 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.9 tttp -118.23 169.87 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 71.030000000000001 110.917 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -149.3 164.75 33.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 72.329999999999998 110.905 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -130.35 172.03 12.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 61.229999999999997 110.926 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -56.05 166.39 3.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.75 . . . . 60.25 112.47 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -117.23 161.44 19.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.867 0.365 . . . . 73.209999999999994 110.852 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -61.23 -71.09 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.156 -0.475 . . . . 72.129999999999995 110.934 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 11.6 t -174.8 122.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 70.420000000000002 110.82 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG22 ' H ' ' A' ' 90' ' ' LEU . 63.2 mt -89.24 -53.56 9.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 71.129999999999995 111.135 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 t 61.5 38.88 15.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 72.25 110.908 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 t 52.53 50.21 18.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.513 . . . . 52.43 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 87' ' ' ILE . 2.1 tt -109.79 109.07 19.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 75.310000000000002 110.998 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.66 146.43 0.51 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 30.350000000000001 112.512 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -99.32 -61.12 1.41 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.856 0.36 . . . . 74.519999999999996 110.883 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.6 m -148.94 142.1 18.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 61.299999999999997 111.15 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.5 p -104.77 -72.08 0.72 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 110.853 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -151.06 159.75 44.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 64.239999999999995 110.877 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 11.6 p -121.4 133.81 66.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 111.11 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -148.86 110.29 4.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 110.854 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -103.71 85.87 2.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -158.23 68.74 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.789 -0.719 . . . . 40.530000000000001 112.522 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.69 178.37 4.59 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.715 2.277 . . . . 60.43 112.377 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -171.88 148.82 2.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.255 -0.43 . . . . 73.239999999999995 111.155 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.1 mt -118.13 140.79 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 74.450000000000003 111.103 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.416 ' O ' HD12 ' A' ' 103' ' ' LEU . 3.1 pp -122.44 122.91 40.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 74.0 110.999 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.6 p -155.33 157.17 36.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.43 110.799 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.469 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.1 mm? -100.3 141.06 33.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.039 -0.528 . . . . 65.340000000000003 110.894 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -119.74 152.48 37.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 74.420000000000002 110.913 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -148.65 129.77 14.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 74.420000000000002 110.876 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -131.49 167.09 19.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 74.340000000000003 110.892 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -82.25 89.45 6.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.242 -0.436 . . . . 74.239999999999995 110.938 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -91.92 17.48 9.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.319999999999993 110.911 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.7 m -53.71 -36.33 62.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 52.240000000000002 110.921 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -136.14 -173.91 3.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 64.329999999999998 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.44 90.62 3.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 63.109999999999999 110.919 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -179.48 -173.93 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 110.87 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.7 139.18 58.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 62.310000000000002 110.943 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 31.8 m-85 -157.13 158.78 31.25 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.704 0.764 . . . . 72.319999999999993 110.954 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 169.82 18.1 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.692 2.261 . . . . 74.510000000000005 112.375 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 61.520000000000003 110.847 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.88 128.28 73.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.118 -0.492 . . . . 63.210000000000001 111.131 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -127.68 137.8 10.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.78 -0.724 . . . . 72.519999999999996 112.512 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.0 m -151.41 146.49 15.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.898 0.38 . . . . 53.439999999999998 111.176 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.43 -153.36 21.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.676 -0.773 . . . . 65.140000000000001 112.452 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 147' ' ' PRO . 29.2 m -129.27 153.05 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.861 0.362 . . . . 75.120000000000005 111.171 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -115.82 152.14 18.12 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.708 -0.758 . . . . 72.239999999999995 112.497 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -125.73 127.6 46.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.783 0.325 . . . . 71.299999999999997 110.923 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 14.0 p -121.73 139.61 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.419 . . . . 64.530000000000001 111.144 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.79 119.35 21.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 63.420000000000002 110.874 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -109.84 164.96 12.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.230000000000004 110.9 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -67.46 104.73 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 73.310000000000002 110.882 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -88.59 109.24 19.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 75.510000000000005 110.825 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -106.96 91.56 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.928 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.4 t -164.19 136.35 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 44.299999999999997 111.163 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -94.59 -71.48 0.66 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.192 -0.458 . . . . 60.219999999999999 110.91 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 79.97 148.19 4.95 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.757 -0.735 . . . . 71.349999999999994 112.462 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.64 171.26 0.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.339 . . . . 75.109999999999999 111.097 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 tt -79.95 75.13 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 63.119999999999997 110.939 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.8 m -148.96 179.42 7.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 71.219999999999999 110.86 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -68.34 152.59 45.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.499 . . . . 73.439999999999998 110.876 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -154.65 151.58 28.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.124 -0.489 . . . . 55.240000000000002 110.929 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.63 147.65 23.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 61.539999999999999 110.783 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.2 mt -63.22 134.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 74.319999999999993 111.09 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.0 ttpt -103.63 144.51 31.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.495 . . . . 54.530000000000001 110.877 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.5 p30 -165.13 -176.49 4.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.241 -0.436 . . . . 71.230000000000004 110.859 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -140.19 122.73 16.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.310000000000002 110.865 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.458 ' CZ3' HG11 ' A' ' 123' ' ' VAL . 25.3 p-90 -118.72 131.07 56.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.257 -0.429 . . . . 62.140000000000001 110.983 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -127.8 159.96 63.58 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.573 0.702 . . . . 63.310000000000002 111.094 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.619 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.2 Cg_endo -69.74 154.53 67.72 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.679 2.253 . . . . 74.540000000000006 112.314 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -172.95 138.54 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 64.450000000000003 111.123 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -125.55 170.74 11.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 64.510000000000005 110.87 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.35 141.8 5.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.230000000000004 110.955 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.52 ' O ' HG12 ' A' ' 167' ' ' VAL . 27.0 m -122.55 136.05 60.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 74.450000000000003 111.201 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.603 ' C ' HD13 ' A' ' 153' ' ' LEU . . . -157.71 -165.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.728 . . . . 35.210000000000001 112.451 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -151.91 163.11 39.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 74.319999999999993 110.894 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.64 135.02 47.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.873 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 153' ' ' LEU . 1.1 p90 -152.35 153.08 32.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.166 -0.47 . . . . 73.019999999999996 110.947 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -70.36 144.44 51.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.506 . . . . 72.519999999999996 110.855 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -177.1 93.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 72.540000000000006 110.878 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 128.71 -159.61 22.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 75.510000000000005 112.446 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -118.95 125.91 50.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.894 0.378 . . . . 62.340000000000003 110.871 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.5 m 51.74 35.23 14.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 63.140000000000001 110.838 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -159.97 142.56 13.5 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 74.019999999999996 110.88 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 12.4 mtt -105.54 152.42 23.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 73.25 110.911 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.455 HD23 ' HE1' ' A' ' 155' ' ' TYR . 10.0 tp -109.75 122.78 48.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 74.420000000000002 110.918 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -127.75 151.05 49.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.230000000000004 110.896 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -142.85 136.15 28.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.189 -0.46 . . . . 50.109999999999999 110.795 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -126.91 165.95 18.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 60.5 110.858 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.571 HG23 HD22 ' A' ' 196' ' ' LEU . 7.2 p -155.01 145.5 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 70.430000000000007 111.136 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.4 ttt85 -146.05 146.2 30.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 64.209999999999994 110.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -112.07 131.98 55.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 63.130000000000003 110.969 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.438 HG23 ' HD2' ' A' ' 171' ' ' PRO . 67.5 mt -68.35 133.12 91.28 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.68 0.753 . . . . 72.329999999999998 111.082 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.8 Cg_endo -69.8 -44.9 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.669 2.246 . . . . 71.239999999999995 112.31 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -130.09 123.99 31.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 71.519999999999996 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -173.08 104.4 0.13 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 62.140000000000001 110.922 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.8 t -141.15 150.12 42.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 54.219999999999999 111.14 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -169.03 117.02 0.65 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.246 -0.434 . . . . 75.230000000000004 110.847 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.1 p -167.97 134.15 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 65.120000000000005 111.131 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -172.04 129.71 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 54.549999999999997 111.23 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 130.04 52.13 0.11 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.692 -0.766 . . . . 41.420000000000002 112.414 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.7 p -85.49 60.21 6.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.797 0.332 . . . . 71.340000000000003 111.153 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.591 HD23 ' N ' ' A' ' 181' ' ' GLY . 2.3 tt -175.19 146.32 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 72.340000000000003 110.865 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.591 ' N ' HD23 ' A' ' 180' ' ' LEU . . . 171.74 174.87 39.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.793 -0.718 . . . . 54.210000000000001 112.535 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -45.88 1.42 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.664 2.243 . . . . 75.209999999999994 112.333 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.95 156.24 74.29 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.643 0.735 . . . . 75.109999999999999 111.14 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.89 110.99 2.72 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.633 2.222 . . . . 73.409999999999997 112.335 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.25 176.72 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 65.25 111.128 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.9 t -52.38 118.6 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 62.530000000000001 110.842 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.1 m -116.45 -38.78 3.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 63.049999999999997 111.198 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.12 136.43 51.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 75.150000000000006 110.911 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 15.2 pt -118.39 -35.8 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 61.140000000000001 111.147 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -125.13 131.01 53.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 64.109999999999999 110.838 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.5 m -123.74 -36.13 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 72.439999999999998 111.129 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.65 73.33 0.95 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.698 0.761 . . . . 71.200000000000003 110.879 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 146.22 59.33 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.619 2.213 . . . . 74.430000000000007 112.355 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -116.8 146.42 42.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 65.340000000000003 110.894 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 44.7 mm -89.29 106.19 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 73.120000000000005 111.116 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.571 HD22 HG23 ' A' ' 167' ' ' VAL . 4.1 mm? -104.95 114.33 28.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 70.519999999999996 110.957 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.0 m -110.67 137.94 47.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 53.539999999999999 110.828 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 199' ' ' GLY . 10.3 tt -148.68 143.89 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.93 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.489 ' N ' HD23 ' A' ' 198' ' ' LEU . . . 176.33 -154.66 17.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.695 -0.764 . . . . 62.100000000000001 112.443 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -129.43 173.97 10.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.813 0.34 . . . . 71.129999999999995 111.068 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.8 m -160.71 165.03 31.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.875 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 13.3 p90 -149.56 141.18 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 61.43 110.841 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.836 HG23 HG22 ' A' ' 18' ' ' VAL . 14.9 p -93.76 141.96 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.109 -0.496 . . . . 73.340000000000003 111.115 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -139.92 119.53 13.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 74.439999999999998 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.96 67.28 9.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.876 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.6 tt -61.09 -58.72 7.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.989 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -112.74 134.85 54.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 111.149 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -140.63 161.87 36.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 60.439999999999998 111.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.31 84.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 111.126 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 pp -165.28 175.23 9.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.19 -0.459 . . . . 75.099999999999994 110.972 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 43.240000000000002 110.849 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.748 0.308 . . . . 72.120000000000005 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -131.23 86.12 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.446 . . . . 73.230000000000004 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -113.34 133.33 55.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.835 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.88 154.13 17.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 62.229999999999997 110.861 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -65.09 160.51 56.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.724 0.773 . . . . 72.129999999999995 110.884 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 132.57 23.7 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.662 2.241 . . . . 74.409999999999997 112.346 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.45 176.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 64.150000000000006 111.072 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 161.28 28.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 110.906 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.9 t -160.15 160.93 33.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 70.209999999999994 110.862 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.82 114.11 8.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.501 . . . . 64.140000000000001 111.084 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -178.47 175.94 47.71 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.762 -0.732 . . . . 43.409999999999997 112.449 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -117.58 103.83 10.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 74.019999999999996 110.92 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -103.99 164.27 11.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 73.099999999999994 110.882 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -67.57 143.3 56.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 75.420000000000002 110.917 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.35 7.82 31.89 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 64.25 112.471 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -75.14 151.68 38.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.821 0.343 . . . . 65.319999999999993 110.864 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 7.3 m0 -125.83 130.67 51.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.9 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 202' ' ' TYR . 43.5 t -129.9 119.29 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.209999999999994 111.168 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.31 104.95 17.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 63.32 111.086 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.2 t -97.98 143.33 28.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.430000000000007 110.774 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -148.6 125.43 11.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.119 -0.492 . . . . 73.219999999999999 110.882 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -148.39 173.66 12.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 72.219999999999999 110.915 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -112.58 142.9 44.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 110.902 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -103.88 154.73 19.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 71.140000000000001 110.844 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -158.68 149.0 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 72.099999999999994 110.904 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -85.96 135.77 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.218 -0.447 . . . . 72.140000000000001 111.147 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -132.26 141.04 48.86 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.202 -0.454 . . . . 74.129999999999995 110.904 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.9 m -122.26 139.19 49.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 111.148 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -129.68 0.39 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.726 -0.749 . . . . 75.209999999999994 112.527 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.44 -40.34 78.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.807 0.336 . . . . 70.010000000000005 110.904 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 62.48 38.18 12.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.097 -0.501 . . . . 74.040000000000006 110.907 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 78.8 mt -126.35 -61.32 1.22 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.122 -0.49 . . . . 53.350000000000001 110.937 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.49 -103.94 1.6 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 62.420000000000002 112.526 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.497 ' C ' HD22 ' A' ' 35' ' ' LEU . 9.4 t70 -127.11 166.15 18.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 72.340000000000003 110.88 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.497 HD22 ' C ' ' A' ' 34' ' ' ASP . 4.6 mm? -121.07 74.24 1.07 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 72.329999999999998 110.952 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -101.13 170.15 8.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 71.109999999999999 110.916 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.2 m -65.72 160.43 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.187 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 132.61 -99.3 0.38 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.757 -0.735 . . . . 65.25 112.462 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -111.41 91.9 0.63 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.763 . . . . 65.209999999999994 112.505 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 158.4 129.34 1.08 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.662 -0.78 . . . . 73.5 112.477 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.98 -71.32 0.7 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 52.509999999999998 111.05 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 mp -112.15 160.68 29.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.585 0.707 . . . . 70.400000000000006 110.902 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 104.49 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.709 2.273 . . . . 73.030000000000001 112.304 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -169.62 125.83 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 73.439999999999998 110.853 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.49 113.8 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.126 -0.488 . . . . 62.399999999999999 111.106 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -168.5 115.45 0.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 73.049999999999997 110.89 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 p -163.17 138.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 111.132 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.2 t -172.84 115.34 0.28 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.881 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.4 tp -169.04 135.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 73.450000000000003 111.11 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.27 175.38 14.03 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.773 -0.727 . . . . 71.299999999999997 112.497 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -111.35 87.06 2.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.812 0.339 . . . . 64.349999999999994 110.862 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.24 30.58 3.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 73.329999999999998 110.91 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.7 m -104.19 134.25 47.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 74.549999999999997 111.141 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.1 t -126.81 164.13 22.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.14 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 mp -102.74 151.62 22.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 55.049999999999997 110.953 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 t -153.24 147.26 25.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 72.340000000000003 111.141 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -122.53 143.67 49.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 74.530000000000001 110.914 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -139.22 142.27 37.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 74.150000000000006 110.841 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -103.57 122.41 56.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 111.124 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -106.02 109.38 21.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.119999999999997 111.083 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -98.61 122.34 41.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 65.420000000000002 110.923 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.2 t80 -99.11 105.29 17.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 73.5 110.908 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -133.74 35.71 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 111.123 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.4 t -161.72 -172.14 3.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 72.349999999999994 110.85 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -84.81 -46.76 11.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 55.439999999999998 110.886 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -131.45 -41.72 1.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 72.099999999999994 110.885 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.424 HG22 HD23 ' A' ' 105' ' ' LEU . 61.2 mt -76.89 97.5 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.200000000000003 111.111 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -107.07 165.53 11.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 53.43 111.151 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.93 146.18 11.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 55.119999999999997 111.15 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.18 123.56 9.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 75.230000000000004 110.862 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.76 117.81 34.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 72.340000000000003 110.867 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -94.15 129.98 40.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.1 t -139.39 128.07 28.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.519999999999996 111.126 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.8 176.25 39.11 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.802 -0.713 . . . . 55.340000000000003 112.523 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 m -116.09 85.36 15.12 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.664 0.745 . . . . 74.299999999999997 111.09 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 173.64 10.7 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.667 2.245 . . . . 74.409999999999997 112.403 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -37.51 85.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 111.107 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -84.33 77.71 9.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 64.209999999999994 110.852 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.749 ' HB1' ' HB2' ' A' ' 98' ' ' TYR . . . -111.1 -37.59 5.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.26 -0.427 . . . . 74.439999999999998 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -126.25 58.75 1.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.44 . . . . 62.43 110.929 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -126.16 71.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.540000000000006 110.917 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -126.27 -64.02 1.06 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 73.010000000000005 110.951 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -54.72 128.49 42.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.821 -0.704 . . . . 75.329999999999998 112.444 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -127.6 -40.12 1.78 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.899 0.38 . . . . 72.439999999999998 110.934 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -105.56 -74.42 0.65 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 74.310000000000002 110.881 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -164.08 160.4 21.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 64.219999999999999 110.86 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.2 mp -108.07 68.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.409999999999997 111.14 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 t -125.3 44.12 2.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 62.140000000000001 110.823 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.3 t -118.29 -179.81 3.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.922 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.1 mt -124.78 65.24 1.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.888 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 173.92 -108.24 0.27 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.716 -0.754 . . . . 70.430000000000007 112.456 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -72.47 93.42 1.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.804 0.335 . . . . 72.409999999999997 110.919 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 m -110.54 167.88 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.236 -0.438 . . . . 72.540000000000006 111.105 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -73.21 -176.73 2.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.874 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.3 167.61 29.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 71.439999999999998 110.922 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -105.84 -35.85 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 72.209999999999994 111.139 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -52.06 157.07 1.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 73.400000000000006 110.926 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.749 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . 40.7 p90 -149.02 168.21 23.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.976 0.417 . . . . 75.030000000000001 110.891 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.16 72.29 1.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 65.340000000000003 112.503 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -170.87 0.42 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.656 2.238 . . . . 53.420000000000002 112.37 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -163.93 140.95 6.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.224 -0.444 . . . . 63.020000000000003 111.094 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.489 HG22 ' CA ' ' A' ' 124' ' ' GLY . 18.3 pt -128.34 143.03 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 35.32 111.152 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 pp -116.78 133.75 55.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 72.310000000000002 110.871 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 45.8 m -155.78 160.0 39.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 60.130000000000003 110.886 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 67' ' ' ILE . 6.4 mp -103.95 141.79 35.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 74.319999999999993 110.883 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -111.76 148.1 34.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 70.140000000000001 110.903 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -153.26 137.29 16.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 110.989 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -130.92 88.01 2.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 71.120000000000005 110.845 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -106.66 37.42 2.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 75.420000000000002 110.931 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -86.18 -40.16 15.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.494 . . . . 70.439999999999998 110.835 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.9 m -142.47 -74.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 73.340000000000003 110.873 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -174.61 -176.65 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.095 -0.502 . . . . 74.239999999999995 110.931 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.52 95.84 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 64.019999999999996 110.817 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -179.51 -173.72 0.27 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 75.409999999999997 110.925 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.69 98.09 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 74.129999999999995 110.919 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -161.17 161.0 24.3 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.655 0.741 . . . . 70.040000000000006 110.945 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 54.2 Cg_endo -69.73 148.69 65.83 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.726 2.284 . . . . 72.109999999999999 112.378 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -134.61 153.27 52.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.929 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.24 150.72 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 111.096 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.51 137.89 9.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.766 -0.73 . . . . 61.420000000000002 112.534 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 149' ' ' PHE . 7.8 p -144.24 138.8 24.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.876 0.369 . . . . 54.340000000000003 111.106 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 104' ' ' SER . . . 179.09 -153.17 11.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.726 -0.749 . . . . 64.430000000000007 112.5 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.9 t -129.63 154.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.845 0.355 . . . . 72.340000000000003 111.163 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.489 ' CA ' HG22 ' A' ' 102' ' ' ILE . . . -116.02 157.58 14.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 44.32 112.485 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -145.1 164.39 31.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.823 0.344 . . . . 75.150000000000006 110.885 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.48 155.27 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 74.310000000000002 111.072 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 130' ' ' ASP . 15.9 tp -86.39 146.53 26.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 45.420000000000002 110.915 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -123.52 -36.31 2.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 73.019999999999996 110.893 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.08 86.22 2.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 110.898 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' HB2' HD23 ' A' ' 127' ' ' LEU . 25.8 t0 -115.33 -61.82 1.69 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.163 -0.472 . . . . 75.329999999999998 110.812 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -151.47 146.25 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.844 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 72.6 p -105.89 85.22 2.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 75.109999999999999 111.157 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.94 -67.97 0.82 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 72.040000000000006 110.856 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.43 -62.67 1.26 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.717 -0.754 . . . . 62.109999999999999 112.501 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.46 43.55 19.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.809 0.338 . . . . 64.019999999999996 111.147 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.7 tt -72.54 91.34 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 74.109999999999999 110.888 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 73.7 m 53.84 40.62 31.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 74.25 110.862 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 m -122.84 71.89 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.88 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -113.16 42.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 74.140000000000001 110.844 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.422 ' O ' HD13 ' A' ' 141' ' ' ILE . 53.6 t0 -172.24 109.78 0.24 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 110.903 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 140' ' ' ASP . 30.6 mm -121.6 124.97 72.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 63.43 111.117 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -90.61 154.34 19.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 73.239999999999995 110.919 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -88.63 133.65 34.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.244 -0.435 . . . . 60.130000000000003 110.855 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -118.08 72.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 110.949 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.7 p-90 -53.68 139.32 32.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 74.510000000000005 110.89 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -137.03 95.04 12.21 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.622 0.725 . . . . 73.340000000000003 111.158 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 131.24 20.94 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.255 . . . . 63.109999999999999 112.34 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -162.14 -179.93 7.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 62.32 111.13 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.447 ' HB3' HG23 ' A' ' 121' ' ' VAL . 42.7 p90 -144.07 141.43 30.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.469 . . . . 71.439999999999998 110.904 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -124.25 163.77 20.94 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.239999999999995 110.915 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.611 HG13 HG13 ' A' ' 167' ' ' VAL . 6.7 p -126.29 142.62 42.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 63.399999999999999 111.166 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -153.55 -166.51 14.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 64.140000000000001 112.433 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.6 mp -145.54 150.93 37.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.806 0.336 . . . . 71.140000000000001 110.857 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 22.6 ttp180 -130.96 120.02 22.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 75.420000000000002 110.825 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.662 ' CZ ' HD12 ' A' ' 163' ' ' LEU . 14.5 p90 -152.65 141.31 20.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.095 -0.502 . . . . 72.299999999999997 110.93 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -105.98 155.38 19.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 73.0 110.83 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.661 ' N ' HD13 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -125.45 37.59 4.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 72.409999999999997 110.951 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 63.65 82.27 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 43.43 112.453 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -175.81 169.72 2.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.788 0.328 . . . . 74.420000000000002 110.997 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 25.6 m -56.05 -36.31 67.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 65.129999999999995 110.783 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 16.4 p90 -108.65 164.47 12.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 74.349999999999994 110.854 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.4 mtt -118.02 163.55 16.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 65.209999999999994 110.853 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.662 HD12 ' CZ ' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -91.93 129.01 37.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 74.5 110.917 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.535 ' N ' HD13 ' A' ' 163' ' ' LEU . 47.6 t30 -130.82 137.0 49.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 72.140000000000001 110.915 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.1 t -129.62 140.98 51.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 74.420000000000002 110.925 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.68 144.67 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 63.130000000000003 110.839 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.775 HG23 HD22 ' A' ' 196' ' ' LEU . 5.2 p -156.59 141.83 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 62.420000000000002 111.133 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 195' ' ' ILE . 0.0 OUTLIER -152.55 165.63 34.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.868 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -142.08 152.34 43.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 72.409999999999997 110.913 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 55.3 mt -120.5 130.0 25.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.659 0.743 . . . . 73.530000000000001 111.073 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 -36.83 10.37 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 73.219999999999999 112.392 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -54.68 179.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.874 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.11 91.77 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.909 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.3 -172.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 63.329999999999998 111.133 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.641 ' OD2' HG22 ' A' ' 191' ' ' VAL . 3.0 t70 -101.79 102.86 13.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.467 . . . . 64.040000000000006 110.876 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.7 p -89.45 133.25 32.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 72.420000000000002 111.121 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 72.4 p -91.8 146.91 23.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 73.549999999999997 111.149 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -161.31 83.82 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.659 -0.782 . . . . 74.209999999999994 112.459 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 21.6 m -156.59 122.5 4.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.81 0.338 . . . . 71.450000000000003 111.172 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 47.6 mt -69.67 -57.48 5.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 73.400000000000006 110.973 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 133.55 -74.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.691 -0.766 . . . . 74.329999999999998 112.524 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 149.31 66.4 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.714 2.276 . . . . 62.399999999999999 112.32 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.689 HG12 HG23 ' A' ' 185' ' ' VAL . 38.2 t 61.39 69.89 0.97 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 111.148 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.87 88.21 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.685 2.257 . . . . 72.140000000000001 112.361 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.689 HG23 HG12 ' A' ' 183' ' ' VAL . 41.0 t -102.35 -70.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 43.409999999999997 111.054 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 21.9 t -139.16 151.69 46.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 33.210000000000001 110.8 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.4 t -171.94 142.57 1.49 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 54.149999999999999 111.186 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -133.79 147.35 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.239999999999995 110.901 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.8 tt -157.14 132.28 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 64.329999999999998 111.062 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -100.14 113.73 26.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 53.420000000000002 110.918 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.641 HG22 ' OD2' ' A' ' 175' ' ' ASP . 22.3 t -113.18 88.5 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 72.299999999999997 111.136 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 12.2 t0 52.88 74.59 0.75 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.602 0.715 . . . . 63.420000000000002 110.816 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 148.7 65.61 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.726 2.284 . . . . 72.510000000000005 112.325 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -120.53 144.27 48.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 42.109999999999999 110.861 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.42 HG21 ' NH1' ' A' ' 168' ' ' ARG . 4.6 mp -95.8 109.89 23.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 65.120000000000005 111.156 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.775 HD22 HG23 ' A' ' 167' ' ' VAL . 3.9 mm? -114.08 125.42 53.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.236 -0.438 . . . . 70.450000000000003 110.951 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.37 152.27 51.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.819 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -156.36 153.37 28.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 74.010000000000005 110.872 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 174.34 -143.21 6.82 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 74.209999999999994 112.5 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -139.54 179.8 6.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 73.319999999999993 111.13 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 13.3 m -149.94 170.28 19.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 54.509999999999998 110.883 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.474 ' O ' HG13 ' A' ' 18' ' ' VAL . 25.9 m-85 -133.86 123.94 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.924 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.436 ' HA ' HG22 ' A' ' 18' ' ' VAL . 7.3 p -88.31 136.73 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 111.08 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -139.88 121.78 15.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 75.530000000000001 110.779 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.05 68.12 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.5 . . . . 74.310000000000002 110.88 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.57 HD12 ' HB3' ' A' ' 208' ' ' ALA . 0.3 OUTLIER -96.49 -37.37 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 74.030000000000001 110.945 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 57.23 46.59 18.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 53.409999999999997 111.12 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.57 ' HB3' HD12 ' A' ' 206' ' ' LEU . . . -101.32 83.36 2.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.5 . . . . 64.140000000000001 111.081 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -93.66 168.98 10.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 54.409999999999997 111.092 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.4 109.97 3.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 74.420000000000002 110.903 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 110.897 179.921 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.0 mtm . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.803 0.335 . . . . 72.310000000000002 110.872 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -161.93 159.49 26.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 60.020000000000003 110.858 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -129.12 125.1 36.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 110.91 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -121.24 143.23 49.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 70.540000000000006 110.931 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -143.93 157.56 57.51 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.627 0.727 . . . . 74.340000000000003 110.957 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 137.16 34.7 Favored 'Trans proline' 0 N--CA 1.465 -0.161 0 C-N-CA 122.701 2.267 . . . . 74.519999999999996 112.347 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.17 151.5 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 71.099999999999994 111.094 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -119.39 -38.69 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.908 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.8 m -138.54 138.66 38.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 74.299999999999997 110.823 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.8 140.67 32.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.111 -0.495 . . . . 63.009999999999998 111.131 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -174.93 -152.28 9.12 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.723 . . . . 60.420000000000002 112.529 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -145.5 119.15 9.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 74.129999999999995 110.947 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -149.96 149.77 30.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 52.030000000000001 110.904 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -54.34 140.93 31.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 71.450000000000003 110.929 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.72 7.38 51.04 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.687 -0.768 . . . . 14.140000000000001 112.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -72.36 141.55 48.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.8 0.333 . . . . 73.329999999999998 110.863 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.496 ' HE1' HG23 ' A' ' 59' ' ' ILE . 21.2 t90 -132.6 125.19 29.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.175 -0.466 . . . . 72.0 110.876 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.711 ' CG2' ' HB3' ' A' ' 60' ' ' ALA . 17.5 m -133.12 136.45 55.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.264 -0.425 . . . . 75.329999999999998 111.128 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -99.32 129.7 45.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 53.149999999999999 111.109 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 m -111.42 115.84 29.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.863 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -120.61 115.22 22.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.131 -0.486 . . . . 64.129999999999995 110.868 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -148.37 178.35 8.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.209999999999994 110.852 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -124.28 137.66 54.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.083 -0.508 . . . . 61.020000000000003 110.942 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.37 150.19 23.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 62.149999999999999 110.832 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.36 146.16 28.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 61.530000000000001 110.89 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -83.83 123.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 53.329999999999998 111.128 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.607 ' CD2' HD23 ' A' ' 196' ' ' LEU . 13.5 m-85 -123.92 148.93 46.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 73.340000000000003 110.931 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.01 -179.52 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.11 -0.495 . . . . 45.439999999999998 111.114 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.78 -162.22 18.03 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.806 -0.711 . . . . 71.299999999999997 112.44 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.458 ' CG ' HD23 ' A' ' 32' ' ' LEU . 1.3 tp10 -52.27 -40.9 62.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.778 0.323 . . . . 74.129999999999995 110.875 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' C ' HD22 ' A' ' 32' ' ' LEU . 36.8 tt0 64.38 57.66 1.16 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 64.109999999999999 110.864 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.458 HD23 ' CG ' ' A' ' 30' ' ' GLU . 4.5 mm? -116.83 34.49 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 63.140000000000001 110.87 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.59 119.69 19.69 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.727 -0.749 . . . . 74.420000000000002 112.468 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -76.41 169.19 18.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.81 0.338 . . . . 73.239999999999995 110.831 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 tp 60.11 36.71 21.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.907 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -94.52 -38.03 11.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 110.948 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -130.97 132.98 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.25 111.09 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -86.98 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.768 -0.729 . . . . 61.210000000000001 112.418 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.98 160.46 40.79 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.761 . . . . 50.409999999999997 112.526 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.52 82.0 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.754 -0.736 . . . . 44.420000000000002 112.457 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.5 70.76 0.74 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.814 0.34 . . . . 63.350000000000001 111.074 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -110.2 159.19 32.92 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.554 0.692 . . . . 74.349999999999994 110.946 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 169.86 17.88 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 75.219999999999999 112.358 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.0 t30 -156.08 120.08 4.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 72.319999999999993 110.892 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.65 47.86 2.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 63.140000000000001 111.04 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -79.67 150.48 30.92 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 71.030000000000001 110.82 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.94 147.13 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 74.230000000000004 111.108 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.5 p -169.06 132.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 63.119999999999997 110.88 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.8 tp -119.97 134.7 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 73.120000000000005 111.093 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -133.75 142.3 13.78 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.777 -0.725 . . . . 75.420000000000002 112.498 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -81.11 100.9 9.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 71.230000000000004 110.861 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -117.4 30.56 7.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 70.329999999999998 110.872 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.7 t -67.42 126.02 27.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 71.140000000000001 111.117 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.8 p -121.9 129.14 52.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.238 -0.437 . . . . 73.5 111.154 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.7 tp -57.17 125.83 24.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 73.219999999999999 110.936 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.438 HG22 ' CE1' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -135.77 118.8 16.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 111.219 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -115.57 131.44 56.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 75.430000000000007 110.877 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.53 131.0 39.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 63.130000000000003 110.887 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.496 HG23 ' HE1' ' A' ' 17' ' ' TRP . 74.4 mt -103.53 125.77 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 73.310000000000002 111.137 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.711 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -111.96 143.99 42.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 63.100000000000001 111.075 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.477 ' HB3' HG12 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -139.1 120.66 15.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.887 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.762 ' CD1' ' HB2' ' A' ' 68' ' ' ALA . 1.1 t80 -97.59 110.02 22.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 70.140000000000001 110.862 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.477 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -135.14 31.18 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 71.510000000000005 111.147 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 m -143.72 -174.97 4.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 54.43 110.839 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 m -73.35 -46.71 47.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 73.120000000000005 110.818 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.54 35.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.6 mt -141.94 140.21 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 111.125 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.762 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . . . -138.27 132.27 31.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.138 -0.483 . . . . 63.020000000000003 111.082 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.795 ' HA ' HD13 ' A' ' 105' ' ' LEU . 11.7 p -71.73 142.53 15.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.409999999999997 111.137 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -129.99 136.44 49.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 64.430000000000007 110.882 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.73 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 10.7 t80 -127.55 118.07 23.25 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.24 -0.436 . . . . 71.329999999999998 110.857 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' CE1' HG22 ' A' ' 56' ' ' THR . 2.0 t80 -88.64 138.66 31.22 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.114 -0.494 . . . . 73.349999999999994 110.858 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.6 p -155.66 144.85 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 61.039999999999999 111.145 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -156.97 -154.64 7.13 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.727 -0.749 . . . . 53.130000000000003 112.528 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.06 155.88 42.72 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.622 0.725 . . . . 75.129999999999995 111.125 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 174.5 9.38 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.679 2.253 . . . . 73.040000000000006 112.334 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.21 77.67 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.448 . . . . 71.129999999999995 111.095 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -52.59 -37.37 57.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.918 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.71 -55.52 19.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 111.146 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -76.91 133.36 39.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 71.450000000000003 110.906 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -143.82 160.88 39.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 64.549999999999997 110.889 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -172.7 150.88 2.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.986 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 143.45 153.28 5.84 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 44.439999999999998 112.506 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.3 -37.63 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.911 0.386 . . . . 74.319999999999993 110.838 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.65 149.0 19.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 65.430000000000007 110.93 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.4 p -162.05 108.53 1.31 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.212 -0.449 . . . . 65.209999999999994 110.897 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.7 mt -124.73 94.78 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 62.310000000000002 111.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.8 p -159.35 179.63 8.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 63.329999999999998 110.914 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 m -164.75 139.7 5.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 62.299999999999997 110.913 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.41 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.8 OUTLIER -146.53 163.91 34.24 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 74.329999999999998 110.957 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -160.31 77.51 0.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.777 -0.725 . . . . 71.319999999999993 112.512 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.39 41.59 2.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.843 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 p -144.52 139.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 75.019999999999996 111.131 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 m -132.16 -61.16 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 64.5 110.86 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -113.61 -69.23 0.87 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 74.219999999999999 110.883 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.9 p -63.5 140.56 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.108 -0.496 . . . . 70.310000000000002 111.17 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -117.06 137.31 52.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.179 -0.464 . . . . 63.219999999999999 110.837 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -74.1 -67.34 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 110.958 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 64.73 -167.96 28.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 74.329999999999998 112.446 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 141.48 45.43 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.658 2.238 . . . . 63.130000000000003 112.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -139.82 137.68 35.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.187 -0.46 . . . . 62.219999999999999 111.12 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 36.5 mt -132.16 131.92 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 73.319999999999993 111.116 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.72 120.59 39.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.400000000000006 110.85 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.2 p -155.82 153.38 29.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.836 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.795 HD13 ' HA ' ' A' ' 69' ' ' VAL . 4.1 mm? -94.14 141.36 28.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 110.96 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -112.87 141.24 46.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 73.230000000000004 110.935 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -153.49 157.42 39.81 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.186 -0.461 . . . . 72.310000000000002 110.894 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -121.98 143.28 49.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 73.329999999999998 110.803 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -49.37 -46.82 47.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 71.340000000000003 110.923 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.4 -41.9 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 51.409999999999997 110.898 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.6 t 50.43 64.42 1.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 75.230000000000004 110.863 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -120.34 23.26 10.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.9 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 48.54 85.51 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 64.340000000000003 110.91 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -173.44 173.31 3.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 70.420000000000002 110.874 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.34 96.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 110.862 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -162.87 161.07 19.27 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.665 0.745 . . . . 73.209999999999994 110.952 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 165.36 31.3 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.633 2.222 . . . . 71.439999999999998 112.276 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -142.38 139.7 31.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 72.120000000000005 110.93 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.0 p -108.09 134.16 50.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 65.519999999999996 111.094 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -128.21 144.85 15.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.773 -0.727 . . . . 74.120000000000005 112.48 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 58.1 t -147.04 144.34 19.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.871 0.367 . . . . 74.099999999999994 111.17 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.12 -153.64 21.76 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.748 -0.739 . . . . 44.109999999999999 112.502 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.5 m -121.43 171.88 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 71.010000000000005 111.155 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -157.33 174.26 34.83 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 33.530000000000001 112.482 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 68.1 ttt-85 -171.52 156.72 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.818 0.342 . . . . 75.519999999999996 110.893 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.25 136.92 33.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 72.430000000000007 111.132 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.98 111.38 17.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.2 -0.455 . . . . 75.150000000000006 110.898 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -52.68 145.04 12.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 71.420000000000002 110.916 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -100.0 97.72 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 70.219999999999999 110.909 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -59.74 168.89 1.55 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 63.25 110.863 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -74.33 -175.26 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.846 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.45 163.77 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 53.039999999999999 111.124 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.03 38.95 13.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 70.310000000000002 110.913 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.95 -174.64 6.59 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 54.210000000000001 112.518 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.19 36.33 2.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 51.32 111.106 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 12.8 tp 59.43 37.72 23.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.99 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 2.2 t -96.52 164.42 12.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 73.409999999999997 110.821 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 37.3 p -141.34 174.59 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 71.340000000000003 110.906 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -168.96 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 65.540000000000006 110.853 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.73 145.9 52.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 54.409999999999997 110.933 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 32.2 mt -116.26 132.08 66.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 53.32 111.135 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -123.01 60.36 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 63.140000000000001 110.892 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.58 -176.98 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.049999999999997 110.882 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -140.27 170.31 16.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 110.826 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 3.1 m0 -65.87 152.22 44.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 65.219999999999999 110.907 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.59 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -110.31 160.4 28.53 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.573 0.702 . . . . 45.229999999999997 111.086 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.59 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.74 153.82 68.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.263 . . . . 72.120000000000005 112.324 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.27 139.83 1.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 74.109999999999999 111.089 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -139.47 148.0 42.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 63.140000000000001 110.906 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -165.31 163.68 19.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.165 -0.47 . . . . 75.200000000000003 110.959 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 167' ' ' VAL . 32.9 m -123.32 -178.96 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 63.509999999999998 111.146 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -167.45 -177.9 39.28 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.809 -0.71 . . . . 71.200000000000003 112.558 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.436 HD12 ' CD1' ' A' ' 155' ' ' TYR . 0.1 OUTLIER -124.54 127.69 47.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.339 . . . . 73.530000000000001 110.877 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.451 HH21 HG21 ' A' ' 18' ' ' VAL . 16.7 ttt-85 -111.81 107.26 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.873 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.436 ' CD1' HD12 ' A' ' 153' ' ' LEU . 1.2 m-85 -118.73 115.17 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 75.540000000000006 110.959 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.3 96.09 6.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.143 -0.481 . . . . 72.230000000000004 110.841 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.72 HD22 ' CH2' ' A' ' 161' ' ' TRP . 4.6 tp -60.27 -36.04 76.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.159 -0.473 . . . . 53.420000000000002 110.926 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 139.45 -47.68 0.89 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.744 -0.741 . . . . 73.129999999999995 112.487 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.23 174.58 1.55 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.848 0.356 . . . . 70.420000000000002 110.937 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.0 p -52.35 -36.81 54.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 60.210000000000001 110.931 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.72 ' CH2' HD22 ' A' ' 157' ' ' LEU . 69.1 p-90 -87.61 150.2 23.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.09 -0.505 . . . . 74.230000000000004 110.975 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 65.0 mtt -141.51 170.39 15.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 71.120000000000005 110.901 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.587 HD13 ' N ' ' A' ' 164' ' ' ASN . 0.4 OUTLIER -98.49 129.69 45.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 72.5 110.87 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.587 ' N ' HD13 ' A' ' 163' ' ' LEU . 1.3 t30 -128.14 133.45 48.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 64.219999999999999 110.909 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.33 151.3 50.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 51.210000000000001 110.891 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -131.69 144.81 51.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 71.329999999999998 110.872 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 151' ' ' VAL . 43.8 t -142.6 123.72 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 111.126 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 29.7 ttt-85 -149.44 135.41 18.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.182 -0.463 . . . . 63.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -141.71 139.96 33.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.420000000000002 110.941 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.6 153.11 81.01 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.64 0.733 . . . . 64.040000000000006 111.123 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.83 132.91 24.2 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.683 2.255 . . . . 65.099999999999994 112.355 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -143.88 131.34 21.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 74.120000000000005 110.924 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -139.46 140.35 37.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.479 . . . . 61.329999999999998 110.903 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.2 m -148.2 144.53 27.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 72.310000000000002 111.159 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -77.37 98.36 5.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.469 . . . . 74.129999999999995 110.882 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.73 109.98 25.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 65.349999999999994 111.099 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 7.3 t -56.47 -35.31 67.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.208 -0.451 . . . . 71.099999999999994 111.105 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.51 172.79 38.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 43.25 112.493 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 10.7 t -98.73 145.26 27.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.35 . . . . 72.310000000000002 111.169 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.7 tt -112.35 93.36 4.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 71.109999999999999 110.91 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 111.43 175.14 20.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.698 -0.763 . . . . 61.340000000000003 112.453 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 126.01 12.83 Favored 'Trans proline' 0 C--O 1.231 0.137 0 C-N-CA 122.729 2.286 . . . . 74.439999999999998 112.326 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 184' ' ' PRO . 58.3 t -134.11 133.22 21.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.587 0.708 . . . . 72.239999999999995 111.127 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 183' ' ' VAL . 53.8 Cg_endo -69.66 -48.35 0.76 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.673 2.249 . . . . 53.109999999999999 112.381 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.6 t -148.09 139.1 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 55.439999999999998 111.19 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.1 m -172.39 113.56 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 71.239999999999995 110.943 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 68.6 p -118.85 107.67 13.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 74.010000000000005 111.144 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.3 mmmt -89.64 -64.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 110.841 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 16.2 tt -167.32 137.13 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 111.117 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -52.74 163.37 0.47 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 74.319999999999993 110.921 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 43.9 t -101.19 -55.37 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 53.329999999999998 111.091 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -153.55 71.54 6.75 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.64 0.733 . . . . 73.239999999999995 110.867 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 134.13 27.27 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.666 2.244 . . . . 64.129999999999995 112.367 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -98.53 141.91 30.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.223 -0.444 . . . . 71.430000000000007 110.812 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 51.1 mm -93.04 106.01 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 61.420000000000002 111.11 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.607 HD23 ' CD2' ' A' ' 27' ' ' TYR . 34.7 tp -121.56 115.57 23.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 61.439999999999998 110.885 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.1 t -110.48 152.18 26.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 72.219999999999999 110.851 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.9 mt -151.98 142.73 22.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 75.329999999999998 110.939 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.38 -146.04 7.21 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.717 -0.754 . . . . 74.129999999999995 112.463 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.34 -179.18 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 64.099999999999994 111.103 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 51.5 p -158.06 157.45 32.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.185 -0.461 . . . . 73.340000000000003 110.841 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -121.85 140.53 52.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.200000000000003 110.934 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.674 ' HA ' HG12 ' A' ' 18' ' ' VAL . 29.7 m -102.09 136.82 32.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 65.340000000000003 111.135 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -139.56 127.45 22.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.209999999999994 110.851 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.5 ptmt -115.04 84.13 2.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 72.319999999999993 110.946 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -63.83 -62.04 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.975 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.06 154.09 16.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.319999999999993 111.105 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -169.11 165.55 11.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 62.310000000000002 111.047 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -71.62 96.63 1.59 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 73.540000000000006 111.165 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 12.2 tp -101.27 65.25 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 72.120000000000005 110.928 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 60.149999999999999 110.893 179.911 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 CA--C 1.527 0.065 0 CA-C-O 120.754 0.312 . . . . 50.439999999999998 110.85 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -140.43 151.4 44.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 63.340000000000003 110.929 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -119.07 179.8 4.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 71.120000000000005 110.89 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -141.7 165.71 26.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.072 -0.513 . . . . 61.420000000000002 110.917 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -150.39 72.2 9.14 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.74 0.781 . . . . 74.010000000000005 110.929 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 149.41 67.24 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.632 2.222 . . . . 72.010000000000005 112.378 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.44 160.45 31.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 75.239999999999995 111.079 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.42 58.38 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 50.450000000000003 110.834 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -81.88 157.87 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 64.299999999999997 110.867 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.8 171.31 11.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.147 -0.479 . . . . 64.109999999999999 111.095 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -144.45 163.78 27.8 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.75 . . . . 70.319999999999993 112.441 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -140.65 117.55 11.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.924 0.392 . . . . 70.299999999999997 110.98 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -152.79 173.41 15.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.084 -0.507 . . . . 64.510000000000005 110.828 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.609 ' HB2' HG13 ' A' ' 63' ' ' VAL . 14.7 pt20 -69.84 142.5 53.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 73.450000000000003 110.88 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.23 7.45 49.47 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 74.239999999999995 112.456 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -61.5 148.06 43.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.796 0.331 . . . . 54.340000000000003 110.832 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 24.1 m-90 -119.69 120.93 38.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.979 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 202' ' ' TYR . 33.5 t -119.18 129.92 74.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.275 -0.42 . . . . 74.040000000000006 111.113 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -106.21 107.39 18.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 71.129999999999995 111.124 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.2 t -103.74 121.32 42.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.162 -0.472 . . . . 54.25 110.862 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 30.1 p90 -119.94 122.89 42.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 63.140000000000001 110.89 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.14 175.7 10.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.448 . . . . 72.540000000000006 110.947 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' HE1' HD12 ' A' ' 55' ' ' LEU . 8.7 m-85 -117.81 143.36 46.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.242 -0.436 . . . . 73.099999999999994 110.836 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.686 ' OG ' HG21 ' A' ' 56' ' ' THR . 58.5 m -104.92 153.89 20.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 70.319999999999993 110.801 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -156.19 143.34 19.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 64.329999999999998 110.935 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -84.87 132.61 31.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 72.099999999999994 111.087 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -129.08 154.21 46.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 72.200000000000003 110.919 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -138.51 142.85 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 73.140000000000001 111.14 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.98 133.19 11.2 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.684 -0.77 . . . . 65.409999999999997 112.486 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -88.57 -42.67 11.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 74.049999999999997 110.883 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 63.2 45.97 4.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 70.310000000000002 110.871 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 tp -99.94 36.29 1.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.71 135.04 13.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 73.409999999999997 112.484 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -163.76 166.33 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.333 . . . . 73.140000000000001 110.881 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.9 mp -63.27 -47.06 83.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 75.109999999999999 110.929 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -151.94 122.58 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 72.219999999999999 110.897 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 m -119.07 -36.05 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 65.310000000000002 111.114 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.88 -176.61 42.71 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.791 -0.719 . . . . 60.439999999999998 112.506 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 158.06 -133.24 3.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 71.140000000000001 112.533 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.33 -158.75 26.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 44.219999999999999 112.405 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -110.72 -68.56 0.92 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.89 0.376 . . . . 73.140000000000001 111.124 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.64 160.68 58.83 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.647 0.737 . . . . 75.329999999999998 110.874 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 113.68 3.45 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.672 2.248 . . . . 71.239999999999995 112.336 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -108.84 105.65 15.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 64.340000000000003 110.886 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -170.17 110.7 0.41 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 72.329999999999998 111.044 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.51 149.86 28.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 64.120000000000005 110.863 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.504 HG22 ' H ' ' A' ' 49' ' ' ILE . 10.4 p -139.5 137.14 40.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.299999999999997 111.18 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.7 m -125.63 39.72 3.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 72.299999999999997 110.84 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.504 ' H ' HG22 ' A' ' 47' ' ' VAL . 8.4 pt -142.56 -178.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 65.340000000000003 111.068 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 168.39 -137.2 4.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 61.25 112.502 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 53.62 45.83 27.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.347 . . . . 63.5 110.883 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -109.05 -37.32 5.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.21 -0.45 . . . . 73.109999999999999 110.83 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 7.5 t -57.76 138.27 55.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 54.420000000000002 111.14 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.5 p -125.85 146.63 49.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 70.340000000000003 111.175 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' HE1' ' A' ' 23' ' ' PHE . 5.7 tp -74.95 125.1 28.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.251 -0.431 . . . . 63.340000000000003 110.892 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' OG ' ' A' ' 24' ' ' SER . 20.7 p -132.35 120.2 21.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.44 . . . . 74.25 111.159 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -110.75 131.23 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 65.420000000000002 110.875 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -128.26 124.66 37.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 73.430000000000007 110.919 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 61' ' ' TYR . 27.8 mt -105.64 118.3 52.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 63.109999999999999 111.163 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.03 154.47 26.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 60.43 111.163 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' CE1' HG22 ' A' ' 59' ' ' ILE . 13.8 m-85 -129.59 131.42 46.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 71.310000000000002 110.866 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -95.94 106.71 18.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 62.009999999999998 110.875 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 14' ' ' GLN . 21.9 t -125.45 -37.19 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 73.349999999999994 111.078 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 m -123.02 149.96 43.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 64.129999999999995 110.848 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.5 m -79.73 -36.47 37.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 110.828 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -66.24 -41.62 89.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.086 -0.506 . . . . 72.140000000000001 110.895 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.426 HD12 HD13 ' A' ' 105' ' ' LEU . 6.9 pt -141.87 156.87 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 63.520000000000003 111.093 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -128.2 157.3 41.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 74.420000000000002 111.081 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' HA ' HD23 ' A' ' 105' ' ' LEU . 21.7 t -85.93 141.79 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 111.123 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -144.37 128.0 17.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.030000000000001 110.918 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.448 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 4.9 t80 -127.15 115.73 19.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 72.209999999999994 110.932 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -88.88 138.21 31.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 72.329999999999998 110.799 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 90.8 t -149.77 132.71 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 62.009999999999998 111.125 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.76 -157.04 27.06 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.737 -0.744 . . . . 62.310000000000002 112.448 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 76' ' ' PRO . 59.0 t -89.27 133.3 35.22 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.643 0.735 . . . . 72.120000000000005 111.187 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.7 166.72 26.57 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 75.120000000000005 112.308 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.56 -59.82 2.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 42.350000000000001 111.18 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -114.75 -178.84 3.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 73.340000000000003 110.803 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.21 148.71 41.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 111.1 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -159.55 137.64 10.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 75.209999999999994 110.931 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -123.33 -39.66 2.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.253 -0.431 . . . . 73.299999999999997 110.905 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -114.15 -68.21 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.882 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 111.05 -79.16 0.25 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.686 -0.768 . . . . 72.519999999999996 112.478 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -94.07 66.5 3.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.966 0.412 . . . . 62.119999999999997 110.906 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 10.1 tmtt? -162.44 135.42 5.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 71.049999999999997 110.901 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 m -52.67 160.87 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 75.25 110.819 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.8 pt -54.94 173.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.102 -0.499 . . . . 54.299999999999997 111.134 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 t -131.8 -60.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 64.010000000000005 110.87 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 p -170.47 172.29 6.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 61.310000000000002 110.909 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.0 pp -64.82 146.43 54.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 70.400000000000006 110.916 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 151.04 140.08 3.11 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.722 -0.752 . . . . 74.219999999999999 112.449 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -172.45 127.75 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.891 0.377 . . . . 75.239999999999995 110.894 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.23 176.28 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 73.409999999999997 111.125 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 38.7 p -131.49 -175.44 3.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.097 -0.501 . . . . 74.420000000000002 110.844 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -161.5 121.56 2.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.091 -0.504 . . . . 70.430000000000007 110.855 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.3 m -118.89 43.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.175 -0.466 . . . . 63.409999999999997 111.107 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -127.49 150.58 49.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 65.010000000000005 110.87 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -54.56 145.21 19.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 73.439999999999998 110.909 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.4 -71.87 0.22 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.664 -0.779 . . . . 74.219999999999999 112.463 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 154.75 67.1 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.702 2.268 . . . . 74.120000000000005 112.332 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.448 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -171.51 166.86 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 72.239999999999995 111.117 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.565 HD12 ' HA3' ' A' ' 124' ' ' GLY . 24.6 mm -126.15 131.16 71.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 62.340000000000003 111.177 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.2 tt -113.52 119.87 39.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.878 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 7.4 p -156.9 169.32 25.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 52.340000000000003 110.817 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.426 HD13 HD12 ' A' ' 67' ' ' ILE . 16.0 mt -115.93 134.52 54.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 64.010000000000005 110.911 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -107.91 142.42 38.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 73.439999999999998 110.919 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -132.3 144.32 50.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.206 -0.452 . . . . 74.400000000000006 110.933 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.9 m80 -112.6 150.83 30.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.319999999999993 110.913 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.79 -47.58 64.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 75.319999999999993 110.889 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.13 -41.76 5.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.052 -0.522 . . . . 73.420000000000002 110.838 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.3 m 63.54 35.78 11.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 70.120000000000005 110.811 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -115.31 33.18 5.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 74.209999999999994 110.86 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 51.55 59.03 4.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 75.239999999999995 110.935 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 30.8 mtp85 -137.65 165.92 25.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 71.129999999999995 110.876 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.769 HD23 ' HB2' ' A' ' 155' ' ' TYR . 2.0 mp -68.75 98.32 0.9 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 63.32 110.91 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -160.33 160.6 26.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.717 0.77 . . . . 72.219999999999999 110.894 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.6 Cg_endo -69.75 170.16 17.21 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.672 2.248 . . . . 72.349999999999994 112.327 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -163.68 162.26 24.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 110.926 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.815 HG22 HG13 ' A' ' 151' ' ' VAL . 46.5 t -143.95 146.71 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 75.0 111.217 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -135.11 158.85 23.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.736 -0.745 . . . . 52.119999999999997 112.445 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.484 HG23 ' HB3' ' A' ' 149' ' ' PHE . 10.7 p -151.04 151.88 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.842 0.353 . . . . 75.510000000000005 111.177 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.37 -154.07 20.49 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.718 -0.753 . . . . 34.409999999999997 112.502 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.67 151.77 17.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.867 0.365 . . . . 63.340000000000003 111.073 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HD12 ' A' ' 102' ' ' ILE . . . -128.14 141.0 12.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.733 -0.746 . . . . 73.340000000000003 112.476 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -125.16 110.38 14.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 73.239999999999995 110.859 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.452 ' C ' HD13 ' A' ' 127' ' ' LEU . 22.7 t -140.39 134.46 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 73.230000000000004 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -140.68 157.18 45.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.864 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.78 55.07 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 64.299999999999997 110.817 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -52.18 140.94 19.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 65.030000000000001 110.839 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -160.68 130.84 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 63.399999999999999 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -151.98 133.77 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.88 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.4 p -84.11 69.72 10.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 53.350000000000001 111.106 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -158.54 151.3 22.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 110.89 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.03 56.24 0.47 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.725 -0.75 . . . . 62.109999999999999 112.535 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.07 53.36 0.81 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 75.319999999999993 111.115 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tp 52.54 37.0 21.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 61.140000000000001 110.933 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.1 p 51.88 37.66 21.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 44.140000000000001 110.87 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.6 p -84.59 -179.19 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 72.030000000000001 110.891 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 56.91 50.27 12.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.88 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -109.4 61.54 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 74.230000000000004 110.825 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 24.4 pt -95.96 45.58 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 63.439999999999998 111.106 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -132.22 132.61 43.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.877 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -172.83 164.4 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.510000000000005 110.818 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -160.45 152.94 20.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.459 . . . . 75.030000000000001 110.862 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 6.3 p90 -152.96 160.66 43.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 65.310000000000002 110.989 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -161.65 160.44 22.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 72.420000000000002 111.107 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.8 Cg_endo -69.84 156.73 62.39 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 51.119999999999997 112.291 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -174.12 161.07 3.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 111.099 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.484 ' HB3' HG23 ' A' ' 121' ' ' VAL . 17.9 p90 -137.92 163.94 30.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 71.129999999999995 110.893 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -148.2 145.66 28.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 71.209999999999994 110.955 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.815 HG13 HG22 ' A' ' 119' ' ' VAL . 21.8 t -116.6 133.35 63.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 52.509999999999998 111.154 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -151.64 -166.73 14.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 61.240000000000002 112.535 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 117' ' ' PRO . 1.5 pp -152.44 149.22 28.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 72.109999999999999 110.89 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -121.18 131.14 54.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 71.140000000000001 110.87 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.769 ' HB2' HD23 ' A' ' 115' ' ' LEU . 6.4 p90 -152.31 131.59 12.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 63.32 110.936 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -78.26 127.13 31.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.219999999999999 110.895 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.535 ' HB3' HD12 ' A' ' 163' ' ' LEU . 5.8 tt -170.16 119.23 0.59 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 72.310000000000002 110.915 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 147.26 -120.03 1.2 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.748 -0.739 . . . . 44.340000000000003 112.484 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -114.79 -69.59 0.85 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.824 0.345 . . . . 71.420000000000002 110.925 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.6 p -120.62 -48.86 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 73.450000000000003 110.898 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -72.33 172.26 10.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.052 -0.522 . . . . 75.519999999999996 110.957 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 2.2 ptt? -112.33 167.27 10.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 72.400000000000006 110.82 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.535 HD12 ' HB3' ' A' ' 157' ' ' LEU . 52.8 mt -106.6 138.25 43.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 110.914 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -138.68 148.41 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 71.340000000000003 110.873 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 5.1 p -133.04 142.27 48.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 63.219999999999999 110.84 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -133.05 143.82 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.230000000000004 110.838 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.0 m -150.6 149.58 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.082 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 63.0 ttt-85 -149.27 129.25 13.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 71.349999999999994 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -88.29 127.45 35.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 70.409999999999997 110.903 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' ILE . 3.3 tp -143.83 96.55 5.54 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.65 0.738 . . . . 63.5 111.158 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 91.44 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.687 2.258 . . . . 70.019999999999996 112.308 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -81.89 100.9 9.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.283 -0.417 . . . . 71.349999999999994 110.871 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -70.65 158.34 36.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 63.030000000000001 110.945 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.3 p -111.51 164.65 12.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 62.399999999999999 111.155 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -125.59 101.37 6.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 64.219999999999999 110.88 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 13.7 p -78.41 136.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 111.122 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.2 m -56.61 145.76 27.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 73.349999999999994 111.173 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.61 94.4 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 24.43 112.467 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.473 ' O ' HD22 ' A' ' 180' ' ' LEU . 63.1 p -128.95 126.95 40.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 41.039999999999999 111.169 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 179' ' ' THR . 4.4 mm? -123.66 90.01 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 63.399999999999999 110.916 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 177.93 -74.65 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.81 -0.709 . . . . 55.219999999999999 112.493 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 -173.66 0.75 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.671 2.247 . . . . 72.140000000000001 112.35 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.6 m -147.68 70.19 11.37 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.568 0.699 . . . . 71.319999999999993 111.121 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.7 -179.77 3.11 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.754 2.303 . . . . 64.019999999999996 112.396 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 87.4 t -90.17 102.63 13.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.291 -0.413 . . . . 54.350000000000001 111.151 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 187' ' ' THR . 3.1 p -83.07 -60.51 2.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.833 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 186' ' ' SER . 10.1 t 37.39 43.45 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 111.188 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -128.67 72.82 1.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.882 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.8 mp -105.74 -63.27 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 75.310000000000002 111.087 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -67.74 96.57 0.57 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.449 . . . . 70.310000000000002 110.888 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.35 108.95 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 75.230000000000004 111.133 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -164.69 73.18 1.55 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.609 0.718 . . . . 73.310000000000002 110.869 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.8 146.78 60.97 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.651 2.234 . . . . 70.019999999999996 112.325 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -133.05 156.2 47.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 74.5 110.845 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 47.9 mm -99.06 122.3 50.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 54.109999999999999 111.136 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.14 122.87 36.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 41.43 110.905 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.49 152.25 51.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.219999999999999 110.895 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.444 ' O ' HD12 ' A' ' 198' ' ' LEU . 3.0 pp -155.85 155.9 33.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.193 -0.458 . . . . 73.439999999999998 110.975 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.92 -143.41 7.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 53.420000000000002 112.535 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -135.17 175.15 9.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.849 0.357 . . . . 73.219999999999999 111.024 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 46.5 t -152.67 162.58 41.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.156 -0.474 . . . . 74.150000000000006 110.802 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.477 ' O ' HG13 ' A' ' 18' ' ' VAL . 48.2 t80 -137.8 144.99 41.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 71.349999999999994 110.925 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.3 p -100.82 140.5 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 64.530000000000001 111.132 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -139.72 124.76 18.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 75.219999999999999 110.868 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.62 61.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 75.239999999999995 110.944 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 207' ' ' ALA . 4.1 pp -52.14 -36.19 50.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.349999999999994 110.866 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.423 ' N ' HD12 ' A' ' 206' ' ' LEU . . . -80.17 127.61 32.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 64.129999999999995 111.045 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -108.87 -51.49 2.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 111.082 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -125.43 128.71 48.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 62.420000000000002 111.171 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.0 pp -129.15 -176.55 3.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 54.030000000000001 110.907 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 72.200000000000003 110.89 179.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 mtt . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.726 0.298 . . . . 75.349999999999994 110.926 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -136.73 -179.77 5.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 71.150000000000006 110.85 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -109.82 176.01 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 74.109999999999999 110.93 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -152.49 111.01 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 71.109999999999999 110.892 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -100.27 159.43 29.79 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.69 0.757 . . . . 74.109999999999999 110.893 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.84 107.76 1.94 Allowed 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.683 2.255 . . . . 62.329999999999998 112.343 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.48 155.99 38.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 111.038 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.02 159.61 33.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 70.120000000000005 110.909 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.3 t -143.37 169.68 17.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.26 -0.427 . . . . 54.229999999999997 110.811 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -117.42 179.33 4.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 62.439999999999998 111.079 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.65 -174.0 27.8 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.736 -0.745 . . . . 61.149999999999999 112.495 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -150.1 124.08 9.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.863 0.363 . . . . 70.109999999999999 110.904 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -153.98 -176.26 5.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 70.049999999999997 110.907 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -52.33 143.03 15.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 73.239999999999995 110.86 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.73 7.6 50.54 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.732 -0.747 . . . . 53.310000000000002 112.492 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.73 144.35 41.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.859 0.361 . . . . 74.299999999999997 110.793 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.553 ' CZ2' HD11 ' A' ' 59' ' ' ILE . 1.6 t90 -115.96 128.5 55.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.420000000000002 110.934 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 75.9 t -121.65 128.42 75.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.078 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.06 105.33 13.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.095 -0.502 . . . . 32.509999999999998 111.049 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.3 m -101.61 153.32 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 74.120000000000005 110.854 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -156.57 120.27 4.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 62.509999999999998 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.8 178.31 9.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 73.049999999999997 110.929 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -120.5 139.3 53.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 61.210000000000001 110.846 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 54.6 p -98.32 157.52 16.13 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.862 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -154.96 148.7 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.511 . . . . 74.230000000000004 110.87 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.03 135.48 24.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 64.109999999999999 111.093 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -122.74 115.49 22.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 75.340000000000003 111.001 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 p -144.54 152.68 15.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.093 -0.503 . . . . 63.299999999999997 111.192 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.77 -39.45 5.85 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.725 -0.75 . . . . 63.420000000000002 112.491 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.84 -34.7 41.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.803 0.335 . . . . 73.409999999999997 110.831 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.19 -44.72 75.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 73.439999999999998 110.902 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.38 -36.12 68.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.129 -0.487 . . . . 75.530000000000001 110.889 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.85 168.45 36.47 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.663 -0.78 . . . . 64.329999999999998 112.475 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -83.32 89.71 7.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 73.519999999999996 110.91 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.0 mp -58.64 -51.11 71.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.174 -0.467 . . . . 64.230000000000004 110.873 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -142.58 174.78 10.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 75.519999999999996 110.939 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.62 -36.53 42.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.400000000000006 111.115 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.55 -149.72 37.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 61.240000000000002 112.484 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.92 166.78 17.89 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.728 -0.748 . . . . 63.530000000000001 112.556 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.02 174.59 31.06 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.688 -0.768 . . . . 63.409999999999997 112.431 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.65 -51.18 68.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.86 0.362 . . . . 61.030000000000001 111.153 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.71 159.25 72.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.615 0.722 . . . . 75.239999999999995 110.907 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 169.97 17.6 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 60.140000000000001 112.363 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -78.94 88.63 4.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 70.129999999999995 110.935 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.629 ' O ' HG13 ' A' ' 47' ' ' VAL . . . -136.8 143.27 43.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 74.109999999999999 111.072 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 41.82 39.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.885 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 45' ' ' ALA . 27.8 m -106.01 -35.79 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 74.019999999999996 111.067 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.2 m -52.08 -61.51 2.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 64.150000000000006 110.863 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.9 mm -91.28 102.78 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.074 -0.512 . . . . 71.299999999999997 111.185 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -68.36 136.57 30.24 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.735 -0.745 . . . . 72.530000000000001 112.493 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -88.7 74.14 8.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 74.120000000000005 110.907 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -98.69 30.56 3.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.932 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.8 t -60.61 128.0 34.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.448 . . . . 73.439999999999998 111.183 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p -124.12 109.02 12.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 111.106 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.4 pt? -58.69 147.38 33.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.893 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -159.07 144.27 16.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 111.098 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -114.9 136.28 53.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 71.25 110.856 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.66 127.89 51.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 70.200000000000003 110.863 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 71' ' ' PHE . 13.7 tt -105.0 122.21 57.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 74.530000000000001 111.094 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -113.53 156.18 24.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 72.310000000000002 111.154 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.94 119.05 14.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.019999999999996 110.918 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -91.51 94.85 9.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 110.882 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.9 t -127.65 51.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 41.020000000000003 111.053 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.37 -172.91 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 32.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 m -84.6 -46.24 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 74.530000000000001 110.891 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -128.91 -39.05 1.61 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 64.120000000000005 110.844 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.576 HG23 ' CE2' ' A' ' 107' ' ' TYR . 48.7 mt -70.88 117.19 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 60.5 111.204 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.694 ' HB3' ' CG ' ' A' ' 106' ' ' GLN . . . -119.17 161.59 20.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 72.219999999999999 111.099 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.616 ' HA ' HD23 ' A' ' 105' ' ' LEU . 50.0 t -102.51 145.78 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 111.066 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.73 121.46 9.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 63.240000000000002 110.842 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HB2' HG23 ' A' ' 59' ' ' ILE . 3.5 m-85 -118.02 126.39 52.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 72.310000000000002 110.875 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -88.85 122.82 32.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 72.030000000000001 110.866 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 50.1 t -128.58 112.59 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 70.209999999999994 111.185 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.67 -178.01 32.38 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.769 -0.729 . . . . 33.020000000000003 112.464 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.8 t -113.8 85.28 9.37 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.651 0.739 . . . . 74.239999999999995 111.138 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 132.17 22.78 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.274 . . . . 73.409999999999997 112.335 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.86 86.63 6.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 111.115 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -107.53 149.6 27.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.140000000000001 110.889 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.1 101.19 5.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.164 -0.471 . . . . 74.200000000000003 111.032 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -171.0 156.93 5.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.898 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -112.39 178.63 4.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 75.239999999999995 110.91 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -88.79 175.67 7.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 53.43 110.953 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.9 76.2 0.3 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 51.140000000000001 112.504 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.51 84.48 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.89 0.376 . . . . 73.519999999999996 110.895 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -100.07 142.89 30.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 63.030000000000001 110.884 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 65.0 m -94.7 -42.36 8.8 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 52.399999999999999 110.838 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 16.5 pt -51.78 -35.55 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 74.400000000000006 111.135 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 61.3 m -120.88 85.45 2.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.873 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.3 t -149.72 145.02 26.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 62.049999999999997 110.959 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.94 -40.4 1.06 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.146 -0.479 . . . . 71.109999999999999 110.877 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -159.67 -119.57 0.54 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.695 -0.764 . . . . 55.420000000000002 112.492 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -111.16 96.16 5.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 74.140000000000001 110.896 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.6 t -75.81 91.4 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 111.087 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -99.49 53.56 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 65.109999999999999 110.804 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -112.35 104.96 13.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.832 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 17.0 m -138.17 136.55 44.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 63.310000000000002 111.121 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.35 165.75 1.0 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 74.129999999999995 110.856 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -85.26 -36.82 20.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.463 . . . . 74.340000000000003 110.909 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.25 -167.78 22.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.726 -0.749 . . . . 40.299999999999997 112.481 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 138.73 38.48 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.733 2.289 . . . . 74.439999999999998 112.35 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -176.33 164.7 2.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.192 -0.458 . . . . 54.530000000000001 111.074 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.739 HG23 ' CA ' ' A' ' 124' ' ' GLY . 20.4 mt -126.72 136.92 59.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 71.310000000000002 111.152 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.53 113.91 25.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 51.100000000000001 110.896 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 47.1 p -147.01 173.08 12.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 110.902 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' A' ' 69' ' ' VAL . 14.0 mt -123.3 149.77 44.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 110.907 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.694 ' CG ' ' HB3' ' A' ' 68' ' ' ALA . 11.3 pt20 -111.24 153.46 25.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 44.32 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.576 ' CE2' HG23 ' A' ' 67' ' ' ILE . 12.9 m-85 -143.36 140.7 30.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 73.120000000000005 110.924 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.02 166.83 20.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 71.040000000000006 110.819 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -132.33 36.03 3.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.935 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -104.11 -41.57 5.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.492 . . . . 74.049999999999997 110.854 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 54.62 55.49 7.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.442 . . . . 74.409999999999997 110.881 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.37 174.0 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 74.530000000000001 110.867 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -102.06 94.78 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 72.5 110.878 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -174.58 -173.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 74.25 110.942 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.763 HD12 ' CE2' ' A' ' 155' ' ' TYR . 1.8 pt? -81.0 134.01 35.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 75.140000000000001 110.877 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -173.05 157.02 3.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.727 0.775 . . . . 72.530000000000001 110.845 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.75 165.6 30.39 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.645 2.23 . . . . 71.420000000000002 112.379 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -156.76 141.49 16.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 110.91 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.0 m -101.07 152.45 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.074 -0.512 . . . . 51.130000000000003 111.125 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -142.0 137.46 7.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.748 -0.739 . . . . 73.0 112.47 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 149' ' ' PHE . 8.9 p -148.59 144.13 18.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 62.200000000000003 111.087 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.53 -153.98 17.67 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.759 -0.734 . . . . 61.149999999999999 112.479 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' CG ' ' A' ' 145' ' ' TRP . 7.9 p -126.54 145.45 34.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.877 0.37 . . . . 51.240000000000002 111.104 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.739 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.25 156.6 15.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.664 -0.779 . . . . 64.109999999999999 112.44 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -139.08 123.93 18.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.789 0.328 . . . . 62.539999999999999 110.873 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.92 133.95 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 64.329999999999998 111.119 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 13.9 tp -130.91 139.49 50.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 75.120000000000005 110.936 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -138.08 127.69 25.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.25 110.879 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -102.48 90.64 3.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 73.329999999999998 110.846 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -165.37 124.66 1.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 72.040000000000006 110.856 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.9 pttt -136.73 150.02 48.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 74.129999999999995 110.925 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.0 t -163.81 135.57 4.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 75.530000000000001 111.117 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.45 121.63 29.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 63.009999999999998 110.902 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -175.37 -119.38 0.56 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.7 -0.762 . . . . 71.230000000000004 112.482 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.15 -72.57 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.838 0.352 . . . . 73.420000000000002 111.077 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -53.62 128.0 27.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 73.0 110.937 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 3.4 p -89.78 -44.39 10.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 74.019999999999996 110.886 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.4 m -120.93 108.24 13.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 73.209999999999994 110.875 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -118.38 37.39 4.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 70.420000000000002 110.842 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -105.29 68.85 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 73.140000000000001 110.913 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 142' ' ' LYS . 0.0 OUTLIER -159.98 144.57 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 74.519999999999996 111.081 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.443 ' N ' HD13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -168.69 165.47 12.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 62.530000000000001 110.915 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -106.42 116.15 31.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 74.319999999999993 110.848 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -100.6 -43.94 6.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.873 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.516 ' CG ' HG21 ' A' ' 123' ' ' VAL . 15.5 t-105 -106.47 81.23 1.57 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.219 -0.446 . . . . 64.25 110.894 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.401 ' HA ' ' HD2' ' A' ' 147' ' ' PRO . . . -106.33 95.67 12.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 53.310000000000002 111.099 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 146' ' ' ALA . 54.1 Cg_endo -69.71 129.9 18.45 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.712 2.274 . . . . 70.0 112.308 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -147.85 168.32 22.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 74.209999999999994 111.068 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.431 ' HB2' HG23 ' A' ' 121' ' ' VAL . 6.0 t80 -134.96 118.73 17.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 72.150000000000006 110.881 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -118.28 163.69 16.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 75.129999999999995 110.917 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.3 t -132.05 150.44 33.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 72.319999999999993 111.157 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -152.19 177.52 29.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.509 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 152' ' ' GLY . 7.6 mt -133.87 137.53 45.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.359 . . . . 70.349999999999994 110.84 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -104.89 128.65 53.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.215 -0.448 . . . . 72.040000000000006 110.93 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.763 ' CE2' HD12 ' A' ' 115' ' ' LEU . 12.1 m-85 -130.49 129.07 42.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 75.530000000000001 110.949 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -103.53 122.53 45.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.146 -0.479 . . . . 74.049999999999997 110.853 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 18.5 mt -140.99 -179.89 6.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 64.340000000000003 110.89 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.31 -125.99 29.77 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.69 -0.767 . . . . 64.299999999999997 112.497 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -127.73 -52.99 1.34 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.831 0.348 . . . . 53.420000000000002 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.9 m -114.95 -44.52 3.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 70.230000000000004 110.827 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.5 t-105 -71.23 124.14 23.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.148 -0.478 . . . . 74.019999999999996 110.934 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . 0.404 ' O ' ' HB1' ' A' ' 200' ' ' ALA . 6.2 mtm -116.77 167.74 10.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.284 -0.416 . . . . 62.310000000000002 110.879 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.87 141.92 37.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.206 -0.452 . . . . 64.25 110.918 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -140.8 138.12 33.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 74.219999999999999 110.881 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.88 143.78 49.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 110.836 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.93 147.36 52.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 55.25 110.872 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.7 m -152.1 136.42 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 72.299999999999997 111.129 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 7.9 tpp180 -130.98 123.99 30.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 64.200000000000003 110.861 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -140.6 126.86 19.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 75.5 110.915 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 170' ' ' ILE . 5.2 mp -85.14 133.11 43.52 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.593 0.711 . . . . 73.109999999999999 111.141 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.43 ' HD2' HG23 ' A' ' 170' ' ' ILE . 54.1 Cg_endo -69.79 140.0 41.5 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.718 2.279 . . . . 44.530000000000001 112.389 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -114.18 149.21 36.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 73.450000000000003 110.915 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.09 135.58 38.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 71.510000000000005 110.921 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 77.9 p -70.26 168.19 16.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 75.319999999999993 111.167 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.98 143.1 50.62 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.191 -0.459 . . . . 71.450000000000003 110.867 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.54 141.83 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 111.128 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 21.5 p -121.18 155.26 34.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 73.239999999999995 111.218 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -100.43 158.69 19.34 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 41.420000000000002 112.496 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 1.9 t -118.2 74.59 0.96 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.78 0.324 . . . . 73.019999999999996 111.123 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -94.3 137.24 33.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 64.099999999999994 110.986 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 79.35 -174.61 55.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 71.019999999999996 112.511 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -33.93 15.7 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.653 2.235 . . . . 71.409999999999997 112.347 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -126.2 156.12 72.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.568 0.699 . . . . 63.340000000000003 111.164 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 114.93 3.86 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.71 2.273 . . . . 63.43 112.318 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.15 105.14 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 61.350000000000001 111.127 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.1 t -164.33 149.23 10.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 72.409999999999997 110.812 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.46 75.78 0.94 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.108 -0.496 . . . . 74.540000000000006 111.154 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -103.16 86.27 2.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.856 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 63.1 mt -107.03 106.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.454 . . . . 44.329999999999998 111.107 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.06 105.67 8.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.255 -0.429 . . . . 62.329999999999998 110.951 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 16.8 m -120.31 -38.18 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.219999999999999 111.181 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.14 160.54 0.12 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.633 0.73 . . . . 74.420000000000002 110.916 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.68 148.78 66.38 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.716 2.278 . . . . 75.109999999999999 112.349 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -138.47 177.47 7.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 72.120000000000005 110.882 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.583 ' O ' HD23 ' A' ' 196' ' ' LEU . 45.2 mm -114.4 134.13 58.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 72.310000000000002 111.082 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 195' ' ' ILE . 16.4 mt -135.01 128.9 33.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 62.130000000000003 110.929 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.572 ' C ' HD12 ' A' ' 198' ' ' LEU . 1.0 OUTLIER -128.65 152.29 48.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.349999999999994 110.823 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 197' ' ' SER . 4.6 mp -155.15 148.93 25.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.132 -0.486 . . . . 73.420000000000002 110.958 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.97 -143.03 5.85 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.663 -0.779 . . . . 54.119999999999997 112.425 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 162' ' ' MET . . . -126.17 -178.5 4.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.34 . . . . 72.25 111.154 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 62.0 p -163.83 172.49 14.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 110.889 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -147.58 148.29 30.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 64.549999999999997 110.921 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.593 HG13 HG22 ' A' ' 18' ' ' VAL . 40.0 t -121.54 133.78 66.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.093 -0.503 . . . . 64.510000000000005 111.191 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -139.79 161.77 36.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 75.209999999999994 110.858 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -116.91 70.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 70.219999999999999 110.943 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.0 tp -54.8 -60.06 3.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 110.903 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.46 93.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 72.140000000000001 111.107 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -123.26 177.63 5.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 75.400000000000006 111.052 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -118.06 98.88 6.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.474 . . . . 74.430000000000007 111.151 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 4.0 tp -83.77 138.35 33.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.467 . . . . 74.310000000000002 110.908 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.153 -0.476 . . . . 71.329999999999998 110.927 179.872 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mmm . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.82 0.343 . . . . 71.299999999999997 110.93 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -144.5 106.2 4.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 65.200000000000003 110.867 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.68 123.0 0.63 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 53.439999999999998 110.819 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -147.19 128.69 15.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.329999999999998 110.902 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -115.87 160.63 34.4 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.712 0.768 . . . . 72.430000000000007 110.87 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.69 145.37 57.36 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.708 2.272 . . . . 74.310000000000002 112.354 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.2 121.61 22.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 73.109999999999999 111.111 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -93.05 106.17 18.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 70.030000000000001 110.908 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 43.4 t -171.08 131.14 0.78 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 51.240000000000002 110.844 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.15 97.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 64.209999999999994 111.109 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -94.5 -172.11 38.02 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.678 -0.772 . . . . 50.32 112.508 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -129.17 102.13 6.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.918 0.389 . . . . 75.239999999999995 110.935 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -123.3 175.07 6.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 73.25 110.891 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' HB2' HG23 ' A' ' 63' ' ' VAL . 2.3 pt20 -61.84 139.21 58.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 72.420000000000002 110.947 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.78 8.05 35.25 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.745 -0.74 . . . . 63.420000000000002 112.457 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.63 156.44 29.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.738 0.304 . . . . 61.020000000000003 110.945 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -123.94 130.4 52.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 53.299999999999997 110.967 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.77 HG12 ' HA ' ' A' ' 203' ' ' VAL . 13.9 m -123.11 133.39 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 64.040000000000006 111.144 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.7 115.45 30.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 54.350000000000001 111.087 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -112.05 116.41 30.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 61.25 110.867 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -113.79 124.27 51.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 110.882 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.39 163.35 39.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.120000000000005 110.933 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -105.9 145.58 31.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 61.350000000000001 110.864 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -100.84 143.81 30.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 73.310000000000002 110.873 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.8 mttm -129.61 113.12 14.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 110.934 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.5 m -81.07 134.18 27.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 111.091 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.614 ' CD2' HD12 ' A' ' 196' ' ' LEU . 64.8 m-85 -132.39 108.19 9.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 73.109999999999999 110.978 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.725 HG12 ' HA ' ' A' ' 193' ' ' PRO . 18.1 m -135.44 -179.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 64.540000000000006 111.099 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.95 -165.56 25.01 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 51.119999999999997 112.454 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -93.4 8.5 40.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.845 0.355 . . . . 72.129999999999995 110.885 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -63.65 -37.75 88.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 73.420000000000002 110.891 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 tp -120.8 61.91 0.88 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.953 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -79.3 -155.88 9.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.734 -0.746 . . . . 74.420000000000002 112.473 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -122.36 116.0 23.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.879 0.371 . . . . 51.130000000000003 110.858 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 68.0 mt -110.76 53.73 0.69 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 60.539999999999999 110.901 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -52.74 123.09 10.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 53.409999999999997 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.14 -36.29 2.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 65.549999999999997 111.146 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.47 155.98 5.98 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.81 -0.71 . . . . 61.32 112.437 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.5 142.15 4.04 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.776 -0.726 . . . . 73.140000000000001 112.53 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.3 34.19 5.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 71.010000000000005 112.537 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 52.33 36.75 20.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.828 0.347 . . . . 60.229999999999997 111.147 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.41 159.64 33.27 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.699 0.762 . . . . 72.409999999999997 110.866 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.78 130.33 19.13 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.693 2.262 . . . . 70.219999999999999 112.394 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -141.21 118.83 11.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 110.905 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.69 168.5 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 73.120000000000005 111.131 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -77.19 135.79 38.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.417 . . . . 75.430000000000007 110.872 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 64.1 t -106.52 116.1 49.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 111.151 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.5 t -108.65 113.93 27.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 65.239999999999995 110.883 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.5 pt -67.52 169.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 62.210000000000001 111.109 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.35 -57.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 64.319999999999993 112.527 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -58.71 117.89 5.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.801 0.334 . . . . 74.329999999999998 110.857 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -119.36 30.64 7.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.22 -0.445 . . . . 71.340000000000003 110.839 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 20.9 p -144.42 117.84 9.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 63.329999999999998 111.16 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 5.2 m -107.93 128.66 54.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 60.32 111.171 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 mp -54.0 118.73 4.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.216 -0.447 . . . . 71.420000000000002 110.931 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.82 126.56 45.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 41.020000000000003 111.138 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -106.15 134.41 49.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 110.94 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -135.5 121.64 20.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.89 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 29.1 mm -108.65 116.59 52.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 64.540000000000006 111.117 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -110.17 150.85 28.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 62.329999999999998 111.165 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -120.16 126.37 50.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 74.239999999999995 110.916 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -91.5 105.79 18.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 61.130000000000003 110.878 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.474 HG13 ' OG ' ' A' ' 64' ' ' SER . 8.2 p -123.43 -35.47 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 73.129999999999995 111.129 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.474 ' OG ' HG13 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -127.9 149.11 50.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 54.130000000000003 110.806 -179.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.96 -35.61 50.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.109 -0.496 . . . . 64.430000000000007 110.918 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.718 ' OD1' HD12 ' A' ' 67' ' ' ILE . 5.6 p30 -73.84 -42.02 61.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 73.349999999999994 110.866 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.718 HD12 ' OD1' ' A' ' 66' ' ' ASN . 3.2 mt -136.64 143.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 75.329999999999998 111.138 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -125.25 165.15 18.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 72.329999999999998 111.083 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.8 t -96.97 142.54 13.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 75.030000000000001 111.095 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -141.44 134.04 28.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 71.25 110.844 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 73.8 t80 -128.27 113.85 16.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 110.89 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -90.96 143.71 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 73.219999999999999 110.862 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.1 p -160.06 133.31 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 111.136 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -143.62 -174.86 16.22 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.777 -0.725 . . . . 62.420000000000002 112.527 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.0 m -56.52 155.55 13.75 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.594 0.712 . . . . 60.020000000000003 111.133 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 113.64 3.45 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.239 . . . . 74.230000000000004 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.31 165.46 11.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 55.240000000000002 111.1 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -72.08 133.97 45.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 55.530000000000001 110.848 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -133.84 179.27 6.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 53.420000000000002 111.068 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.7 tptt -89.49 156.32 18.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 75.230000000000004 110.936 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -97.29 45.28 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 73.519999999999996 110.913 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -112.64 137.52 50.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.109 -0.496 . . . . 75.140000000000001 110.866 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 177.08 -152.54 12.29 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.75 -0.738 . . . . 61.310000000000002 112.506 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.405 ' O ' HG22 ' A' ' 141' ' ' ILE . 11.8 tt0 -121.63 120.45 34.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.875 0.369 . . . . 61.340000000000003 110.883 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.67 151.82 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 61.200000000000003 110.855 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.8 t -142.36 134.16 26.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 64.200000000000003 110.859 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.4 mt -91.67 -70.29 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 74.5 111.102 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 m -63.82 147.98 50.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 74.040000000000006 110.913 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 p -172.42 161.8 5.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 73.219999999999999 110.871 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 tt -123.95 133.32 53.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.959 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.04 131.4 3.06 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.753 . . . . 64.439999999999998 112.493 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -117.5 -44.43 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.913 0.387 . . . . 73.349999999999994 110.914 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 59.3 t -61.49 130.44 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.105 -0.498 . . . . 54.409999999999997 111.141 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.4 p -104.8 116.28 31.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.889 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.03 155.96 49.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.888 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.1 m -109.9 41.54 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 63.130000000000003 111.126 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -120.63 67.46 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.874 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.545 ' HB3' HD23 ' A' ' 127' ' ' LEU . 34.0 m-85 -149.17 137.91 21.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.140000000000001 110.901 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -134.78 -167.6 11.46 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.794 -0.717 . . . . 73.049999999999997 112.514 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 166.35 27.92 Favored 'Trans proline' 0 N--CA 1.466 -0.137 0 C-N-CA 122.706 2.27 . . . . 72.200000000000003 112.324 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.561 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -159.27 140.71 13.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 54.130000000000003 111.05 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.6 mt -128.91 131.34 68.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 62.140000000000001 111.109 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.0 tt -114.73 120.06 38.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 74.049999999999997 110.946 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -155.17 160.98 41.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 73.120000000000005 110.871 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 HG21 ' A' ' 67' ' ' ILE . 73.5 mt -100.18 139.94 35.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 63.030000000000001 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.625 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -105.44 152.49 22.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 73.409999999999997 110.887 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.429 ' HH ' ' HE1' ' A' ' 109' ' ' TYR . 13.0 t80 -138.4 108.77 6.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 70.349999999999994 110.892 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -130.86 166.81 20.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 71.239999999999995 110.904 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.429 ' HE1' ' HH ' ' A' ' 107' ' ' TYR . 23.4 m-85 -113.09 87.1 2.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.420000000000002 110.96 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -51.93 -41.74 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 63.210000000000001 110.874 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.8 t 51.5 36.03 15.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 73.109999999999999 110.873 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 t80 62.92 63.73 0.93 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 74.150000000000006 110.885 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 63.27 95.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.299999999999997 110.936 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 8.0 ttt85 -179.17 137.47 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.489 . . . . 72.040000000000006 110.869 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.22 131.86 50.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 53.450000000000003 110.966 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -161.57 160.43 23.12 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.702 0.763 . . . . 70.430000000000007 110.848 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 170.29 16.96 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.677 2.251 . . . . 74.349999999999994 112.286 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -165.32 151.58 9.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 110.948 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 151' ' ' VAL . 32.7 m -131.02 145.86 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 70.230000000000004 111.044 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -129.24 147.24 17.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 73.319999999999993 112.439 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -148.47 149.32 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 73.530000000000001 111.154 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 166.41 -153.7 23.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.849 -0.691 . . . . 70.129999999999995 112.569 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.26 151.48 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.808 0.337 . . . . 52.210000000000001 111.149 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -132.37 159.07 23.26 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.733 -0.746 . . . . 54.329999999999998 112.516 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 29.5 ptt85 -152.83 165.06 36.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.834 0.349 . . . . 75.299999999999997 110.866 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.6 m -130.14 138.47 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 72.030000000000001 111.149 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.545 HD23 ' HB3' ' A' ' 98' ' ' TYR . 6.6 tp -108.27 136.22 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 73.430000000000007 110.892 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -168.23 130.9 1.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 74.140000000000001 110.828 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -79.18 172.28 14.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.122 -0.49 . . . . 71.349999999999994 110.786 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -133.97 162.03 33.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.125 -0.488 . . . . 75.219999999999999 110.858 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -96.07 52.65 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 61.130000000000003 110.899 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.3 m -96.3 143.82 27.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 71.099999999999994 111.124 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.03 157.72 15.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 55.409999999999997 110.866 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -99.69 80.08 0.51 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.804 -0.712 . . . . 64.109999999999999 112.546 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -119.89 109.68 15.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.875 0.369 . . . . 60.210000000000001 111.101 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 52.69 36.04 19.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 73.109999999999999 110.949 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 60.7 m -152.48 159.38 43.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.482 . . . . 65.129999999999995 110.809 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.8 t -131.66 -47.22 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 62.43 110.789 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.72 155.28 25.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 74.150000000000006 110.926 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -88.42 -73.27 0.5 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 110.849 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 84' ' ' GLU . 32.0 pt -148.96 140.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 71.340000000000003 111.148 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -123.87 -40.35 2.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 70.219999999999999 110.911 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -80.03 108.32 13.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 73.340000000000003 110.905 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.2 tmtm? -171.68 123.88 0.55 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 110.893 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -179.03 153.72 0.64 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 71.510000000000005 110.923 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.591 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -140.84 160.34 58.91 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.596 0.712 . . . . 74.150000000000006 111.071 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.591 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.8 Cg_endo -69.78 155.96 64.51 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 112.388 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.94 153.67 4.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.272 -0.422 . . . . 54.240000000000002 111.116 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -149.03 151.07 33.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.915 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -144.39 163.6 33.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 55.130000000000003 110.892 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 167' ' ' VAL . 10.3 p -131.61 136.11 57.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.186 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -152.06 -176.68 25.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.717 -0.754 . . . . 52.509999999999998 112.478 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 8.0 tt -130.65 149.78 52.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.793 0.33 . . . . 72.0 110.921 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.3 mmt85 -113.38 129.97 56.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.222 -0.444 . . . . 72.299999999999997 110.904 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -121.76 105.35 10.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.239999999999995 110.94 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -79.76 96.93 6.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 71.129999999999995 110.884 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 157' ' ' LEU . 2.3 tt -179.4 122.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.510000000000005 110.945 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 159.28 176.01 30.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.772 -0.728 . . . . 45.219999999999999 112.467 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -74.57 84.98 2.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 63.039999999999999 110.934 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.1 t 65.84 29.83 10.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.039999999999999 110.927 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -162.79 164.66 26.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 72.010000000000005 110.915 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 24.0 mtt -120.86 159.45 25.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.200000000000003 110.841 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 13.6 mt -103.37 118.06 35.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 74.230000000000004 110.897 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -118.76 143.49 46.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.400000000000006 110.886 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.427 ' HB3' HD13 ' A' ' 198' ' ' LEU . 2.7 p -135.6 137.25 41.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.133 -0.485 . . . . 74.340000000000003 110.849 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -126.96 154.94 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 61.420000000000002 110.879 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 151' ' ' VAL . 35.8 m -150.69 149.54 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 62.030000000000001 111.079 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.4 ttt-85 -151.95 144.42 24.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.165 -0.47 . . . . 73.25 110.911 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -141.88 153.28 44.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 71.120000000000005 110.936 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 10.8 tt -67.65 132.04 92.76 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.575 0.703 . . . . 63.109999999999999 111.127 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 82.1 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.664 2.243 . . . . 74.129999999999995 112.302 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -133.16 132.65 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 75.150000000000006 110.808 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.3 153.19 27.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 74.120000000000005 110.954 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.8 m -142.94 148.34 36.72 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 75.409999999999997 111.159 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -128.35 149.77 50.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.271 -0.422 . . . . 61.130000000000003 110.913 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 49.0 t -139.01 127.87 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 111.113 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 8.9 t -56.59 166.79 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 111.187 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -76.01 89.66 0.88 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.704 -0.76 . . . . 65.019999999999996 112.522 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.464 ' C ' ' HG ' ' A' ' 180' ' ' LEU . 60.8 m -71.99 -36.0 69.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.823 0.344 . . . . 63.43 111.095 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 179' ' ' THR . 1.5 pp 33.58 47.68 0.16 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 72.340000000000003 110.891 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -146.27 -169.98 14.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.727 -0.749 . . . . 44.030000000000001 112.53 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 112.95 3.23 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.668 2.245 . . . . 75.219999999999999 112.292 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 183' ' ' VAL . 4.0 p -160.32 77.96 2.61 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.595 0.712 . . . . 44.240000000000002 111.135 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 -45.17 1.65 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.698 2.266 . . . . 73.230000000000004 112.3 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.5 p -99.66 141.88 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 74.239999999999995 111.1 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 66.5 m -127.43 57.01 1.52 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.806 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.2 p -115.84 38.13 3.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.46 . . . . 72.510000000000005 111.177 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -127.61 77.66 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 74.129999999999995 110.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.59 -66.91 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 54.210000000000001 111.12 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 54.42 51.54 13.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 73.129999999999995 110.804 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 86.6 t -131.1 -70.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 111.14 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.05 160.59 57.42 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.632 0.729 . . . . 73.010000000000005 110.88 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.725 ' HA ' HG12 ' A' ' 28' ' ' VAL . 53.8 Cg_endo -69.75 126.83 13.78 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.701 2.267 . . . . 64.329999999999998 112.351 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' CE2' HD21 ' A' ' 196' ' ' LEU . 0.8 OUTLIER -140.0 122.61 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 64.109999999999999 110.881 -179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 12.6 tt -107.22 137.63 37.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 43.409999999999997 111.126 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.614 HD12 ' CD2' ' A' ' 27' ' ' TYR . 6.6 mt -137.39 119.08 15.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.109 -0.496 . . . . 72.420000000000002 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 3.8 p -116.13 151.28 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 73.530000000000001 110.829 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.486 HD12 ' H ' ' A' ' 199' ' ' GLY . 28.3 tp -154.67 150.46 27.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.329999999999998 110.937 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.486 ' H ' HD12 ' A' ' 198' ' ' LEU . . . 172.67 -150.88 13.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.767 -0.73 . . . . 73.140000000000001 112.51 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -130.38 172.72 11.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.877 0.37 . . . . 74.230000000000004 111.035 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 33.8 t -151.8 159.76 43.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.155 -0.475 . . . . 72.120000000000005 110.854 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -137.34 150.76 47.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.953 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.77 ' HA ' HG12 ' A' ' 18' ' ' VAL . 19.2 m -103.03 142.88 16.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.102 -0.499 . . . . 72.099999999999994 111.138 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -139.75 132.29 28.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.140000000000001 110.896 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -94.86 74.72 3.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 110.905 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 23.0 tp -52.06 -44.01 64.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 62.450000000000003 110.953 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.85 108.4 1.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.113 -0.494 . . . . 75.209999999999994 111.119 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -100.58 50.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 62.25 111.083 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.449 ' C ' HD22 ' A' ' 210' ' ' LEU . . . -148.94 150.33 32.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 44.409999999999997 111.124 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 209' ' ' ALA . 4.6 mm? -120.25 173.25 7.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 73.329999999999998 110.892 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 24.5 tp10 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 71.019999999999996 110.933 179.901 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.785 0.326 . . . . 55.240000000000002 110.835 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -77.51 155.17 31.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 63.43 110.925 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pm0 -57.96 167.92 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 72.140000000000001 110.932 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -141.29 173.84 11.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 62.149999999999999 110.906 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -117.17 157.63 46.41 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.755 0.788 . . . . 64.140000000000001 110.903 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.99 69.59 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.716 2.278 . . . . 72.510000000000005 112.323 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.33 -178.95 7.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 111.106 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -96.34 141.24 29.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 63.420000000000002 110.878 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.4 m -74.96 159.08 32.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 60.140000000000001 110.844 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -157.12 145.89 19.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.519999999999996 111.05 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.37 -150.08 0.38 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 54.119999999999997 112.498 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -166.87 135.62 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.88 0.371 . . . . 51.350000000000001 110.931 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -115.65 175.33 5.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 70.140000000000001 110.885 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -68.46 137.42 54.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 53.130000000000003 110.905 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.7 7.94 28.95 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 74.310000000000002 112.465 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.68 151.22 30.61 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.85 0.357 . . . . 72.129999999999995 110.842 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -130.72 139.49 50.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 65.200000000000003 110.972 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.632 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 36.9 t -131.65 129.56 61.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.262 -0.426 . . . . 75.299999999999997 111.152 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.97 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 44.240000000000002 111.123 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -103.91 150.39 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 63.100000000000001 110.914 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -161.46 126.16 3.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 71.099999999999994 110.893 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.3 167.79 25.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 54.43 110.831 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' O ' HD23 ' A' ' 198' ' ' LEU . 4.0 m-85 -109.52 131.26 55.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 74.420000000000002 110.79 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.13 150.19 21.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 64.200000000000003 110.907 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.6 147.45 25.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.112 -0.494 . . . . 64.129999999999995 110.957 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.5 m -89.37 139.33 17.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.253 -0.43 . . . . 63.030000000000001 111.096 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -132.18 131.61 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 70.420000000000002 111.026 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 30' ' ' GLU . 7.4 p -151.88 141.69 15.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 63.409999999999997 111.112 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.92 -33.51 36.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.764 -0.731 . . . . 71.349999999999994 112.463 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 28' ' ' VAL . 7.2 mt-10 -51.98 -45.69 64.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.758 0.313 . . . . 63.509999999999998 110.911 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 58.78 52.72 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 75.5 110.858 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.0 tp -65.31 -37.53 87.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.200000000000003 110.917 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.67 -123.83 8.04 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.717 -0.754 . . . . 45.229999999999997 112.509 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -168.97 162.17 10.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 73.439999999999998 110.864 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.54 89.89 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 110.919 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -126.5 167.75 15.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 71.010000000000005 110.902 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.0 t -130.92 144.46 37.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 62.149999999999999 111.174 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.22 167.56 28.99 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.666 -0.778 . . . . 35.140000000000001 112.449 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.11 -146.44 17.21 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 71.109999999999999 112.522 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.53 81.73 0.84 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.687 -0.768 . . . . 62.409999999999997 112.528 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.67 -176.6 5.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 64.140000000000001 111.089 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.61 159.28 1.75 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.729 . . . . 62.219999999999999 110.897 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 125.7 12.4 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.659 2.239 . . . . 54.229999999999997 112.316 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -144.26 168.23 20.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 71.5 110.897 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -77.82 143.31 37.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 73.0 111.147 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -136.57 159.19 42.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 110.855 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.47 141.6 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.144 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -104.67 145.59 30.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 63.43 110.841 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.7 mt -90.38 121.24 40.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 44.539999999999999 111.097 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 130.18 -33.45 2.91 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.721 -0.752 . . . . 73.340000000000003 112.427 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -126.02 77.48 1.68 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.887 0.375 . . . . 73.150000000000006 110.897 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -97.76 30.54 2.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 71.140000000000001 110.883 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.5 t -128.62 153.25 47.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 70.010000000000005 111.166 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.3 p -131.55 124.04 29.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 53.439999999999998 111.137 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.78 152.83 43.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 64.310000000000002 110.884 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.0 t -153.13 139.2 18.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 55.43 111.18 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -114.0 154.23 28.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.329999999999998 110.834 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -155.21 149.82 26.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 50.009999999999998 110.843 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 32.9 mm -118.74 121.1 66.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 71.219999999999999 111.172 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.05 109.06 21.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 63.149999999999999 111.145 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.96 120.15 37.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.109999999999999 110.921 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -99.01 97.92 9.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.056 -0.52 . . . . 74.140000000000001 110.866 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.5 t -137.1 60.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 24.120000000000001 111.107 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -173.24 -169.98 0.58 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 74.299999999999997 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -83.48 -46.85 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.209999999999994 110.847 -179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.44 -41.88 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.489 . . . . 61.43 110.877 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.94 118.43 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 73.040000000000006 111.134 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -113.11 161.34 17.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 74.299999999999997 111.114 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.83 141.47 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.434 . . . . 65.420000000000002 111.11 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -133.25 103.73 6.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.430000000000007 110.857 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.545 ' CE1' HD21 ' A' ' 103' ' ' LEU . 9.9 t80 -85.75 109.63 18.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.472 . . . . 74.530000000000001 110.848 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.538 ' HE2' ' HG ' ' A' ' 104' ' ' SER . 8.1 m-85 -88.64 135.95 33.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 72.310000000000002 110.896 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.73 124.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.127 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -136.79 -179.33 16.62 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.7 -0.762 . . . . 50.240000000000002 112.418 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -101.7 133.27 20.88 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.598 0.713 . . . . 63.119999999999997 111.078 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.79 150.73 68.41 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.686 2.258 . . . . 64.299999999999997 112.331 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.16 86.91 0.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.435 . . . . 65.310000000000002 111.087 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -66.92 126.55 29.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 63.210000000000001 110.904 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -130.12 91.36 3.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 111.083 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -100.36 117.67 35.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.853 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -128.2 154.51 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 70.409999999999997 110.873 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -55.51 122.11 10.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 110.823 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.71 92.05 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.715 -0.755 . . . . 64.329999999999998 112.481 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -125.24 142.63 51.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.913 0.387 . . . . 72.5 110.928 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -85.58 -45.73 11.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 110.927 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 90.7 p -53.09 121.27 7.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 74.530000000000001 110.879 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -64.04 -35.8 74.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 72.230000000000004 111.122 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.8 t -77.59 139.78 39.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.6 m -93.38 108.66 20.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.062 -0.517 . . . . 74.329999999999998 110.888 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -102.83 178.03 4.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.086 -0.507 . . . . 72.530000000000001 110.886 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -146.89 150.05 22.27 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.749 -0.738 . . . . 22.129999999999999 112.475 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.7 174.05 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 72.519999999999996 110.861 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.44 139.08 48.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 64.140000000000001 111.121 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.0 p -77.01 134.34 38.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 70.310000000000002 110.82 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -154.0 171.51 18.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 53.32 110.861 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.61 133.37 19.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 54.409999999999997 111.182 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -109.46 127.26 54.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 74.519999999999996 110.888 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -105.88 151.59 24.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 71.230000000000004 110.91 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 146.27 -74.92 0.29 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.716 -0.754 . . . . 64.319999999999993 112.456 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.73 147.56 63.31 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.662 2.242 . . . . 73.329999999999998 112.376 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -175.42 161.0 2.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.276 -0.42 . . . . 63.439999999999998 111.087 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 64.7 mt -124.97 138.45 54.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 72.329999999999998 111.177 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 71' ' ' PHE . 4.4 mm? -110.44 106.84 16.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.878 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.538 ' HG ' ' HE2' ' A' ' 72' ' ' PHE . 76.4 p -118.87 133.91 55.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.429 . . . . 74.239999999999995 110.808 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.6 tp -90.5 140.81 29.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.077 -0.511 . . . . 72.439999999999998 110.881 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -102.54 133.77 46.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 54.539999999999999 110.939 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -129.65 133.81 47.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 74.140000000000001 110.932 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -129.15 136.63 50.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 65.340000000000003 110.811 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -66.32 -33.32 75.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 73.109999999999999 110.965 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.51 -35.64 10.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.010000000000005 110.806 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.8 t 63.36 56.81 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 74.400000000000006 110.874 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -155.97 -176.04 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 53.549999999999997 110.918 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -93.45 101.83 14.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 64.200000000000003 110.877 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.59 169.73 18.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 110.859 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.533 HD23 ' CD2' ' A' ' 155' ' ' TYR . 4.2 mp -86.43 103.99 15.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 110.982 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -166.34 163.07 11.8 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.624 0.726 . . . . 75.200000000000003 110.925 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.5 Cg_endo -69.84 144.81 54.76 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.737 2.291 . . . . 71.530000000000001 112.332 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -124.39 149.24 46.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.873 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 144.1 11.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 73.010000000000005 111.148 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.48 123.17 3.3 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.773 . . . . 52.32 112.481 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 7.8 p -145.64 135.48 18.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 111.047 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.37 -154.12 14.1 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.745 -0.74 . . . . 55.439999999999998 112.441 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.93 174.16 11.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.852 0.358 . . . . 51.340000000000003 111.139 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -144.77 153.8 25.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.802 -0.713 . . . . 44.020000000000003 112.524 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -141.22 117.09 10.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.929 0.395 . . . . 71.510000000000005 110.872 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.75 151.32 26.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 42.049999999999997 111.156 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.77 91.74 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 63.030000000000001 110.917 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -76.56 -43.3 39.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 55.549999999999997 110.846 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -73.47 77.32 1.43 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 72.239999999999995 110.889 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -91.35 -53.91 4.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 110.861 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 58.77 43.29 18.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 75.129999999999995 110.849 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.1 m -52.68 -40.7 63.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.27 -0.423 . . . . 73.219999999999999 111.178 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -69.21 170.79 9.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.25 110.829 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 111.92 -179.7 19.66 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 55.039999999999999 112.451 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.58 -53.6 6.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 75.409999999999997 111.1 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.93 115.32 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 54.32 110.882 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 t -157.67 140.7 15.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.439999999999998 110.865 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.5 t -168.79 115.17 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 62.310000000000002 110.892 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -108.14 165.45 11.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.843 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -102.64 167.03 10.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 62.409999999999997 110.831 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 61.6 mt -82.68 120.37 33.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 52.409999999999997 111.124 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 24.4 mtmm -100.14 53.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 74.030000000000001 110.894 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 57.77 53.93 6.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 74.439999999999998 110.864 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -90.3 96.81 10.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 75.140000000000001 110.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -169.9 165.42 9.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 71.340000000000003 110.894 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -158.07 160.4 29.83 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.621 0.724 . . . . 75.299999999999997 111.072 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 52.6 Cg_endo -69.83 166.01 29.13 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.718 2.279 . . . . 62.509999999999998 112.277 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.87 132.48 0.88 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 111.098 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -126.07 149.36 48.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 74.409999999999997 110.862 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -165.76 163.71 18.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 71.120000000000005 110.877 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.0 t -130.98 133.8 62.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 111.175 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.702 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -129.9 -171.27 12.9 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.742 -0.742 . . . . 74.349999999999994 112.533 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 152' ' ' GLY . 4.0 mt -135.13 140.12 45.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.769 0.319 . . . . 73.25 110.882 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 5.4 ptm85 -121.62 115.49 22.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 72.109999999999999 110.871 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 115' ' ' LEU . 7.7 m-85 -120.85 178.59 4.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 71.239999999999995 110.92 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -106.8 135.75 47.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 72.239999999999995 110.816 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.91 -68.1 0.81 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 45.219999999999999 110.93 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -136.27 -85.93 0.19 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 63.439999999999998 112.498 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.51 -40.39 1.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.866 0.365 . . . . 72.109999999999999 110.888 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.29 -53.72 2.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 65.340000000000003 110.948 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -71.95 151.22 43.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.088 -0.506 . . . . 73.140000000000001 110.93 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 7.0 mmt -135.6 153.53 51.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 71.430000000000007 110.845 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 mt -80.97 136.15 35.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.799 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -132.0 131.91 42.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.913 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.3 m -136.94 148.77 47.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 64.329999999999998 110.877 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -136.23 138.64 42.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 73.329999999999998 110.93 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.762 HG13 HD11 ' A' ' 196' ' ' LEU . 25.4 t -135.77 120.45 27.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 65.120000000000005 111.156 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -137.86 141.42 40.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 110.831 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -130.99 118.01 20.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.944 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . . . . . . . . . 2.8 tp -75.04 131.57 78.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.727 . . . . 73.230000000000004 111.136 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 89.5 0.53 Allowed 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.72 2.28 . . . . 51.420000000000002 112.342 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -130.73 56.59 1.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 61.229999999999997 110.893 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 29.0 tttp -169.45 147.81 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.913 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.1 p -91.86 89.41 7.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 74.450000000000003 111.111 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.56 170.74 8.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 32.100000000000001 110.889 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.86 169.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 62.219999999999999 111.136 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.5 m -115.34 153.2 31.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 71.299999999999997 111.102 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -111.01 -99.8 2.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.693 -0.765 . . . . 62.350000000000001 112.541 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 13.5 p -128.27 99.38 5.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.813 0.339 . . . . 72.530000000000001 111.174 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.63 159.16 11.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.441 . . . . 73.540000000000006 110.909 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 139.33 179.09 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.496 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.85 -173.14 0.67 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.678 2.252 . . . . 71.409999999999997 112.334 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 32.4 t 61.12 68.74 1.18 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.641 0.734 . . . . 64.319999999999993 111.148 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 149.11 66.53 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.638 2.225 . . . . 62.119999999999997 112.343 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.9 p -125.74 135.25 64.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 63.009999999999998 111.12 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.5 m -82.7 107.63 15.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.857 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 10.1 t -104.22 159.68 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.085 -0.507 . . . . 75.510000000000005 111.161 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -63.06 154.11 31.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 62.32 110.859 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 21.2 tt -125.99 142.32 43.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 70.340000000000003 111.084 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -165.15 143.82 6.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 74.329999999999998 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 39.9 t 56.51 75.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 72.530000000000001 111.127 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -150.46 73.5 9.02 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 75.439999999999998 110.812 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.65 130.15 18.97 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.732 2.288 . . . . 73.219999999999999 112.421 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -150.07 178.19 9.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 74.010000000000005 110.868 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.42 HD13 ' N ' ' A' ' 196' ' ' LEU . 0.0 OUTLIER -118.91 143.83 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 74.420000000000002 111.112 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 167' ' ' VAL . 1.2 mp -140.19 142.99 35.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.897 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -118.47 141.52 48.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 54.439999999999998 110.908 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.509 HD23 ' H ' ' A' ' 198' ' ' LEU . 2.4 pt? -135.04 133.58 39.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.150000000000006 110.918 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.98 -145.65 6.04 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.683 -0.77 . . . . 53.310000000000002 112.474 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -146.44 -178.51 6.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.761 0.315 . . . . 55.200000000000003 111.126 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.0 m -156.04 171.81 19.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.248 -0.433 . . . . 42.439999999999998 110.869 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.547 ' C ' HG13 ' A' ' 18' ' ' VAL . 12.5 t80 -139.14 116.87 11.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 65.219999999999999 110.888 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.609 ' HA ' HG22 ' A' ' 18' ' ' VAL . 29.2 t -85.25 131.4 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 61.409999999999997 111.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.76 124.8 18.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.12 -0.491 . . . . 74.349999999999994 110.864 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -118.14 101.94 8.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.0 mt -86.72 -45.7 10.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 53.229999999999997 110.966 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 63.56 40.36 8.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.474 . . . . 75.439999999999998 111.088 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -122.33 131.66 54.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 71.310000000000002 111.15 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -59.47 121.39 11.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.234 -0.439 . . . . 73.319999999999993 111.048 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 5.3 tp -115.44 43.36 2.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.891 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.891 179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.8 mtt . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.758 0.313 . . . . 73.340000000000003 110.9 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -58.44 155.91 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 65.409999999999997 110.838 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -108.82 178.6 4.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.47 . . . . 74.120000000000005 110.856 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -130.39 32.68 4.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 75.129999999999995 110.875 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.54 145.04 47.46 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.676 0.75 . . . . 72.340000000000003 110.908 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 143.81 52.16 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.653 2.235 . . . . 64.209999999999994 112.323 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.19 151.77 20.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 111.02 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 38.3 mmtm -88.45 176.57 7.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 63.409999999999997 110.924 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 t -130.45 145.74 51.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 33.229999999999997 110.88 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -120.1 -53.46 2.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 64.420000000000002 111.091 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -89.64 -153.21 27.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.774 -0.727 . . . . 63.310000000000002 112.49 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -136.69 116.94 13.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 73.150000000000006 110.91 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -119.49 -170.59 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 72.010000000000005 110.882 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -61.93 143.19 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.902 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' N ' HG12 ' A' ' 63' ' ' VAL . . . 110.42 7.73 25.89 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.744 -0.741 . . . . 34.399999999999999 112.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -78.38 147.23 34.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.761 0.315 . . . . 74.049999999999997 110.894 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 32.5 t90 -127.19 136.63 52.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.267 -0.424 . . . . 71.329999999999998 110.991 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 203' ' ' VAL . 17.3 m -138.01 131.73 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.307 -0.406 . . . . 64.129999999999995 111.154 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -101.05 117.28 34.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 72.540000000000006 111.097 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.98 124.04 51.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 72.319999999999993 110.929 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -128.29 127.87 43.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 74.120000000000005 110.884 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -158.68 161.4 37.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 64.340000000000003 110.874 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -105.47 143.17 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 70.239999999999995 110.906 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -102.63 160.07 14.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 110.85 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.4 ptmt -157.79 142.79 16.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 50.329999999999998 110.855 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 p -87.7 138.54 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 64.200000000000003 111.161 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -131.55 137.06 48.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 65.439999999999998 110.945 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 30' ' ' GLU . 46.7 t -120.44 132.25 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 71.219999999999999 111.129 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -52.44 -33.61 40.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.815 -0.707 . . . . 62.25 112.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HG2' HD12 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -52.22 -46.89 65.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 71.25 110.91 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 60.72 47.67 7.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.469 . . . . 74.219999999999999 110.883 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.718 HD12 ' HG2' ' A' ' 30' ' ' GLU . 17.5 mt -103.58 -42.86 5.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 61.149999999999999 110.941 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 64.79 75.58 0.37 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.441 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.7 106.87 10.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 71.030000000000001 110.869 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -131.97 48.72 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 50.130000000000003 110.917 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -165.35 161.51 19.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.922 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.99 -36.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 73.450000000000003 111.134 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 174.34 178.36 44.19 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.722 -0.751 . . . . 75.209999999999994 112.433 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.92 -135.85 7.84 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.768 -0.73 . . . . 73.430000000000007 112.574 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.39 -141.56 9.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 65.209999999999994 112.514 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.39 -45.77 4.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.907 0.384 . . . . 23.350000000000001 111.12 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.01 159.21 73.76 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.667 0.746 . . . . 74.400000000000006 110.911 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 110.07 2.46 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.708 2.272 . . . . 72.209999999999994 112.379 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -164.49 151.18 11.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 110.936 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.46 112.78 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 45.100000000000001 111.116 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -94.39 102.12 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 63.439999999999998 110.874 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 t -85.89 86.97 2.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 73.150000000000006 111.095 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.0 m -136.22 116.37 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 71.230000000000004 110.836 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.6 tp -147.2 131.63 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 61.530000000000001 111.154 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.59 -175.91 14.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.716 -0.754 . . . . 65.310000000000002 112.523 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -60.82 156.16 17.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.881 0.372 . . . . 63.219999999999999 110.871 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -123.62 30.6 6.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 62.109999999999999 110.814 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.6 t -106.75 163.19 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 74.519999999999996 111.177 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.6 t -133.82 119.37 19.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 61.229999999999997 111.138 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 55' ' ' LEU . 1.2 pt? -63.15 144.23 57.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 74.219999999999999 110.887 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 18.8 p -145.19 142.98 30.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 61.43 111.192 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -107.11 151.77 24.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.434 . . . . 65.310000000000002 110.852 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -147.81 134.72 20.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.103 -0.499 . . . . 73.25 110.865 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 9.3 pt -111.99 122.53 66.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 50.420000000000002 111.086 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 18' ' ' VAL . . . -126.13 162.85 24.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 72.439999999999998 111.106 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -158.41 144.43 17.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 73.329999999999998 110.922 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.87 118.41 36.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 74.319999999999993 110.889 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 15' ' ' GLY . 6.2 m -141.38 38.79 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 71.030000000000001 111.101 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.0 t -152.27 -171.17 3.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.456 . . . . 74.040000000000006 110.851 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.1 p -84.03 -46.81 11.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 71.099999999999994 110.948 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -144.37 33.32 1.19 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 74.109999999999999 110.839 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.6 mt -142.15 124.58 13.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.25 111.117 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.513 ' HB3' ' HG3' ' A' ' 106' ' ' GLN . . . -117.99 153.28 33.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 73.450000000000003 111.127 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 105' ' ' LEU . 21.8 t -105.72 145.94 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.114 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -148.16 136.02 20.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 64.409999999999997 110.878 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.445 ' CE2' HD23 ' A' ' 103' ' ' LEU . 17.0 m-85 -122.71 122.03 37.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 73.140000000000001 110.893 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -88.69 143.05 27.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 71.010000000000005 110.833 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.5 p -155.02 130.48 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 62.310000000000002 111.129 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.22 -159.94 35.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.756 -0.735 . . . . 44.340000000000003 112.515 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 HG13 ' HD2' ' A' ' 76' ' ' PRO . 58.7 t -76.55 133.29 70.93 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.645 0.736 . . . . 61.119999999999997 111.12 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' HG13 ' A' ' 75' ' ' VAL . 53.6 Cg_endo -69.75 155.71 65.27 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.666 2.244 . . . . 64.439999999999998 112.371 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.7 70.6 1.46 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 74.019999999999996 111.074 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.1 ttt85 -137.06 141.7 42.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.318 -0.401 . . . . 64.109999999999999 110.836 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.55 156.37 47.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.487 . . . . 72.040000000000006 111.104 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 59.66 38.46 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 73.340000000000003 110.894 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -98.96 104.59 16.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.442 . . . . 72.519999999999996 110.92 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -109.0 155.85 20.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.122 -0.49 . . . . 65.150000000000006 110.895 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.89 147.87 16.8 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 71.450000000000003 112.487 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.44 120.99 29.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.924 0.393 . . . . 70.030000000000001 110.92 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -109.37 135.28 50.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 71.430000000000007 110.985 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.2 p -79.37 164.85 23.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 62.43 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 7.7 tp -52.99 -35.82 22.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.130000000000003 111.154 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.5 m -80.68 160.29 25.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 71.140000000000001 110.908 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.5 t -156.9 115.71 3.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.823 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.1 mt -113.71 -54.19 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.097 -0.501 . . . . 73.239999999999995 110.869 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.5 40.82 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.726 -0.75 . . . . 60.009999999999998 112.512 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -157.22 133.9 10.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.200000000000003 110.911 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.34 169.73 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 75.209999999999994 111.164 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.7 p -156.72 123.55 5.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 62.409999999999997 110.885 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -123.4 171.45 9.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 73.439999999999998 110.912 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 31.3 m -145.03 129.29 12.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 74.219999999999999 111.145 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -174.06 136.89 0.53 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.434 . . . . 71.310000000000002 110.827 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -129.48 99.38 5.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 74.430000000000007 110.935 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.57 -165.86 39.79 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 74.5 112.424 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 141.68 45.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.599 2.2 . . . . 64.200000000000003 112.403 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -178.0 -177.73 0.63 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 74.540000000000006 111.046 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.691 HG23 ' CA ' ' A' ' 124' ' ' GLY . 66.1 mt -132.73 145.94 33.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 111.148 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 71' ' ' PHE . 5.3 mp -128.26 131.2 48.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 72.540000000000006 110.94 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 9.7 p -156.39 165.77 35.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.485 . . . . 64.430000000000007 110.834 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 69' ' ' VAL . 2.1 mm? -110.29 144.17 39.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.513 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 1.1 pp0? -116.83 141.11 48.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.200000000000003 110.916 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -153.32 156.24 38.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 63.25 110.945 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -131.57 163.84 27.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 60.119999999999997 110.854 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -51.47 -41.76 61.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 65.120000000000005 110.97 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -104.81 -41.82 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 74.340000000000003 110.842 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 62.89 75.05 0.41 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.234 -0.439 . . . . 73.140000000000001 110.842 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.97 144.2 23.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.468 . . . . 73.450000000000003 110.931 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.05 107.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 64.209999999999994 110.894 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.71 -172.36 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.856 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.46 98.41 9.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 64.010000000000005 110.927 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -160.55 162.18 23.73 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.712 0.768 . . . . 62.229999999999997 110.909 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . 53.8 Cg_endo -69.75 171.22 14.85 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.723 2.282 . . . . 73.310000000000002 112.35 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -161.43 157.07 24.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 52.210000000000001 110.967 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.7 p -113.75 144.41 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 74.209999999999994 111.112 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -133.28 138.16 9.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.129999999999995 112.565 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.12 148.11 17.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.9 0.381 . . . . 71.099999999999994 111.122 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.38 -153.26 17.42 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.711 -0.757 . . . . 74.409999999999997 112.446 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 146' ' ' ALA . 9.7 p -128.86 140.81 48.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.918 0.39 . . . . 75.019999999999996 111.096 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.691 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -116.65 151.36 18.3 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.763 -0.732 . . . . 23.300000000000001 112.519 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -141.23 112.54 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.839 0.352 . . . . 73.140000000000001 110.861 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.0 m -122.23 149.96 25.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.445 . . . . 74.430000000000007 111.183 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.51 146.86 40.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 65.439999999999998 110.877 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 54.61 36.13 25.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.872 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -51.92 -37.4 52.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 62.219999999999999 110.911 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -150.53 169.35 21.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 52.020000000000003 110.865 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -113.94 150.9 33.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 70.340000000000003 110.892 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 3.3 m -114.05 -67.51 0.99 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 50.32 111.157 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -170.71 164.73 8.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.885 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -102.56 44.67 1.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.230000000000004 112.527 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -88.84 -175.68 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 73.409999999999997 111.036 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.76 41.18 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.439999999999998 110.919 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.65 162.55 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.889 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 2.9 p -124.61 141.34 52.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 72.0 110.883 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -146.97 -176.93 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.400000000000006 110.901 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 141' ' ' ILE . 6.3 m-20 -81.25 -74.36 0.33 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 73.530000000000001 110.882 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.414 ' C ' ' O ' ' A' ' 140' ' ' ASP . 41.3 pt 36.74 44.44 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 65.0 111.097 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.0 mttp -58.83 -74.45 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 74.140000000000001 110.831 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.08 43.27 30.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 64.409999999999997 110.887 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -67.86 -49.94 59.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 72.329999999999998 110.957 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -139.26 125.27 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 71.239999999999995 110.949 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.575 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -113.94 160.28 32.84 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.601 0.715 . . . . 74.219999999999999 111.113 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.575 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 54.5 Cg_endo -69.69 126.75 13.73 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.699 2.266 . . . . 71.230000000000004 112.348 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -116.54 129.92 56.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 74.450000000000003 111.138 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -160.91 118.18 2.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 63.109999999999999 110.858 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 -151.24 163.78 38.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.891 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 29.4 m -121.75 137.01 56.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.420000000000002 111.127 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.05 -166.99 10.97 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.701 -0.762 . . . . 73.400000000000006 112.477 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.471 HD21 ' OG ' ' A' ' 165' ' ' SER . 0.8 OUTLIER -151.94 150.01 29.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 64.239999999999995 110.913 -179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -129.3 117.4 20.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.47 . . . . 72.230000000000004 110.906 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.48 ' CE2' HD12 ' A' ' 163' ' ' LEU . 17.9 p90 -152.41 132.54 13.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 70.349999999999994 110.945 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -67.52 154.19 41.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 63.539999999999999 110.862 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 30.6 tp -150.54 -74.41 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 73.5 110.907 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -73.59 175.84 46.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.777 -0.725 . . . . 72.219999999999999 112.497 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -79.21 135.01 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 63.109999999999999 110.886 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 19.4 m 51.32 34.41 11.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 71.049999999999997 110.885 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -162.22 131.84 4.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 73.329999999999998 110.906 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -100.88 153.45 19.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 73.140000000000001 110.879 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.48 HD12 ' CE2' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -97.9 123.46 41.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 72.239999999999995 110.886 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 163' ' ' LEU . 3.2 t30 -122.56 134.64 54.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 71.420000000000002 110.863 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.471 ' OG ' HD21 ' A' ' 153' ' ' LEU . 1.4 t -133.83 153.4 51.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 72.230000000000004 110.912 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -148.0 157.04 43.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.1 -0.5 . . . . 72.230000000000004 110.856 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.882 HG23 HD23 ' A' ' 196' ' ' LEU . 6.3 p -154.76 139.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 60.350000000000001 111.151 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.9 ttm-85 -132.89 116.43 16.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 73.219999999999999 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -103.86 153.32 20.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 61.049999999999997 110.946 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.402 ' HA ' ' HD2' ' A' ' 171' ' ' PRO . 46.9 mt -106.43 96.55 14.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.655 0.74 . . . . 74.140000000000001 111.092 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 170' ' ' ILE . 54.4 Cg_endo -69.64 -172.2 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.689 2.259 . . . . 72.540000000000006 112.398 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -169.02 162.87 11.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.437 . . . . 75.510000000000005 110.888 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.81 120.55 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 75.510000000000005 110.909 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.7 m -113.85 135.97 53.39 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.253 -0.43 . . . . 73.209999999999994 111.206 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -58.68 174.35 0.34 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 71.120000000000005 110.816 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 12.6 p -80.25 142.17 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 75.310000000000002 111.135 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.3 t -71.12 148.73 47.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 65.209999999999994 111.118 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -86.16 140.28 17.52 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.736 -0.745 . . . . 65.400000000000006 112.439 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.7 -48.66 80.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.763 0.316 . . . . 51.310000000000002 111.168 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.635 HD23 ' N ' ' A' ' 181' ' ' GLY . 1.4 tt -139.99 154.6 47.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.948 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.635 ' N ' HD23 ' A' ' 180' ' ' LEU . . . 168.41 -171.61 42.67 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 62.109999999999999 112.471 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -38.77 7.16 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.671 2.247 . . . . 74.329999999999998 112.296 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 183' ' ' VAL . 3.9 p -155.24 77.96 4.81 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.622 0.725 . . . . 74.400000000000006 111.109 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -47.5 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.696 2.264 . . . . 72.329999999999998 112.343 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.0 m -86.01 131.31 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 72.150000000000006 111.137 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.581 ' HB3' HD11 ' A' ' 189' ' ' ILE . 2.6 t -125.65 174.49 8.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 63.329999999999998 110.853 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.1 p -98.66 -39.23 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 72.150000000000006 111.22 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -148.4 120.57 8.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 72.540000000000006 110.91 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.581 HD11 ' HB3' ' A' ' 186' ' ' SER . 3.8 mp -120.82 63.12 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 75.219999999999999 111.142 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -176.15 148.36 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 110.83 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 21.9 t -135.96 88.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.11 -0.496 . . . . 62.109999999999999 111.106 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -150.57 160.51 32.58 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.535 0.683 . . . . 74.049999999999997 110.893 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 169.01 19.84 Favored 'Trans proline' 0 C--O 1.233 0.23 0 C-N-CA 122.752 2.302 . . . . 74.129999999999995 112.371 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.578 ' HE1' HD11 ' A' ' 196' ' ' LEU . 13.2 p90 -157.18 168.51 27.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 63.119999999999997 110.874 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 34.7 mt -108.2 145.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 55.119999999999997 111.094 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.882 HD23 HG23 ' A' ' 167' ' ' VAL . 6.1 mt -137.37 132.92 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.909 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.408 ' O ' HD23 ' A' ' 198' ' ' LEU . 0.3 OUTLIER -125.99 144.3 50.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 43.530000000000001 110.875 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.408 HD23 ' O ' ' A' ' 197' ' ' SER . 47.7 mt -149.93 142.91 24.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 71.099999999999994 110.907 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 177.89 -148.99 8.92 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 63.020000000000003 112.454 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -128.95 -178.4 4.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.864 0.364 . . . . 75.519999999999996 111.019 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 42.5 t -162.64 167.21 23.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 51.130000000000003 110.831 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -139.27 143.58 37.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 71.310000000000002 110.941 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.763 ' HA ' HG12 ' A' ' 18' ' ' VAL . 11.4 p -106.85 138.68 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 55.32 111.196 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.74 130.18 25.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 75.230000000000004 110.924 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -112.85 97.78 6.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.854 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.89 -36.24 11.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 64.230000000000004 110.941 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -53.36 120.78 6.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 60.130000000000003 111.1 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -142.16 149.21 39.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 62.100000000000001 111.099 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -52.15 169.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 51.439999999999998 111.049 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.61 166.43 18.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 71.329999999999998 110.954 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 73.109999999999999 110.955 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 mtp . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.786 0.327 . . . . 73.430000000000007 110.883 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -99.45 170.96 8.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 63.229999999999997 110.893 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -110.13 159.18 17.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 61.140000000000001 110.884 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -85.97 173.3 10.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 62.439999999999998 110.918 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -126.65 160.5 58.21 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.637 0.732 . . . . 74.430000000000007 110.972 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.78 162.02 43.68 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.674 2.249 . . . . 64.439999999999998 112.32 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.27 168.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 53.109999999999999 111.118 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -117.55 153.75 32.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 m -68.77 -177.16 0.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.155 -0.475 . . . . 74.230000000000004 110.867 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.7 153.85 4.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 73.510000000000005 111.176 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.5 -150.81 5.5 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 42.409999999999997 112.424 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -145.9 118.82 8.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.881 0.372 . . . . 75.0 110.881 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -116.82 171.27 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 110.943 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.455 ' HB3' HG13 ' A' ' 63' ' ' VAL . 64.9 mt-30 -65.66 136.86 56.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 74.450000000000003 110.918 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 63' ' ' VAL . . . 101.45 7.56 48.55 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.718 -0.753 . . . . 74.109999999999999 112.485 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.27 142.7 56.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.751 0.31 . . . . 73.409999999999997 110.816 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.642 ' HE1' HG23 ' A' ' 59' ' ' ILE . 16.4 t90 -119.28 119.42 33.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 110.943 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.79 HG12 HG23 ' A' ' 203' ' ' VAL . 17.0 m -122.63 139.94 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 111.19 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -118.57 122.24 42.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 111.103 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 m -114.88 123.63 49.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 62.5 110.821 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -118.02 122.23 42.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 74.25 110.89 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -145.52 168.88 19.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.85 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.499 ' CE1' HD22 ' A' ' 55' ' ' LEU . 4.9 m-85 -107.26 138.8 42.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 110.882 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.2 p -98.58 146.21 26.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 64.109999999999999 110.887 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -138.42 112.85 8.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 74.329999999999998 110.908 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.53 134.18 27.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.173 -0.467 . . . . 72.409999999999997 111.213 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -128.68 116.17 19.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 64.409999999999997 110.914 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.6 HG22 ' CB ' ' A' ' 193' ' ' PRO . 93.0 t -140.08 144.23 28.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 72.319999999999993 111.152 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.1 -172.75 0.48 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.698 -0.763 . . . . 72.239999999999995 112.456 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -90.44 -36.16 14.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.831 0.348 . . . . 74.120000000000005 110.883 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -52.18 -36.17 51.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 71.239999999999995 110.867 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.503 HD23 HG11 ' A' ' 28' ' ' VAL . 13.8 tp -91.92 46.92 1.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 61.509999999999998 110.888 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -137.49 33.53 2.27 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.682 -0.77 . . . . 35.310000000000002 112.447 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -114.81 102.76 10.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.352 . . . . 70.030000000000001 110.892 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.8 tp -99.7 49.12 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 75.310000000000002 110.911 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.75 54.71 0.67 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 60.229999999999997 110.89 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.7 p -95.72 142.19 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 72.230000000000004 111.139 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.53 -87.47 0.72 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.715 -0.755 . . . . 74.349999999999994 112.478 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.84 175.16 30.5 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.705 -0.76 . . . . 44.219999999999999 112.437 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.53 57.12 2.13 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.737 . . . . 73.310000000000002 112.485 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.63 146.44 36.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 73.230000000000004 111.127 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.27 163.1 20.57 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.564 0.697 . . . . 75.010000000000005 110.928 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 119.82 6.71 Favored 'Trans proline' 0 N--CA 1.465 -0.15 0 C-N-CA 122.705 2.27 . . . . 75.109999999999999 112.31 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -170.18 130.75 0.96 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 72.200000000000003 110.913 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -177.44 137.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 75.239999999999995 111.121 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -144.8 171.99 13.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 72.150000000000006 110.875 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 t -111.97 68.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 53.229999999999997 111.145 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 93.3 p -115.47 36.35 3.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.498 . . . . 55.310000000000002 110.886 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.5 tp -77.23 142.93 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.148 -0.478 . . . . 72.109999999999999 111.064 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 112.06 155.85 13.0 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.675 -0.774 . . . . 74.140000000000001 112.447 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 62.21 38.71 13.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.857 0.36 . . . . 64.420000000000002 110.895 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -114.49 30.5 7.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 73.329999999999998 110.869 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.8 t -69.98 136.71 50.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 111.156 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -112.08 166.07 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 111.144 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' CE1' ' A' ' 23' ' ' PHE . 7.4 mt -96.72 141.82 29.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 110.944 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 t -149.95 136.47 19.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 62.240000000000002 111.218 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -112.19 163.64 14.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.411 . . . . 75.200000000000003 110.893 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.09 127.54 13.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 74.120000000000005 110.846 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG23 ' HE1' ' A' ' 17' ' ' TRP . 81.0 mt -106.34 111.65 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 111.164 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.702 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . . . -108.75 152.21 25.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.134 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -130.98 119.47 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.91 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -90.79 102.08 14.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 75.010000000000005 110.936 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 HG22 ' HA2' ' A' ' 15' ' ' GLY . 3.4 t -135.16 36.27 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 60.32 111.066 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -158.94 -173.66 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 65.040000000000006 110.889 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 p -84.66 -42.24 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 72.099999999999994 110.901 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -134.48 -41.84 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 63.32 110.916 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.3 mt -71.72 101.55 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 71.430000000000007 111.089 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.64 157.42 17.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 50.509999999999998 111.122 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -92.28 141.18 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 73.109999999999999 111.113 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -137.18 123.78 20.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 71.120000000000005 110.837 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.659 ' CE2' ' HB1' ' A' ' 101' ' ' ALA . 7.0 t80 -117.63 119.36 34.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 110.876 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -88.88 126.99 35.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.122 -0.49 . . . . 72.129999999999995 110.851 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HD2' ' A' ' 71' ' ' PHE . 6.7 m -138.66 123.48 21.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.102 -0.499 . . . . 42.329999999999998 111.067 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 159.6 -166.85 35.02 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.698 -0.763 . . . . 75.540000000000006 112.501 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -63.66 133.2 95.45 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.596 0.712 . . . . 74.400000000000006 111.168 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 75' ' ' VAL . 54.0 Cg_endo -69.69 141.1 44.6 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.763 2.309 . . . . 71.219999999999999 112.338 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -95.52 -74.71 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 111.081 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 140.02 0.75 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 110.802 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -176.41 156.75 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.475 . . . . 75.209999999999994 111.101 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -173.59 134.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.169 -0.469 . . . . 63.219999999999999 110.897 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -162.46 165.29 26.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.279 -0.419 . . . . 75.129999999999995 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -69.34 147.14 51.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 74.010000000000005 110.921 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -112.08 -157.77 13.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.789 -0.719 . . . . 74.349999999999994 112.477 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -107.67 -36.73 6.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.898 0.38 . . . . 73.310000000000002 110.847 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -62.3 -176.28 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 74.340000000000003 110.875 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.8 p -52.47 134.35 34.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 52.229999999999997 110.854 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.02 -177.39 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 54.32 111.185 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.0 p 51.91 37.54 21.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 74.540000000000006 110.847 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.6 t -114.31 64.81 0.66 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 54.219999999999999 110.797 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 tp -169.72 131.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.924 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 163.05 123.09 0.64 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.733 -0.746 . . . . 73.209999999999994 112.474 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.55 164.26 38.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.868 0.366 . . . . 64.510000000000005 110.848 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -123.99 -36.78 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 63.450000000000003 111.149 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 95.3 p -159.17 124.97 4.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.310000000000002 110.881 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -169.93 175.95 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 61.310000000000002 110.919 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 14.0 m -122.65 150.75 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 72.25 111.17 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.46 173.48 11.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.010000000000005 110.871 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -119.33 -67.52 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.968 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -166.09 75.7 0.14 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.787 -0.721 . . . . 64.340000000000003 112.483 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.508 ' CB ' HG12 ' A' ' 126' ' ' VAL . 54.0 Cg_endo -69.82 162.2 43.03 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.663 2.242 . . . . 74.109999999999999 112.337 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB1' ' CE2' ' A' ' 71' ' ' PHE . . . -164.71 151.39 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 64.450000000000003 111.076 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.71 HG23 ' CA ' ' A' ' 124' ' ' GLY . 29.0 mt -130.6 143.38 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.174 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.83 123.95 41.6 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 75.430000000000007 110.944 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.3 p -154.3 166.07 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 70.409999999999997 110.928 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 105' ' ' LEU . 2.5 mm? -110.24 142.36 41.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 70.209999999999994 110.857 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -106.13 145.28 31.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 75.209999999999994 110.894 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -153.13 148.49 27.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.99 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -130.98 166.88 20.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 64.209999999999994 110.892 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -130.29 35.32 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 73.310000000000002 110.888 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -104.15 -41.61 5.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 64.209999999999994 110.877 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.7 t 54.77 65.65 1.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 75.049999999999997 110.872 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -152.36 -177.52 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.184 -0.462 . . . . 62.439999999999998 110.855 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.29 36.12 4.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.142 -0.481 . . . . 55.030000000000001 110.79 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.31 -179.32 5.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.471 . . . . 73.519999999999996 110.922 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -60.02 131.44 50.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 74.5 110.969 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.559 ' C ' HD12 ' A' ' 153' ' ' LEU . 6.1 m-85 -161.51 160.45 23.31 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.665 0.745 . . . . 72.430000000000007 110.884 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.88 168.51 21.5 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.57 2.18 . . . . 74.239999999999995 112.349 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -154.85 135.53 13.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 74.409999999999997 110.948 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.46 145.64 14.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 64.120000000000005 111.129 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -134.82 130.31 5.45 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.716 -0.754 . . . . 74.219999999999999 112.505 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -132.67 146.11 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 52.130000000000003 111.147 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.33 -153.99 23.51 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 62.25 112.533 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.652 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.2 m -133.25 150.85 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.863 0.363 . . . . 75.519999999999996 111.143 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.71 ' CA ' HG23 ' A' ' 102' ' ' ILE . . . -133.59 167.17 23.65 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.757 -0.735 . . . . 72.430000000000007 112.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -154.0 151.92 29.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.792 0.329 . . . . 62.219999999999999 110.921 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.508 HG12 ' CB ' ' A' ' 100' ' ' PRO . 32.8 m -133.23 134.99 57.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 73.420000000000002 111.128 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 44.5 tp -92.28 136.91 32.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 71.299999999999997 110.895 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -106.59 162.39 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 110.924 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -135.57 105.87 6.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 110.95 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -79.4 150.45 31.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.154 -0.475 . . . . 73.349999999999994 110.914 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -133.45 145.2 50.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 74.239999999999995 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.9 m -56.02 133.52 51.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 53.200000000000003 111.173 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -146.52 173.91 11.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 60.43 110.911 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -53.74 -64.95 3.77 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.754 -0.736 . . . . 70.349999999999994 112.495 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.78 122.33 38.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.723 0.297 . . . . 64.239999999999995 111.164 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 137' ' ' SER . 0.3 OUTLIER -172.66 121.47 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.242 -0.435 . . . . 73.040000000000006 110.919 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.407 ' N ' HD13 ' A' ' 136' ' ' LEU . 3.3 t -149.29 113.39 5.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.457 . . . . 51.140000000000001 110.851 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.1 t -173.65 147.47 1.41 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.91 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -81.51 153.35 26.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.107 -0.497 . . . . 74.120000000000005 110.893 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -118.67 170.85 8.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.116 -0.493 . . . . 75.439999999999998 110.869 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.7 pt -150.52 150.5 13.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 54.409999999999997 111.145 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -116.51 -179.18 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 62.020000000000003 110.869 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 52.33 44.81 29.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.454 . . . . 63.409999999999997 110.875 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.56 104.07 13.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.132 -0.485 . . . . 70.140000000000001 110.908 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.532 ' CZ3' HG11 ' A' ' 123' ' ' VAL . 64.1 p-90 -124.96 151.78 45.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.274 -0.421 . . . . 74.519999999999996 110.913 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.588 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -135.6 160.39 67.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.602 0.715 . . . . 62.539999999999999 111.164 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.652 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.4 Cg_endo -69.72 156.05 64.46 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.681 2.254 . . . . 74.400000000000006 112.361 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -175.21 162.96 3.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 61.329999999999998 111.106 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -158.68 156.82 30.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.902 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.2 163.71 37.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.208 -0.451 . . . . 63.450000000000003 110.906 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.428 ' O ' HG12 ' A' ' 167' ' ' VAL . 11.0 p -130.03 139.43 51.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 64.030000000000001 111.102 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -147.75 -168.25 14.0 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.693 -0.765 . . . . 55.030000000000001 112.443 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 116' ' ' TYR . 19.0 tp -134.2 143.86 48.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.82 0.343 . . . . 54.420000000000002 110.843 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -121.48 135.47 55.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 45.350000000000001 110.851 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -140.14 110.31 6.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 61.149999999999999 110.875 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -106.5 155.04 20.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 72.209999999999994 110.854 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.91 -63.73 1.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 110.872 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.26 -126.48 0.91 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.768 -0.73 . . . . 41.539999999999999 112.465 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -81.93 57.0 3.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.85 0.357 . . . . 73.530000000000001 110.858 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.4 m -160.96 -172.85 3.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 74.239999999999995 110.852 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -70.81 135.92 48.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.495 . . . . 73.430000000000007 110.913 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 18.2 ptm -103.7 162.52 13.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.400000000000006 110.845 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 10.5 tp -90.11 134.51 34.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 75.329999999999998 110.886 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -134.88 128.74 33.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 40.32 110.881 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 33.5 p -133.47 146.86 51.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 110.842 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -142.61 157.39 44.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.420000000000002 110.826 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 151' ' ' VAL . 9.5 p -160.05 147.05 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 62.520000000000003 111.137 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.7 135.68 26.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.448 . . . . 70.010000000000005 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -94.6 140.62 29.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 64.409999999999997 110.912 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 171' ' ' PRO . 67.5 mt -129.64 133.12 24.71 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.669 0.747 . . . . 72.540000000000006 111.128 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.6 Cg_endo -69.8 173.75 10.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.717 2.278 . . . . 74.120000000000005 112.365 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -153.71 143.14 21.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.438 . . . . 73.349999999999994 110.861 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -127.9 89.41 2.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.126 -0.488 . . . . 64.109999999999999 110.842 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 p -84.19 -179.54 7.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 55.350000000000001 111.107 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -112.51 130.37 56.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.204 -0.453 . . . . 61.420000000000002 110.845 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 37.1 t -80.32 135.06 26.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 63.219999999999999 111.128 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.0 m 54.55 43.63 29.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 64.030000000000001 111.142 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.8 -95.43 0.71 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 64.230000000000004 112.517 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 3.0 p -97.09 -39.16 9.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.841 0.353 . . . . 71.329999999999998 111.124 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 25.0 mt -130.18 -49.2 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 63.140000000000001 110.943 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.57 176.97 3.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.706 -0.759 . . . . 70.0 112.476 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 135.11 29.54 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.664 2.242 . . . . 60.229999999999997 112.328 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.3 m -117.72 156.15 49.95 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.621 0.724 . . . . 63.109999999999999 111.142 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 148.16 64.49 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 63.149999999999999 112.337 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 185' ' ' VAL . 13.0 p 39.68 38.48 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 51.130000000000003 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.7 t -167.58 148.35 5.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 74.040000000000006 110.838 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 5.1 m 65.17 48.72 2.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 61.109999999999999 111.161 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 189' ' ' ILE . 5.8 mptp? -110.73 35.19 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.955 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 188' ' ' LYS . 25.7 mm -133.48 66.74 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 71.409999999999997 111.159 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -154.05 118.62 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 74.150000000000006 110.903 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.39 -70.16 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 73.450000000000003 111.087 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.2 144.87 0.5 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.65 0.738 . . . . 62.420000000000002 110.852 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.6 ' CB ' HG22 ' A' ' 28' ' ' VAL . 53.3 Cg_endo -69.78 133.6 25.94 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.707 2.271 . . . . 64.400000000000006 112.299 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -153.55 175.1 13.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.944 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 9.0 tt -122.52 126.06 73.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 70.329999999999998 111.067 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.95 123.93 42.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 72.099999999999994 110.907 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -125.48 152.43 44.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.349999999999994 110.947 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -153.67 154.64 34.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.894 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 173.15 -139.41 5.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 71.549999999999997 112.517 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -141.38 173.61 11.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.89 0.376 . . . . 71.540000000000006 111.097 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.1 p -152.98 169.66 22.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 73.120000000000005 110.877 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.666 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 18.2 p90 -149.74 139.92 22.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.14 -0.482 . . . . 74.430000000000007 110.931 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.79 HG23 HG12 ' A' ' 18' ' ' VAL . 7.0 p -97.35 142.95 13.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.099 -0.5 . . . . 73.209999999999994 111.149 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.75 138.28 35.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.855 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 43.0 tttm -91.65 83.83 5.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.876 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.37 -34.83 10.9 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.238 -0.437 . . . . 73.010000000000005 110.869 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 64.13 102.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 61.240000000000002 111.117 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -51.78 164.16 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 71.530000000000001 111.069 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.35 -176.42 5.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.115 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.611 HD23 ' O ' ' A' ' 210' ' ' LEU . 5.0 tt -51.85 -37.09 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 73.319999999999993 110.89 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 74.439999999999998 110.868 179.972 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mmt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.733 0.302 . . . . 63.130000000000003 110.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -173.48 128.54 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 64.109999999999999 110.915 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -125.36 -178.09 4.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 110.824 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -130.01 177.6 7.16 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.86 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -145.28 157.59 52.8 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.647 0.737 . . . . 74.409999999999997 110.981 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 154.39 67.95 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.691 2.261 . . . . 73.040000000000006 112.417 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.3 140.55 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 63.229999999999997 111.119 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -85.55 172.02 11.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 71.150000000000006 110.917 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 p -84.51 170.62 13.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 72.120000000000005 110.943 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -139.81 144.72 37.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 62.240000000000002 111.055 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.78 -177.09 15.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.733 -0.746 . . . . 73.549999999999997 112.499 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -47.43 105.05 0.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.997 0.427 . . . . 74.430000000000007 110.928 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -114.86 -175.81 2.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 74.530000000000001 110.937 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -56.36 141.2 42.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.099999999999994 110.848 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.35 7.43 62.05 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 62.350000000000001 112.471 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.24 145.78 55.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 72.230000000000004 110.901 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -114.33 122.86 47.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 110.878 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG22 HG12 ' A' ' 203' ' ' VAL . 67.8 t -116.33 142.61 29.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.156 -0.475 . . . . 61.109999999999999 111.106 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -124.79 121.85 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 111.111 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.2 t -121.85 135.04 54.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.310000000000002 110.834 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -135.72 132.76 37.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 75.129999999999995 110.824 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -153.19 178.25 9.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 75.340000000000003 110.884 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' HD13 ' A' ' 55' ' ' LEU . 7.6 m-85 -121.7 131.02 53.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.096 -0.502 . . . . 72.0 110.804 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.424 ' OG ' HG21 ' A' ' 56' ' ' THR . 70.1 m -81.37 145.17 30.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.439999999999998 110.863 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -153.44 150.26 28.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 110.876 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.7 m -86.73 131.81 33.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 64.030000000000001 111.108 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.15 140.9 48.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.439999999999998 110.913 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -98.22 123.28 50.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 73.010000000000005 111.175 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -157.51 51.52 0.41 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.762 -0.733 . . . . 71.439999999999998 112.506 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -73.57 -38.86 65.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.752 0.31 . . . . 74.209999999999994 110.803 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.07 -36.3 83.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 73.329999999999998 110.894 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.5 mt -86.43 -58.95 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 62.299999999999997 110.891 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.08 -106.2 0.38 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.793 -0.718 . . . . 74.409999999999997 112.5 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -150.31 141.74 23.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.89 0.376 . . . . 71.150000000000006 110.858 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 8.3 mp -126.77 74.31 1.47 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 110.91 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -124.79 -44.61 1.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 73.049999999999997 110.878 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.8 m -118.25 36.82 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 111.181 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.41 -130.09 9.89 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.723 -0.751 . . . . 62.140000000000001 112.539 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.04 175.03 19.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 73.400000000000006 112.419 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -131.11 -179.45 16.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 62.509999999999998 112.497 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.3 105.06 7.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.802 0.334 . . . . 73.129999999999995 111.132 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.3 mp -108.85 160.68 26.46 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.566 0.698 . . . . 73.420000000000002 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 131.64 21.59 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.64 2.226 . . . . 75.439999999999998 112.364 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -98.14 167.96 10.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 60.049999999999997 110.922 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.11 118.9 10.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 62.32 111.053 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -56.48 167.39 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.867 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.8 p -157.44 143.85 9.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 75.209999999999994 111.164 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.1 m -99.47 55.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 110.866 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -53.42 146.4 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 74.010000000000005 111.183 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.35 -90.82 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.756 -0.735 . . . . 64.239999999999995 112.436 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -163.0 115.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.85 0.357 . . . . 65.420000000000002 110.896 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -114.68 30.5 7.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 72.209999999999994 110.842 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 10.1 t -60.32 128.39 36.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 64.230000000000004 111.169 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.1 m -122.26 123.02 40.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 111.113 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 23' ' ' PHE . 4.1 mm? -59.2 116.26 3.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 51.130000000000003 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.424 HG21 ' OG ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -125.63 127.16 45.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 74.239999999999995 111.136 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -120.58 145.93 46.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 75.230000000000004 110.802 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -149.93 126.79 11.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.14 -0.482 . . . . 61.340000000000003 110.886 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -110.25 130.94 62.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.441 . . . . 71.209999999999994 111.153 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.61 168.07 11.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 73.200000000000003 111.08 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.42 ' O ' ' HB1' ' A' ' 68' ' ' ALA . 24.3 m-85 -144.42 125.57 14.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 74.239999999999995 110.893 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -87.64 111.96 21.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 64.439999999999998 110.911 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.479 ' O ' HG22 ' A' ' 63' ' ' VAL . 9.9 p -137.26 31.27 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.519999999999996 111.155 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.37 -170.01 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.857 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.3 t -75.42 -46.68 31.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 72.450000000000003 110.922 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -133.93 -41.79 0.83 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 62.530000000000001 110.881 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.478 HG22 ' CD2' ' A' ' 107' ' ' TYR . 25.2 pt -72.86 139.8 18.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.136 -0.483 . . . . 73.430000000000007 111.143 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 61' ' ' TYR . . . -143.44 170.48 15.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 70.409999999999997 111.071 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.32 145.95 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 111.124 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -137.52 132.68 33.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 74.540000000000006 110.821 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CE1' ' HB1' ' A' ' 101' ' ' ALA . 67.1 t80 -129.81 112.15 13.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.473 . . . . 73.140000000000001 110.87 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.546 ' HB3' HD13 ' A' ' 102' ' ' ILE . 2.0 t80 -88.86 148.31 23.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 60.030000000000001 110.84 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -162.45 149.25 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 63.130000000000003 111.163 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -112.0 -173.32 19.31 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.715 -0.755 . . . . 33.520000000000003 112.517 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -86.87 133.24 39.85 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.654 0.74 . . . . 71.200000000000003 111.136 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.2 Cg_endo -69.79 128.41 15.96 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.695 2.264 . . . . 71.030000000000001 112.336 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.66 37.56 4.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 73.109999999999999 111.133 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 55.41 51.32 13.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 74.019999999999996 110.896 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.17 142.64 20.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 43.219999999999999 111.035 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -81.85 164.87 21.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 74.430000000000007 110.893 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -108.12 -175.18 2.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.892 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -124.27 162.99 22.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 61.009999999999998 110.935 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -76.18 -123.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.736 -0.745 . . . . 74.129999999999995 112.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 tt0 -160.66 139.06 10.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.898 0.38 . . . . 72.420000000000002 110.85 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.0 ttpt -144.3 138.83 28.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.09 -0.504 . . . . 72.340000000000003 110.888 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.5 t -70.38 97.87 1.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 64.450000000000003 110.764 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 tp -145.25 137.91 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 111.088 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.2 m -57.85 173.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 110.907 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.8 m -81.42 64.18 6.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 54.130000000000003 110.891 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.5 tt -171.32 125.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 74.420000000000002 110.919 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.36 174.8 37.97 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 51.140000000000001 112.512 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.3 mmt180 -133.52 91.29 2.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.828 0.347 . . . . 73.519999999999996 110.914 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 p -175.83 137.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.145 -0.48 . . . . 73.409999999999997 111.17 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.3 p -105.08 142.56 34.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.229 -0.441 . . . . 73.109999999999999 110.913 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -82.35 177.34 8.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 70.519999999999996 110.844 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.4 m -135.11 57.75 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 111.108 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -68.7 173.63 5.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 64.200000000000003 110.866 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -95.26 -63.23 1.18 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.882 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.67 68.61 0.27 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.792 -0.718 . . . . 70.540000000000006 112.475 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.509 ' HB3' HG12 ' A' ' 126' ' ' VAL . 53.5 Cg_endo -69.84 -170.96 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.682 2.255 . . . . 75.120000000000005 112.268 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB1' ' CE1' ' A' ' 71' ' ' PHE . . . -132.6 125.85 31.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.186 -0.461 . . . . 74.319999999999993 111.008 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.546 HD13 ' HB3' ' A' ' 72' ' ' PHE . 5.3 mp -117.97 125.59 74.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 73.510000000000005 111.108 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 103' ' ' LEU . 3.8 mp -109.01 119.06 38.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.175 -0.466 . . . . 65.420000000000002 110.999 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.0 p -157.64 157.06 32.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 72.409999999999997 110.868 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 93.4 mt -95.64 141.07 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 61.340000000000003 110.894 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -105.81 126.71 52.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 74.439999999999998 110.904 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.621 ' O ' HG22 ' A' ' 119' ' ' VAL . 6.9 m-85 -120.26 114.34 21.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.400000000000006 110.911 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -131.16 166.87 20.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.079 -0.509 . . . . 74.329999999999998 110.838 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -124.09 80.69 1.85 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 74.109999999999999 110.896 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -93.29 17.69 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 65.319999999999993 110.84 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 70.2 m -95.15 36.39 1.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 53.210000000000001 110.803 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -161.95 151.83 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.894 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 87.66 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 73.25 110.899 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -179.83 -173.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 62.450000000000003 110.826 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.621 HD23 HD12 ' A' ' 153' ' ' LEU . 6.8 mp -59.43 165.54 2.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 65.230000000000004 110.892 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -115.29 70.46 2.89 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.617 0.722 . . . . 63.450000000000003 110.925 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 121.66 8.35 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.706 2.271 . . . . 64.129999999999995 112.315 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -115.77 135.38 54.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 75.530000000000001 110.926 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 107' ' ' TYR . 6.4 m -111.52 121.25 63.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 75.109999999999999 111.1 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -96.86 125.94 8.66 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.71 -0.757 . . . . 75.430000000000007 112.5 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 121' ' ' VAL . 6.8 p -136.54 122.99 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.349999999999994 111.146 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.39 -153.26 12.53 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.852 -0.69 . . . . 63.5 112.513 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.17 150.48 21.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 74.340000000000003 111.06 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -124.15 145.55 15.94 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.72 -0.752 . . . . 74.420000000000002 112.465 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.2 mtp180 -143.89 165.9 26.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.83 0.348 . . . . 63.229999999999997 110.886 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.509 HG12 ' HB3' ' A' ' 100' ' ' PRO . 28.6 m -110.34 156.52 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 111.112 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.0 tp -133.49 143.72 48.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 71.430000000000007 110.91 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -152.75 175.49 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.866 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -139.56 133.48 30.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 64.420000000000002 110.977 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -72.92 102.98 3.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.227 -0.442 . . . . 63.219999999999999 110.808 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.1 mtmm -77.65 171.41 14.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 34.299999999999997 110.896 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -93.95 69.67 3.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.468 . . . . 63.420000000000002 111.143 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -87.53 80.61 8.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.846 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 75.59 -109.73 2.86 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.753 . . . . 62.439999999999998 112.542 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -129.25 41.49 3.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.749 0.309 . . . . 71.030000000000001 111.055 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -116.95 120.0 37.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 73.549999999999997 110.892 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 74.2 m -157.8 122.3 4.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 65.530000000000001 110.877 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.1 t -173.64 164.18 4.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 63.240000000000002 110.909 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -98.27 147.2 24.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 62.310000000000002 110.897 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -127.51 126.88 43.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 70.140000000000001 110.875 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.7 tt -118.96 125.6 74.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 75.349999999999994 111.089 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -151.76 178.96 8.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.108 -0.496 . . . . 72.409999999999997 110.819 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -80.89 64.18 5.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 61.039999999999999 110.863 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.0 mtmp? -76.05 -38.35 57.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.912 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 56.4 p-90 -55.14 119.89 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.510000000000005 110.904 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.592 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -131.73 160.41 67.66 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.602 0.715 . . . . 53.219999999999999 111.144 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.592 ' HD2' ' HB1' ' A' ' 146' ' ' ALA . 53.6 Cg_endo -69.73 141.54 45.62 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.734 2.289 . . . . 71.329999999999998 112.329 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -121.14 128.31 52.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 111.029 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -156.62 119.02 3.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 72.420000000000002 110.874 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -139.6 159.27 42.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 45.219999999999999 110.97 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 167' ' ' VAL . 6.2 p -133.67 121.85 41.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 71.409999999999997 111.122 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -137.44 -171.61 12.25 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 74.030000000000001 112.445 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.621 HD12 HD23 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -160.13 156.44 26.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.755 0.312 . . . . 63.109999999999999 110.927 -179.883 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 42.5 mtm180 -128.7 153.96 46.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 110.916 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -152.2 132.91 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 110.883 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -58.47 111.6 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 72.299999999999997 110.93 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.815 HD13 HD12 ' A' ' 163' ' ' LEU . 6.5 tt -151.51 104.35 3.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 74.120000000000005 110.916 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 130.68 -139.43 10.94 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.689 -0.767 . . . . 52.520000000000003 112.501 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -112.13 -65.65 1.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.92 0.39 . . . . 72.540000000000006 110.85 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 13.2 m -108.0 -46.79 3.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.472 . . . . 72.0 110.829 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 19.2 m0 -80.76 141.56 34.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.134 -0.485 . . . . 71.019999999999996 110.911 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 11.0 ptp -107.78 153.04 23.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 72.420000000000002 110.892 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.815 HD12 HD13 ' A' ' 157' ' ' LEU . 4.6 tt -60.34 132.17 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 51.420000000000002 110.914 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -130.18 128.0 40.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 74.230000000000004 110.858 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.8 t -130.07 141.58 50.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.177 -0.465 . . . . 54.140000000000001 110.865 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.72 140.69 52.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 65.430000000000007 110.903 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.443 ' HB ' HG13 ' A' ' 151' ' ' VAL . 25.7 t -131.81 131.77 61.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 51.439999999999998 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 88.6 mtm-85 -146.26 145.05 30.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 75.109999999999999 110.862 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.551 ' O ' HD13 ' A' ' 170' ' ' ILE . 10.1 t80 -131.75 112.59 12.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 73.310000000000002 110.916 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 169' ' ' TYR . 50.2 mm -130.49 133.07 24.44 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.567 0.699 . . . . 72.420000000000002 111.129 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.439 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.6 Cg_endo -69.72 132.59 23.72 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.713 2.275 . . . . 71.299999999999997 112.342 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -83.98 154.07 23.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 53.140000000000001 110.865 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -87.19 -42.02 13.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 75.209999999999994 110.909 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.3 t -170.72 161.82 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 111.176 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -119.41 173.11 7.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 74.230000000000004 110.842 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.1 142.81 23.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 111.143 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 28.0 m -79.83 142.19 35.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 74.230000000000004 111.172 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.38 -134.41 4.23 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.73 . . . . 62.030000000000001 112.473 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.0 t -138.96 149.2 44.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.829 0.347 . . . . 73.230000000000004 111.128 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -133.17 163.85 28.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 71.439999999999998 110.94 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 155.63 -73.64 0.24 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 43.340000000000003 112.483 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -34.24 14.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.644 2.229 . . . . 72.129999999999995 112.41 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.429 HG13 ' HD2' ' A' ' 184' ' ' PRO . 58.1 t -121.65 133.33 24.22 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.642 0.734 . . . . 75.010000000000005 111.088 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.429 ' HD2' HG13 ' A' ' 183' ' ' VAL . 53.6 Cg_endo -69.78 135.26 29.96 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.635 2.223 . . . . 53.530000000000001 112.328 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 41.4 t -121.09 121.87 66.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 71.450000000000003 111.152 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 2.9 t -76.43 -176.93 3.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.049999999999997 110.832 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 3.6 m -53.3 120.3 5.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 54.450000000000003 111.104 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -82.4 93.17 7.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 72.209999999999994 110.908 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 49.3 mm -74.58 145.14 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 65.349999999999994 111.14 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -52.04 139.75 22.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 75.109999999999999 110.878 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 30.0 t -116.87 139.88 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 63.229999999999997 111.083 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -114.12 73.51 2.52 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 75.120000000000005 110.864 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 140.31 42.54 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.77 2.313 . . . . 73.209999999999994 112.33 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -104.59 162.88 12.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.282 -0.417 . . . . 64.329999999999998 110.84 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 5.4 mp -102.92 116.98 47.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.450000000000003 111.142 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 5.3 mp -130.33 131.92 45.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.914 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 1.6 m -116.41 146.28 42.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 71.349999999999994 110.892 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 3.5 pp -131.91 135.63 46.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 53.130000000000003 110.957 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 178.91 -146.52 7.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.793 -0.718 . . . . 72.430000000000007 112.515 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -148.83 167.87 24.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 45.140000000000001 111.174 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 2.8 m -144.43 163.39 33.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 65.340000000000003 110.787 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 35.6 p90 -149.62 143.29 25.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.499 . . . . 71.25 110.964 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.492 HG12 HG22 ' A' ' 18' ' ' VAL . 34.0 m -98.88 146.19 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 55.539999999999999 111.111 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -139.61 140.55 37.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.846 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 1.5 ptpp? -106.43 76.47 1.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 74.319999999999993 110.87 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.723 HD12 ' HB2' ' A' ' 208' ' ' ALA . 0.2 OUTLIER -68.13 -50.17 56.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 64.140000000000001 110.939 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 53.44 53.44 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 60.299999999999997 111.077 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.723 ' HB2' HD12 ' A' ' 206' ' ' LEU . . . -82.85 161.99 21.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.200000000000003 111.09 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.43 129.03 34.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 74.239999999999995 111.061 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 7.3 mt -123.28 138.21 54.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.215 -0.448 . . . . 70.109999999999999 110.929 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.209999999999994 110.881 179.891 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.847 0.356 . . . . 54.409999999999997 110.83 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -154.72 164.56 38.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 72.439999999999998 110.911 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -135.25 174.35 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 61.229999999999997 110.872 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -114.89 141.31 48.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 63.409999999999997 110.882 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -87.21 161.01 47.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 74.129999999999995 110.92 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.71 157.34 60.83 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.655 2.237 . . . . 71.25 112.334 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.76 -177.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 51.109999999999999 111.098 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.6 mmtm -118.77 160.64 21.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.249 -0.432 . . . . 74.349999999999994 110.906 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 t -103.93 158.61 16.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 63.020000000000003 110.836 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.47 -175.54 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.158 -0.473 . . . . 70.549999999999997 111.039 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.4 -175.81 49.4 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 73.400000000000006 112.495 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -173.28 129.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.907 0.384 . . . . 62.229999999999997 110.925 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -133.18 163.48 29.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 73.109999999999999 110.837 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -71.09 143.19 50.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.921 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.47 7.47 26.14 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.753 -0.737 . . . . 54.109999999999999 112.499 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.49 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.753 0.311 . . . . 71.120000000000005 110.871 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -139.27 141.23 37.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 110.928 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.726 HG22 HG23 ' A' ' 203' ' ' VAL . 59.1 t -120.45 127.65 75.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 62.539999999999999 111.127 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.36 109.05 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.420000000000002 111.12 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -108.51 133.0 53.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 73.099999999999994 110.865 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -147.84 123.27 10.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 72.439999999999998 110.897 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.84 175.63 12.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.909 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -115.61 137.05 52.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 64.299999999999997 110.825 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.8 t -90.43 147.13 23.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.163 -0.471 . . . . 71.129999999999995 110.834 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 tttt -139.94 147.11 40.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 63.329999999999998 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.3 m -81.31 129.54 37.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 111.146 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -119.82 107.05 12.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 71.019999999999996 110.916 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.1 t -134.61 145.35 32.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.146 -0.479 . . . . 61.5 111.145 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.44 138.48 10.23 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.699 -0.763 . . . . 73.230000000000004 112.471 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -81.88 -44.0 17.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.811 0.339 . . . . 60.149999999999999 110.851 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 53.54 48.12 22.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.926 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pp -115.5 36.29 4.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 60.310000000000002 110.871 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 53.67 -124.49 29.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 74.239999999999995 112.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -129.83 177.19 7.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.859 0.362 . . . . 62.109999999999999 110.842 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.9 mt -107.56 61.07 0.62 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 73.430000000000007 110.922 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -63.74 119.9 10.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 62.32 110.971 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.4 p -169.08 148.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 52.420000000000002 111.098 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -78.18 106.15 2.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 32.409999999999997 112.485 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -106.13 -110.66 3.51 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 65.209999999999994 112.481 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.89 -133.59 7.98 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.74 . . . . 71.340000000000003 112.483 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -120.59 -50.8 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.855 0.359 . . . . 71.329999999999998 111.111 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -108.67 90.93 7.97 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.534 0.683 . . . . 71.209999999999994 110.952 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 54.6 Cg_endo -69.64 135.53 30.96 Favored 'Trans proline' 0 C--N 1.34 0.126 0 C-N-CA 122.721 2.281 . . . . 73.400000000000006 112.381 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -148.15 113.94 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 72.219999999999999 110.916 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.4 134.82 20.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 43.020000000000003 111.088 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -160.53 106.69 1.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 64.200000000000003 110.929 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.3 p -174.44 138.09 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 54.420000000000002 111.086 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.0 p -162.74 136.15 5.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.1 -0.5 . . . . 53.310000000000002 110.822 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.3 mt -136.56 124.68 34.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 62.240000000000002 111.134 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -163.36 70.68 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.749 -0.738 . . . . 61.329999999999998 112.487 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 29.2 t30 -120.86 79.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 74.049999999999997 110.89 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -110.67 30.54 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.120000000000005 110.807 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.3 p -65.32 96.03 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 111.102 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 31.6 m -96.28 117.08 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 111.15 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 75' ' ' VAL . 9.6 tt -54.35 121.64 8.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.896 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.91 133.8 43.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.126 -0.488 . . . . 63.210000000000001 111.191 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.524 ' CE2' HD21 ' A' ' 55' ' ' LEU . 6.2 m-85 -106.14 163.21 12.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 74.040000000000006 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -163.99 140.77 6.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 75.109999999999999 110.894 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.1 pt -126.23 128.1 71.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 111.124 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -112.1 156.87 21.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.107 -0.497 . . . . 71.209999999999994 111.113 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -130.18 123.64 30.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.294 -0.412 . . . . 72.230000000000004 110.935 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -97.77 109.97 22.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 64.120000000000005 110.853 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.92 -37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.514 . . . . 75.030000000000001 111.132 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.9 m -124.81 149.18 47.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.863 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -78.75 -36.1 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 52.310000000000002 110.871 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.492 ' ND2' HG22 ' A' ' 67' ' ' ILE . 2.6 p-10 -64.04 -41.57 97.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.477 . . . . 74.310000000000002 110.904 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 105' ' ' LEU . 14.8 tt -141.88 150.7 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 65.120000000000005 111.12 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.35 161.07 24.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 111.078 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 91.3 t -99.67 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 71.319999999999993 111.089 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -142.57 135.03 27.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.845 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.669 ' CZ ' ' HB1' ' A' ' 101' ' ' ALA . 17.9 t80 -131.45 118.87 20.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.873 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -93.2 140.33 29.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 72.140000000000001 110.887 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.5 t -144.94 115.32 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 70.049999999999997 111.195 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -98.03 170.09 24.67 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.821 -0.705 . . . . 52.539999999999999 112.517 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 55' ' ' LEU . 58.4 t -57.34 133.26 81.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.623 0.725 . . . . 60.039999999999999 111.172 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 75' ' ' VAL . 54.1 Cg_endo -69.71 -177.37 1.83 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.675 2.25 . . . . 65.510000000000005 112.374 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 63.77 45.17 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 72.219999999999999 111.093 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 ttm180 -62.34 116.05 4.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.874 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.32 95.71 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.465 . . . . 64.409999999999997 111.132 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -128.91 166.96 18.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 74.430000000000007 110.868 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -69.59 173.11 6.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.182 -0.463 . . . . 75.129999999999995 110.861 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -75.41 -71.27 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.494 . . . . 71.349999999999994 110.885 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 133.45 -45.38 1.12 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 73.530000000000001 112.468 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 53.24 44.82 29.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.93 0.395 . . . . 73.040000000000006 110.894 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -116.27 133.85 55.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 73.140000000000001 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.8 t 58.02 50.81 9.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 23.219999999999999 110.836 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 10.4 tp -56.41 142.38 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 72.109999999999999 111.153 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.4 m -151.57 148.15 27.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 72.209999999999994 110.884 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 p -99.82 148.85 23.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 45.140000000000001 110.869 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 58.86 38.29 24.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 75.209999999999994 110.985 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.76 53.6 0.28 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 74.530000000000001 112.529 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.9 mmp_? -117.98 61.45 0.77 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.859 0.362 . . . . 65.129999999999995 110.885 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG11 ' OD2' ' A' ' 133' ' ' ASP . 60.4 t -93.82 96.8 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.129 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.9 p -119.22 42.55 2.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 110.801 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -55.98 -37.41 69.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 62.399999999999999 110.852 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.76 179.16 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 74.239999999999995 111.153 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -136.3 179.29 6.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 62.530000000000001 110.814 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.26 149.74 44.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.101 -0.499 . . . . 71.450000000000003 110.969 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -143.23 76.03 0.3 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.737 -0.744 . . . . 73.340000000000003 112.513 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 118.97 6.0 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.605 2.203 . . . . 43.200000000000003 112.4 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.669 ' HB1' ' CZ ' ' A' ' 71' ' ' PHE . . . -136.67 135.87 38.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.298 -0.41 . . . . 53.219999999999999 111.11 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' A' ' 124' ' ' GLY . 32.1 mt -126.17 131.32 71.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 111.11 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.62 125.68 52.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 71.340000000000003 110.901 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 19.2 p -155.1 167.21 31.12 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.156 -0.474 . . . . 71.430000000000007 110.79 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 67' ' ' ILE . 3.3 mm? -109.95 140.32 44.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 73.439999999999998 110.915 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.84 152.07 21.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.481 . . . . 51.420000000000002 110.975 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -141.22 143.01 33.92 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.26 -0.427 . . . . 75.439999999999998 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.9 m80 -130.97 103.8 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.48 . . . . 72.120000000000005 110.869 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -51.66 -35.13 41.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 75.510000000000005 110.922 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -82.83 -41.54 18.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.141 -0.482 . . . . 72.349999999999994 110.891 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.7 t 52.41 39.39 27.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 70.430000000000007 110.946 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -102.34 176.11 5.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.06 -0.518 . . . . 64.409999999999997 110.916 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -105.1 39.38 1.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 73.310000000000002 110.886 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -144.39 -175.87 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 63.140000000000001 110.86 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.704 HD13 ' CE2' ' A' ' 155' ' ' TYR . 1.5 pp -60.09 116.48 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 52.200000000000003 110.866 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -160.29 160.53 26.32 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.753 0.787 . . . . 74.319999999999993 110.866 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.88 171.13 15.16 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.625 2.217 . . . . 72.540000000000006 112.311 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -165.84 143.63 5.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 65.319999999999993 110.93 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG12 HG23 ' A' ' 151' ' ' VAL . 28.6 m -120.45 164.14 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 64.450000000000003 111.088 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -153.57 143.59 10.34 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.703 -0.76 . . . . 70.349999999999994 112.461 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 149' ' ' PHE . 21.3 t -144.93 145.96 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.828 0.347 . . . . 71.109999999999999 111.083 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.33 -154.0 22.31 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 70.209999999999994 112.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.04 151.3 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.921 0.391 . . . . 64.340000000000003 111.116 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.568 ' HA3' HG23 ' A' ' 102' ' ' ILE . . . -138.3 154.79 23.11 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 51.049999999999997 112.469 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -160.83 -175.18 4.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 110.869 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 t -117.55 101.42 11.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 73.010000000000005 111.231 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.625 HD23 ' N ' ' A' ' 128' ' ' PHE . 1.6 tt -89.14 155.08 19.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 60.329999999999998 110.976 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.625 ' N ' HD23 ' A' ' 127' ' ' LEU . 36.7 p90 -116.05 138.4 51.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.010000000000005 110.842 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -77.17 169.76 17.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.91 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -136.7 154.66 50.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 72.129999999999995 110.855 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -142.03 165.31 27.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.852 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 19.1 m -71.73 91.03 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 63.439999999999998 111.176 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.409 ' OD2' HG11 ' A' ' 93' ' ' VAL . 10.5 t70 -157.05 151.35 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 110.814 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.41 135.91 29.63 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.767 -0.73 . . . . 74.129999999999995 112.42 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.585 ' C ' HD23 ' A' ' 136' ' ' LEU . . . -124.98 -45.52 1.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.821 0.343 . . . . 71.239999999999995 111.145 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.585 HD23 ' C ' ' A' ' 135' ' ' ALA . 0.8 OUTLIER 41.44 37.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.951 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 19.3 p -117.31 143.19 46.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 110.85 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.9 t -145.85 172.1 13.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 73.540000000000006 110.859 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.3 t80 54.97 48.62 19.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.844 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -102.25 153.03 20.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 71.420000000000002 110.867 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.7 mm -82.8 145.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 111.128 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -119.22 174.84 6.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 72.129999999999995 110.864 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -93.99 171.25 8.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 110.839 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -112.45 178.7 4.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 75.450000000000003 110.835 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -97.05 149.78 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 110.935 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -125.83 95.15 40.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.566 0.698 . . . . 74.25 111.166 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 139.73 41.01 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.642 2.228 . . . . 74.329999999999998 112.343 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -169.69 -179.85 3.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 54.140000000000001 111.111 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' HB3' HG13 ' A' ' 121' ' ' VAL . 20.0 p90 -147.93 153.59 39.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.879 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -127.22 148.74 50.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 75.129999999999995 110.984 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' VAL . 7.4 p -133.8 135.47 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 75.109999999999999 111.13 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -164.0 -166.68 23.29 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.805 -0.712 . . . . 71.420000000000002 112.519 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.61 HD12 ' CE1' ' A' ' 155' ' ' TYR . 0.4 OUTLIER -145.2 148.73 33.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.749 0.309 . . . . 62.100000000000001 110.97 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -116.19 131.86 56.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 71.420000000000002 110.898 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.704 ' CE2' HD13 ' A' ' 115' ' ' LEU . 7.5 m-85 -126.79 150.71 49.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.431 . . . . 74.140000000000001 110.978 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -104.46 95.12 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.877 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.2 tp -89.36 -74.03 0.49 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.466 . . . . 72.400000000000006 110.942 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -77.34 -160.41 12.33 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.751 -0.738 . . . . 50.210000000000001 112.512 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -110.81 -36.4 5.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.832 0.349 . . . . 54.530000000000001 110.898 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 23.1 m -60.43 -65.58 0.66 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 54.149999999999999 110.873 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -128.95 171.87 11.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.138 -0.483 . . . . 74.140000000000001 110.954 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 38.6 mtm -110.87 155.32 22.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 72.25 110.9 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 155' ' ' TYR . 2.3 pp -88.19 141.46 28.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.425 . . . . 63.420000000000002 110.922 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -139.02 131.93 29.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.329999999999998 110.943 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.29 121.99 22.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 71.510000000000005 110.92 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -139.01 159.26 42.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 73.129999999999995 110.862 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 196' ' ' LEU . 19.3 m -140.8 163.25 22.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.189 -0.46 . . . . 74.230000000000004 111.087 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -150.57 160.79 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 71.299999999999997 110.922 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -124.41 98.28 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 70.030000000000001 110.939 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.428 HG23 ' HD2' ' A' ' 171' ' ' PRO . 64.3 mt -70.9 133.07 86.36 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.635 0.731 . . . . 71.200000000000003 111.148 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.428 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.9 Cg_endo -69.76 95.8 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.615 2.21 . . . . 74.5 112.344 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -62.49 171.17 2.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -153.14 113.46 4.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 75.409999999999997 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 5.6 p -152.1 170.63 19.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 72.219999999999999 111.109 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -80.33 -179.87 7.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 72.530000000000001 110.86 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.0 m -58.27 160.95 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.195 -0.457 . . . . 54.450000000000003 111.183 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 65.0 p -117.72 -55.06 2.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 74.200000000000003 111.126 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 94.26 -168.14 28.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.741 . . . . 74.530000000000001 112.509 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.5 ' C ' HD12 ' A' ' 180' ' ' LEU . 8.9 t -119.66 165.46 14.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 64.299999999999997 111.093 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.5 HD12 ' C ' ' A' ' 179' ' ' THR . 4.4 mp -149.19 138.95 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 65.230000000000004 110.869 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 104.92 166.06 24.14 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.759 -0.734 . . . . 61.200000000000003 112.512 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -47.64 0.89 Allowed 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.695 2.263 . . . . 70.129999999999995 112.354 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 6.4 m -146.6 73.42 12.7 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.608 0.718 . . . . 52.509999999999998 111.1 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 130.46 19.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.658 2.239 . . . . 62.329999999999998 112.408 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 19.6 m -124.85 -36.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 111.1 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 42.5 p -132.35 48.89 2.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 63.340000000000003 110.813 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.7 p -127.41 83.06 2.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 70.25 111.133 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.71 151.34 36.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 72.310000000000002 110.931 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.42 -33.74 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 73.530000000000001 111.145 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -53.17 156.23 2.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 74.040000000000006 110.863 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.814 HG12 ' HD3' ' A' ' 193' ' ' PRO . 21.7 t -124.05 102.78 11.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 61.539999999999999 111.152 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -113.85 73.51 2.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.551 0.691 . . . . 74.319999999999993 110.815 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.814 ' HD3' HG12 ' A' ' 191' ' ' VAL . 54.3 Cg_endo -69.76 142.28 47.52 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.687 2.258 . . . . 71.310000000000002 112.334 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -117.3 152.75 34.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.211 -0.449 . . . . 75.310000000000002 110.862 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 43.4 mm -103.82 128.76 56.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.131 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 167' ' ' VAL . 10.2 tt -123.91 113.33 18.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 110.923 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.4 m -106.85 131.8 53.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 52.409999999999997 110.869 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 199' ' ' GLY . 4.7 tt -138.85 136.87 36.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 63.439999999999998 110.894 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.44 ' N ' HD23 ' A' ' 198' ' ' LEU . . . -179.13 -136.54 2.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.694 -0.765 . . . . 61.439999999999998 112.446 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -145.57 178.77 7.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.838 0.351 . . . . 34.32 111.118 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 15.3 p -164.21 170.75 15.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 55.439999999999998 110.895 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -149.63 127.79 12.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 73.540000000000006 110.967 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.726 HG23 HG22 ' A' ' 18' ' ' VAL . 7.1 p -86.41 138.27 19.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.082 -0.508 . . . . 75.400000000000006 111.116 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -139.45 143.77 37.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 110.914 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.03 77.64 1.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 110.936 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 6.8 tp -77.28 -36.72 54.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.340000000000003 110.921 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.35 107.03 1.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 60.439999999999998 111.035 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -119.84 177.32 5.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 43.340000000000003 111.091 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -85.93 157.4 20.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 63.100000000000001 111.113 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -62.49 135.46 57.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 73.25 110.882 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 74.120000000000005 110.862 179.961 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 mmm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.78 0.324 . . . . 73.129999999999995 110.958 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -109.09 89.22 2.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 110.823 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -114.25 178.06 4.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 72.120000000000005 110.915 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -80.08 78.28 6.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 73.019999999999996 110.841 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.65 160.48 68.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.615 0.721 . . . . 65.510000000000005 110.966 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 97.45 0.64 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 70.109999999999999 112.314 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.41 133.59 47.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 73.109999999999999 111.111 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 28.1 mmtt -143.85 136.25 26.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 70.340000000000003 110.9 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.2 t -119.17 142.27 48.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 60.439999999999998 110.935 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.92 -56.85 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 74.109999999999999 111.029 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -153.44 -154.36 6.73 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.743 -0.741 . . . . 53.030000000000001 112.495 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -119.99 102.89 8.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.823 0.345 . . . . 64.019999999999996 110.898 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.07 155.96 17.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 62.530000000000001 110.911 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -60.99 143.1 55.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 75.120000000000005 110.88 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.49 7.5 53.92 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.8 -0.715 . . . . 43.009999999999998 112.523 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.45 149.02 49.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 71.109999999999999 110.866 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.696 ' HE1' HD12 ' A' ' 59' ' ' ILE . 19.3 t90 -121.55 124.34 44.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 74.349999999999994 110.887 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.787 ' HB ' ' HB3' ' A' ' 60' ' ' ALA . 48.1 t -119.56 128.35 75.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 72.099999999999994 111.171 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.54 105.35 17.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 61.200000000000003 111.095 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -103.14 140.76 36.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 54.039999999999999 110.889 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -145.91 126.58 14.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 71.430000000000007 110.818 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.21 167.71 28.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 60.5 110.872 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -113.21 136.33 52.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 63.119999999999997 110.846 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.2 p -93.09 154.02 18.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 71.219999999999999 110.853 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -145.18 138.85 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 72.010000000000005 110.907 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.29 132.89 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 53.25 111.062 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -125.02 105.87 9.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 64.439999999999998 110.918 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 193' ' ' PRO . 19.0 m -133.44 -179.53 3.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.349999999999994 111.173 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -166.67 34.53 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.778 -0.725 . . . . 64.299999999999997 112.499 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -63.89 -40.35 96.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.814 0.34 . . . . 75.140000000000001 110.883 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 63.29 47.97 3.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 74.310000000000002 110.889 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 ' O ' HD13 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -79.75 -43.69 22.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.483 . . . . 63.329999999999998 110.907 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.05 -169.52 34.35 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.757 -0.735 . . . . 74.530000000000001 112.452 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -99.33 90.29 4.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 74.120000000000005 110.91 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.38 -48.32 61.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 74.5 110.873 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -86.28 146.06 26.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 65.430000000000007 110.945 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.2 p -125.23 147.17 29.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 72.129999999999995 111.153 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.05 116.75 7.17 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.686 -0.769 . . . . 71.340000000000003 112.541 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 137.23 108.2 0.86 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.744 -0.741 . . . . 45.32 112.541 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 147.72 172.54 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.705 -0.76 . . . . 64.5 112.503 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -100.76 -67.73 0.84 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 63.310000000000002 111.085 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 7.6 mt -111.49 91.05 13.32 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-O 121.632 0.73 . . . . 54.32 110.864 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 42' ' ' LEU . 53.6 Cg_endo -69.84 102.6 1.06 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.678 2.252 . . . . 73.099999999999994 112.357 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -171.33 140.29 1.42 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 74.120000000000005 110.953 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -172.17 169.07 5.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 51.229999999999997 111.102 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -132.71 -48.94 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 74.420000000000002 110.878 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.99 127.72 22.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 74.019999999999996 111.131 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -151.01 104.4 3.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 73.099999999999994 110.875 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.97 122.46 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 74.450000000000003 111.101 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.38 -159.61 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.791 -0.718 . . . . 42.520000000000003 112.544 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -129.39 56.26 1.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 75.349999999999994 110.834 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -116.96 30.58 7.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.204 -0.453 . . . . 63.240000000000002 110.915 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.3 t -86.19 131.44 34.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 65.409999999999997 111.145 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.5 m -124.43 122.61 38.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 45.100000000000001 111.095 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.0 mt -74.2 126.77 31.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 72.530000000000001 110.907 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.5 t -143.0 160.19 40.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.231 -0.441 . . . . 73.409999999999997 111.139 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -135.53 157.26 47.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.873 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -143.46 145.14 32.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 74.219999999999999 110.879 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.696 HD12 ' HE1' ' A' ' 17' ' ' TRP . 45.8 mm -103.7 114.15 42.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 54.520000000000003 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.787 ' HB3' ' HB ' ' A' ' 18' ' ' VAL . . . -95.99 109.48 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.133 -0.485 . . . . 73.230000000000004 111.12 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.9 114.3 26.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 75.219999999999999 110.889 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.87 103.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.058 -0.519 . . . . 74.400000000000006 110.887 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.59 -35.01 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 64.129999999999995 111.063 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.78 149.23 50.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 60.439999999999998 110.853 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.9 t -77.59 -36.25 52.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 73.040000000000006 110.929 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -72.78 -40.84 65.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.057 -0.52 . . . . 75.219999999999999 110.913 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 106' ' ' GLN . 9.9 tp -141.88 141.46 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.109 -0.496 . . . . 74.439999999999998 111.058 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -124.49 167.18 14.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 55.140000000000001 111.058 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.2 t -100.86 145.94 10.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 111.137 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -148.7 118.46 7.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.234 -0.439 . . . . 73.409999999999997 110.902 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -110.72 110.41 21.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 73.040000000000006 110.89 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -88.66 138.66 31.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.924 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.4 p -154.16 134.37 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 60.420000000000002 111.194 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.79 -157.25 7.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.753 . . . . 70.409999999999997 112.476 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG23 ' HD2' ' A' ' 76' ' ' PRO . 7.3 p -117.06 133.27 23.14 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 74.420000000000002 111.091 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' HG23 ' A' ' 75' ' ' VAL . 53.5 Cg_endo -69.76 138.64 38.28 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.731 2.288 . . . . 73.0 112.294 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -112.81 -175.77 2.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 50.32 111.113 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 ptt-85 -67.9 139.77 56.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 65.319999999999993 110.879 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.82 106.06 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 65.030000000000001 111.131 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -82.39 120.46 25.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 73.430000000000007 110.892 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -129.64 -42.86 1.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 64.209999999999994 110.887 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -111.71 142.15 44.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 64.5 110.917 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.72 109.07 2.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.749 -0.738 . . . . 73.219999999999999 112.49 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -95.83 128.54 42.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.91 0.386 . . . . 61.119999999999997 110.935 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.2 tptt -115.2 73.97 0.86 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 61.520000000000003 110.903 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.5 t -80.44 174.07 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 72.239999999999995 110.897 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.4 mp -108.49 -36.91 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.319999999999993 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.9 p -152.0 126.15 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.101 -0.499 . . . . 62.549999999999997 110.853 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.9 p -168.62 107.64 0.48 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.107 -0.497 . . . . 63.119999999999997 110.853 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.18 -65.54 1.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 110.921 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.2 137.87 1.85 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 73.209999999999994 112.478 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -122.54 75.93 1.29 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 64.540000000000006 110.867 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.8 m -142.96 124.94 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.439999999999998 111.151 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.0 t -160.31 150.59 18.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.89 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 57.17 51.08 10.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 60.439999999999998 110.887 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.9 m -110.62 -35.88 2.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 111.153 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -149.32 155.22 40.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.129 -0.487 . . . . 60.310000000000002 110.903 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -114.17 163.25 15.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 54.109999999999999 110.859 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 173.91 -71.42 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 61.039999999999999 112.534 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.8 136.98 34.25 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.642 2.228 . . . . 60.140000000000001 112.321 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.453 ' HB1' ' HE2' ' A' ' 71' ' ' PHE . . . -175.08 160.87 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 63.130000000000003 111.071 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.643 HD11 ' HB3' ' A' ' 148' ' ' ALA . 5.8 tt -148.97 134.41 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 63.530000000000001 111.136 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' A' ' 71' ' ' PHE . 43.6 tp -109.2 125.48 52.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 110.945 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.0 p -154.39 157.35 38.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 22.129999999999999 110.889 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.4 143.61 27.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 70.140000000000001 110.941 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . 0.57 ' O ' HD12 ' A' ' 67' ' ' ILE . 3.4 tp60 -102.95 149.44 24.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.922 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -135.55 118.01 15.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 71.219999999999999 110.901 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -108.36 124.74 50.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.487 . . . . 74.299999999999997 110.865 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -53.05 -35.87 59.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 75.409999999999997 110.901 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -103.14 -41.66 6.01 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.848 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.1 p 51.72 38.51 23.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 110.867 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -128.31 -179.96 5.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.84 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.97 69.73 2.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.098 -0.501 . . . . 63.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -166.99 150.26 6.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.329999999999998 110.923 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.437 HD22 ' CE1' ' A' ' 155' ' ' TYR . 3.0 pp -60.63 132.17 53.05 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.188 -0.46 . . . . 63.420000000000002 110.929 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -173.16 139.66 0.87 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.672 0.748 . . . . 74.319999999999993 110.964 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 141.54 45.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.669 2.246 . . . . 73.129999999999995 112.328 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -133.0 166.0 23.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 74.120000000000005 110.872 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 76.7 t -127.91 141.45 46.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.093 -0.503 . . . . 72.25 111.147 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -124.75 144.27 15.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.767 -0.73 . . . . 52.439999999999998 112.455 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.9 t -144.38 147.31 19.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 73.140000000000001 111.096 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 168.83 -153.5 22.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.741 -0.742 . . . . 75.230000000000004 112.489 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' A' ' 147' ' ' PRO . 27.0 m -136.81 156.68 35.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.868 0.366 . . . . 71.310000000000002 111.122 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -167.45 -168.17 29.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.678 -0.772 . . . . 72.409999999999997 112.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -157.44 141.37 16.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.833 0.349 . . . . 73.420000000000002 110.899 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.65 134.1 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 72.540000000000006 111.093 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.468 ' O ' HD12 ' A' ' 127' ' ' LEU . 4.3 pp -130.99 144.68 51.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.445 . . . . 73.019999999999996 110.949 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -112.33 -36.3 5.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 61.350000000000001 110.862 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -116.85 126.79 53.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 52.25 110.904 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -142.07 160.7 39.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 52.219999999999999 110.862 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.57 151.26 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 110.909 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.1 m -130.48 119.17 22.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.235 -0.439 . . . . 52.140000000000001 111.085 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 54.12 54.72 9.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 110.897 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -110.41 108.67 2.49 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 72.519999999999996 112.54 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -99.99 -55.61 2.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 74.239999999999995 111.065 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.15 -50.58 63.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 73.209999999999994 110.954 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.9 t -56.05 163.29 1.59 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 65.430000000000007 110.807 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 57.9 p -103.98 168.24 9.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 64.5 110.817 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -79.1 150.69 31.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.059 -0.518 . . . . 75.519999999999996 110.939 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -92.87 152.66 19.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.83 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -79.84 117.86 26.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 64.019999999999996 111.094 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -146.09 141.46 27.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 71.5 110.917 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -64.63 172.08 2.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 75.049999999999997 110.862 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.83 146.24 4.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 54.009999999999998 110.885 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.49 ' CE2' HG21 ' A' ' 123' ' ' VAL . 0.9 OUTLIER 52.35 62.34 2.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.430000000000007 110.98 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -103.38 160.32 26.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.591 0.71 . . . . 61.43 111.125 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.793 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.7 Cg_endo -69.76 142.52 48.16 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.668 2.245 . . . . 74.510000000000005 112.35 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.643 ' HB3' HD11 ' A' ' 102' ' ' ILE . . . -160.46 149.2 16.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.215 -0.448 . . . . 53.43 111.109 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -148.51 145.48 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 71.400000000000006 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -146.89 163.67 35.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.124 -0.489 . . . . 53.140000000000001 110.913 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.416 ' O ' HG12 ' A' ' 167' ' ' VAL . 70.4 t -120.92 136.31 58.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 71.109999999999999 111.163 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -134.28 -166.92 11.37 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 62.340000000000003 112.425 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.0 pp -164.81 140.6 5.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 74.140000000000001 110.879 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -104.31 150.31 24.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 64.230000000000004 110.901 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.437 ' CE1' HD22 ' A' ' 115' ' ' LEU . 75.1 t80 -152.23 115.23 4.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.944 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -100.96 117.23 34.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 62.32 110.833 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 17.4 tp -94.96 38.55 1.12 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 72.530000000000001 110.882 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 52.68 34.86 44.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 60.140000000000001 112.479 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -121.06 173.29 7.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.853 0.359 . . . . 50.420000000000002 110.883 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.5 m -57.57 -44.04 84.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 53.219999999999999 110.883 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 6.4 p90 -100.52 155.45 17.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.095 -0.502 . . . . 74.120000000000005 110.92 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -110.67 141.33 44.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.94 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -87.89 122.7 31.83 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 60.329999999999998 110.877 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.44 143.35 50.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.204 -0.453 . . . . 52.399999999999999 110.863 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -134.03 134.72 42.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 64.129999999999995 110.874 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -127.05 147.78 50.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 64.329999999999998 110.87 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.688 ' HB ' HD12 ' A' ' 196' ' ' LEU . 10.8 p -145.91 144.4 20.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 71.5 111.101 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -145.3 132.3 20.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 64.109999999999999 110.836 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -107.47 122.74 47.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 64.540000000000006 110.934 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.435 HG23 ' HD2' ' A' ' 171' ' ' PRO . 56.9 mt -92.28 133.04 30.67 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.58 0.705 . . . . 70.349999999999994 111.159 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.4 Cg_endo -69.75 -46.08 1.36 Allowed 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.766 2.311 . . . . 72.310000000000002 112.354 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 26.4 t80 52.37 38.92 26.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.843 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm 58.21 39.51 25.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 62.200000000000003 110.886 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.613 HG22 HG22 ' A' ' 176' ' ' VAL . 23.7 m -116.06 111.86 20.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 73.120000000000005 111.157 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -115.23 78.07 1.13 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 75.510000000000005 110.905 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.613 HG22 HG22 ' A' ' 174' ' ' THR . 19.1 m -143.79 179.43 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 53.229999999999997 111.135 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 2.6 t -51.92 135.32 30.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 65.239999999999995 111.136 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.92 51.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.749 -0.739 . . . . 55.350000000000001 112.536 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 15.1 t -133.33 172.27 12.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.831 0.348 . . . . 74.140000000000001 111.148 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 3.6 tt -67.05 108.68 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 71.239999999999995 110.857 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 145.33 -75.17 0.3 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.781 -0.723 . . . . 74.310000000000002 112.53 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 183' ' ' VAL . 54.3 Cg_endo -69.75 -171.36 0.47 Allowed 'Trans proline' 0 N--CA 1.465 -0.148 0 C-N-CA 122.73 2.287 . . . . 64.450000000000003 112.333 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 182' ' ' PRO . 5.9 m 35.59 67.6 1.46 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.671 0.748 . . . . 50.509999999999998 111.162 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -171.96 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.719 2.28 . . . . 73.420000000000002 112.346 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.36 93.2 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.26 -0.427 . . . . 73.319999999999993 111.088 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.7 m -148.84 -171.8 3.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 75.319999999999993 110.933 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.6 m -129.48 106.39 8.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 65.140000000000001 111.129 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 -176.23 5.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.428 . . . . 71.340000000000003 110.905 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 13.2 tt -79.05 136.7 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 111.124 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -166.37 171.81 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 61.409999999999997 110.903 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 6.3 m -152.49 124.43 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 111.108 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -171.33 69.17 0.48 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.691 0.758 . . . . 52.140000000000001 110.908 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.605 ' HB3' HG12 ' A' ' 28' ' ' VAL . 54.6 Cg_endo -69.78 142.84 48.91 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.718 2.279 . . . . 71.239999999999995 112.339 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.79 173.58 16.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.140000000000001 110.931 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 66.0 mt -114.97 135.75 53.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 72.219999999999999 111.104 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.688 HD12 ' HB ' ' A' ' 167' ' ' VAL . 3.7 tp -133.18 124.22 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 72.129999999999995 110.913 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.507 ' C ' HD12 ' A' ' 198' ' ' LEU . 3.3 t -119.23 149.24 42.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.891 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.507 HD12 ' C ' ' A' ' 197' ' ' SER . 4.0 mp -148.0 144.74 28.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 73.310000000000002 110.947 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 179.9 -147.26 7.38 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 73.439999999999998 112.471 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -134.76 -178.37 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.76 0.314 . . . . 70.120000000000005 111.079 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 3.3 m -160.82 168.24 25.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.456 . . . . 52.530000000000001 110.811 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -144.37 129.28 18.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 74.019999999999996 110.862 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.442 ' HA ' HG22 ' A' ' 18' ' ' VAL . 19.0 m -88.62 139.94 16.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 75.049999999999997 111.126 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -139.67 142.22 36.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 74.129999999999995 110.884 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.08 67.5 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 110.899 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.7 tt -73.41 -55.89 5.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.530000000000001 110.965 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.71 144.58 52.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 62.509999999999998 111.112 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -162.11 161.8 28.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 65.519999999999996 111.143 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -55.23 133.47 49.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 72.329999999999998 111.086 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -151.0 169.18 22.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 71.239999999999995 110.906 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 65.400000000000006 110.884 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.2 mtt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.805 0.336 . . . . 60.240000000000002 110.86 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -142.81 120.28 11.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 65.420000000000002 110.855 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -91.03 138.6 31.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 71.340000000000003 110.887 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -130.27 -176.38 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 53.219999999999999 110.904 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -123.43 157.63 61.2 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.673 0.749 . . . . 74.510000000000005 110.936 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 82.64 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.251 . . . . 73.409999999999997 112.324 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.26 161.56 28.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 63.240000000000002 111.162 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -103.17 108.83 20.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.289 -0.414 . . . . 75.329999999999998 110.892 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 76.7 p -110.73 67.94 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 65.510000000000005 110.839 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.76 126.94 47.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 54.329999999999998 111.079 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.24 178.97 43.35 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 63.210000000000001 112.477 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.5 92.08 3.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.873 0.368 . . . . 73.030000000000001 110.944 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -108.22 174.32 5.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.094 -0.503 . . . . 75.200000000000003 110.834 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -51.84 142.61 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 70.209999999999994 110.853 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.1 8.21 42.13 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 74.219999999999999 112.494 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.72 147.58 43.46 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.821 0.343 . . . . 74.150000000000006 110.848 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.545 ' HE1' HG23 ' A' ' 59' ' ' ILE . 13.1 t90 -129.31 112.03 13.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 73.239999999999995 110.893 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.975 HG13 ' HB3' ' A' ' 60' ' ' ALA . 3.4 p -118.27 131.22 71.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 55.009999999999998 111.178 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 202' ' ' TYR . . . -93.81 119.73 33.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.143 -0.481 . . . . 73.219999999999999 111.136 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.2 t -111.97 114.89 28.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 72.5 110.899 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 200' ' ' ALA . 30.0 p90 -119.76 128.88 54.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 63.439999999999998 110.855 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.07 166.56 32.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 74.030000000000001 110.818 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -115.3 142.86 46.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.923 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 t -90.65 149.89 21.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 61.049999999999997 110.846 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -141.42 122.86 14.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.927 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.6 p -81.57 136.03 23.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.301 -0.409 . . . . 70.319999999999993 111.173 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -129.26 104.13 7.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.148 -0.478 . . . . 60.219999999999999 110.885 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.668 HG12 ' CB ' ' A' ' 193' ' ' PRO . 19.1 m -136.23 -179.34 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.057 -0.519 . . . . 63.439999999999998 111.136 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.04 33.3 0.34 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.792 -0.718 . . . . 63.520000000000003 112.455 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -93.43 -37.63 11.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.735 0.302 . . . . 64.519999999999996 110.877 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.467 ' C ' ' HG ' ' A' ' 32' ' ' LEU . 16.5 pt-20 -75.0 -40.15 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 74.010000000000005 110.88 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 31' ' ' GLU . 1.5 pp 33.55 47.69 0.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.169 -0.469 . . . . 73.329999999999998 110.911 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.99 -163.22 22.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 54.340000000000003 112.514 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.3 t0 59.29 53.44 5.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.786 0.327 . . . . 61.43 110.828 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.42 -52.23 4.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 71.340000000000003 110.935 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -131.36 86.62 2.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 110.859 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.0 t -128.67 106.9 15.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 65.510000000000005 111.092 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.98 -64.61 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.671 -0.776 . . . . 64.5 112.432 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.72 -49.31 79.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.762 -0.733 . . . . 73.25 112.47 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.28 128.27 8.64 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.67 -0.776 . . . . 52.039999999999999 112.53 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.76 36.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.78 0.324 . . . . 62.130000000000003 111.085 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.446 HD23 ' HD2' ' A' ' 43' ' ' PRO . 1.1 mt -83.91 159.61 59.89 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.615 0.721 . . . . 73.409999999999997 110.88 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.446 ' HD2' HD23 ' A' ' 42' ' ' LEU . 54.6 Cg_endo -69.75 121.53 8.22 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.705 2.27 . . . . 70.340000000000003 112.393 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -132.32 152.89 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 73.129999999999995 110.853 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.03 139.98 39.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 63.009999999999998 111.108 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -152.68 149.24 28.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 62.149999999999999 110.874 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.3 m -127.93 166.35 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.266 -0.424 . . . . 72.120000000000005 111.134 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.7 p -123.31 156.08 36.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 71.519999999999996 110.867 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.8 tp -140.41 135.35 35.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 111.147 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 143.91 -155.36 26.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 73.310000000000002 112.471 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -122.51 117.97 27.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.771 0.32 . . . . 73.400000000000006 110.893 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -83.51 -37.98 22.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.211 -0.45 . . . . 75.019999999999996 110.869 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 21.5 p -57.61 143.51 40.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.169 -0.468 . . . . 73.319999999999993 111.176 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.5 m -124.41 116.23 22.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.349999999999994 111.144 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mp -60.05 137.8 58.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 72.329999999999998 110.913 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.24 141.5 27.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.130000000000003 111.065 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -110.91 146.34 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 72.209999999999994 110.842 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.38 132.27 17.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 70.109999999999999 110.822 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.545 HG23 ' HE1' ' A' ' 17' ' ' TRP . 48.9 mm -103.68 126.55 58.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 51.420000000000002 111.157 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.975 ' HB3' HG13 ' A' ' 18' ' ' VAL . . . -109.67 132.15 54.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 50.420000000000002 111.098 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.89 115.64 25.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.924 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -92.78 101.74 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 75.109999999999999 110.897 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.3 t -137.21 47.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.113 -0.494 . . . . 75.25 111.122 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -170.18 -170.58 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 72.140000000000001 110.911 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -84.74 -46.89 10.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.019999999999996 110.855 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -133.46 -41.98 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.9 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 107' ' ' TYR . 25.3 mt -72.62 108.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 71.430000000000007 111.192 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.29 169.88 8.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 74.349999999999994 111.022 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.72 146.42 14.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 64.319999999999993 111.095 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -149.26 123.33 9.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 65.329999999999998 110.888 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.593 ' CE2' HD23 ' A' ' 103' ' ' LEU . 25.1 m-85 -113.27 110.91 21.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.869 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -88.76 142.91 27.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.116 -0.493 . . . . 74.310000000000002 110.807 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 13.9 p -160.91 148.32 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 73.540000000000006 111.109 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -108.2 -157.09 19.17 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.745 -0.74 . . . . 72.200000000000003 112.459 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.1 t -109.79 85.37 3.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.649 0.738 . . . . 72.420000000000002 111.104 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 129.99 18.61 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.738 2.292 . . . . 70.230000000000004 112.341 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.19 -176.91 4.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 74.450000000000003 111.122 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.5 134.67 54.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 71.310000000000002 110.877 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -160.16 165.24 32.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.436 . . . . 64.420000000000002 111.131 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -88.32 152.08 22.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 65.129999999999995 110.911 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.0 p90 -152.08 151.01 30.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.434 . . . . 73.099999999999994 110.846 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -146.71 137.22 23.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 62.140000000000001 110.942 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -155.86 176.49 33.34 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.79 -0.719 . . . . 52.210000000000001 112.549 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -76.8 160.57 29.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.861 0.362 . . . . 73.409999999999997 110.935 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? -137.95 67.21 1.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.893 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 62.3 p -166.46 177.63 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.3 -0.409 . . . . 74.340000000000003 110.832 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.0 mt -82.68 97.83 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.219999999999999 111.116 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.73 -176.76 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.842 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.6 p -58.88 128.39 37.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 74.049999999999997 110.821 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -89.37 107.07 18.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 72.530000000000001 110.901 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.3 116.72 0.52 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 54.32 112.502 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -128.31 -171.49 2.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.814 0.34 . . . . 72.25 110.895 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.5 p -154.67 134.0 3.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.249 -0.432 . . . . 62.329999999999998 111.141 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.8 p -101.11 165.54 11.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.862 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -101.34 -171.94 2.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 71.140000000000001 110.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 60.8 t -106.03 104.08 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 52.140000000000001 111.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -176.44 173.39 2.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 110.896 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -63.2 149.44 45.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 73.349999999999994 110.885 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.98 -69.74 0.53 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.68 -0.772 . . . . 70.299999999999997 112.48 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.62 -170.36 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.732 2.288 . . . . 64.439999999999998 112.369 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.06 143.96 33.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 70.040000000000006 111.044 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.31 136.4 56.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 61.439999999999998 111.153 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 71' ' ' PHE . 2.5 mp -114.18 128.01 56.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.93 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 11.0 p -152.87 167.91 27.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 71.120000000000005 110.857 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.735 HD13 ' CE1' ' A' ' 107' ' ' TYR . 1.1 pp -104.35 150.29 24.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.481 . . . . 63.520000000000003 110.946 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.31 139.16 38.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 73.549999999999997 110.957 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.735 ' CE1' HD13 ' A' ' 105' ' ' LEU . 5.1 m-85 -123.5 97.37 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 73.019999999999996 110.888 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.65 167.24 19.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.1 -0.5 . . . . 63.299999999999997 110.846 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -77.4 61.08 2.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.92 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -51.38 -35.22 37.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.135 -0.484 . . . . 72.010000000000005 110.863 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.5 p -51.02 -35.43 34.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.200000000000003 110.753 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -82.56 -38.73 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 71.340000000000003 110.92 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 57.9 59.72 3.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 63.43 110.848 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -159.75 -176.01 5.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 71.019999999999996 110.907 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.674 HD23 ' CD2' ' A' ' 155' ' ' TYR . 6.4 mp -59.1 109.95 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.471 . . . . 55.299999999999997 110.91 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -161.23 160.38 24.13 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.72 0.771 . . . . 75.150000000000006 110.929 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 170.07 17.48 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.691 2.261 . . . . 71.519999999999996 112.364 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -159.49 148.08 17.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.296 -0.411 . . . . 72.109999999999999 110.938 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 151' ' ' VAL . 26.9 m -121.57 131.84 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 74.040000000000006 111.158 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -110.94 136.54 13.68 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.741 -0.742 . . . . 75.25 112.512 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.527 HG22 ' CD2' ' A' ' 149' ' ' PHE . 16.2 t -139.49 141.22 35.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.883 0.373 . . . . 74.129999999999995 111.088 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 170.86 -152.64 19.04 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 63.329999999999998 112.427 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 147' ' ' PRO . 19.6 m -139.02 151.9 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.85 0.357 . . . . 74.219999999999999 111.129 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.25 176.44 21.34 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.683 -0.77 . . . . 74.040000000000006 112.463 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.26 -177.02 2.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.819 0.342 . . . . 63.43 110.852 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.65 126.83 71.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 72.450000000000003 111.059 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 127' ' ' LEU . 2.2 pt? -139.39 150.35 45.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.069 -0.514 . . . . 73.409999999999997 110.982 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.15 163.47 38.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 72.120000000000005 110.804 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.3 124.32 20.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.074 -0.512 . . . . 64.040000000000006 110.888 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -61.04 -40.68 94.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 62.530000000000001 110.863 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -164.05 142.6 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 42.43 110.923 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 73.2 p -110.36 -43.81 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 71.109999999999999 111.171 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -121.1 161.29 22.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 74.230000000000004 110.873 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.67 147.43 45.18 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.749 -0.738 . . . . 73.319999999999993 112.439 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.11 159.03 22.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.82 0.343 . . . . 64.5 111.122 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -67.64 -41.96 83.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 45.439999999999998 110.863 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 9.6 t -76.54 155.0 34.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 63.420000000000002 110.83 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 47.6 m -134.03 154.63 51.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.107 -0.497 . . . . 72.329999999999998 110.874 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -146.64 115.13 6.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 75.030000000000001 110.858 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -132.32 102.62 5.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.010000000000005 110.882 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 31.8 pt -139.88 157.52 26.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.149 -0.478 . . . . 72.530000000000001 111.13 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.482 ' O ' HD11 ' A' ' 90' ' ' LEU . 6.0 ptpt -143.04 144.88 32.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 63.219999999999999 110.892 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -118.85 172.83 7.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.150000000000006 110.854 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -102.52 159.78 15.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.937 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -84.43 151.16 24.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.21 -0.45 . . . . 73.0 110.927 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HB1' ' HD2' ' A' ' 147' ' ' PRO . . . -123.24 160.0 52.06 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 42.299999999999997 111.077 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PRO . . . . . 0.752 ' HA ' HG12 ' A' ' 123' ' ' VAL . 53.3 Cg_endo -69.84 157.61 59.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.646 2.23 . . . . 73.099999999999994 112.312 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.61 128.2 9.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 54.32 111.125 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 121' ' ' VAL . 9.7 t80 -145.02 129.22 17.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 73.530000000000001 110.844 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 163.81 36.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 74.439999999999998 110.906 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.568 HG12 HG12 ' A' ' 119' ' ' VAL . 32.4 m -119.81 -178.98 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 72.200000000000003 111.162 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 153' ' ' LEU . . . -175.25 -177.56 44.42 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.484 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 152' ' ' GLY . 8.5 mt -133.84 139.07 46.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 61.340000000000003 110.931 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.0 mtp85 -111.97 108.81 18.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 51.5 110.878 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.674 ' CD2' HD23 ' A' ' 115' ' ' LEU . 11.7 m-85 -127.33 178.68 5.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.127 -0.488 . . . . 74.530000000000001 110.904 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -106.67 152.01 24.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.13 -0.487 . . . . 72.150000000000006 110.86 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.595 HD23 HD12 ' A' ' 163' ' ' LEU . 0.3 OUTLIER -125.94 -37.37 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 64.010000000000005 110.901 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.86 4.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.671 -0.776 . . . . 63.210000000000001 112.433 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -100.62 -38.04 8.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.86 0.362 . . . . 72.349999999999994 110.878 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 1.2 m -100.59 -56.33 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.815 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . . . . . . . . . 42.3 p90 -77.39 -179.88 6.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.168 -0.469 . . . . 73.340000000000003 110.866 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.91 176.27 10.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.438 . . . . 73.299999999999997 110.845 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.595 HD12 HD23 ' A' ' 157' ' ' LEU . 9.3 tt -111.12 144.64 39.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 73.099999999999994 110.888 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.06 141.96 36.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.851 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 81.0 p -135.14 160.99 36.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 52.420000000000002 110.815 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -138.09 158.47 44.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 72.540000000000006 110.839 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 99.0 t -150.29 137.45 13.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 54.130000000000003 111.101 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 -136.15 118.77 15.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 73.439999999999998 110.922 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -120.84 116.47 25.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 73.439999999999998 110.938 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.427 HG23 ' HD2' ' A' ' 171' ' ' PRO . 5.2 mp -103.8 133.09 20.45 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.621 0.724 . . . . 60.219999999999999 111.143 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 170' ' ' ILE . 53.8 Cg_endo -69.77 138.93 38.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.655 2.236 . . . . 64.310000000000002 112.349 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -137.6 175.16 9.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 110.918 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 10.9 ttmm -61.08 109.37 1.07 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 72.209999999999994 110.901 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 m -87.53 129.65 35.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 73.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -101.64 121.16 41.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.150000000000006 110.913 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 25.1 t -103.54 112.6 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 72.530000000000001 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 37.6 p -78.19 137.46 38.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 71.319999999999993 111.124 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.63 -173.68 48.13 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 70.439999999999998 112.469 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 27.1 m -72.48 99.37 2.47 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.872 0.368 . . . . 62.119999999999997 111.163 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 2.8 pp -98.85 135.37 40.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 63.100000000000001 110.989 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -91.58 -73.3 1.25 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 74.450000000000003 112.412 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 143.7 51.75 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.666 2.244 . . . . 65.040000000000006 112.348 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 183' ' ' VAL . 4.0 p -138.75 78.01 31.76 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.585 0.707 . . . . 74.140000000000001 111.11 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.84 -44.97 1.72 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.663 2.242 . . . . 72.510000000000005 112.362 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.49 145.98 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.435 . . . . 75.340000000000003 111.188 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 32.3 t -63.23 133.69 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 54.009999999999998 110.84 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 4.5 t -99.65 149.37 23.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 64.239999999999995 111.125 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -67.97 177.64 2.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.463 . . . . 70.450000000000003 110.909 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 12.3 pt -144.16 168.51 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 74.140000000000001 111.114 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -68.66 151.49 46.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.129 -0.487 . . . . 70.109999999999999 110.918 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.642 HG23 ' HD3' ' A' ' 193' ' ' PRO . 27.2 m -122.14 -35.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 72.120000000000005 111.131 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.41 73.36 0.5 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.636 0.732 . . . . 72.439999999999998 110.862 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . 0.668 ' CB ' HG12 ' A' ' 28' ' ' VAL . 54.3 Cg_endo -69.68 141.39 45.43 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.651 2.234 . . . . 72.120000000000005 112.387 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.43 172.4 16.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.27 -0.423 . . . . 74.450000000000003 110.86 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 4.8 mp -114.05 140.73 33.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.149 -0.478 . . . . 72.450000000000003 111.163 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 196' ' ' LEU . 3.6 pp -139.96 131.48 27.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 72.310000000000002 110.94 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -115.68 152.44 33.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 110.861 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 25.4 tp -147.72 141.87 26.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 65.310000000000002 110.905 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -177.27 -153.63 11.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.784 -0.722 . . . . 24.120000000000001 112.505 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . . . -130.33 -179.73 5.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.753 0.311 . . . . 62.509999999999998 111.128 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 41.0 t -164.2 158.31 18.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 61.329999999999998 110.919 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 19' ' ' ALA . 12.6 p90 -142.86 126.08 16.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 110.915 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 14.9 p -85.86 141.48 14.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.120000000000005 111.129 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -140.14 150.26 44.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 61.530000000000001 110.823 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -120.62 101.16 7.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 72.549999999999997 110.88 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 7.8 mt -61.1 -49.35 77.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.5 110.943 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . 62.78 45.17 5.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 55.039999999999999 111.107 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -141.79 155.38 45.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.272 -0.422 . . . . 71.409999999999997 111.101 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -134.52 108.87 8.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 64.420000000000002 111.062 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 210' ' ' LEU . 1.7 pt? -52.38 164.62 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 110.957 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 73.540000000000006 110.891 179.898 . . . . . . . . 0 0 . 1 stop_ save_